PT J
AU Halberg, SE
   Visek, AJ
   Blake, EF
   Essel, KD
   Sacheck, J
   Sylvetsky, AC
AF Halberg, Sabrina E.
   Visek, Amanda J.
   Blake, Emily F.
   Essel, Kofi D.
   Sacheck, Jennifer
   Sylvetsky, Allison C.
TI SODA MAPS: A Framework for Understanding Caffeinated Sugary Drink Consumption Among Children
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE youth; sugar-sweetened beverages; diet; caffeine; obesity; concept mapping
ID sweetened beverage consumption; home food environment; childhood obesity; body-weight; adolescents; access; disparity; trends; parent; school
AB Excess sugary drink (SD) consumption is associated with childhood obesity and development of cardiometabolic disease. In addition to having high added sugar content, many SDs also contain caffeine, which may further encourage excess SD consumption among children. The objective of this study was to develop a conceptual framework of children's caffeinated SD consumption using group concept mapping, an applied social research multimethodology that collectively harnesses qualitative and quantitative data from participants to generate a visual representation of their ideas and input. Children, 8-14 years old, who reported consuming >= 12 ounces of caffeinated SDs (e.g., sodas, sweet teas) per day were recruited throughout Washington, D.C. and invited to participate. Concept mapping included three participant-driven activities: (1) brainstorming (n = 51), during which children reported reasons for their SD consumption, from which 58 unique reasons were identified; (2) sorting (n = 70), during which children sorted each of the reported reasons into categories and named each category; and (3) rating (n = 74), during which children rated the influence of each reason on their own caffeinated SD consumption. Similarity matrices, multidimensional scaling, and hierarchical cluster analysis were used to generate concept maps (hereafter "SODA MAPS"), which display the 58 reasons organized within eight overarching clusters. Among these eight clusters, Taste and Feel, Something to Do, and Energy were rated as particularly influential. Children's caffeinated SD consumption is encouraged not only by the palatable taste and reported preferences for these beverages (e.g., Taste and Feel), but also by psychological (e.g., Mood and Focus), biological (e.g., Energy), social (e.g., Something to Do) and environmental reasons (e.g., Nothing Better Available). Thus, the SODA MAPS can inform the development of tailored, multi-level SD reduction interventions that incorporate strategies to address important and currently overlooked reasons for caffeinated SD consumption among children.
C1 [Halberg, Sabrina E.; Visek, Amanda J.; Blake, Emily F.; Sacheck, Jennifer; Sylvetsky, Allison C.] George Washington Univ, Dept Exercise & Nutr Sci, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA.
   [Blake, Emily F.] Univ Maryland, Dept Kinesiol, Sch Publ Hlth, College Pk, MD 20742 USA.
   [Essel, Kofi D.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA.
   [Essel, Kofi D.] Childrens Natl Hosp, Div Gen & Community Pediat, Washington, DC USA.
C3 George Washington University; University System of Maryland; University of Maryland College Park; George Washington University; Children's National Health System
RP Sylvetsky, AC (corresponding author), George Washington Univ, Dept Exercise & Nutr Sci, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA.
EM asylvets@gwu.edu
FU National Institutes of Health's (NIH) National Center for Advancing Translational Sciences (NCATS) [UL1TR001876, KL2TR00187]
CR Ahluwalia N, 2015, ADV NUTR, V6, P102, DOI 10.3945/an.114.007401
   Algert SJ, 2006, AM J PREV MED, V30, P365, DOI 10.1016/j.amepre.2006.01.009
   Bleich SN, 2015, OBESITY, V23, P1039, DOI 10.1002/oby.21050
   Block JP, 2004, AM J PREV MED, V27, P211, DOI 10.1016/j.amepre.2004.06.007
   Bobowski N, 2017, CHILD OBES, V13, P369, DOI 10.1089/chi.2017.0023
   Bogart LM, 2013, ACAD PEDIATR, V13, P348, DOI 10.1016/j.acap.2013.02.009
   Bradbury KM, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0223912
   Brown CL, 2015, PEDIATR CLIN N AM, V62, P1241, DOI 10.1016/j.pcl.2015.05.013
   Brownell KD, 2009, J ADOLESCENT HEALTH, V45, PS8, DOI 10.1016/j.jadohealth.2009.03.004
   Bruening M, 2014, J NUTR EDUC BEHAV, V46, P277, DOI 10.1016/j.jneb.2014.02.009
   Burke MV, 2015, PHYSIOL BEHAV, V152, P381, DOI 10.1016/j.physbeh.2015.05.036
   Chi Donald L, 2019, DENT CLIN NORTH AM, V63, P17, DOI 10.1016/j.cden.2018.08.003
   Chung SJ, 2017, J PEDIATR NURS, V36, P44, DOI 10.1016/j.pedn.2017.04.010
   Couch SC, 2014, J ACAD NUTR DIET, V114, P1569, DOI 10.1016/j.jand.2014.05.015
   Cruz ML, 2005, ANNU REV NUTR, V25, P435, DOI 10.1146/annurev.nutr.25.050304.092625
   Davis JN, 2010, AM J CLIN NUTR, V92, P1522, DOI 10.3945/ajcn.2010.30185
   DESOR JA, 1975, SCIENCE, V190, P686, DOI 10.1126/science.1188365
   DESOR JA, 1987, PHYSIOL BEHAV, V39, P639, DOI 10.1016/0031-9384(87)90166-1
   Dohnke B, 2011, ADDICT BEHAV, V36, P286, DOI 10.1016/j.addbeh.2010.11.001
   Drewnowski A, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8030154
   Eck KM, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10091232
   Falbe J, 2019, APPETITE, V133, P130, DOI 10.1016/j.appet.2018.10.032
   Fulkerson JA, 2018, J ACAD NUTR DIET, V118, P240, DOI 10.1016/j.jand.2017.04.006
   Gearhardt AN, 2012, INT J EAT DISORDER, V45, P657, DOI 10.1002/eat.20957
   Guerrero AD, 2016, J RACIAL ETHN HEALTH, V3, P129, DOI 10.1007/s40615-015-0122-y
   Hebebrand J, 2009, CHILD ADOL PSYCH CL, V18, P49, DOI 10.1016/j.chc.2008.08.002
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Juliano LM, 2004, PSYCHOPHARMACOLOGY, V176, P1, DOI 10.1007/s00213-004-2000-x
   Kane M, 2007, CONCEPT MAPPING FOR PLANNING AND EVALUATION, V0, P0, DOI DOI 10.4135/9781412983730
   Kiess W, 2001, OBES REV, V2, P29, DOI 10.1046/j.1467-789x.2001.00017.x
   Klassen KM, 2018, J MED INTERNET RES, V20, P0, DOI 10.2196/10227
   Kwate NOA, 2010, PREV MED, V51, P153, DOI 10.1016/j.ypmed.2010.04.020
   Lopez NV, 2012, J ACAD NUTR DIET, V112, P541, DOI 10.1016/j.jand.2011.11.013
   Ludden AB, 2010, HEALTH EDUC BEHAV, V37, P330, DOI 10.1177/1090198109341783
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Maller O, 1973, SYMP ORAL SENS PERCEPT, V0, P279
   Martin KB, 2021, J SLEEP RES, V30, P0, DOI 10.1111/jsr.13130
   Mendez MA, 2019, AM J CLIN NUTR, V109, P79, DOI 10.1093/ajcn/nqy123
   Meredith Steven E, 2013, J CAFFEINE RES, V3, P114, DOI 10.1089/jcr.2013.0016
   Mitchell DC, 2014, FOOD CHEM TOXICOL, V63, P136, DOI 10.1016/j.fct.2013.10.042
   Owens JA, 2014, NUTR REV, V72, P65, DOI 10.1111/nure.12150
   Patel AI, 2011, AM J PUBLIC HEALTH, V101, P1370, DOI 10.2105/AJPH.2011.300142
   Puder JJ, 2010, INT J OBESITY, V34, PS37, DOI 10.1038/ijo.2010.238
   Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557
   Pulgar√≥n ER, 2013, CLIN THER, V35, PA18, DOI 10.1016/j.clinthera.2012.12.014
   Rosas SR, 2012, EVAL PROGRAM PLANN, V35, P236, DOI 10.1016/j.evalprogplan.2011.10.003
   Rosinger Asher, 2017, NCHS DATA BRIEF, V0, P1
   Scaglioni S, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10060706
   Scharf RJ, 2016, ANNU REV PUBL HEALTH, V37, P273, DOI 10.1146/annurev-publhealth-032315-021528
   Schulte EM, 2016, PROG BRAIN RES, V223, P329, DOI 10.1016/bs.pbr.2015.07.011
   Schulte EM, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0117959
   Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578
   Stead M, 2011, SOC SCI MED, V72, P1131, DOI 10.1016/j.socscimed.2010.12.029
   Striley Catherine L W, 2011, J CAFFEINE RES, V1, P219, DOI 10.1089/jcr.2011.0029
   Sturrock K, 2000, FIELD METHODS, V12, P49, DOI 10.1177/1525822X0001200104
   Sylvetsky AC, 2020, FRONT PEDIATR, V8, P0, DOI 10.3389/fped.2020.594513
   Sylvetsky AC, 2020, APPETITE, V155, P0, DOI 10.1016/j.appet.2020.104826
   Sylvetsky AC, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12040885
   Tipton JA, 2014, J PEDIATR NURS, V29, P47, DOI 10.1016/j.pedn.2013.06.006
   Trochim W, 2005, INT J QUAL HEALTH C, V17, P187, DOI 10.1093/intqhc/mzi038
   Trochim WM, 2017, EVAL PROGRAM PLANN, V60, P166, DOI 10.1016/j.evalprogplan.2016.10.006
   USDepartment of Health and Human Services and USDepartment of Agriculture, 2015, 2015 2020 DIET GUID, V8, P0
   Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487
   Visek AJ, 2019, CURR DEV NUTR, V3, P0, DOI 10.1093/cdn/nzy103
   Visek AJ, 2015, J PHYS ACT HEALTH, V12, P424, DOI 10.1123/jpah.2013-0180
   Vos MB, 2017, GASTROENTEROLOGY, V153, P642, DOI 10.1053/j.gastro.2017.07.029
   Vos MB, 2017, CIRCULATION, V135, PE1017, DOI 10.1161/CIR.0000000000000439
   Watts AW, 2018, EAT BEHAV, V30, P42, DOI 10.1016/j.eatbeh.2018.04.003
   Zahid A, 2017, INT J ENV RES PUB HE, V14, P0, DOI 10.3390/ijerph14080929
   Zenk SN, 2006, ETHNIC DIS, V16, P275
   Zytnick D, 2016, AM J HEALTH PROMOT, V30, PE110, DOI 10.4278/ajhp.140103-QUAN-8
NR 72
TC 5
Z9 6
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
EI 
J9 FRONT NUTR
JI Front. Nutr.
PD MAR 10
PY 2021
VL 8
IS 
BP 
EP 
DI 10.3389/fnut.2021.640531
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA RB0YK
UT WOS:000631843300001
PM 33777993
DA 2025-04-28
ER

PT J
AU Xie, LY
   Tang, QY
   Yao, D
   Gu, QY
   Zheng, H
   Wang, XD
   Yu, ZP
   Shen, XH
AF Xie, Luyao
   Tang, Qingya
   Yao, Die
   Gu, Qiuyun
   Zheng, Hao
   Wang, Xiaodi
   Yu, Zhiping
   Shen, Xiuhua
TI Effect of Decaffeinated Green Tea Polyphenols on Body Fat and Precocious Puberty in Obese Girls: A Randomized Controlled Trial
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Article
DE obesity; precocious puberty; decaffeinated green tea polyphenol; girls; randomized controlled trial
ID xanthine-oxidase; blood-pressure; mass index; black tea; extract; caffeine; menarche; consumption; maturation; reduction
AB Background Obesity has been reported to be an important contributing factor for precocious puberty, especially in girls. The effect of green tea polyphenols on weight reduction in adult population has been shown, but few related studies have been conducted in children. This study was performed to examine the effectiveness and safety of decaffeinated green tea polyphenols (DGTP) on ameliorating obesity and early sexual development in girls with obesity. Design This is a double-blinded randomized controlled trial. Girls with obesity aged 6-10 years old were randomly assigned to receive 400 mg/day DGTP or isodose placebo orally for 12 weeks. During this period, all participants received the same instruction on diet and exercise from trained dietitians. Anthropometric measurements, secondary sexual characteristics, B-scan ultrasonography of uterus, ovaries and breast tissues, and related biochemical parameters were examined and assessed pre- and post-treatment. Results Between August 2018 and January 2020, 62 girls with obesity (DGTP group n = 31, control group n = 31) completed the intervention and were included in analysis. After the intervention, body mass index, waist circumference, and waist-to-hip ratio significantly decreased in both groups, but the percentage of body fat (PBF), serum uric acid (UA), and the volumes of ovaries decreased significantly only within the DGTP group. After controlling confounders, DGTP showed a significantly decreased effect on the change of PBF (beta = 2.932, 95% CI: 0.214 to 5.650), serum UA (beta = 52.601, 95% CI: 2.520 to 102.681), and ovarian volumes (right: beta = 1.881, 95% CI: 0.062 to 3.699, left: beta = 0.971, 95% CI: 0.019 to 1.923) in girls with obesity. No side effect was reported in both groups during the whole period. Conclusion DGTP have shown beneficial effects of ameliorated obesity and postponed early sexual development in girls with obesity without any adverse effects.
C1 [Xie, Luyao; Tang, Qingya; Zheng, Hao] Shanghai Jiao Tong Univ, Dept Clin Nutr, Sch Med, Xinhua Hosp, Shanghai, Peoples R China.
   [Xie, Luyao; Yao, Die; Gu, Qiuyun; Wang, Xiaodi] Shanghai Jiao Tong Univ, Sch Publ Hlth, Sch Med, Shanghai, Peoples R China.
   [Xie, Luyao; Yao, Die; Gu, Qiuyun; Wang, Xiaodi; Shen, Xiuhua] Shanghai Jiao Tong Univ, Dept Nutr, Sch Med, Shanghai, Peoples R China.
   [Yu, Zhiping] Univ North Florida, Dept Nutr & Dietet, Jacksonville, FL USA.
   [Shen, Xiuhua] Shanghai Jiao Tong Univ, Shanghai Key Lab Pediat Gastroenterol & Nutr, Sch Med, Shanghai, Peoples R China.
C3 Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; State University System of Florida; University of North Florida; Shanghai Jiao Tong University
RP Shen, XH (corresponding author), Shanghai Jiao Tong Univ, Dept Nutr, Sch Med, Shanghai, Peoples R China.; Shen, XH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Pediat Gastroenterol & Nutr, Sch Med, Shanghai, Peoples R China.
EM srachel@126.com
FU National Natural Science Foundation of China; National Natural Science Foundation of China [81773407]
CR Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Barash IA, 1996, ENDOCRINOLOGY, V137, P3144, DOI 10.1210/en.137.7.3144
   Biro FM, 2001, J PEDIATR-US, V138, P636, DOI 10.1067/mpd.2001.114476
   Biro FM, 2010, PEDIATRICS, V126, PE583, DOI 10.1542/peds.2009-3079
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Cesario SK, 2007, JOGNN-J OBST GYN NEO, V36, P263, DOI 10.1111/J.1552-6909.2007.00145.x
   Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318
   Chen G, 2015, J ETHNOPHARMACOL, V175, P14, DOI 10.1016/j.jep.2015.08.043
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Chinese Preventive Medicine Association Adolescent health care group of women health care society, 2018, CHIN J WOMAN CHILD H, V29, P135, DOI 10.3969/j.issn.1673-5293.2018.02.001
   Clarkson J, 2010, MOL CELL ENDOCRINOL, V324, P45, DOI 10.1016/j.mce.2010.01.026
   Denham M, 2005, PEDIATRICS, V115, PE127, DOI 10.1542/peds.2004-1161
   Gavela-P√©rez T, 2015, PEDIATR OBES, V10, P410, DOI 10.1111/ijpo.277
   Glisan SL, 2017, FOOD CHEM, V216, P296, DOI 10.1016/j.foodchem.2016.08.052
   Golub MS, 2008, PEDIATRICS, V121, PS218, DOI 10.1542/peds.2007-1813G
   Group of China Obesity Task Force, 2004, ZHONGHUA LIU XING BING XUE ZA ZHI, V25, P97
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Jaruratanasirikul S, 2014, WORLD J PEDIATR, V10, P256, DOI 10.1007/s12519-014-0472-2
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kaplowitz PB, 2001, PEDIATRICS, V108, P347, DOI 10.1542/peds.108.2.347
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Li F, 2020, ANN PALLIAT MED, V9, P331, DOI 10.21037/apm.2019.11.28
   Li WY, 2018, AM J HUM BIOL, V30, P0, DOI 10.1002/ajhb.23195
   Ma HM, 2009, PEDIATRICS, V124, PE269, DOI 10.1542/peds.2008-2638
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Pubertal Study Group of the Subspecialty Group of Endocrinologic Hereditary and Metabolic Diseases Society of Pediatrics Chinese Medical Association, 2010, ZHONG HUA NEI FEN MI, V26, P669, DOI 10.3760/CMA.J.ISSN.1000-6699.2010.08.011
   Richards G, 2015, J PSYCHOPHARMACOL, V29, P1236, DOI 10.1177/0269881115612404
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Rosenfield RL, 2009, PEDIATRICS, V123, P84, DOI 10.1542/peds.2008-0146
   Rubin C, 2009, PAEDIATR PERINAT EP, V23, P492, DOI 10.1111/j.1365-3016.2009.01055.x
   Satoh T, 2015, J ETHNOPHARMACOL, V161, P147, DOI 10.1016/j.jep.2014.12.009
   Shen CL, 2012, NUTR RES, V32, P448, DOI 10.1016/j.nutres.2012.05.001
   Tehrani FR, 2014, INT J ENDOCRINOL MET, V12, P0, DOI 10.5812/ijem.16130
   Teilmann G, 2005, PEDIATRICS, V116, P1323, DOI 10.1542/peds.2005-0012
   tsuchida t, 2002, PROG MED, V9, P2189
   Turley KR, 2007, PEDIATR EXERC SCI, V19, P481, DOI 10.1123/pes.19.4.481
   Wang SM, 2017, EUR J NUTR, V56, P2037, DOI 10.1007/s00394-016-1241-x
   Watson EJ, 2017, J CLIN SLEEP MED, V13, P533, DOI 10.5664/jcsm.6536
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Wu YM, 2016, MED HYPOTHESES, V95, P24, DOI 10.1016/j.mehy.2016.07.017
   Zhai LL, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0134656
   Zhu Mingqiang, 2013, ZHEJIANG DA XUE XUE BAO YI XUE BAN, V42, P396
NR 46
TC 13
Z9 14
U1 0
U2 16
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
EI 
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD OCT 12
PY 2021
VL 12
IS 
BP 
EP 
DI 10.3389/fendo.2021.736724
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA WP6XG
UT WOS:000713271300001
PM 34712203
DA 2025-04-28
ER

PT J
AU Xu, N
   Chu, J
   Dong, RR
   Lu, FJ
   Zhang, XF
   Wang, M
   Shen, Y
   Xie, ZW
   Ho, CT
   Yang, CS
   Wang, YJ
   Wan, XC
AF Xu, Na
   Chu, Jun
   Dong, Rongrong
   Lu, Fengjuan
   Zhang, Xinfeng
   Wang, Min
   Shen, Ying
   Xie, Zhongwen
   Ho, Chi-Tang
   Yang, Chung S.
   Wang, Yijun
   Wan, Xiaochun
TI Yellow Tea Stimulates Thermogenesis in Mice through Heterogeneous Browning of Adipose Tissues
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE beigeing; browning; diet induced thermogenesis; energy expenditures; large-leaf yellow tea
ID catechol-o-methyltransferase; beige fat development; diet-induced obesity; green tea; energy-expenditure; rich; antiobesity; mechanisms; caffeine; luteolin
AB Scope Large-leaf yellow tea (YT) exhibits interesting beneficial metabolic effects in previous studies. Here, the authors elucidated the actions of YT on thermogenesis, energy metabolism, and adipocyte metabolic conversion. Methods and Results Five-week-old male C57BL/6 mice are fed low-fat diet, high-fat diet (HFD), and HFD supplemented with 0.5% or 2.5% YT. After treatment for 10 or 14 weeks, YT enhances energy expenditure, O-2 consumption and CO2 production. YT strongly boosts thermogenic program in brown adipose tissue (BAT) and subcutaneous adipose tissue (SAT), while only weakly in epididymal adipose tissue (EAT). These are accompanied by higher body temperature, increased mitochondrial copy numbers, and upregulation of thermogenic genes (Ucp1, Pgc1 alpha, etc.) and proteins. The classic brown adipocyte markers (Eva1, Zic1) are induced only in BAT, while beige adipocyte markers (Tbx1, Tmem26) are boosted only in SAT. Furthermore, subcutaneous-originated preadipocytes are induced by YT in vitro to differentiate to brown-like adipocytes - a browning effect. Conclusion Dietary YT induces adaptive thermogenesis through increasing mitochondrial biogenesis in EAT, inducing beigeing in SAT and enhancing browning in the BAT.
C1 [Xu, Na; Dong, Rongrong; Lu, Fengjuan; Zhang, Xinfeng; Wang, Min; Shen, Ying; Xie, Zhongwen; Wang, Yijun; Wan, Xiaochun] Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Sch Tea & Food Sci, Hefei 230036, Anhui, Peoples R China.
   [Xu, Na; Dong, Rongrong; Lu, Fengjuan; Zhang, Xinfeng; Wang, Min; Shen, Ying; Xie, Zhongwen; Ho, Chi-Tang; Yang, Chung S.; Wang, Yijun; Wan, Xiaochun] Anhui Agr Univ, Int Joint Lab Tea Chem & Hlth Effects, Minist Educ, Hefei 230036, Anhui, Peoples R China.
   [Xu, Na; Chu, Jun] Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline, Boston, MA 02215 USA.
   [Chu, Jun] Anhui Univ Chinese Med, Key Lab Xin An Med, Minist Educ, Hefei 230038, Anhui, Peoples R China.
   [Ho, Chi-Tang] Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.
   [Yang, Chung S.] Rutgers State Univ, Dept Biol Chem, Ernest Mario Sch Pharm, 164 Frelinghuysen Rd, Piscataway, NJ 08855 USA.
C3 Anhui Agricultural University; Anhui Agricultural University; Harvard University; Harvard University Medical Affiliates; Dana-Farber Cancer Institute; Anhui University of Chinese Medicine; Rutgers University System; Rutgers University New Brunswick; Rutgers University System; Rutgers University New Brunswick
RP Xu, N; Wan, XC (corresponding author), Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Sch Tea & Food Sci, Hefei 230036, Anhui, Peoples R China.; Xu, N; Wan, XC (corresponding author), Anhui Agr Univ, Int Joint Lab Tea Chem & Hlth Effects, Minist Educ, Hefei 230036, Anhui, Peoples R China.; Xu, N (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline, Boston, MA 02215 USA.
EM naxu2014@ahau.edu.cn; xcwan@ahau.edu.cn
FU China Scholarship Council [201908340044]; Natural Science Foundation of Anhui Province [1808085MC71]; Key Research and Development Projects of Anhui Province [1804b06020367]; Anhui Province Postdoctoral Science Foundation [2017B230]; Department of Sciences and Technology of Anhui Province [11080001]; China Agriculture Research System [CARS-19]; key support in program for outstanding talents in higher education institutions of Anhui province [gxgwfx2019027]
CR Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Berbee JFP, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7356
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   Chen TT, 2020, CRIT REV FOOD SCI, V60, P2691, DOI 10.1080/10408398.2019.1654430
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021
   Dong J, 2014, J LIPID RES, V55, P363, DOI 10.1194/jlr.M038786
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Dulloo AG, 2002, SCIENCE, V297, P780, DOI 10.1126/science.1074923
   Fan FY, 2016, FOOD CHEM, V196, P347, DOI 10.1016/j.foodchem.2015.09.056
   Gosslau A, 2018, J FOOD BIOACTIVES, V0, PP151, DOI 10.31665/JFB.2018.3158
   Haczeyni F, 2018, OBES REV, V19, P406, DOI 10.1111/obr.12646
   Han MM, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep31703
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   Janssens PLHR, 2015, J NUTR, V145, P864, DOI 10.3945/jn.114.207829
   Jin DY, 2013, J FUNCT FOODS, V5, P1142, DOI 10.1016/j.jff.2013.03.011
   Kadowaki M, 2005, BIOL PHARM BULL, V28, P1509, DOI 10.1248/bpb.28.1509
   Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252
   Kurogi M, 2015, CHEM SENSES, V40, P27, DOI 10.1093/chemse/bju057
   Lee SM, 2008, LIPIDS, V43, P419, DOI 10.1007/s11745-008-3167-4
   Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012
   Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994
   Lorenz M, 2014, EUR J PHARMACOL, V740, P645, DOI 10.1016/j.ejphar.2014.06.014
   Ma CY, 2018, FOOD RES INT, V108, P413, DOI 10.1016/j.foodres.2018.03.052
   Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009
   Okla M, 2017, ADV NUTR, V8, P473, DOI 10.3945/an.116.014332
   Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477
   PERONNET F, 1991, CAN J SPORT SCI, V16, P23
   Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012
   Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740
   Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943
   Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108
   Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271
   Sidossis LS, 2015, CELL METAB, V22, P219, DOI 10.1016/j.cmet.2015.06.022
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Takahashi M, 2014, BRIT J NUTR, V112, P1542, DOI 10.1017/S0007114514002530
   Teng Y, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10010075
   Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004
   Velazquez-Villegas LA, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-017-02068-0
   Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430
   Wang R, 2008, J AGR FOOD CHEM, V56, P2694, DOI 10.1021/jf0730338
   Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016
   Xu N, 2018, J AGR FOOD CHEM, V66, P3823, DOI 10.1021/acs.jafc.8b00138
   Xu N, 2014, MOL NUTR FOOD RES, V58, P1258, DOI 10.1002/mnfr.201300830
   Yang CS, 2019, J AGR FOOD CHEM, V67, P5446, DOI 10.1021/acs.jafc.8b05242
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yoneshiro T, 2013, CURR OPIN CLIN NUTR, V16, P625, DOI 10.1097/MCO.0b013e3283653ee1
   Zhang L, 2011, J AGR FOOD CHEM, V59, P8754, DOI 10.1021/jf2015733
   Zhang X, 2016, INT J OBESITY, V40, P1841, DOI 10.1038/ijo.2016.108
   Zhang ZG, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6493
   Zhou J, 2019, J AGR FOOD CHEM, V67, P5405, DOI 10.1021/acs.jafc.8b05062
   Zhou J, 2018, FOOD FUNCT, V9, P5162, DOI 10.1039/c8fo01429a
   Zhou JH, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10111681
NR 55
TC 15
Z9 16
U1 2
U2 83
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD JAN 15
PY 2021
VL 65
IS 2
BP 
EP 
DI 10.1002/mnfr.202000864
EA JAN 2021
PG 13
WC Food Science & Technology
SC Food Science & Technology
GA PZ8OB
UT WOS:000605579100001
PM 33258303
DA 2025-04-28
ER

PT J
AU Hussain, A
   Cho, JS
   Kim, JS
   Lee, YI
AF Hussain, Ahtesham
   Cho, Jin Sook
   Kim, Jong-Seok
   Lee, Young Ik
TI Protective Effects of Polyphenol Enriched Complex Plants Extract on Metabolic Dysfunctions Associated with Obesity and Related Nonalcoholic Fatty Liver Diseases in High Fat Diet-Induced C57BL/6 Mice
SO MOLECULES
LA English
DT Article
DE plants extract; Rubus crataegifolius; Crataegus pinnatifida Bunge; Cinnamomum cassia; obesity; metabolic dysfunctions; NAFLD; HFD-induced mouse model
AB Background: Currently, obesity is a global health challenge due to its increasing prevalence and associated health risk. It is associated with various metabolic diseases, including diabetes, hypertension, cardiovascular disease, stroke, certain forms of cancer, and non-alcoholic liver diseases (NAFLD). Objective: The aim of this study to evaluate the effects of polyphenol enriched herbal complex (Rubus crataegifolius/ellagic acid, Crataegus pinnatifida Bunge/vitexin, chlorogenic acid, Cinnamomum cassiaa/cinnamic acid) on obesity and obesity induced NAFLD in the high-fat diet (HFD)-induced obese mouse model. Methods: Obesity was induced in male C57BL/6 mice using HFD. After 8 weeks, the mice were treated with HFD+ plants extract for 8 weeks. Body weight, food intake weekly, and blood sugar level were measured. After sacrifice, changes in the treated group's liver weight, fat weight, serum biochemical parameters, hormone levels, and enzyme levels were measured. For histological analysis, tissues were stained with hematoxylin-eosin (H&E) and Oil Red-O. Results: Our results showed that the herbal complex ameliorated body weight and liver weight gain, and decreased total body fat in HFD-fed animals. Post prandial blood glucose (PBG) and fasting blood glucose (FBG) were lower in the herbal complex-treated group than in the HFD control group. Additionally, herbal formulation treatment significantly increased HDL levels in serum and decreased TC, TG, AST, ALT, deposition of fat droplets in the liver, and intima media thickness (IMT) in the aorta. Herbal complex increased serum adiponectin and decreased serum leptin. Herbal complex also increased carnitine palmityl transferase (CPT) activity and significantly decreased enzyme activity of beta-hydroxy beta methyl glutamyl-CoA (HMG-CoA) reductase, and fatty acid synthase (FAS). Conclusions: The results of this study demonstrated that the herbal complex is an effective herbal formulation in the attenuation of obesity and obesity-induced metabolic dysfunction including NAFLD in HFD-induced mouse model.
C1 [Hussain, Ahtesham; Cho, Jin Sook; Lee, Young Ik] Lees Biotech Co Ltd, 416,C Dong,17 Techno 4 Ro, Daejeon 34013, South Korea.
   [Kim, Jong-Seok] Konyang Univ, Myunggok Med Res Inst, Coll Med, Daejeon 35365, South Korea.
C3 Konyang University
RP Lee, YI (corresponding author), Lees Biotech Co Ltd, 416,C Dong,17 Techno 4 Ro, Daejeon 34013, South Korea.
EM ahtsham07@gmail.com; nabucco1@hanmail.net; jskim7488@konyang.ac.kr; yilee@kribb.re.kr
FU Small and Medium Business Administration and Lee's Biotech Company, Republic of Korea
CR Unknown -, 2015, J MED BIOENG, V0, P0, DOI DOI 10.12720/JOMB.4.5.342-349
   Unknown -, 1991, CONSTITUENTS USES ME, V0, P0
   Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8
   Azab KS, 2011, ECOTOX ENVIRON SAFE, V74, P2324, DOI 10.1016/j.ecoenv.2011.06.016
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   Chang Q, 2002, J CLIN PHARMACOL, V42, P605, DOI 10.1177/00970002042006003
   Cheng TO, 2007, INT J CARDIOL, V121, P9, DOI 10.1016/j.ijcard.2007.01.004
   Choe SS, 2016, FRONT ENDOCRINOL, V7, P0, DOI 10.3389/fendo.2016.00030
   Dahmer S, 2010, AM FAM PHYSICIAN, V81, P465
   Guh DP, 2009, BMC PUBLIC HEALTH, V9, P0, DOI 10.1186/1471-2458-9-88
   Han K, 2015, FOOD FUNCT, V6, P2684, DOI 10.1039/c5fo00232j
   Hoffman KB, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0042866
   HULCHER FH, 1973, J LIPID RES, V14, P625
   Hussain A, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0165483
   Jeon SK, 2007, J LIFE SCI, V17, P1723
   Jo J, 2009, PLOS COMPUT BIOL, V5, P0, DOI 10.1371/journal.pcbi.1000324
   Jung KA, 2007, J MED FOOD, V10, P689, DOI 10.1089/jmf.2006.006
   Kim S, 2013, J ETHNOPHARMACOL, V146, P515, DOI 10.1016/j.jep.2013.01.016
   Kuo DH, 2009, J ETHNOPHARMACOL, V124, P544, DOI 10.1016/j.jep.2009.05.005
   Lee SC, 2013, J AGR FOOD CHEM, V61, P4905, DOI 10.1021/jf401039z
   Lee SJ, 2014, CLIN NUTR, V33, P973, DOI 10.1016/j.clnu.2013.12.006
   Lim JW, 2012, J AGR FOOD CHEM, V60, P5121, DOI 10.1021/jf205350k
   Luo M, 2016, J FOOD SCI, V81, PC1102, DOI 10.1111/1750-3841.13291
   Mang B, 2006, EUR J CLIN INVEST, V36, P340, DOI 10.1111/j.1365-2362.2006.01629.x
   Markwell MAK, 1973, ARCH BIOCH BIOPHYSIO, V176, P497
   Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004
   Moselhy SS, 2009, BIOL RES, V42, P93, DOI /S0716-97602009000100009
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Pichiah PBT, 2012, NUTR RES, V32, P856, DOI 10.1016/j.nutres.2012.09.015
   Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347
   Qian WB, 2016, YONAGO ACTA MED, V59, P149
   Qin B, 2004, HORM METAB RES, V36, P119, DOI 10.1055/s-2004-814223
   Qin BL, 2003, DIABETES RES CLIN PR, V62, P139, DOI 10.1016/S0168-8227(03)00173-6
   Sanders FWB, 2016, BIOL REV, V91, P452, DOI 10.1111/brv.12178
   Shatwan IA, 2013, J MED FOOD, V16, P656, DOI 10.1089/jmf.2012.0083
   Vafa M, 2012, INT J PREVENTIVE MED, V3, P531
   Wang JH, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0086117
   Wang JH, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep08391
   Wang XA, 2013, ENDOCRINOLOGY, V154, P685, DOI 10.1210/en.2012-1911
   Yoo JH, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8050283
NR 40
TC 19
Z9 20
U1 5
U2 34
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JAN 15
PY 2021
VL 26
IS 2
BP 
EP 
DI 10.3390/molecules26020302
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA PX6HA
UT WOS:000611454000001
PM 33435558
DA 2025-04-28
ER

PT J
AU Hsu, CS
   Chang, ST
   Nfor, ON
   Lee, KJ
   Ho, CC
   Liu, CC
   Lee, SS
   Liaw, YP
AF Hsu, Chun-Sheng
   Chang, Shin-Tsu
   Nfor, Oswald Ndi
   Lee, Kuan-Jung
   Ho, Chien-Chang
   Liu, Chuan-Ching
   Lee, Shiuan-Shinn
   Liaw, Yung-Po
TI Association of Metabolic Syndrome with Aerobic Exercise and LPL rs3779788 Polymorphism in Taiwan Biobank Individuals
SO DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
LA English
DT Article
DE polymorphisms; variant; physical activity; metabolic disorders
ID lipoprotein-lipase gene; hindiii; expression; resistance; disease; health; s447x; risk
AB Purpose: The Lipoprotein lipase (LPL) gene is a significant contributor to dyslipidemia. It has shown associations with several conditions including atherosclerosis, obesity, and metabolic syndrome (MetS). We assessed the interactive association between MetS and rs3779788 of the LPL gene based on aerobic exercise. Materials and Methods: Data were available for 7532 Taiwan Biobank (TWB) participants recruited between 2008 and 2016. We used multiple logistic regression to determine the odds ratios (OR) for MetS and their 95% confident intervals (C.I.). Potential variables included LPL rs3779788, aerobic exercise, sex, age, education, marital status, body mass index (BMI), smoking, alcohol consumption, midnight snacking, vegetarian diet, coffee, dietary fat, and tea drinking. Results: Aerobic exercise was protective against MetS (OR, 0.858; 95% C.I., 0.743-0.991). Compared to CC/CT genotype, the OR for developing MetS was 0.875, (95% C.I., 0.571- 1.341) in TT individuals. The test for interaction was significant for the rs3779788 variant and aerobic exercise (p = 0.0484). In our group analyses, the OR for MetS was 0.841 (95% C.I., 0.727-0.974) in CC/CT and 4.076 (95% C.I., 1.158-14.346) in TT individuals who did aerobic exercise compared to those who did not. Conclusion: Our study indicated that aerobic exercise improved metabolic syndrome in Taiwanese adults with rs3779788 CC/CT genotype relative to those with TT genotype.
C1 [Hsu, Chun-Sheng; Chang, Shin-Tsu; Liu, Chuan-Ching] Taichung Vet Gen Hosp, Dept Phys Med & Rehabil, Taichung 40201, Taiwan.
   [Hsu, Chun-Sheng; Nfor, Oswald Ndi; Lee, Kuan-Jung; Lee, Shiuan-Shinn; Liaw, Yung-Po] Chung Shan Med Univ, Dept Publ Hlth, 110 Sec 1 Jianguo N Rd, Taichung 40201, Taiwan.
   [Hsu, Chun-Sheng; Nfor, Oswald Ndi; Lee, Kuan-Jung; Lee, Shiuan-Shinn; Liaw, Yung-Po] Chung Shan Med Univ, Inst Publ Hlth, 110 Sec 1 Jianguo N Rd, Taichung 40201, Taiwan.
   [Hsu, Chun-Sheng] Natl Def Med Ctr, Sch Med, Taipei 11490, Taiwan.
   [Hsu, Chun-Sheng] Natl Chung Hsing Univ, Coll Med, Taichung 402, Taiwan.
   [Chang, Shin-Tsu] Natl Def Med Ctr, Triserv Gen Hosp, Sch Med, Dept Phys Med & Rehabil, Taipei 11490, Taiwan.
   [Chang, Shin-Tsu] Kaohsiung Vet Gen Hosp, Dept Phys Med & Rehabil, Kaohsiung 813414, Taiwan.
   [Ho, Chien-Chang] Fu Jen Catholic Univ, Dept Phys Educ, New Taipei 24205, Taiwan.
   [Ho, Chien-Chang] Fu Jen Catholic Univ, Res & Dev Ctr Phys Educ Hlth & Informat Technol, New Taipei 24205, Taiwan.
   [Liaw, Yung-Po] Chung Shan Med Univ Hosp, Dept Med Imaging, Taichung, Taiwan.
C3 Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University; National Defense Medical Center; National Chung Hsing University; National Defense Medical Center; Tri-Service General Hospital; Kaohsiung Veterans General Hospital; Fu Jen Catholic University; Fu Jen Catholic University; Chung Shan Medical University; Chung Shan Medical University Hospital
RP Lee, SS; Liaw, YP (corresponding author), Chung Shan Med Univ, Dept Publ Hlth, 110 Sec 1 Jianguo N Rd, Taichung 40201, Taiwan.; Lee, SS; Liaw, YP (corresponding author), Chung Shan Med Univ, Inst Publ Hlth, 110 Sec 1 Jianguo N Rd, Taichung 40201, Taiwan.
EM shinn@csmu.edu.tw; Liawyp@csmu.edu.tw
FU Ministry of Science and Technology, Taiwan [MOST 107-2627-M-040-002, 108-2621-M-040-001, 109-2121-M-040-002]
CR Alinaghian N, 2019, GENE, V706, P13, DOI 10.1016/j.gene.2019.04.069
   Cahua-Pablo JA, 2015, INT J MOL SCI, V16, P21539, DOI 10.3390/ijms160921539
   Bakker EA, 2017, MAYO CLIN PROC, V92, P1214, DOI 10.1016/j.mayocp.2017.02.018
   Castellano-Castillo D, 2018, CLIN CHEM, V64, P210, DOI 10.1373/clinchem.2017.277921
   Cheema AN, 2017, DATABASE-OXFORD, V0, PP1, DOI 10.1093/database/bax078
   Chen YF, 2020, EVID-BASED COMPL ALT, V2020, P0, DOI 10.1155/2020/6612447
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Earnest CP, 2013, AM J CARDIOL, V111, P1805, DOI 10.1016/j.amjcard.2013.02.037
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Fan AZ, 2006, EUR J EPIDEMIOL, V21, P129, DOI 10.1007/s10654-005-5457-y
   Fenwick PH, 2019, CRIT REV FOOD SCI, V59, P2028, DOI 10.1080/10408398.2018.1437022
   Gehrisch S, 1999, CURR ATHEROSCLER REP, V1, P70, DOI 10.1007/s11883-999-0052-4
   Goodarzi MO, 2004, DIABETES, V53, P214, DOI 10.2337/diabetes.53.1.214
   H√∂lzl B, 2002, DIABETOLOGIA, V45, P378, DOI 10.1007/s00125-001-0771-8
   Information(NCBI) NCfB, 2020, LPL LIP LIP, V0, P0
   JEMAA R, 1995, INT J OBESITY, V19, P270
   Jeong Seok Won, 2014, GENOMICS & INFORMATICS, V12, P187, DOI 10.5808/GI.2014.12.4.187
   Kassi E, 2011, BMC MED, V9, P0, DOI 10.1186/1741-7015-9-48
   Kastelein JJP, 1999, CLIN GENET, V56, P297, DOI 10.1034/j.1399-0004.1999.560407.x
   Katzmarzyk PT, 2003, MED SCI SPORT EXER, V35, P1703, DOI 10.1249/01.MSS.0000089337.73244.9B
   ÍπÄÏÉÅÌõà, 2009, JOURNAL OF THE KOREA GERONTOLOGICAL SOCIETY ÌïúÍµ≠ÎÖ∏ÎÖÑÌïô, V29, P823
   Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9
   Lin E, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep36830
   Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060
   Ma YQ, 2003, METABOLISM, V52, P338, DOI 10.1053/meta.2003.50053
   McMurray RG, 2010, AM J LIFESTYLE MED, V4, P176, DOI 10.1177/1559827609351234
   Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9
   Morales-Palomo F, 2019, MED SCI SPORT EXER, V51, P1876, DOI 10.1249/MSS.0000000000001983
   Mu√±oz-Barrios S, 2012, DIS MARKERS, V33, P313, DOI 10.1155/2012/673452
   Myers J, 2003, CIRCULATION, V107, PE2, DOI 10.1161/01.CIR.0000048890.59383.8D
   Myers J, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11071652
   Oh SW, 2005, DIABETES CARE, V28, P2064, DOI 10.2337/diacare.28.8.2064
   Okura T, 2007, OBESITY, V15, P2478, DOI 10.1038/oby.2007.294
   Pattyn N, 2013, SPORTS MED, V43, P121, DOI 10.1007/s40279-012-0003-z
   Pourranjbar Mohammad, 2018, J MED LIFE, V11, P381, DOI 10.25122/jml-2018-0033
   Radha V, 2007, INT J OBESITY, V31, P913, DOI 10.1038/sj.ijo.0803547
   Rahalkar AR, 2009, CAN J PHYSIOL PHARM, V87, P151, DOI 10.1139/Y09-005
   Ranjith N, 2009, METAB SYNDR RELAT D, V7, P571, DOI 10.1089/met.2009.0015
   Riddell Michael, 2009, J DIABETES SCI TECHNOL, V3, P914
   SEIP RL, 1995, AM J PHYSIOL-ENDOC M, V268, PE229, DOI 10.1152/ajpendo.1995.268.2.E229
   Stanc√°kov√° A, 2014, REV ENDOCR METAB DIS, V15, P243, DOI 10.1007/s11154-014-9293-9
   Ukkola O, 2001, ANN MED, V33, P79, DOI 10.3109/07853890109002062
   Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, PE271, DOI 10.1152/ajpendo.90920.2008
   Welfare MoHa, 2018, STAT CAUS DEATH, V0, P0
   Welfare MoHa, 2017, STAT CAUS DEATH, V0, P0
   Wung SF, 2006, LIPIDS HEALTH DIS, V5, P0, DOI 10.1186/1476-511X-5-19
   Yamada Y, 2007, ATHEROSCLEROSIS, V191, P298, DOI 10.1016/j.atherosclerosis.2006.05.035
   Yoo Yong-Kwon, 2013, J EXERC NUTRITION BIOCHEM, V17, P133, DOI 10.5717/jenb.2013.17.4.133
   Zhang XL, 2014, HUM MOL GENET, V23, P782, DOI 10.1093/hmg/ddt461
NR 49
TC 4
Z9 5
U1 0
U2 4
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-7007
EI 
J9 DIABET METAB SYND OB
JI Diabetes Metab. Syndr. Obes.
PD JUN 15
PY 2021
VL 14
IS 
BP 3997
EP 4004
DI 10.2147/DMSO.S328308
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA UR8ZI
UT WOS:000697029700004
PM 34548800
DA 2025-04-28
ER

PT J
AU Leonard, W
   Zhang, PZ
   Ying, DY
   Fang, ZX
AF Leonard, William
   Zhang, Pangzhen
   Ying, Danyang
   Fang, Zhongxiang
TI Hydroxycinnamic acids on gut microbiota and health
SO COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY
LA English
DT Review
DE food processing; gut microbiota; health benefits; hydroxycinnamic acids; metabolism
ID in-vitro bioaccessibility; caffeic acid; chlorogenic acid; phenethyl ester; ferulic acid; sinapic acid; colonic metabolism; green coffee; inflammatory response; caffeoylquinic acids
AB Hydroxycinnamic acids (HCAs) are a major class of phenolic acids with the characteristic phenylpropanoid C-6-C-3 backbone. Its typically conjugated status with plant cell wall components and liberation by limited enzymes might be the reason for its neglect by researchers compared to flavonoid-type polyphenols. The polyphenol-gut microbiota interactions and their impact on human health have captured the interest of researchers recently. In addition, there has been a significant progress over the past few years in understanding the gut microbiota-modulating effect of HCA using animal model studies. This review discusses the metabolism of HCA in the digestive tract, HCA-gut microbiota interactions, and its link to colorectal cancer, inflammatory bowel diseases, mental-cognitive impairments, nonalcoholic liver disease, and obesity. The effects of food matrix and processing technologies on HCA bioavailability and HCA-gut microbiota interactions, and HCA safety concerns are also featured in this review. This paper has provided an in-depth insight on HCA-gut microbiota relationship and identified the current literature gaps for future research.
C1 [Leonard, William; Zhang, Pangzhen; Fang, Zhongxiang] Univ Melbourne, Sch Agr & Food, Parkville, Vic 3010, Australia.
   [Ying, Danyang] CSIRO, Agr & Food, Werribee, Vic, Australia.
C3 University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO)
RP Fang, ZX (corresponding author), Univ Melbourne, Sch Agr & Food, Parkville, Vic 3010, Australia.
EM zhongxiang.fang@unimelb.edu.au
CR Adam A, 2002, J NUTR, V132, P1962, DOI 10.1093/jn/132.7.1962
   Amano Y, 2019, PHARMACEUTICALS-BASE, V12, P0, DOI 10.3390/ph12030110
   Ames NJ, 2017, NURS RES, V66, P184, DOI 10.1097/NNR.0000000000000212
   Anson NM, 2009, J AGR FOOD CHEM, V57, P6148, DOI 10.1021/jf900492h
   Armougom F, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0007125
   Attri S, 2018, FOOD RES INT, V111, P314, DOI 10.1016/j.foodres.2018.05.045
   Badr DA, 2019, APPL BIOL CHEM, V62, P0, DOI 10.1186/s13765-019-0462-0
   Balaji C, 2014, HUM EXP TOXICOL, V33, P1253, DOI 10.1177/0960327114522501
   Ben Lagha A, 2015, J AGR FOOD CHEM, V63, P6999, DOI 10.1021/acs.jafc.5b01525
   Bhalli JA, 2019, ENVIRON MOL MUTAGEN, V60, P837, DOI 10.1002/em.22333
   Bharath Nagaraj, 2015, CONTEMP CLIN DENT, V6, P166, DOI 10.4103/0976-237X.156036
   Bischoff SC, 2011, BMC MED, V9, P0, DOI 10.1186/1741-7015-9-24
   Budryn G, 2016, FOOD RES INT, V89, P1004, DOI 10.1016/j.foodres.2015.12.011
   Budryn G, 2015, FOOD CHEM, V168, P276, DOI 10.1016/j.foodchem.2014.07.056
   Budryn G, 2013, FOOD REV INT, V29, P217, DOI 10.1080/87559129.2012.751545
   Bugianesi R, 2004, EUR J NUTR, V43, P360, DOI 10.1007/s00394-004-0483-1
   Cai JR, 2019, GASTROENT RES PRACT, V2019, P0, DOI 10.1155/2019/8536952
   Castaner O, 2018, INT J ENDOCRINOL, V2018, P0, DOI 10.1155/2018/4095789
   Celebioglu HU, 2018, MOL NUTR FOOD RES, V62, P0, DOI 10.1002/mnfr.201700638
   Chen JL, 2019, APPL MICROBIOL BIOT, V103, P8157, DOI 10.1007/s00253-019-10025-8
   Cheng D, 2019, FOOD FUNCT, V10, P681, DOI 10.1039/c8fo01755g
   Chou DA, 2012, FOOD CHEM, V131, P1460, DOI 10.1016/j.foodchem.2011.10.027
   Cladis DP, 2020, FOOD CHEM TOXICOL, V139, P0, DOI 10.1016/j.fct.2020.111254
   Clifford MN, 2020, COMPR REV FOOD SCI F, V19, P1299, DOI 10.1111/1541-4337.12518
   Clifford MN, 2017, NAT PROD REP, V34, P1391, DOI 10.1039/c7np00030h
   Coman V, 2020, J SCI FOOD AGR, V100, P483, DOI 10.1002/jsfa.10010
   Couteau D, 2001, J APPL MICROBIOL, V90, P873, DOI 10.1046/j.1365-2672.2001.01316.x
   Cueva C, 2010, RES MICROBIOL, V161, P372, DOI 10.1016/j.resmic.2010.04.006
   Dalile B, 2019, NAT REV GASTRO HEPAT, V16, P461, DOI 10.1038/s41575-019-0157-3
   Do MH, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10060761
   Due√±as M, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/850902
   Duncan SH, 2016, ENVIRON MICROBIOL, V18, P2214, DOI 10.1111/1462-2920.13158
   Dupas C, 2006, MOL NUTR FOOD RES, V50, P1053, DOI 10.1002/mnfr.200600034
   Ekbatan SS, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19030723
   El-Seedi HR, 2012, J AGR FOOD CHEM, V60, P10877, DOI 10.1021/jf301807g
   Erk T, 2014, EUR J NUTR, V53, P159, DOI 10.1007/s00394-013-0512-z
   Erk T, 2012, MOL NUTR FOOD RES, V56, P1488, DOI 10.1002/mnfr.201200222
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Feliciano RP, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9030268
   Fetzner A, 2004, EUR J PHARM BIOPHARM, V58, P91, DOI 10.1016/j.ejpb.2004.02.001
   Gao WY, 2019, BIOMED RES INT, V2019, P0, DOI 10.1155/2019/6769789
   Gillet JP, 2013, JNCI-J NATL CANCER I, V105, P452, DOI 10.1093/jnci/djt007
   G√≥mez-Juaristi M, 2018, FOOD FUNCT, V9, P331, DOI 10.1039/c7fo01553d
   G√≥mez-Juaristi M, 2018, FOOD CHEM, V240, P1028, DOI 10.1016/j.foodchem.2017.08.003
   Gong LX, 2019, J FUNCT FOODS, V60, P0, DOI 10.1016/j.jff.2019.103453
   Gonthier MP, 2006, BIOMED PHARMACOTHER, V60, P536, DOI 10.1016/j.biopha.2006.07.084
   Gonzalez LM, 2015, TRANSL RES, V166, P12, DOI 10.1016/j.trsl.2015.01.004
   Granato D, 2020, TRENDS FOOD SCI TECH, V98, P162, DOI 10.1016/j.tifs.2020.01.010
   HAGIWARA A, 1991, CANCER RES, V51, P5655
   He YJ, 2006, WORLD J GASTROENTERO, V12, P4981, DOI 10.3748/wjg.v12.i31.4981
   Heinritz SN, 2013, NUTR RES REV, V26, P191, DOI 10.1017/S0954422413000152
   Hirose M, 1998, CARCINOGENESIS, V19, P207, DOI 10.1093/carcin/19.1.207
   Honzawa Y, 2010, INFLAMM BOWEL DIS, V16, P2004, DOI 10.1002/ibd.21243
   Hou N, 2017, ANTI-CANCER DRUG, V28, P59, DOI 10.1097/CAD.0000000000000430
   Hugenholtz F, 2018, CELL MOL LIFE SCI, V75, P149, DOI 10.1007/s00018-017-2693-8
   Johnson ML, 2008, POULTRY SCI, V87, P958, DOI 10.3382/ps.2007-00349
   Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, P0, DOI 10.3309/fcimb.2015.00004
   Katayama S, 2017, J AGR FOOD CHEM, V65, P10730, DOI 10.1021/acs.jafc.7b03933
   Kelly SM, 2018, FRONT MICROBIOL, V9, P0, DOI 10.3389/fmicb.2018.02690
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P2518, DOI 10.1021/jf035407c
   Kumar CS, 2020, CARBOHYD POLYM, V231, P0, DOI 10.1016/j.carbpol.2019.115682
   Lee B, 2018, J IMMUNOL RES, V2018, P0, DOI 10.1155/2018/2645465
   Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004
   Lee JY, 2018, ARCH PHARM RES, V41, P243, DOI 10.1007/s12272-018-1006-6
   Lee SJ, 2013, ARCH PHARM RES, V36, P1437, DOI 10.1007/s12272-013-0139-x
   Liu JW, 2016, SPECTROSC LETT, V49, P44, DOI 10.1080/00387010.2015.1066826
   Lou ZX, 2011, J FOOD SCI, V76, PM398, DOI 10.1111/j.1750-3841.2011.02213.x
   Ma YC, 2019, BIOMED PHARMACOTHER, V113, P0, DOI 10.1016/j.biopha.2019.108753
   Malapert A, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10111653
   Mart√≠nez-Hu√©lamo M, 2016, MOL NUTR FOOD RES, V60, P1578, DOI 10.1002/mnfr.201500820
   Martini S, 2019, J AGR FOOD CHEM, V67, P3919, DOI 10.1021/acs.jafc.9b00522
   Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948
   Miyamoto S, 2008, NUTR CANCER, V60, P675, DOI 10.1080/01635580802008286
   Murad LD, 2015, NUTR CANCER, V67, P532, DOI 10.1080/01635581.2015.1004736
   Nardini M, 2002, J AGR FOOD CHEM, V50, P5735, DOI 10.1021/jf0257547
   OCallaghan A, 2016, FRONT MICROBIOL, V7, P0, DOI 10.3389/fmicb.2016.00925
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Os√©s SM, 2020, ANTIOXIDANTS-BASEL, V9, P0, DOI 10.3390/antiox9010075
   Parkar SG, 2013, ANAEROBE, V23, P12, DOI 10.1016/j.anaerobe.2013.07.009
   Pellerito C, 2020, J INORG BIOCHEM, V205, P0, DOI 10.1016/j.jinorgbio.2020.110999
   Peng JH, 2018, FRONT PHARMACOL, V9, P0, DOI 10.3389/fphar.2018.01399
   PEPPERCORN MA, 1971, J BACTERIOL, V108, P996, DOI 10.1128/JB.108.3.996-1000.1971
   Perse M, 2012, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2012/718617
   Poquet L, 2008, DRUG METAB DISPOS, V36, P190, DOI 10.1124/dmd.107.017558
   Raimondi S, 2015, MICROBIOLOGYOPEN, V4, P41, DOI 10.1002/mbo3.219
   Rajilic-Stojanovic M, 2013, INFLAMM BOWEL DIS, V19, P481, DOI 10.1097/MIB.0b013e31827fec6d
   Rechner AR, 2004, FREE RADICAL BIO MED, V36, P212, DOI 10.1016/j.freeradbiomed.2003.09.022
   Renouf M, 2014, MOL NUTR FOOD RES, V58, P301, DOI 10.1002/mnfr.201300349
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Renouf M, 2010, J NUTR, V140, P259, DOI 10.3945/jn.109.113027
   Ribas-Agust√≠ A, 2018, CRIT REV FOOD SCI, V58, P2531, DOI 10.1080/10408398.2017.1331200
   Rodriguez-Mateos A, 2014, MOL NUTR FOOD RES, V58, P1952, DOI 10.1002/mnfr.201400231
   Ruan Z, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0097815
   Rychlik I, 2020, ANIMALS-BASEL, V10, P0, DOI 10.3390/ani10010103
   Sanchez-Bridge B, 2016, BIOFACTORS, V42, P259, DOI 10.1002/biof.1268
   Scherbl D, 2017, EUR FOOD RES TECHNOL, V243, P791, DOI 10.1007/s00217-016-2793-y
   Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d
   Shen HH, 2020, FOOD FUNCT, V11, P5389, DOI 10.1039/D0FO00775G
   Silberberg M, 2006, J AGR FOOD CHEM, V54, P3541, DOI 10.1021/jf060104e
   Song J, 2019, FOOD FUNCT, V10, P2947, DOI 10.1039/c8fo02599a
   Stalmach A, 2014, FOOD FUNCT, V5, P1727, DOI 10.1039/c4fo00316k
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Tagliazucchi D, 2012, J AGR FOOD CHEM, V60, P11056, DOI 10.1021/jf302694a
   Tambuwala MM, 2018, PATHOL RES PRACT, V214, P1909, DOI 10.1016/j.prp.2018.08.020
   Tang HY, 2020, TRENDS FOOD SCI TECH, V100, P333, DOI 10.1016/j.tifs.2020.04.028
   Tang Q, 2020, FRONT CELL INFECT MI, V10, P0, DOI 10.3389/fcimb.2020.00151
   Tayman C, 2011, PEDIATR SURG INT, V27, P1179, DOI 10.1007/s00383-011-2942-0
   Teke Z, 2012, J INVEST SURG, V25, P354, DOI 10.3109/08941939.2012.677968
   Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400
   Thursby E, 2017, BIOCHEM J, V474, P1823, DOI 10.1042/BCJ20160510
   Tomas-Barberan F, 2014, MOL NUTR FOOD RES, V58, P1122, DOI 10.1002/mnfr.201300441
   Tom√°s-Barber√°n FA, 2019, ANNU REV FOOD SCI T, V10, P221, DOI 10.1146/annurev-food-032818-121615
   Turner PV, 2018, ANIM MODEL EXP MED, V1, P109, DOI 10.1002/ame2.12022
   Vollmer M, 2017, FOOD RES INT, V100, P375, DOI 10.1016/j.foodres.2017.06.013
   Vukelic I, 2018, FOOD CHEM TOXICOL, V121, P140, DOI 10.1016/j.fct.2018.08.061
   Wallace TC, 2011, NUTR REV, V69, P392, DOI 10.1111/j.1753-4887.2011.00402.x
   Wang QY, 2011, NUTR CANCER, V63, P1044, DOI 10.1080/01635581.2011.597538
   Wang WW, 2019, FRONT MICROBIOL, V10, P0, DOI 10.3389/fmicb.2019.01681
   Wang WW, 2019, J AGR FOOD CHEM, V67, P4250, DOI 10.1021/acs.jafc.8b06760
   Wang XK, 2004, APPL ENVIRON MICROB, V70, P2367, DOI 10.1128/AEM.70.4.2367-2372.2004
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Wittemer SM, 2005, PHYTOMEDICINE, V12, P28, DOI 10.1016/j.phymed.2003.11.002
   Wong SH, 2019, NAT REV GASTRO HEPAT, V16, P690, DOI 10.1038/s41575-019-0209-8
   Xiao L, 2016, NAT MICROBIOL, V1, P0, DOI 10.1038/NMICROBIOL.2016.161
   Xie MH, 2019, J AGR FOOD CHEM, V67, P171, DOI 10.1021/acs.jafc.8b05444
   Xu Y, 2020, FRONT MICROBIOL, V11, P0, DOI 10.3389/fmicb.2020.00219
   Yang C, 2019, FOOD RES INT, V116, P1202, DOI 10.1016/j.foodres.2018.10.003
   Yang C, 2007, J PHARMACEUT BIOMED, V43, P945, DOI 10.1016/j.jpba.2006.09.027
   Yang XW, 2013, FOOD CHEM TOXICOL, V55, P297, DOI 10.1016/j.fct.2012.12.039
   Yildiz Y, 2009, DIGEST DIS SCI, V54, P738, DOI 10.1007/s10620-008-0405-9
   Yuan XP, 2005, ANAEROBE, V11, P225, DOI 10.1016/j.anaerobe.2005.02.002
   Zatorski H, 2015, N-S ARCH PHARMACOL, V388, P643, DOI 10.1007/s00210-015-1110-9
   Zhang MY, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-15141-x
   Zhang P, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00325
   Zhang Y, 2018, FOOD FUNCT, V9, P4968, DOI 10.1039/C8FO01126E
   Zhang Z, 2016, ONCOTARGET, V7, P31790, DOI 10.18632/oncotarget.9306
   Zhao ZH, 2010, PHYTOCHEM REV, V9, P133, DOI 10.1007/s11101-009-9145-5
   Zheng YH, 2019, ADV FUNCT MATER, V29, P0, DOI 10.1002/adfm.201808646
NR 139
TC 64
Z9 66
U1 13
U2 112
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1541-4337
EI 
J9 COMPR REV FOOD SCI F
JI Compr. Rev. Food. Sci. Food Saf.
PD JAN 15
PY 2021
VL 20
IS 1
BP 710
EP 737
DI 10.1111/1541-4337.12663
EA OCT 2020
PG 28
WC Food Science & Technology
SC Food Science & Technology
GA PR7ZX
UT WOS:000582920000001
PM 33443803
DA 2025-04-28
ER

PT J
AU Ferreira, GA
   Wagner, L
   Maziero, R
   Ataide-Silva, T
   Silva, NA
   Bertuzzi, R
   Lima-Silva, AE
AF Ferreira, G. A.
   Wagner, L.
   Maziero, R.
   Ataide-Silva, T.
   Silva, N. A.
   Bertuzzi, R.
   Lima-Silva, A. E.
TI Caffeine intake reduces sedentary time and increases physical activity predisposition in obese police officers
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE Sedentary time; Physical inactivity; Light physical activity; Health; Cardiometabolic risk; Obesity
ID exercise; behavior; energy; risk
AB Sedentary time is associated with increased obesity in police officers. Caffeine intake may reduce sedentary time but it has not been extensively investigated. In the present study, the effect of caffeine ingestion on sedentary time was investigated in obese police officers. Fourteen obese police officers ingested either 5 mg/kg of caffeine or cellulose (placebo) for six days. Information on inactivity time, time spent with physical activities, self-reported perception of tiredness, and physical activity disposition was obtained daily during the intervention period. Sedentary and physical activity times were divided into two intraday periods (T-1: 08:00 am-02:00 pm and T-2: 02:00 pm-08:00 pm). Caffeine intake decreased the sedentary time in both T-1 (79.2 +/- 2.2%) and T-2 (79.1 +/- 2.5%), when compared with T-2 of the placebo condition (81.1 +/- 3.6%, P<0.05). Caffeine intake also increased the time spent on light physical activities in T-1 and T-2 (17 +/- 2 and 18 +/- 2%), when compared with T-2 of the placebo condition (16 +/- 3%, P<0.05). In addition, sedentary time increased and light physical activity time decreased from T-1 to T-2 in the placebo (P<0.001) but not in the caffeine condition (P=0.81). Caffeine intake had no effect on tiredness (P>0.05), but it increased the self-reported physical activity disposition compared to the placebo condition (4.5 +/- 2.7 vs 3.2 +/- 2.3 units, P<0.05). Caffeine intake reduced the sedentary time and increased the time spent on light physical activities of obese police officers, which seems to be related to a higher disposition for the practice of physical activity.
C1 [Ferreira, G. A.; Wagner, L.; Maziero, R.; Lima-Silva, A. E.] Univ Tecnol Fed Parana, Grp Pesquisa Performance Humano, Curitiba, Parana, Brazil.
   [Ferreira, G. A.] Univ Fed Pernambuco, Ctr Acad Vitoria, Vitoria De Santo Antao, PE, Brazil.
   [Ataide-Silva, T.; Silva, N. A.] Univ Fed Alagoas, Fac Nutr, Maceio, Alagoas, Brazil.
   [Bertuzzi, R.] Univ Sao Paulo, Grp Estudos Desempenho Aerobio, Sao Paulo, SP, Brazil.
C3 Pontificia Universidade Catolica do Parana; Universidade Tecnologica Federal do Parana; Universidade Federal do Parana; Universidade Federal de Pernambuco; Universidade Federal de Alagoas; Universidade de Sao Paulo
RP Bertuzzi, R (corresponding author), Univ Sao Paulo, Grp Estudos Desempenho Aerobio, Sao Paulo, SP, Brazil.
EM bertuzzi@usp.br
CR ABERNETHY DR, 1985, BRIT J CLIN PHARMACO, V20, P61, DOI 10.1111/j.1365-2125.1985.tb02799.x
   Unknown -, 2004, APPL BODY COMPOSITIO, V0, P0
   BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815
   Cortis C, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0182709
   Ferraz AD, 2020, REV BRAS MED ESPORTE, V26, P117, DOI 10.1590/1517-869220202602208923
   Ferreira GA, 2019, BRAZ J MED BIOL RES, V52, P0, DOI 10.1590/1414-431X20199169
   Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021
   Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb
   Hartley Tara A, 2011, INT J EMERG MENT HEALTH, V13, P211
   Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046
   J√∫dice PB, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0068936
   Meeusen R, 2013, NESTLE NUTR WORKS SE, V76, P1, DOI 10.1159/000350223
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Paing AC, 2020, J SCI MED SPORT, V23, P1074, DOI 10.1016/j.jsams.2020.06.003
   Puetz TW, 2006, SPORTS MED, V36, P767, DOI 10.2165/00007256-200636090-00004
   Saleh ZT, 2015, HEART LUNG, V44, P382, DOI 10.1016/j.hrtlng.2015.06.008
   Saunders B, 2017, SCAND J MED SCI SPOR, V27, P1240, DOI 10.1111/sms.12793
   Schubert MM, 2014, J APPL PHYSIOL, V117, P745, DOI 10.1152/japplphysiol.00570.2014
   Souissi Makram, 2012, ASIAN J SPORTS MED, V3, P161
   Thivel D, 2018, FRONT PUBLIC HEALTH, V6, P0, DOI 10.3389/fpubh.2018.00288
NR 20
TC 0
Z9 0
U1 0
U2 12
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP 14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD JUN 15
PY 2021
VL 54
IS 11
BP 
EP 
DI 10.1590/1414-431X2021e11556
PG 6
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental Medicine
GA UX4DB
UT WOS:000700791400001
PM 34550274
DA 2025-04-28
ER

PT J
AU Crovesy, L
   Kaippert, VC
   Lopes, MCOD
   Magno, FCCM
   Fialho, E
   Rosado, EL
AF Crovesy, Louise
   Kaippert, Vanessa Chaia
   Oliveira dos Santos Lopes, Marcelly Cunha
   Carvalho Mattos Magno, Fernanda Cristina
   Fialho, Eliane
   Rosado, Eliane Lopes
TI Profile of polyphenol intake by women with different classes of obesity: Consumption of these compounds does not reflect healthy eating
SO NUTRITION
LA English
DT Article
DE Obesity; Polyphenol; Phenolic compounds; Food intake; Phenol-Explorer
ID dietary-intake; population; overweight; serum
AB Objectives: The aim of this study was to evaluate polyphenol intake in women with different classes of obesity and identify which are consumed more frequently and what the food sources are. Methods: A cross-sectional study was conducted with 114 women with obesity. The study evaluated polyphenol intake via a 3-d food record using Phenol-Explorer. Anthropometric, biochemical, and dietetic variables were evaluated. Results: The women's habitual food intake was low calorie and adequate in macronutrients. Mean polyphenol intake by the group was 573 +/- 490, 614 +/- 475, and 379 +/- 25 mg/d for class I, class II, and class III obesity (P = 0.002), respectively. The most frequent food or beverage consumed by the group was coffee and caffeoylquinic acid, its phenolic compound. Fruits, vegetables, and nuts contributed the least to the intake of polyphenols. Conclusions: Although the diets of the study participants did include some food sources of polyphenols, they were not of sufficient quality to significantly contribute to a healthy diet; instead, they sometimes were foods may have that contributed to weight gain. Women with class III obesity consumed the most calories; however, they had low fruit, vegetable, and whole foods intake. (C) 2020 Elsevier Inc. All rights reserved.
C1 [Crovesy, Louise; Carvalho Mattos Magno, Fernanda Cristina; Rosado, Eliane Lopes] Univ Fed Rio Janeiro, Fundao Isl, Inst Nutr Josu de Castro, Dept Nutr & Dietet DND, Rio De Janeiro, Brazil.
   [Kaippert, Vanessa Chaia; Oliveira dos Santos Lopes, Marcelly Cunha] Univ Fed Rio de Janeiro, Nutr Assessment Lab, Inst Nutr Josu de Castro, Rio De Janeiro, Brazil.
   [Fialho, Eliane] Univ Fed Rio de Janeiro, Dept Basic & Expt Nutr DNBE, Inst Nutr Josu de Castro, Rio De Janeiro, Brazil.
C3 Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro
RP Crovesy, L (corresponding author), Univ Fed Rio Janeiro, Fundao Isl, Inst Nutr Josu de Castro, Dept Nutr & Dietet DND, Rio De Janeiro, Brazil.
EM louisecrovesy@yahoo.com.br
FU Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro; Coordcao de Aperfeicoamento de Pessoal de Nivel Superior ~ Brasil (CAPES) [001]
CR Adriouch S, 2018, INT J OBESITY, V42, P310, DOI 10.1038/ijo.2017.227
   Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
   Amiot MJ, 2016, OBES REV, V17, P573, DOI 10.1111/obr.12409
   Associacao Brasileira para o Estudo da Obesidade e Sindrome Metabolica (Abeso), 2022, OBESIDADE E A GORDOFOBIA: PERCEPCOES 2022, V0, P0
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Karam J, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0191573
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   KOSTNER GM, 1979, CLIN CHEM, V25, P939
   Lee MS, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23081853
   Liu SL, 2015, FOOD FUNCT, V6, P2779, DOI 10.1039/c5fo00626k
   LOTT JA, 1975, CLIN CHEM, V21, P1754
   MCGOWAN MW, 1983, CLIN CHEM, V29, P538
   Miranda AM, 2016, BRIT J NUTR, V115, P1061, DOI 10.1017/S0007114515005061
   Most J, 2014, INT J OBESITY, V38, P698, DOI 10.1038/ijo.2013.231
   Neveu V, 2010, DATABASE-OXFORD, V0, P0, DOI DOI 10.1093/database/bap024
   P√©rez-Jim√©nez J, 2011, AM J CLIN NUTR, V93, P1220, DOI 10.3945/ajcn.110.007096
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   RICHMOND W, 1973, CLIN CHEM, V19, P1350
   Schlesinger S, 2019, ADV NUTR, V10, P205, DOI 10.1093/advances/nmy092
   Sousa AG, 2015, BRIT J NUTR, V113, P1615, DOI 10.1017/S0007114515000835
   Souza AD, 2013, REV SAUDE PUBL, V47, PS190, DOI 10.1590/S0034-89102013000700005
   THOMPSON FE, 1994, J NUTR, V124, PS2245, DOI 10.1093/jn/124.suppl_11.2245s
   Tresserra-Rimbau A, 2013, NUTR METAB CARDIOVAS, V23, P953, DOI 10.1016/j.numecd.2012.10.008
   Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F
   WHO, 2022, LINGUIST INQ, V0, P0, DOI DOI 10.1162/ling_a_00422
   WHO Consultation, 2000, WHO TECH REP SER, V894, P1
   World Health Organization, 2015, GUID SUG INT ADULTS, V0, P51
   Zang YQ, 2015, FOOD FUNCT, V6, P834, DOI 10.1039/c4fo00844h
NR 29
TC 5
Z9 5
U1 1
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD FEB 15
PY 2021
VL 82
IS 
BP 
EP 
DI 10.1016/j.nut.2020.111045
EA JAN 2021
PG 5
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA WH1LW
UT WOS:000707449600012
PM 33279359
DA 2025-04-28
ER

PT J
AU Bombak, AE
   Colotti, T
   Riediger, ND
   Raji, D
   Eckhart, N
AF Bombak, Andrea E.
   Colotti, Taylor
   Riediger, Natalie D.
   Raji, Dolapo
   Eckhart, Nicholas
TI Fizzy foibles: examining attitudes toward sugar-sweetened beverages in Michigan
SO CRITICAL PUBLIC HEALTH
LA English
DT Article
DE Sugar-sweetened beverage; stigma; food; shame; weight
ID perceived discrimination; obesity; fat; association; disparity; campaigns; american; children; tobacco; policy
AB Health educators are increasingly publicizing the noxious health effects of sugar-sweetened beverages (SSB). American counties are implementing SSB taxes, as modeled after the 'success' of tobacco policies, to address the 'obesity crisis'. Under-explored is how the linking of SSB to a stigmatized condition, 'obesity', has affected attitudes toward the purchasing and consumption of SSB and those individuals who purchase and consume SSB. This study sought to explore individuals' attitudes and experiences with SSB in rural Michigan. Three themes emerged: Negativity, Egregious beverages and Implicated imbibers. These attitudes were situated within a context of increased exposure to SSB health discourses, particularly among younger participants. Additional themes arose regarding which SSB were labelled especially problematic, who should or should not be drinking SSB, as well as the consequences of drinking SSB. Pop/soda, energy drinks, and diet pop/soda were identified as particularly harmful, albeit for different reasons - sugar, caffeine, and unnatural additives. Many participants reported reacting negatively when they saw children of higher weights drinking SSB, though judgement was reserved for parents. Ultimately, SSB and their consumers appear increasingly stigmatized in ways that carry important equity implications for already marginalized groups.
C1 [Bombak, Andrea E.] Univ New Brunswick, Dept Sociol, Fredericton, NB, Canada.
   [Colotti, Taylor; Raji, Dolapo] Cent Michigan Univ, Sch Hlth Sci, Community Hlth Div, Mt Pleasant, MI 48859 USA.
   [Riediger, Natalie D.] Univ Manitoba, Fac Agr & Food Sci, Dept Food & Human Nutr Sci, Winnipeg, MB, Canada.
   [Riediger, Natalie D.] Univ Manitoba, Rady Fac Hlth Sci, Dept Community Hlth Sci, Winnipeg, MB, Canada.
   [Eckhart, Nicholas] Univ Alabama, Coll Commun & Informat Sci, Tuscaloosa, AL USA.
   [Colotti, Taylor] Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT 84112 USA.
   [Raji, Dolapo] Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA.
C3 University of New Brunswick; Central Michigan University; University of Manitoba; University of Manitoba; University of Alabama System; University of Alabama Tuscaloosa; Utah System of Higher Education; University of Utah; University of Michigan System; University of Michigan
RP Bombak, AE (corresponding author), Univ New Brunswick, Dept Sociol, Fredericton, NB, Canada.
EM andrea.bombak@unb.ca
FU Central Michigan University; CIHR Early Career Investigator Award for NDR [155435]
CR Unknown -, 2014, RED CONS SUG SWEET B, V0, P0
   Bacon L, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-9
   Bell K, 2009, CRITICAL PUBLIC HEALTH, V19, P155, DOI 10.1080/09581590802385664
   Bell K, 2011, CRIT PUBLIC HEALTH, V21, P49, DOI 10.1080/09581596.2010.529419
   Blecher E, 2015, SOC SCI MED, V136, P175, DOI 10.1016/j.socscimed.2015.05.022
   Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883
   Bombak AE, 2015, FOOD CULT SOC, V18, P681, DOI 10.1080/15528014.2015.1088196
   Burris S, 2008, SOC SCI MED, V67, P473, DOI 10.1016/j.socscimed.2008.03.020
   Creswell JW, 2003, RESEARCH DESIGN: QUALITATIVE, V0, P0, DOI 10.3109/08941939.2012.723954
   Dwyer-Lindgren L, 2014, POPUL HEALTH METR, V12, P0, DOI 10.1186/1478-7954-12-5
   Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x
   Emerson RobertM, 1995, WRITING ETHNOGRAPHIC, V0, P0
   Fee M, 2006, SOC SCI MED, V62, P2988, DOI 10.1016/j.socscimed.2005.11.062
   Gallegos D, 2019, INT J ENV RES PUB HE, V16, P0, DOI 10.3390/ijerph16040561
   Gard Michael, 2005, OBESITY EPIDEMIC SCI, V0, P0
   Goffman E, 1963, STIGMA NOTES MANAGEM, V0, P0, DOI DOI 10.1093/SF/43.1.127
   Greenebaum J, 2018, FOOD CULT SOC, V21, P680, DOI 10.1080/15528014.2018.1512285
   Guthman Julie, 2011, WEIGHING IN: OBESITY, V0, P0, DOI 10.1525/J.CTT1PP061
   Hayes S, 2015, OBES SURG, V25, P191, DOI 10.1007/s11695-014-1478-5
   Hayward LE, 2019, OBES SCI PRACT, V5, P333, DOI 10.1002/osp4.353
   Herndon AM, 2005, SOCIAL SEMIOTICS, V15, P127, DOI 10.1080/10350330500154634
   Herndon AM, 2010, FOOD CULT SOC, V13, P331, DOI 10.2752/175174410X12699432700863
   Jutel A, 2005, SOC SEMIOT, V15, P113, DOI 10.1080/10350330500154717
   Kuo LE, 2016, SURG OBES RELAT DIS, V12, P144, DOI 10.1016/j.soard.2015.05.007
   Kuzawa CW, 2009, AM J HUM BIOL, V21, P2, DOI 10.1002/ajhb.20822
   Kwan Samantha, 2013, FRAMING FAT COMPETIN, V0, P0
   Kwarteng JL, 2016, J BIOSOC SCI, V48, P709, DOI 10.1017/S0021932016000225
   Lauridsen DS, 2018, HEALTH EXPECT, V21, P878, DOI 10.1111/hex.12681
   LeBesco Kathleen, 2004, REVOLTING BODIES? THE STRUGGLE TO REDEFINE FAT IDENTITY, V0, P0
   Lewis S, 2015, HEALTH PROMOT PRACT, V16, P473, DOI 10.1177/1524839915580941
   Long MW, 2015, AM J PREV MED, V49, P112, DOI 10.1016/j.amepre.2015.03.004
   Lucan SC, 2017, J URBAN HEALTH, V94, P220, DOI 10.1007/s11524-016-0127-9
   LUPTON D, 2016, FOOD, V0, P0
   Lupton D, 2015, CRIT PUBLIC HEALTH, V25, P4, DOI 10.1080/09581596.2014.885115
   *MCLAREN HLTH CAR, 2017, COMM HLTH NEEDS ASS, V0, P0
   McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001
   McPhail D, 2015, CRIT PUBLIC HEALTH, V25, P539, DOI 10.1080/09581596.2014.992391
   McPhail D, 2013, HEALTH PLACE, V22, P132, DOI 10.1016/j.healthplace.2013.03.009
   MECHLING EW, 1983, CENT STATES SPEECH J, V34, P19, DOI 10.1080/10510978309368111
   MEEUF R, 2016, CELEBRITY STUDIES, V7, P1
   Mintz S, 1997, MORALITY HLTH, V0, P173
   Mintz SidneyWilfred, 1986, SWEETNESS POWER PLAC, V0, P0
   Monaghan LF, 2018, CRIT PUBLIC HEALTH, V28, P498, DOI 10.1080/09581596.2017.1371278
   Myers AM, 2017, FOOD SECUR, V9, P1419, DOI 10.1007/s12571-017-0733-8
   Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.39
   PACKER M, 2016, BERKELEY J SOCIOLOGY, V0, P0
   Park S, 2016, AM J HEALTH PROMOT, V30, P357, DOI 10.1177/0890117116646343
   Park S, 2015, J ACAD NUTR DIET, V115, P1996, DOI 10.1016/j.jand.2015.06.010
   Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491
   Raisborough Jayne, 2016, FAT BODIES, V0, P0
   RIEDIGER N, 2018, CMAJ CANADIAN MED AS, V190, P11
   *RUR HLTH INF HUB, 2018, AM I RUR, V0, P0
   Saldaa J, 2009, CODING MANUAL QUALIT, V0, P0
   Slobe T, 2018, LANG SOC, V47, P541, DOI 10.1017/S004740451800060X
   Stepanikova I, 2017, AM J PREV MED, V52, PS77, DOI 10.1016/j.amepre.2016.07.034
   Stroehla BC, 2005, J AM DIET ASSOC, V105, P1908, DOI 10.1016/j.jada.2005.09.002
   Tait CA, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0195962
   Thompson LE, 2009, HEALTH RISK SOC, V11, P181, DOI 10.1080/13698570902784281
   Thompson L, 2011, CRIT PUBLIC HEALTH, V21, P105, DOI 10.1080/09581591003797129
   Trivedi T, 2015, RURAL REMOTE HEALTH, V15, P0
   *US BUR CENS, 2016, IS COUNT FAST FACTS, V0, P0
   Wallace AE, 2010, OBES SURG, V20, P1354, DOI 10.1007/s11695-009-0054-x
   Wang YC, 2008, PEDIATRICS, V121, PE1604, DOI 10.1542/peds.2007-2834
   Warin M, 2008, SOCIOL HEALTH ILL, V30, P97, DOI 10.1111/j.1467-9566.2007.01029.x
   Warin M, 2011, SOC THEOR HEALTH, V9, P24, DOI 10.1057/sth.2010.2
   Warin Megan, 2011, FATNESS AND THE MATERNAL BODY: WOMENS EXPERIENCES OF CORPOREALITY AND THE SHAPING OF SOCIAL POLICY, V0, P22
   Wong MS, 2015, PATIENT EDUC COUNS, V98, P492, DOI 10.1016/j.pec.2014.12.007
   Zhang XC, 2011, COMP AM STUD, V9, P68, DOI 10.1179/147757011X12983070064953
   Zivkovic T, 2015, CAREFUL EATING: BODIES, V0, P109
NR 69
TC 7
Z9 7
U1 0
U2 12
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0958-1596
EI 1469-3682
J9 CRIT PUBLIC HEALTH
JI Crit. Public Heath
PD JAN 1
PY 2021
VL 31
IS 1
BP 113
EP 124
DI 10.1080/09581596.2019.1680804
EA OCT 2019
PG 12
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA PN8IE
UT WOS:000492116100001
DA 2025-04-28
ER

PT J
AU Deng, XJ
   Hou, Y
   Zhou, HJ
   Li, YL
   Xue, ZQ
   Xue, XT
   Huang, GH
   Huang, KL
   He, XY
   Xu, WT
AF Deng, Xiujuan
   Hou, Yan
   Zhou, Hongjie
   Li, Yali
   Xue, Zhiqiang
   Xue, Xiaoting
   Huang, Ganghua
   Huang, Kunlun
   He, Xiaoyun
   Xu, Wentao
TI Hypolipidemic, anti-inflammatory, and anti-atherosclerotic effects of tea before and after microbial fermentation
SO FOOD SCIENCE & NUTRITION
LA English
DT Article
DE anti-atherosclerotic; anti-inflammatory; hypolipidemic; microbial fermentation; tea
ID pu-erh tea; nf-kappa-b; theabrownin; inhibition; activation; extracts; caffeine; obesity; rats
AB Background Microbial fermentation significantly affects the flavor and efficacy of tea. It is generally believed that fermented tea is more effective in lowering lipids, while unfermented tea can more effectively inhibit inflammation. However, there is not sufficient evidence to support this claim. To systematically compare the hypolipidemic, anti-inflammatory, and anti-atherosclerotic effects of tea before and after microbial fermentation, hyperlipidemic rats and inflammatory injury cells were treated with Monascus purpureus-fermented pu-erh tea water extract (MPT) and sun-dried green tea water extract (SGT), respectively. Results MPT, with higher levels of theabrownins, flavonoids, gallic acid (GA), and lovastatin, was more effective in reducing serum triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and inflammatory cytokines (TNF-alpha, IL-1 beta, and IL-6), while SGT, with higher levels of tea polyphenols, amino acids, (-)-epigallocatechin gallate (EGCG), and theaflavins, was more effective in increasing serum high-density lipoprotein cholesterol (HDL-C) in hyperlipidemic rats. The foam cells on the arterial wall of the rats in the MPT group were visibly less, and the thrombosis time was longer than that in the SGT group. Cell experiments showed that MPT was more effective in protecting endothelial cells from damage than SGT. Conclusion Surprisingly, Monascus purpureus-fermented pu-erh tea not only had better hypolipidemic and anti-atherosclerotic effects than its raw material (sun-dried green tea), but also was superior in anti-inflammatory effects to the latter, which was possibly attributable to the great changes in functional ingredients during microbial fermentation.
C1 [Deng, Xiujuan] Yunnan Agr Univ, Coll Food Sci & Technol, Kunming, Yunnan, Peoples R China.
   [Hou, Yan; Zhou, Hongjie; Li, Yali; Xue, Zhiqiang; Xue, Xiaoting; Huang, Ganghua] Yunnan Agr Univ, Coll Long Run Pu Erh Tea, Kunming 650201, Yunnan, Peoples R China.
   [Huang, Kunlun; He, Xiaoyun; Xu, Wentao] China Agr Univ, Dept Nutr & Hlth, Key Lab Precis Nutr & Food Qual, Beijing 100083, Peoples R China.
C3 Yunnan Agricultural University; Yunnan Agricultural University; China Agricultural University
RP Zhou, HJ (corresponding author), Yunnan Agr Univ, Coll Long Run Pu Erh Tea, Kunming 650201, Yunnan, Peoples R China.; Xu, WT (corresponding author), China Agr Univ, Dept Nutr & Hlth, Key Lab Precis Nutr & Food Qual, Beijing 100083, Peoples R China.
EM 1984020@ynau.edu.cn; xuwentao@cau.edu.cn
FU National Natural Science Foundation of China [31260197]
CR Badshah H, 2019, BIOMOLECULES, V9, P0, DOI 10.3390/biom9110719
   Cai XB, 2017, J GASTROENTEROL, V52, P1240, DOI 10.1007/s00535-017-1332-3
   Chen LC, 2016, J FUNCT FOODS, V22, P132, DOI 10.1016/j.jff.2016.01
   Cheng MJ, 2011, PHYTOCHEM LETT, V4, P372, DOI 10.1016/j.phytol.2011.08.003
   Choi HW, 2018, INT J MOL MED, V41, P1103, DOI 10.3892/ijmm.2017.3309
   Chu SL, 2011, CHIN J INTEGR MED, V17, P492, DOI 10.1007/s11655-011-0781-4
   Mota MAD, 2015, ACTA CIR BRAS, V30, P242, DOI 10.1590/S0102-865020150040000002
   Gong JS, 2010, J FOOD SCI, V75, PH182, DOI 10.1111/j.1750-3841.2010.01675.x
   Gr√©goire √â, 2018, INT J ARTIF INTELL T, V27, P0, DOI 10.1142/S0218213018400043
   Hou Y, 2009, EXP GERONTOL, V44, P434, DOI 10.1016/j.exger.2009.03.007
   Huang FJ, 2019, FRONT PHARMACOL, V10, P0, DOI 10.3389/fphar.2019.00063
   Indra Mochamad Rasjad, 2013, BMC RES NOTES, V6, P275, DOI 10.1186/1756-0500-6-275
   Jiang XF, 2011, FOOD SCI, V32, P3
   Li Chun-lei, 2011, CHINESE JOURNAL OF BIOLOGICALS, V24, P1293
   [ÊùéÊôìÈ£û Li Xiaofei], 2017, È£üÂìÅÂ∑•‰∏öÁßëÊäÄ SCIENCE & TECHNOLOGY OF FOOD INDUSTRY, V38, P67
   Li Y, 2013, FOOD AND FERMENTATION TECHNOLOGY, V49, P34, DOI 10.3969/j.issn.1674-506X.2013.02-009
   Liu LT, 2017, BIOSCI BIOTECH BIOCH, V81, P1948, DOI 10.1080/09168451.2017.1364618
   Liu YL, 2020, MOL NEUROBIOL, V57, P96, DOI 10.1007/s12035-019-01759-7
   Lu JP, 2019, ANN INTERN MED, V170, P298, DOI 10.7326/M18-1932
   Manning S, 2014, THER ADV CHRONIC DIS, V5, P135, DOI 10.1177/2040622314522848
   Nakamura M, 2017, INT J FOOD SCI NUTR, V68, P321, DOI 10.1080/09637486.2016.1232376
   Sugiura C, 2020, J FOOD SCI, V85, P192, DOI 10.1111/1750-3841.14811
   Sun Q, 2014, PAK J PHARM SCI, V27, P1015
   Sun Y, 2019, FOOD FUNCT, V10, P3502, DOI 10.1039/C9FO00162J
   Tang NN, 2016, MOL CELL BIOCHEM, V422, P11, DOI 10.1007/s11010-016-2799-6
   Ueda P, 2017, LANCET DIABETES ENDO, V5, P196, DOI 10.1016/S2213-8587(17)30015-3
   Wang QP, 2011, J SCI FOOD AGR, V91, P2412, DOI 10.1002/jsfa.4480
   Wang TF, 2017, FRONT IMMUNOL, V8, P0, DOI 10.3389/fimmu.2017.00433
   Wu YT, 2017, EUR J PHARMACOL, V794, P52, DOI 10.1016/j.ejphar.2016.11.027
   [ËÇñÊáøÊÖß Xiao Yihui], 2019, Ë•øÂÆâ‰∫§ÈÄöÂ§ßÂ≠¶Â≠¶Êä•. ÂåªÂ≠¶Áâà JOURNAL OF XIAN JIAOTONG UNIVERSITY. MEDICAL SCIENCES, V40, P847
   Xiong C, 2019, J BIOSCI MED, V7, P120, DOI 10.4236/jbm.2019.72010
   Xiong ZX, 2019, FOOD CHEM TOXICOL, V131, P0, DOI 10.1016/j.fct.2019.110585
   Yang DF, 2020, J CELL MOL MED, V24, P5911, DOI 10.1111/jcmm.15278
   Yao Min, 2020, JOURNAL OF TEA SCIENCE, V40, P1
   Zeng XQ, 2019, J SCI FOOD AGR, V99, P6882, DOI 10.1002/jsfa.9974
   Zhang L, 2012, FOOD CHEM, V135, P2222, DOI 10.1016/j.foodchem.2012.07.033
   Zhang ShuPing Zhang ShuPing, 2019, JOURNAL OF TEA SCIENCE, V39, P231
   Zhao F, 2014, J AGR FOOD CHEM, V62, P2772, DOI 10.1021/jf4056314
   Zhong L, 2020, AQUAC RES, V51, P0, DOI 10.1111/are.14403
   Zhu MZ, 2020, FOOD CHEM, V312, P0, DOI 10.1016/j.foodchem.2019.126043
NR 40
TC 41
Z9 43
U1 5
U2 100
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2048-7177
EI 
J9 FOOD SCI NUTR
JI Food Sci. Nutr.
PD FEB 15
PY 2021
VL 9
IS 2
BP 1160
EP 1170
DI 10.1002/fsn3.2096
EA JAN 2021
PG 11
WC Food Science & Technology
SC Food Science & Technology
GA QD2RF
UT WOS:000604394900001
PM 33598200
DA 2025-04-28
ER

PT J
AU Bode, D
   Semmler, L
   Wakula, P
   Hegemann, N
   Primessnig, U
   Beindorff, N
   Powell, D
   Dahmen, R
   Ruetten, H
   Oeing, C
   Alogna, A
   Messroghli, D
   Pieske, BM
   Heinzel, FR
   Hohendanner, F
AF Bode, David
   Semmler, Lukas
   Wakula, Paulina
   Hegemann, Niklas
   Primessnig, Uwe
   Beindorff, Nicola
   Powell, David
   Dahmen, Raphael
   Ruetten, Hartmut
   Oeing, Christian
   Alogna, Alessio
   Messroghli, Daniel
   Pieske, Burkert M.
   Heinzel, Frank R.
   Hohendanner, Felix
TI Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF
SO CARDIOVASCULAR DIABETOLOGY
LA English
DT Article
DE Atrial cardiomyopathy; Heart failure with preserved ejection fraction; SGLT inhibition; Atrial remodeling; Left atrial cardiomyocytes; Calcium cycling; Mitochondria
AB Background: Sodium-glucose linked transporter type 2 (SGLT-2) inhibition has been shown to reduce cardiovascular mortality in heart failure independently of glycemic control and prevents the onset of atrial arrhythmias, a common co-morbidity in heart failure with preserved ejection fraction (HFpEF). The mechanism behind these effects is not fully understood, and it remains unclear if they could be further enhanced by additional SGLT-1 inhibition. We investigated the effects of chronic treatment with the dual SGLT-1&2 inhibitor sotagliflozin on left atrial (LA) remodeling and cellular arrhythmogenesis (i.e. atrial cardiomyopathy) in a metabolic syndrome-related rat model of HFpEF. Methods: 17 week-old ZSF-1 obese rats, a metabolic syndrome-related model of HFpEF, and wild type rats (Wistar Kyoto), were fed 30 mg/kg/d sotagliflozin for 6 weeks. At 23 weeks, LA were imaged in-vivo by echocardiography. In-vitro, Ca2+ transients (CaT; electrically stimulated, caffeine-induced) and spontaneous Ca2+ release were recorded by ratiometric microscopy using Ca2+-sensitive fluorescent dyes (Fura-2) during various experimental protocols. Mitochondrial structure (dye: Mitotracker), Ca2+ buffer capacity (dye: Rhod-2), mitochondrial depolarization (dye: TMRE) and production of reactive oxygen species (dye: H2DCF) were visualized by confocal microscopy. Statistical analysis was performed with 2-way analysis of variance followed by post-hoc Bonferroni and student's t-test, as applicable. Results: Sotagliflozin ameliorated LA enlargement in HFpEF in-vivo. In-vitro, LA cardiomyocytes in HFpEF showed an increased incidence and amplitude of arrhythmic spontaneous Ca2+ release events (SCaEs). Sotagliflozin significantly reduced the magnitude of SCaEs, while their frequency was unaffected. Sotagliflozin lowered diastolic [Ca2+] of CaT at baseline and in response to glucose influx, possibly related to a similar to 50% increase of sodium sodium-calcium exchanger (NCX) forward-mode activity. Sotagliflozin prevented mitochondrial swelling and enhanced mitochondrial Ca2+ buffer capacity in HFpEF. Sotagliflozin improved mitochondrial fission and reactive oxygen species (ROS) production during glucose starvation and averted Ca2+ accumulation upon glycolytic inhibition. Conclusion: The SGLT-1&2 inhibitor sotagliflozin ameliorated LA remodeling in metabolic HFpEF. It also improved distinct features of Ca2+-mediated cellular arrhythmogenesis in-vitro (i.e. magnitude of SCaEs, mitochondrial Ca2+ buffer capacity, diastolic Ca2+ accumulation, NCX activity). The safety and efficacy of combined SGLT-1&2 inhibition for the treatment and/or prevention of atrial cardiomyopathy associated arrhythmias should be further evaluated in clinical trials.
C1 [Bode, David; Semmler, Lukas; Wakula, Paulina; Hegemann, Niklas; Primessnig, Uwe; Oeing, Christian; Alogna, Alessio; Messroghli, Daniel; Pieske, Burkert M.; Heinzel, Frank R.; Hohendanner, Felix] Charite, Dept Internal Med & Cardiol, Campus Virchow Klinikum,Augustenburgerpl 1, D-13353 Berlin, Germany.
   [Bode, David; Semmler, Lukas; Wakula, Paulina; Hegemann, Niklas; Primessnig, Uwe; Oeing, Christian; Alogna, Alessio; Messroghli, Daniel; Pieske, Burkert M.; Heinzel, Frank R.; Hohendanner, Felix] German Ctr Cardiovasc Res DZHK, Berlin, Germany.
   [Powell, David] Lexicon Pharmaceut, Metab Res, Houston, TX USA.
   [Dahmen, Raphael; Ruetten, Hartmut] Sanofi Aventis Deutschland GmbH, Res & Dev, D-65926 Frankfurt, Germany.
   [Messroghli, Daniel; Pieske, Burkert M.] German Heart Ctr Berlin, Dept Internal Med & Cardiol, D-13353 Berlin, Germany.
   [Bode, David; Primessnig, Uwe; Oeing, Christian; Alogna, Alessio; Hohendanner, Felix] Berlin Inst Hlth BIH, Berlin, Germany.
   [Beindorff, Nicola] Charite Univ Med Berlin, Berlin Expt Radionuclide Imaging Ctr BERIC, Berlin, Germany.
C3 Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Lexicon Pharmaceuticals; Sanofi-Aventis; Sanofi Germany; German Heart Center Berlin; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin
RP Hohendanner, F (corresponding author), Charite, Dept Internal Med & Cardiol, Campus Virchow Klinikum,Augustenburgerpl 1, D-13353 Berlin, Germany.; Hohendanner, F (corresponding author), German Ctr Cardiovasc Res DZHK, Berlin, Germany.; Hohendanner, F (corresponding author), Berlin Inst Hlth BIH, Berlin, Germany.
EM felix.hohendanner@charite.de
FU Projekt DEAL; Else-Kroner-Fresenius-Foundation; DZHK (German Centre for Cardiovascular Research); Berlin Institute of Health
CR Abdul-Ghani MA, 2013, DIABETES, V62, P3324, DOI 10.2337/db13-0604
   Banerjee SK, 2009, CARDIOVASC RES, V84, P111, DOI 10.1093/cvr/cvp190
   Bilan VP, 2011, J ENDOCRINOL, V210, P293, DOI 10.1530/JOE-11-0122
   Bode D, 2018, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/57953
   Bonora BM, 2020, DIABET METAB SYND OB, V13, P161, DOI 10.2147/DMSO.S233538
   Bowen TS, 2017, J AM HEART ASSOC, V6, P0, DOI 10.1161/JAHA.117.006416
   Brown DA, 2010, CARDIOVASC RES, V88, P241, DOI 10.1093/cvr/cvq231
   Cefalo CMA, 2019, CARDIOVASC DIABETOL, V18, P0, DOI 10.1186/s12933-019-0828-y
   Connelly KA, 2018, CARDIOVASC DIABETOL, V17, P0, DOI 10.1186/s12933-018-0741-9
   de Boer RA, 2020, BRIT J CLIN PHARMACO, V86, P1346, DOI 10.1111/bcp.14248
   Drago I, 2012, P NATL ACAD SCI USA, V109, P12986, DOI 10.1073/pnas.1210718109
   Fillmore N, 2018, MOL MED, V24, P0, DOI 10.1186/s10020-018-0005-x
   Goette A, 2016, J ARRYTHM, V32, P247, DOI 10.1016/j.joa.2016.05.002
   Hamdani N, 2013, CIRC-HEART FAIL, V6, P1239, DOI 10.1161/CIRCHEARTFAILURE.113.000539
   Hohendanner F, 2018, ESC HEART FAIL, V5, P211, DOI 10.1002/ehf2.12260
   Hohendanner F, 2018, J MOL CELL CARDIOL, V115, P10, DOI 10.1016/j.yjmcc.2017.12.012
   Hohendanner F, 2018, HEART FAIL REV, V23, P27, DOI 10.1007/s10741-017-9657-9
   Hohendanner F, 2015, CHANNELS, V9, P129, DOI 10.1080/19336950.2015.1040966
   Hohendanner F, 2015, J PHYSIOL-LONDON, V593, P1459, DOI 10.1113/jphysiol.2014.283226
   Hohendanner F, 2013, CIRC RES, V113, P527, DOI 10.1161/CIRCRESAHA.113.300895
   Kashiwagi Y, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0130605
   Kohlhaas M, 2017, J PHYSIOL-LONDON, V595, P3753, DOI 10.1113/JP273609
   Kolijn D, 2021, CARDIOVASC RES, V117, P495, DOI 10.1093/cvr/cvaa123
   Lambert R, 2015, J AM HEART ASSOC, V4, P0, DOI 10.1161/JAHA.115.002183
   Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009
   Leong HS, 2002, AM J PHYSIOL-ENDOC M, V282, PE1039, DOI 10.1152/ajpendo.00507.2001
   Li Z, 2019, CARDIOVASC RES, V115, P1646, DOI 10.1093/cvr/cvz037
   Lindman BR, 2014, J AM COLL CARDIOL, V64, P541, DOI 10.1016/j.jacc.2014.05.030
   Maack C, 2006, CIRC RES, V99, P172, DOI 10.1161/01.RES.0000232546.92777.05
   Marrouche NF, 2018, NEW ENGL J MED, V378, P417, DOI 10.1056/NEJMoa1707855
   Maxwell JT, 2018, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/57225
   McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303
   Miranda-Silva D, 2020, ACTA PHYSIOL, V228, P0, DOI 10.1111/apha.13378
   Piao L, 2013, J MOL MED, V91, P333, DOI 10.1007/s00109-012-0982-0
   Powell DR, 2020, J CLIN ENDOCR METAB, V105, P0, DOI 10.1210/clinem/dgz258
   Powell DR, 2014, J PHARMACOL EXP THER, V350, P232, DOI 10.1124/jpet.114.214304
   Primessnig U, 2019, EUR J HEART FAIL, V21, P1543, DOI 10.1002/ejhf.1619
   Sabatino J, 2020, CARDIOVASC DIABETOL, V19, P0, DOI 10.1186/s12933-020-01040-5
   Schweitzer Maria K, 2017, JACC BASIC TRANSL SCI, V2, P737, DOI 10.1016/j.jacbts.2017.06.008
   Seidelmann SB, 2018, J AM COLL CARDIOL, V72, P1763, DOI 10.1016/j.jacc.2018.07.061
   Shao QM, 2019, CARDIOVASC DIABETOL, V18, P0, DOI 10.1186/s12933-019-0964-4
   Tsimihodimos V, 2018, EUR J PHARMACOL, V838, P153, DOI 10.1016/j.ejphar.2018.09.019
   Uthman L, 2018, DIABETOLOGIA, V61, P722, DOI 10.1007/s00125-017-4509-7
   Voigt N, 2014, CIRCULATION, V129, P145, DOI 10.1161/CIRCULATIONAHA.113.006641
   Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306
   Yoshii A, 2019, CARDIOVASC DIABETOL, V18, P0, DOI 10.1186/s12933-019-0889-y
   Zambrowicz B, 2012, CLIN PHARMACOL THER, V92, P158, DOI 10.1038/clpt.2012.58
   Zelniker TA, 2020, CIRCULATION, V141, P1227, DOI 10.1161/CIRCULATIONAHA.119.044183
NR 48
TC 78
Z9 83
U1 0
U2 26
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1475-2840
J9 CARDIOVASC DIABETOL
JI Cardiovasc. Diabetol.
PD JAN 7
PY 2021
VL 20
IS 1
BP 
EP 
DI 10.1186/s12933-020-01208-z
PG 14
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism
GA PS9YC
UT WOS:000608278200002
PM 33413413
DA 2025-04-28
ER

PT J
AU A√ßikalin, B
   Sanlier, N
AF Acikalin, Busra
   Sanlier, Nevin
TI Coffee and its effects on the immune system
SO TRENDS IN FOOD SCIENCE & TECHNOLOGY
LA English
DT Article
DE Coffee; Caffeine; Chlorogenic acids; Cafestol; Kahweol; Immunity; Health
ID human lymphocyte-activation; in-vitro; cytokine release; green coffee; caffeine; antioxidant; consumption; mechanisms; trigonelline; autoimmunity
AB Background: Coffee is one of the beverages consumed the most worldwide since ancient times. Previously, coffee used to be consumed due to its stimulating effect stemming from caffeine and its distinctive taste. In recent years, it has gone beyond being just a hot drink containing stimulating agents and has started to be consumed with the awareness about its positive effects on health. The compounds of coffee bearing antioxidant potential can be listed as caffeine, chlorogenic acids, caffeic acid, coumaric acid, nicotinic acid, ferulic acid, trigonelline, cafestol, and kahweol. Scope and approach: While it is reported that coffee impacts a range of chronic diseases including obesity, cancer, neurodegenerative and cardiovascular diseases due to the caffeine, chlorogenic acids, and diterpenoid alcohol it contains and that further research is needed in this respect, coffee is also related to a reduced risk of autoimmune diseases. This review aims to elaborate on the relationship between coffee consumption and the immune system. Key findings and conclusions: In addition, it has been highlighted in recent years that the above-mentioned compounds of coffee stimulate the immune system thanks to their antioxidant and anti-inflammatory effects. The positive effects of coffee on the immune system stem from caffeine, chlorogenic acids, kahweol, cafestol and similar compounds it contains. Particularly caffeine and polyphenols are considered as the main agents nourishing coffee with immunomodulatory characteristics depending on the daily dose of consumption.
C1 [Acikalin, Busra] Ankara Medipol Univ, Fac Fine Arts Design & Architecture, Dept Gastron & Culinary Arts, Ankara, Turkey.
   [Sanlier, Nevin] Ankara Medipol Univ, Sch Hlth Sci, Dept Nutr & Dietet, Ankara, Turkey.
C3 Ankara Medipol University; Ankara Medipol University
RP Sanlier, N (corresponding author), Ankara Medipol Univ, Sch Hlth Sci, Dept Nutr & Dietet, Ankara, Turkey.
EM nevin.sanlier@ankaramedipol.edu.tr
CR Abbasi A, 2018, LIFE SCI, V199, P41, DOI 10.1016/j.lfs.2018.03.009
   Agudelo-Ochoa GM, 2016, J NUTR, V146, P524, DOI 10.3945/jn.115.224774
   Al Reef T, 2018, IMMUNOBIOLOGY, V223, P818, DOI 10.1016/j.imbio.2018.08.011
   Unknown -, 2016, CRIT REV FOOD SCI, V0, P0
   Arslan E, 2018, SPORMETRE, V16, P1
   Bharath Nagaraj, 2015, CONTEMP CLIN DENT, V6, P166, DOI 10.4103/0976-237X.156036
   Boettler U, 2011, J NUTR BIOCHEM, V22, P426, DOI 10.1016/j.jnutbio.2010.03.011
   Bortoluzzi A, 2016, ARTHRITIS RES THER, V18, P0, DOI 10.1186/s13075-016-1089-8
   Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002
   Capek P, 2014, CARBOHYD POLYM, V103, P418, DOI 10.1016/j.carbpol.2013.12.068
   Cappelletti S, 2015, CURR NEUROPHARMACOL, V13, P71, DOI 10.2174/1570159X13666141210215655
   C√°rdenas C, 2014, BIOCHEM BIOPH RES CO, V447, P452, DOI 10.1016/j.bbrc.2014.04.026
   Castro ACCM, 2018, FOOD CHEM, V246, P48, DOI 10.1016/j.foodchem.2017.10.153
   Chan JYM, 2017, BMC PUBLIC HEALTH, V17, P0, DOI 10.1186/s12889-017-4362-0
   Chavez-Valdez R, 2016, PEDIATR RES, V80, P101, DOI 10.1038/pr.2016.50
   Chowdhury P, 2020, FRONT IMMUNOL, V11, P0, DOI 10.3389/fimmu.2020.590716
   Clark I, 2017, SLEEP MED REV, V31, P70, DOI 10.1016/j.smrv.2016.01.006
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   Di Dalmazi G, 2016, AUTOIMMUN HIGHLIGHTS, V7, P0, DOI 10.1007/s13317-016-0083-0
   Di Matteo G, 2020, FOODS, V9, P0, DOI 10.3390/foods9081036
   Dulson DK, 2016, APPL PHYSIOL NUTR ME, V41, P224, DOI 10.1139/apnm-2015-0456
   El-Abhar HS, 2014, WORLD J DIABETES, V5, P176, DOI 10.4239/wjd.v5.i2.176
   Esquivel P, 2012, FOOD RES INT, V46, P488, DOI 10.1016/j.foodres.2011.05.028
   Farah A, 2012, COFFEE CONSTITUENTS. COFFEE: EMERGING HEALTH EFFECTS AND DISEASE PREVENTION, V0, P0
   Farah Adriana, 2006, BRAZ. J. PLANT PHYSIOL., V18, P23, DOI 10.1590/S1677-04202006000100003
   Ferreira SS, 2018, FOOD CHEM, V242, P548, DOI 10.1016/j.foodchem.2017.09.059
   Fletcher DK, 2012, SCAND J MED SCI SPOR, V22, P249, DOI 10.1111/j.1600-0838.2010.01223.x
   Folwarczna J, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8030133
   Francis S, 2019, EARLY MOD EXCHANGE, V0, PP1, DOI 10.1080/14789450.2019.1697236
   Gebeyehu B T, 2015, AMERICAN JOURNAL OF APPLIED CHEMISTRY, V3, P69, DOI 10.11648/j.ajac.20150302.16
   G√∂kcen BB, 2019, CRIT REV FOOD SCI, V59, P336, DOI 10.1080/10408398.2017.1369391
   Gostner JM, 2015, J AM COLL NUTR, V34, P212, DOI 10.1080/07315724.2014.907756
   Green TD, 2012, J LEUKOCYTE BIOL, V92, P633, DOI 10.1189/jlb.1211604
   Hashemian F, 2020, EUR J PHARMACOL, V887, P1
   Hirakawa N, 2005, BIOSCI BIOTECH BIOCH, V69, P653, DOI 10.1271/bbb.69.653
   Ilhan M, 2014, EVID-BASED COMPL ALT, V2014, P1, DOI 10.1155/2014/578103
   J√§ger A, 2010, SCAND J IMMUNOL, V72, P173, DOI 10.1111/j.1365-3083.2010.02432.x
   Jia HJ, 2014, GENES NUTR, V9, P0, DOI 10.1007/s12263-014-0389-3
   Jung S, 2017, J MED FOOD, V20, P626
   Kale LB, 2017, INTERNATIONAL JOURNAL OF COMMUNITY MEDICINE AND PUBLIC HEALTH, V4, P835
   Kelly, 2013, P INT CYT SOC ANN M, V0, P0
   K√∂r√∂glu √ñA, 2014, NEONATOLOGY, V106, P235, DOI 10.1159/000363217
   Kurzrock T, 2001, FOOD REV INT, V17, P433, DOI 10.1081/FRI-100108532
   Lee KA, 2012, J BIOMED SCI, V19, P0, DOI 10.1186/1423-0127-19-60
   Liu CW, 2018, AM J PHYSIOL-ENDOC M, V314, PE433, DOI 10.1152/ajpendo.00094.2017
   Loftfield E, 2015, CANCER EPIDEM BIOMAR, V24, P1052, DOI 10.1158/1055-9965.EPI-15-0038-T
   L√≥pez-Barrera DM, 2016, FOOD CHEM, V212, P282, DOI 10.1016/j.foodchem.2016.05.175
   Mes√≠as M, 2014, FOOD RES INT, V62, P1120, DOI 10.1016/j.foodres.2014.05.058
   Molina N, 2015, INT IMMUNOPHARMACOL, V28, P985, DOI 10.1016/j.intimp.2015.08.011
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Niseteo T, 2012, FOOD CHEM, V134, P1870, DOI 10.1016/j.foodchem.2012.03.095
   Owoyele B V, 2015, AFR J MED MED SCI, V44, P229
   Pimentel GD, 2014, NUTRITION IN THE PREVENTION AND TREATMENT OF ABDOMINAL OBESITY, V0, PP245, DOI 10.1016/B978-0-12-407869-7.00024-6
   Pohanka M, 2015, J APPL BIOMED, V13, P1, DOI 10.1016/j.jab.2014.09.001
   Pourshahidi LK, 2016, COMPR REV FOOD SCI F, V15, P671, DOI 10.1111/1541-4337.12206
   Ramamoorthy V, 2017, J ASSOC NURSE AIDS C, V28, P897, DOI 10.1016/j.jana.2017.07.008
   Ramanaviciene A, 2004, J PHARM PHARMACOL, V56, P671, DOI 10.1211/0022357023268
   Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109
   Reichardt N, 2009, MOL NUTR FOOD RES, V53, P287, DOI 10.1002/mnfr.200700509
   Revuelta-Iniesta R, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/482704
   Reyes CM, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10111772
   Samieirad S, 2017, J CRANIO MAXILL SURG, V45, P1614, DOI 10.1016/j.jcms.2017.06.014
   Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005
   Semen S, 2017, FOOD CHEM, V215, P92, DOI 10.1016/j.foodchem.2016.07.176
   Sharif K, 2017, AUTOIMMUN REV, V16, P712, DOI 10.1016/j.autrev.2017.05.007
   Sharma D, 2020, AIJR PREPRINTS, V78, P1
   Steck RP, 2015, PHARMACOL RES PERSPE, V3, P0, DOI 10.1002/prp2.180
   Tek N, 2017, KAHVE TUKETIMI VE BA, V0, P0
   Toci AT, 2008, FOOD CHEM, V108, P1133, DOI 10.1016/j.foodchem.2007.11.064
   Tofalo R, 2016, THE ENCYCLOPEDIA OF FOOD AND HEALTH, V0, P2
   Tomas-Barberan F, 2011, TEAS COCOA COFFEE PL, V0, P169
   Tunc T, 2013, REGUL PEPTIDES, V182, P41, DOI 10.1016/j.regpep.2012.12.016
   Valdez RC, 2011, J PEDIATR-US, V158, P38, DOI 10.1016/j.jpeds.2010.06.051
   V√°zquez-S√°nchez K, 2018, FOOD CHEM, V261, P253, DOI 10.1016/j.foodchem.2018.04.064
   Viani R, 2005, ESPRESSO COFFEE SCI, V0, P148
   Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582
   Wachamo H L, 2017, MEDICINAL AROMATIC PLANTS, V6, P0, DOI 10.4172/2167-0412.1000301
   Xu JG, 2012, J AGR FOOD CHEM, V60, P11625, DOI 10.1021/jf303771s
   Yesilada E, 2015, BESIN DESTEKLERI VE, V0, P0
   You DC, 2011, TOX RESEARCH, V27, P7, DOI 10.5487/TR.2011.27.1.007
   Zampelas A, 2004, AM J CLIN NUTR, V80, P862, DOI 10.1093/ajcn/80.4.862
   Zhang C, 2012, FOOD RES INT, V49, P27, DOI 10.1016/j.foodres.2012.06.032
   Zhou J, 2012, CURR MED CHEM, V19, P3523, DOI 10.2174/092986712801323171
   Zhou JY, 2013, FUND CLIN PHARMACOL, V27, P279, DOI 10.1111/j.1472-8206.2011.01022.x
NR 84
TC 30
Z9 31
U1 5
U2 62
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0924-2244
EI 1879-3053
J9 TRENDS FOOD SCI TECH
JI Trends Food Sci. Technol.
PD AUG 15
PY 2021
VL 114
IS 
BP 625
EP 632
DI 10.1016/j.tifs.2021.06.023
EA JUN 2021
PG 8
WC Food Science & Technology
SC Food Science & Technology
GA TD3EQ
UT WOS:000669214600014
DA 2025-04-28
ER

PT J
AU Cornelis, MC
AF Cornelis, Marilyn C.
TI Recent consumption of a caffeine-containing beverage and serum biomarkers of cardiometabolic function in the UK Biobank
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Caffeine; Coffee; Glucose; Cholesterol; Acute effects; Genetics; Biomarkers
ID cardiovascular-disease; coffee ingestion; epidemiology; metaanalysis; variants; glucose; cyp1a2; risk; age
AB We investigated the impact of recent caffeine drinking on glucose and other biomarkers of cardiometabolic function under free-living conditions while also accounting for lifestyle and genetic factors that alter caffeine metabolism and drinking behaviour. Up to 447 794 UK Biobank participants aged 37-73 years in 2006-2010 provided a non-fasting blood sample, for genetic and biomarker measures, and completed questionnaires regarding sociodemographics, medical history and lifestyle. Caffeine drinking (yes/no) about 1 h before blood collection was also recorded. Multivariable regressions were used to examine the association between recent caffeine drinking and serum levels of glycated Hb, glucose, lipids, apo, lipoprotein(a) and C-reactive protein. Men and women reporting recent caffeine drinking had clinically and significantly higher glucose levels than those not recently drinking caffeine (P < 0 center dot 0001). Larger effect sizes were observed among those 55+ years of age and with higher adiposity and longer fasting times (P <= 0 center dot 02 for interactions). Significant CYP1A2 rs2472297xcaffeine and MLXIPL rs7800944 x caffeine interactions on glucose levels were observed among women (P = 0 center dot 004), with similar but non-significant interactions in men. Larger effect sizes were observed among women with rs2472297 CC or rs7800944 CC genotypes than among rs2472297 T or rs7800944 T carriers, respectively. In summary, men and women drinking caffeine within about 1 h of blood draw had higher glucose levels than those not drinking caffeine. Findings were modified by age, adiposity, fasting time and genetic factors related to caffeine metabolism and drinking behaviour. Implications for clinical and population studies of caffeine-containing beverages and cardiometabolic health are discussed.
C1 [Cornelis, Marilyn C.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
C3 Northwestern University; Feinberg School of Medicine
RP Cornelis, MC (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
EM marilyn.cornelis@northwestern.edu
FU Office of the Provost; Office for Research; National Institute on Aging (NIA) [K01AG053477]; Northwestern University Information Technology
CR Abdul-Wahed A, 2017, CELL METAB, V26, P324, DOI 10.1016/j.cmet.2017.07.004
   Unknown -, 2015, DIABETES CARE, V38, PS8, DOI 10.2337/dc15-S005
   Arnaud Maurice J, 2011, HANDB EXP PHARMACOL, V0, PP33, DOI 10.1007/978-3-642-13443-2_3
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   BLANE D, 1989, BRIT J SOCIOL, V40, P344, DOI 10.2307/590279
   Bradbury KE, 2018, J NUTR SCI, V7, P0, DOI 10.1017/jns.2017.66
   Cheung RJ, 2005, ANN PHARMACOTHER, V39, P1209, DOI 10.1345/aph.1G005
   Chung WG, 2000, CLIN PHARMACOL THER, V67, P258, DOI 10.1067/mcp.2000.104617
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Cornelis MC, 2014, CURRENT NUTRITION REPORTS, V3, P178
   Cornelis MC, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10101343
   Cornelis MC, 2016, HUM MOL GENET, V25, P5472, DOI 10.1093/hmg/ddw334
   Cornelis MC, 2015, CURR OPIN LIPIDOL, V26, P20, DOI 10.1097/MOL.0000000000000143
   Cornelis MC, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002033
   Cornelis MC, 2019, ADV FOOD NUTR RES, V0, P0
   Emami MR, 2019, COMPLEMENT THER MED, V44, P282, DOI 10.1016/j.ctim.2019.05.003
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246
   Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9
   Gunes A, 2008, PHARMACOGENOMICS, V9, P625, DOI 10.2217/14622416.9.5.625
   KAMIMIRO GH, 1987, EUR J CLIN PHARMACOL, V31, P595, DOI 10.1007/BF00606637
   Kolberg JA, 2009, DIABETES CARE, V32, P1207, DOI 10.2337/dc08-1935
   Koupenova Milka, 2013, J CELL PHYSIOL, V0, P0, DOI DOI 10.1002/jcp.24352
   Liu B, 2011, PUBLIC HEALTH NUTR, V14, P1998, DOI 10.1017/S1368980011000942
   Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3
   McKeown NM, 2018, DIABETOLOGIA, V61, P317, DOI 10.1007/s00125-017-4475-0
   Nybo M, 2005, CLIN CHEM, V51, P1563, DOI 10.1373/clinchem.2005.051789
   Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010
   Poole R, 2017, BMJ-BRIT MED J, V359, P0, DOI 10.1136/bmj.j5024
   Reyes CM, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10111772
   Shechter M, 2011, AM J CARDIOL, V107, P1255, DOI 10.1016/j.amjcard.2010.12.035
   Simundic AM, 2014, CLIN CHIM ACTA, V432, P33, DOI 10.1016/j.cca.2013.11.008
   Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086
   Thorn CF, 2012, PHARMACOGENET GENOM, V22, P73, DOI 10.1097/FPC.0b013e32834c6efd
   UK Biobank, 2015, GENOTYPE IMPUTATION, V0, P0
   UK Biobank, 2011, BIOSP MAN COLL BIOL, V0, P0
   UK Biobank, 2011, BLOOD SAMPL COLL PRO, V0, P0
   UK Biobank, 2019, UK BIOB BIOM PROJ CO, V0, P0
   Wang ZM, 2011, AM J CLIN NUTR, V93, P506, DOI 10.3945/ajcn.110.005363
   Yang WS, 2014, BRIT J NUTR, V111, P1329, DOI 10.1017/S0007114513003887
   Zargar A, 2013, J CLIN LIPIDOL, V7, P165, DOI 10.1016/j.jacl.2012.11.001
   Zhong VW, 2019, HUM MOL GENET, V28, P2449, DOI 10.1093/hmg/ddz061
NR 43
TC 3
Z9 3
U1 0
U2 4
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD AUG 28
PY 2021
VL 126
IS 4
BP 582
EP 590
DI 10.1017/S0007114520004377
PG 9
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA TI0CQ
UT WOS:000672449600011
PM 33143770
DA 2025-04-28
ER

PT J
AU Socala, K
   Szopa, A
   Serefko, A
   Poleszak, E
   Wlaz, P
AF Socala, Katarzyna
   Szopa, Aleksandra
   Serefko, Anna
   Poleszak, Ewa
   Wlaz, Piotr
TI Neuroprotective Effects of Coffee Bioactive Compounds: A Review
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE coffee consumption; caffeine; chlorogenic acid; caffeic acid; trigonelline; neuroprotection; Alzheimer's disease; Parkinson's disease; stroke
ID acid phenethyl-ester; adenosine a(2a) receptor; acute ischemic-stroke; neuronal cell-death; cytochrome-p450 1a2 activity; nigral dopaminergic-neurons; acute myocardial-infarction; dose-response metaanalysis; focal cortical infarction; tandem mass-spectrometry
AB Coffee is one of the most widely consumed beverages worldwide. It is usually identified as a stimulant because of a high content of caffeine. However, caffeine is not the only coffee bioactive component. The coffee beverage is in fact a mixture of a number of bioactive compounds such as polyphenols, especially chlorogenic acids (in green beans) and caffeic acid (in roasted coffee beans), alkaloids (caffeine and trigonelline), and the diterpenes (cafestol and kahweol). Extensive research shows that coffee consumption appears to have beneficial effects on human health. Regular coffee intake may protect from many chronic disorders, including cardiovascular disease, type 2 diabetes, obesity, and some types of cancer. Importantly, coffee consumption seems to be also correlated with a decreased risk of developing some neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, and dementia. Regular coffee intake may also reduce the risk of stroke. The mechanism underlying these effects is, however, still poorly understood. This review summarizes the current knowledge on the neuroprotective potential of the main bioactive coffee components, i.e., caffeine, chlorogenic acid, caffeic acid, trigonelline, kahweol, and cafestol. Data from both in vitro and in vivo preclinical experiments, including their potential therapeutic applications, are reviewed and discussed. Epidemiological studies and clinical reports on this matter are also described. Moreover, potential molecular mechanism(s) by which coffee bioactive components may provide neuroprotection are reviewed.
C1 [Socala, Katarzyna; Wlaz, Piotr] Marie Curie Sklodowska Univ, Inst Biol Sci, Dept Anim Physiol & Pharmacol, Akad 19, PL-20033 Lublin, Poland.
   [Szopa, Aleksandra; Serefko, Anna; Poleszak, Ewa] Med Univ Lublin, Chair & Dept Appl & Social Pharm, Lab Preclin Testing, Chodzki 1, PL-20093 Lublin, Poland.
C3 Maria Curie-Sklodowska University; Medical University of Lublin
RP Socala, K (corresponding author), Marie Curie Sklodowska Univ, Inst Biol Sci, Dept Anim Physiol & Pharmacol, Akad 19, PL-20033 Lublin, Poland.
EM k.socala@poczta.umcs.lublin.pl; aleksandra.szopa@umlub.pl; anna.serefko@umlub.pl; ewa.poleszak@umlub.pl; piotr.wlaz@poczta.umcs.lublin.pl
CR Ahn Eun Hee, 2011, EXP NEUROBIOL, V20, P169, DOI 10.5607/en.2011.20.4.169
   Aho L, 2006, STROKE, V37, P2940, DOI 10.1161/01.STR.0000248777.44128.93
   Akomolafe SF, 2017, NEUROTOXICOLOGY, V62, P6, DOI 10.1016/j.neuro.2017.04.008
   Alarc√≥n-Herrera N, 2017, FOOD CHEM TOXICOL, V109, P1018, DOI 10.1016/j.fct.2017.04.048
   Alexander M, 2013, BRAIN SCI, V3, P177, DOI 10.3390/brainsci3010177
   Alexandrov Peter N, 2012, INT J BIOCHEM MOL BIOL, V3, P365
   Altman RD, 2011, MOVEMENT DISORD, V26, P2427, DOI 10.1002/mds.23873
   Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25
   Anjomshoa M, 2020, CURR PHARM DESIGN, V26, P5067, DOI 10.2174/1381612826666200610181259
   Unknown -, 2015, J DRUG ALCOHOL RES, V0, P0, DOI DOI 10.4303/jdar/235959
   Anwar J, 2012, PHARMACOL BIOCHEM BE, V103, P386, DOI 10.1016/j.pbb.2012.09.006
   Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021
   Arendash GW, 2010, J ALZHEIMERS DIS, V20, PS117, DOI 10.3233/JAD-2010-091249
   Arendash GW, 2009, J ALZHEIMERS DIS, V17, P661, DOI 10.3233/JAD-2009-1087
   Arnaud MJ, 1993, CAFFEINE COFFEE HLTH, V0, P43
   Aronowski J, 2003, STROKE, V34, P1246, DOI 10.1161/01.STR.0000068170.80517.B3
   Aseervatham GSB, 2016, BIOMED PHARMACOTHER, V82, P54, DOI 10.1016/j.biopha.2016.04.066
   Backman JT, 2006, BRIT J CLIN PHARMACO, V62, P345, DOI 10.1111/j.1365-2125.2006.02653.x
   Bae JH, 2014, INTEGR MED RES, V3, P189, DOI 10.1016/j.imr.2014.08.002
   Bae Jong Myon, 2020, DEMENT NEUROCOGN DISORD, V19, P108, DOI 10.12779/dnd.2020.19.3.108
   Bagga P, 2016, NEUROCHEM INT, V92, P25, DOI 10.1016/j.neuint.2015.11.006
   Bagheri H, 1999, CLIN NEUROPHARMACOL, V22, P213
   Quintana JLB, 2007, NEUROL RES, V29, P91, DOI 10.1179/174313206X152546
   Silva RB, 2013, NEUROSCIENCE, V233, P86, DOI 10.1016/j.neuroscience.2012.12.041
   Bateman RJ, 2011, ALZHEIMERS RES THER, V3, P0, DOI 10.1186/alzrt59
   Beghi E, 2019, LANCET NEUROL, V18, P357, DOI 10.1016/S1474-4422(19)30034-1
   Beghi E, 2020, NEUROEPIDEMIOLOGY, V54, P185, DOI 10.1159/000503831
   Ben Haim Lucile, 2015, FRONT CELL NEUROSCI, V9, P278, DOI 10.3389/fncel.2015.00278
   Beydoun MA, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-643
   Bizzo MLG, 2015, COFFEE IN HEALTH AND DISEASE PREVENTION, V0, PP11, DOI 10.1016/B978-0-12-409517-5.00002-4
   BLANCHARD J, 1983, EUR J CLIN PHARMACOL, V24, P93, DOI 10.1007/BF00613933
   BLANCHARD J, 1983, J CLIN PHARMACOL, V23, P134, DOI 10.1002/j.1552-4604.1983.tb02716.x
   BLANCHARD J, 1983, J PHARMACOKINET BIOP, V11, P109, DOI 10.1007/BF01061844
   Bl√ºmcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220
   Boettler U, 2011, J NUTR BIOCHEM, V22, P426, DOI 10.1016/j.jnutbio.2010.03.011
   BONATI M, 1982, CLIN PHARMACOL THER, V32, P98, DOI 10.1038/clpt.1982.132
   Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012
   BRACHTEL D, 1988, Z GASTROENTEROL, V26, P245
   Bresciani L, 2020, MOL NUTR FOOD RES, V0, P0, DOI DOI 10.1002/mnfr.202000489
   Briellmann RS, 2002, ANN NEUROL, V51, P641, DOI 10.1002/ana.10171
   Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381
   Brown RG, 2011, J NEUROL NEUROSUR PS, V82, P803, DOI 10.1136/jnnp.2010.213652
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   CALLAHAN MM, 1982, DRUG METAB DISPOS, V10, P417
   Camfield DA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0082897
   Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002
   Carrillo JA, 2000, CLIN PHARMACOKINET, V39, P127, DOI 10.2165/00003088-200039020-00004
   Carta AR, 2009, J NEUROCHEM, V111, P1478, DOI 10.1111/j.1471-4159.2009.06425.x
   Cereda C, 2012, FRONT NEUROL NEUROSC, V30, P128, DOI 10.1159/000333610
   Cervellati C, 2016, J INVEST MED, V64, P21, DOI 10.1136/jim-2015-000017
   Cheek Martin, 2002, KEW BULLETIN, V57, P675, DOI 10.2307/4110998
   Chen JF, 2001, J NEUROSCI, V21, Part. no., DOI 10.1523/JNEUROSCI.21-10-j0001.2001
   Chen XS, 2008, J NEUROCHEM, V107, P1147, DOI 10.1111/j.1471-4159.2008.05697.x
   Chen Y, 2010, ANN PHARMACOTHER, V44, P1038, DOI 10.1345/aph.1M533
   Chen Y, 2009, CLIN EXP PHARMACOL P, V36, P828, DOI 10.1111/j.1440-1681.2009.05158.x
   Chen ZC, 2014, NEUROSCI BULL, V30, P271, DOI 10.1007/s12264-013-1423-y
   Cho ES, 2009, MUTAT RES-FUND MOL M, V661, P18, DOI 10.1016/j.mrfmmm.2008.10.021
   CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6
   Chowdhury AA, 2018, METAB BRAIN DIS, V33, P681, DOI 10.1007/s11011-017-0147-5
   Chowdhury AA, 2018, PHARMACOL REP, V70, P372, DOI 10.1016/j.pharep.2017.09.006
   Christensen A, 2015, FRONT AGING NEUROSCI, V7, P0, DOI 10.3389/fnagi.2015.00130
   Chu YF, 2009, J AGR FOOD CHEM, V57, P9801, DOI 10.1021/jf902095z
   Ciaramelli C, 2019, FOOD CHEM, V278, P47, DOI 10.1016/j.foodchem.2018.11.063
   Clifford MN, 2020, COMPR REV FOOD SCI F, V19, P1299, DOI 10.1111/1541-4337.12518
   Clifford MN, 2017, NAT PROD REP, V34, P1391, DOI 10.1039/c7np00030h
   CLIFFORD MN, 1991, PHYTOCHEMISTRY, V30, P4039, DOI 10.1016/0031-9422(91)83461-S
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Coelho VR, 2016, N-S ARCH PHARMACOL, V389, P1195, DOI 10.1007/s00210-016-1281-z
   Coelho VR, 2015, LIFE SCI, V122, P65, DOI 10.1016/j.lfs.2014.11.009
   Colombo R, 2020, CRIT REV FOOD SCI, V60, P760, DOI 10.1080/10408398.2018.1550384
   Colonnello A, 2020, NEUROTOX RES, V37, P326, DOI 10.1007/s12640-019-00133-8
   Contestabile A, 2011, BEHAV BRAIN RES, V221, P334, DOI 10.1016/j.bbr.2009.12.044
   Cornelis MC, 2007, CURR OPIN LIPIDOL, V18, P13, DOI 10.1097/MOL.0b013e3280127b04
   Costa J, 2010, J ALZHEIMERS DIS, V20, PS221, DOI 10.3233/JAD-2010-091525
   Costa MS, 2008, NEUROSCIENCE, V153, P1071, DOI 10.1016/j.neuroscience.2008.03.038
   Crews L, 2010, HUM MOL GENET, V19, PR12, DOI 10.1093/hmg/ddq160
   Crichton GE, 2013, PLANT FOOD HUM NUTR, V68, P279, DOI 10.1007/s11130-013-0370-0
   Cropley V, 2012, PSYCHOPHARMACOLOGY, V219, P737, DOI 10.1007/s00213-011-2395-0
   DallIgna OP, 2007, EXP NEUROL, V203, P241, DOI 10.1016/j.expneurol.2006.08.008
   Dalllgna OP, 2003, BRIT J PHARMACOL, V138, P1207, DOI 10.1038/sj.bjp.0705185
   Davis AP, 2006, BOT J LINN SOC, V152, P465, DOI 10.1111/j.1095-8339.2006.00584.x
   Davis AP, 2004, BOT J LINN SOC, V146, P237, DOI 10.1111/j.1095-8339.2004.00328.x
   Davis AP, 2003, BOT J LINN SOC, V142, P111, DOI 10.1046/j.1095-8339.2003.00154.x
   de Lanerolle NC, 2005, EPILEPSY BEHAV, V7, P190, DOI 10.1016/j.yebeh.2005.06.003
   de Mendon√ßa A, 2010, J ALZHEIMERS DIS, V20, PS1, DOI 10.3233/JAD-2010-1420
   de Oliveira DM, 2011, QUIM NOVA, V34, P1051, DOI 10.1590/S0100-40422011000600023
   de Oliveira MR, 2020, NEUROTOX RES, V37, P100, DOI 10.1007/s12640-019-00107-w
   De Roos B, 1998, J INTERN MED, V244, P451, DOI 10.1111/j.1365-2796.1998.00386.x
   Delgado-Escueta AV, 2010, HISTOPATHOLOGY HUMAN, V4th, P0
   Dening Tom, 2015, NURS STAND, V29, P37, DOI 10.7748/ns.29.37.37.e9405
   Deshmukh R, 2016, BIOMED PHARMACOTHER, V81, P56, DOI 10.1016/j.biopha.2016.03.017
   Devasagayam TPA, 1996, BBA-BIOMEMBRANES, V1282, P63, DOI 10.1016/0005-2736(96)00040-5
   Di Marco LY, 2015, NEUROBIOL DIS, V82, P593, DOI 10.1016/j.nbd.2015.08.014
   Di Marco LY, 2014, J ALZHEIMERS DIS, V42, P119, DOI 10.3233/JAD-132225
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Divis Pavel, 2019, POTRAVINARSTVO: SLOVAK JOURNAL OF FOOD SCIENCES, V13, P344, DOI 10.5219/1062
   D√≥rea JG, 2005, BRIT J NUTR, V93, P773, DOI 10.1079/BJN20051370
   Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3
   Nunes RGD, 2019, PESTIC BIOCHEM PHYS, V157, P161, DOI 10.1016/j.pestbp.2019.03.017
   Sales IMD, 2011, NEUROL SCI, V32, P375, DOI 10.1007/s10072-010-0420-4
   Erk T, 2012, MOL NUTR FOOD RES, V56, P1488, DOI 10.1002/mnfr.201200222
   Eskelinen MH, 2010, J ALZHEIMERS DIS, V20, PS167, DOI 10.3233/JAD-2010-1404
   Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920
   Esopenko C, 2015, J NEUROTRAUM, V32, P209, DOI 10.1089/neu.2014.3506
   Evans SM, 1999, W INDIAN MED J, V48, P23
   Faber MS, 2004, CLIN PHARMACOL THER, V76, P178, DOI 10.1016/j.clpt.2004.04.003
   Fahanik-Babaei J, 2019, METAB BRAIN DIS, V34, P191, DOI 10.1007/s11011-018-0338-8
   Farah A, 2015, COFFEE HLTH DIS PREV, V0, PP789, DOI 10.1016/B978-0-12-409517-5.00087-5
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Farah A, 2018, BURL DODDS AGR SCI, V39, P259, DOI 10.19103/AS.2017.0036.14
   Farias-Pereira R, 2019, FOOD SCI BIOTECHNOL, V28, P1287, DOI 10.1007/s10068-019-00662-0
   Farrell TL, 2011, DRUG METAB DISPOS, V39, P2338, DOI 10.1124/dmd.111.040147
   Folch J, 2015, LIFE SCI, V140, P19, DOI 10.1016/j.lfs.2015.05.002
   Fondell E, 2015, AMYOTROPH LAT SCL FR, V16, P366, DOI 10.3109/21678421.2015.1020813
   Fontanilla CV, 2011, NEUROSCIENCE, V188, P135, DOI 10.1016/j.neuroscience.2011.04.009
   Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Fu W, 2017, BEHAV BRAIN RES, V328, P81, DOI 10.1016/j.bbr.2017.04.012
   FUHR U, 1995, INT J CLIN PHARM TH, V33, P311
   FUHR U, 1993, BRIT J CLIN PHARMACO, V35, P431, DOI 10.1111/j.1365-2125.1993.tb04162.x
   FUHR U, 1992, ANTIMICROB AGENTS CH, V36, P942, DOI 10.1128/AAC.36.5.942
   Furstenau CR, 2019, TOXICOL IN VITRO, V61, P0, DOI 10.1016/j.tiv.2019.104601
   Gans JMD, 2010, ARTERIOSCL THROM VAS, V30, P1665, DOI 10.1161/ATVBAHA.109.201939
   Gao LJ, 2020, DRUG DES DEV THER, V14, P1705, DOI 10.2147/DDDT.S235969
   Gaur V, 2013, PHARM BIOL, V51, P550, DOI 10.3109/13880209.2012.747547
   GEORGIEV V, 1993, BRAIN RES, V612, P271, DOI 10.1016/0006-8993(93)91672-F
   Gevaerd MS, 2001, BRAIN RES BULL, V55, P101, DOI 10.1016/S0361-9230(01)00501-9
   Giunta S, 2014, INT J BIOCHEM CELL B, V54, P122, DOI 10.1016/j.biocel.2014.07.009
   G√∂kcen BB, 2019, CRIT REV FOOD SCI, V59, P336, DOI 10.1080/10408398.2017.1369391
   GRANT DM, 1983, CLIN PHARMACOL THER, V33, P355, DOI 10.1038/clpt.1983.45
   Greenberg JA, 2008, AM J CARDIOL, V102, P1502, DOI 10.1016/j.amjcard.2008.07.046
   Grosso LM, 2008, ANN EPIDEMIOL, V18, P172, DOI 10.1016/j.annepidem.2007.11.005
   Grutzendler J, 2007, ANN NY ACAD SCI, V1097, P30, DOI 10.1196/annals.1379.003
   dos Santos NAG, 2014, NEUROTOXICOLOGY, V45, P131, DOI 10.1016/j.neuro.2014.09.007
   Gul Z, 2016, NEUROCHEM RES, V41, P2075, DOI 10.1007/s11064-016-1919-8
   Guo ZK, 2017, TRANSL NEUROSCI, V8, P176, DOI 10.1515/tnsci-2017-0024
   Ha HR, 1996, EUR J CLIN PHARMACOL, V49, P309, DOI 10.1007/BF00226333
   Habtemariam S, 2017, MINI-REV MED CHEM, V17, P667, DOI 10.2174/1389557516666161130100947
   Han K, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0158845
   Han ME, 2009, BMC NEUROSCI, V10, P0, DOI 10.1186/1471-2202-10-110
   Hao ML, 2015, EXP THER MED, V9, P1887, DOI 10.3892/etm.2015.2367
   Hao RL, 2020, FOOD CHEM TOXICOL, V144, P0, DOI 10.1016/j.fct.2020.111636
   Hardoff R, 2001, MOVEMENT DISORD, V16, P1041, DOI 10.1002/mds.1203
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Hartley TR, 2004, AM J CARDIOL, V93, P1022, DOI 10.1016/j.amjcard.2003.12.057
   Hayes MT, 2019, AM J MED, V132, P802, DOI 10.1016/j.amjmed.2019.03.001
   Heitman E, 2017, NUTR NEUROSCI, V20, P32, DOI 10.1179/1476830514Y.0000000146
   Henshall DC, 2007, BIOCHEM SOC T, V35, P421, DOI 10.1042/BST0350421
   Hermansen Kjeld, 2012, UGESKR LAEGER, V174, P2293
   Hermawati E, 2020, EUR J NEUROSCI, V51, P651, DOI 10.1111/ejn.14556
   Hern√°n MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277
   Herv√© D, 2005, J NEUROL NEUROSUR PS, V76, P200, DOI 10.1136/jnnp.2004.041012
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Homan DJ, 2006, NUTR REV, V64, P43, DOI 10.1301/nr.2006.jan.43-46
   Hornykiewicz O, 1987, ADV NEUROL, V45, P19
   Horrigan LA, 2006, PHARMACOL THERAPEUT, V111, P877, DOI 10.1016/j.pharmthera.2006.02.002
   Hu G, 2007, MOVEMENT DISORD, V22, P2242, DOI 10.1002/mds.21706
   Huang YJ, 2013, NEUROSCI LETT, V535, P146, DOI 10.1016/j.neulet.2012.12.051
   Hwang JY, 2013, NEUROPSYCHOPHARMACOL, V38, P167, DOI 10.1038/npp.2012.134
   Hwang SA, 2018, KOREAN J PHYSIOL PHA, V22, P101, DOI 10.4196/kjpp.2018.22.1.101
   Hwang YP, 2008, FEBS LETT, V582, P2655, DOI 10.1016/j.febslet.2008.06.045
   Ikeda K, 2002, J NEUROCHEM, V80, P262, DOI 10.1046/j.0022-3042.2001.00694.x
   Im SE, 2010, J MED FOOD, V13, P779, DOI 10.1089/jmf.2009.1204
   Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37
   International Coffee Organization, 2020, COFF TRAD STAT TABL, V0, P0
   Ishida K, 2020, NEUROSCI RES, V154, P35, DOI 10.1016/j.neures.2019.05.001
   Izuta H, 2008, J AGR FOOD CHEM, V56, P8944, DOI 10.1021/jf8014206
   JACKSON GD, 1990, NEUROLOGY, V40, P1869, DOI 10.1212/WNL.40.12.1869
   Jayaraj RL, 2019, J NEUROINFLAMM, V16, P0, DOI 10.1186/s12974-019-1516-2
   Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353
   Jensen MB, 2005, ARCH NEUROL-CHICAGO, V62, P537, DOI 10.1001/archneur.62.4.537
   Jeong CH, 2011, CHIN MED-UK, V6, P0, DOI 10.1186/1749-8546-6-25
   Jimenez-Del-Rio M, 2010, NEUROCHEM RES, V35, P227, DOI 10.1007/s11064-009-0046-1
   Jodynis-Liebert J, 2004, J CLIN PHARMACOL, V44, P338, DOI 10.1177/0091270004263468
   Joghataie MT, 2004, PARKINSONISM RELAT D, V10, P465, DOI 10.1016/j.parkreldis.2004.06.004
   Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283
   Kachroo A, 2010, EXP NEUROL, V223, P657, DOI 10.1016/j.expneurol.2010.02.007
   Kalia LV, 2016, NAT REV NEUROL, V12, P65, DOI 10.1038/nrneurol.2015.249
   Kalonia H, 2009, NEUROSCI BULL, V25, P343, DOI 10.1007/s12264-009-0513-3
   Kato M, 2018, EVID-BASED COMPL ALT, V2018, P0, DOI 10.1155/2018/8608497
   Kawachi I, 1996, ARCH INTERN MED, V156, P521, DOI 10.1001/archinte.156.5.521
   Khalili M, 2018, INT IMMUNOPHARMACOL, V61, P355, DOI 10.1016/j.intimp.2018.06.019
   Khan KA, 2013, J PHARM PHARMACOL, V65, P1745, DOI 10.1111/jphp.12126
   Khan M, 2007, J NEUROCHEM, V102, P365, DOI 10.1111/j.1471-4159.2007.04526.x
   Kilicdag H, 2014, J MATERN-FETAL NEO M, V27, P1470, DOI 10.3109/14767058.2013.878694
   Kim B, 2012, KOREAN J FAM MED, V33, P356, DOI 10.4082/kjfm.2012.33.6.356
   Kim IH, 2013, PLANTA MED, V79, P313, DOI 10.1055/s-0032-1328211
   Kim J, 2012, NEUROCHEM INT, V60, P466, DOI 10.1016/j.neuint.2012.02.004
   Kim SR, 2000, PHYTOCHEMISTRY, V54, P503, DOI 10.1016/S0031-9422(00)00110-2
   Kim YS, 2015, NEUROEPIDEMIOLOGY, V44, P51, DOI 10.1159/000371710
   Klucken J, 2003, NEUROCHEM RES, V28, P1683, DOI 10.1023/A:1026061021946
   Kolahdouzan M, 2017, CNS NEUROSCI THER, V23, P272, DOI 10.1111/cns.12684
   Kolb H, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12061842
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P2518, DOI 10.1021/jf035407c
   Koo KA, 2006, LIFE SCI, V79, P709, DOI 10.1016/j.lfs.2006.02.019
   Kovacs GG, 2019, J CLIN PATHOL, V72, P725, DOI 10.1136/jclinpath-2019-205952
   Kumar G, 2019, N-S ARCH PHARMACOL, V392, P1293, DOI 10.1007/s00210-019-01670-x
   Kumar M, 2017, PHARMACOGN MAG, V13, PS10, DOI 10.4103/0973-1296.203974
   Kumral E, 2002, EUR J NEUROL, V9, P615, DOI 10.1046/j.1468-1331.2002.00452.x
   Kurauchi Y, 2012, BRIT J PHARMACOL, V166, P1151, DOI 10.1111/j.1476-5381.2012.01833.x
   Kwon SH, 2014, J ETHNOPHARMACOL, V152, P173, DOI 10.1016/j.jep.2013.12.048
   Kwon SH, 2010, EUR J PHARMACOL, V649, P210, DOI 10.1016/j.ejphar.2010.09.001
   Lampe JW, 2000, CARCINOGENESIS, V21, P1157, DOI 10.1093/carcin/21.6.1157
   Lang R, 2013, ANAL BIOANAL CHEM, V405, P8487, DOI 10.1007/s00216-013-7288-0
   Lang R, 2010, ANAL CHEM, V82, P1486, DOI 10.1021/ac902616k
   Larsson SC, 2008, STROKE, V39, P1681, DOI 10.1161/STROKEAHA.107.504183
   Larsson SC, 2014, STROKE, V45, P309, DOI 10.1161/STROKEAHA.113.003131
   Larsson SC, 2011, AM J EPIDEMIOL, V174, P993, DOI 10.1093/aje/kwr226
   Lashley T, 2015, NEUROPATH APPL NEURO, V41, P858, DOI 10.1111/nan.12250
   Laurent C, 2014, NEUROBIOL AGING, V35, P2079, DOI 10.1016/j.neurobiolaging.2014.03.027
   Lee DR, 2014, BONE, V63, P20, DOI 10.1016/j.bone.2014.02.007
   Lee HF, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11102301
   Lee JK, 2015, EUR J ENDOCRINOL, V172, P595, DOI 10.1530/EJE-14-0805
   Lee KJ, 2007, TOXICOL LETT, V173, P80, DOI 10.1016/j.toxlet.2007.06.008
   Lee K, 2012, EUR J PHARMACOL, V689, P89, DOI 10.1016/j.ejphar.2012.05.028
   Lee M, 2016, NEUROBIOL AGING, V46, P113, DOI 10.1016/j.neurobiolaging.2016.06.015
   Lee TK, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25163578
   Leite MR, 2011, EXP GERONTOL, V46, P309, DOI 10.1016/j.exger.2010.11.034
   Levine DA, 2015, JAMA-J AM MED ASSOC, V314, P41, DOI 10.1001/jama.2015.6968
   Levy M, 1984, ANN REV CHRONOPHARMA, V1, P97
   Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, P0, DOI 10.3389/fnins.2015.00469
   Li C, 2011, BMC NEUROL, V11, P0, DOI 10.1186/1471-2377-11-49
   Li YJ, 2008, ENVIRON TOXICOL PHAR, V26, P13, DOI 10.1016/j.etap.2007.12.008
   Li ZY, 2008, NEUROSCI LETT, V445, P1, DOI 10.1016/j.neulet.2008.08.053
   Liang GJ, 2015, BEHAV BRAIN FUNCT, V11, P0, DOI 10.1186/s12993-015-0064-x
   Lin CM, 2020, J FOOD DRUG ANAL, V28, P147, DOI 10.1016/j.jfda.2019.10.004
   Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074
   LIPPA CF, 1992, NEUROBIOL AGING, V13, P405, DOI 10.1016/0197-4580(92)90115-E
   Liu DQ, 2020, DRUG DES DEV THER, V14, P51, DOI 10.2147/DDDT.S228751
   Liu G, 2017, AM FAM PHYSICIAN, V96, P87
   Liu QF, 2018, BIOL PHARM BULL, V41, P470, DOI 10.1248/bpb.b17-00750
   Liu R, 2012, AM J EPIDEMIOL, V175, P1200, DOI 10.1093/aje/kwr451
   Lopez-Garcia E, 2009, CIRCULATION, V119, P1116, DOI 10.1161/CIRCULATIONAHA.108.826164
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI 10.1039/C4FO00042K
   Lugo-Huitr√≥n R, 2013, OXID MED CELL LONGEV, V2013, P0, DOI 10.1155/2013/104024
   Machado JA, 2014, BEHAV BRAIN RES, V264, P116, DOI 10.1016/j.bbr.2014.01.051
   Maia L, 2002, EUR J NEUROL, V9, P377, DOI 10.1046/j.1468-1331.2002.00421.x
   Makowska J, 2014, J CHROMATOGR B, V968, P101, DOI 10.1016/j.jchromb.2013.12.001
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Mancini RS, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00735
   Martin-Schild S, 2009, J STROKE CEREBROVASC, V18, P86, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.015
   Masuda M, 2009, FEBS LETT, V583, P787, DOI 10.1016/j.febslet.2009.01.037
   Matsui Y, 2007, J CHROMATOGR B, V858, P96, DOI 10.1016/j.jchromb.2007.08.013
   McCusker RR, 2003, J ANAL TOXICOL, V27, P520, DOI 10.1093/jat/27.7.520
   McGeer PL, 2008, EXP NEUROL, V212, P235, DOI 10.1016/j.expneurol.2008.04.008
   Miao MS, 2017, SAUDI PHARM J, V25, P556, DOI 10.1016/j.jsps.2017.04.023
   Midttun O, 2018, AM J CLIN NUTR, V107, P941, DOI 10.1093/ajcn/nqy059
   Mikami Y, 2015, LIFE SCI, V139, P69, DOI 10.1016/j.lfs.2015.08.005
   Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311
   Mira A, 2015, MOLECULES, V20, P4813, DOI 10.3390/molecules20034813
   Mirzaie M, 2016, NEUROPHYSIOLOGY+, V48, P176, DOI 10.1007/s11062-016-9586-6
   Mitkari B, 2015, J CEREBR BLOOD F MET, V35, P363, DOI 10.1038/jcbfm.2014.235
   Miyazaki I, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8030221
   Mohamadi Neda, 2018, JOURNAL OF DIETARY SUPPLEMENTS, V15, P207, DOI 10.1080/19390211.2017.1329244
   MOLINENGO L, 1994, LIFE SCI, V54, P1247, DOI 10.1016/0024-3205(94)00851-5
   Esp√≠ndola KMM, 2019, FRONT ONCOL, V9, P0, DOI 10.3389/fonc.2019.00541
   Moreira ASP, 2012, FOOD FUNCT, V3, P903, DOI 10.1039/c2fo30048f
   Morelli Micaela, 2009, HANDB EXP PHARMACOL, V0, PP589, DOI 10.1007/978-3-540-89615-9_18
   Morroni F, 2018, AGING DIS, V9, P605, DOI 10.14336/AD.2017.0903
   Mostofsky E, 2010, NEUROLOGY, V75, P1583, DOI 10.1212/WNL.0b013e3181fb443d
   Mukamal KJ, 2009, AM HEART J, V157, P495, DOI 10.1016/j.ahj.2008.11.009
   Mullin S, 2015, NEUROL CLIN, V33, P1, DOI 10.1016/j.ncl.2014.09.010
   Nabavi SF, 2017, CURR NEUROPHARMACOL, V15, P471, DOI 10.2174/1570159X14666160325120625
   NAGEL RA, 1990, J HEPATOL, V10, P149, DOI 10.1016/0168-8278(90)90044-R
   Nakajima Y, 2007, LIFE SCI, V80, P370, DOI 10.1016/j.lfs.2006.09.017
   Nakane M, 2002, NEURORADIOLOGY, V44, P915, DOI 10.1007/s00234-002-0846-3
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Nazir N, 2020, BMC COMPLEMENT MED, V20, P0, DOI 10.1186/s12906-020-02942-3
   NEWTON R, 1981, EUR J CLIN PHARMACOL, V21, P45, DOI 10.1007/BF00609587
   Nieber K, 2017, PLANTA MED, V83, P1256, DOI 10.1055/s-0043-115007
   Noelker C, 2005, NEUROSCI LETT, V383, P39, DOI 10.1016/j.neulet.2005.04.023
   Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442
   Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687
   Nunes FM, 2010, PHYTOCHEM REV, V9, P171, DOI 10.1007/s11101-009-9151-7
   Oboh G, 2013, NEUROCHEM RES, V38, P413, DOI 10.1007/s11064-012-0935-6
   Ochiai R, 2019, J ALZHEIMERS DIS, V72, P1209, DOI 10.3233/JAD-190757
   Oleaga C, 2012, OXID MED CELL LONGEV, V2012, P0, DOI 10.1155/2012/390385
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Omar SH, 2018, FITOTERAPIA, V128, P118, DOI 10.1016/j.fitote.2018.05.011
   Omar SH, 2017, MOLECULES, V22, P0, DOI 10.3390/molecules22111858
   Ong LK, 2017, J CEREBR BLOOD F MET, V37, P1338, DOI 10.1177/0271678X16654920
   Palacios N, 2012, MOVEMENT DISORD, V27, P1276, DOI 10.1002/mds.25076
   Palaz MN, 2020, WORLD NEUROSURG, V138, PE736, DOI 10.1016/j.wneu.2020.03.058
   Park GJH, 2003, HEPATOLOGY, V38, P1227, DOI 10.1053/jhep.2003.50475
   Park JH, 2015, J MOV DISORD, V8, P109, DOI 10.14802/jmd.15018
   Patil Harshal, 2011, MO MED, V108, P431
   Paur I, 2010, FREE RADICAL BIO MED, V48, P1218, DOI 10.1016/j.freeradbiomed.2010.02.005
   Pavlica S, 2005, FREE RADICAL RES, V39, P1377, DOI 10.1080/09670260500197660
   Peltola J, 2000, EPILEPSY RES, V41, P205, DOI 10.1016/S0920-1211(00)00140-6
   Pereira P, 2006, BASIC CLIN PHARMACOL, V99, P374, DOI 10.1111/j.1742-7843.2006.pto_533.x
   Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006
   Pierri M, 2005, NEUROPHARMACOLOGY, V48, P517, DOI 10.1016/j.neuropharm.2004.11.009
   Fernandes FDP, 2014, BEHAV PHARMACOL, V25, P637, DOI 10.1097/FBP.0000000000000076
   Piriyawat P, 2003, STROKE, V34, P1242, DOI 10.1161/01.STR.0000067706.23777.04
   Poewe W, 2008, EUR J NEUROL, V15, P14, DOI 10.1111/j.1468-1331.2008.02056.x
   Poole R, 2017, BMJ-BRIT MED J, V359, P0, DOI 10.1136/bmj.j5024
   Popoli P, 1995, EUR J PHARMACOL, V287, P215, DOI 10.1016/0014-2999(95)00679-6
   Postuma RB, 2017, NEUROLOGY, V89, P310, DOI 10.1212/WNL.0000000000004163
   Postuma RB, 2012, NEUROLOGY, V79, P651, DOI 10.1212/WNL.0b013e318263570d
   Potter M, 2018, INT J DEV NEUROSCI, V70, P46, DOI 10.1016/j.ijdevneu.2018.02.001
   Powers WJ, 2018, STROKE, V49, PE46, DOI 10.1161/STR.0000000000000158
   Prasanthi JRP, 2010, FREE RADICAL BIO MED, V49, P1212, DOI 10.1016/j.freeradbiomed.2010.07.007
   Pravalika K, 2019, LIFE SCI, V216, P49, DOI 10.1016/j.lfs.2018.11.014
   Prediger RDS, 2010, J ALZHEIMERS DIS, V20, PS205, DOI 10.3233/JAD-2010-091459
   PRINEAS RJ, 1980, J CHRON DIS, V33, P67, DOI 10.1016/0021-9681(80)90029-6
   Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123
   Qiu ZG, 2020, CHEM-BIOL INTERACT, V317, P0, DOI 10.1016/j.cbi.2020.108946
   Rasmussen BB, 2002, PHARMACOGENETICS, V12, P473, DOI 10.1097/00008571-200208000-00008
   Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012
   Rebai O, 2018, NEUROTOX RES, V34, P559, DOI 10.1007/s12640-018-9911-5
   Rebai O, 2017, NEUROCHEM RES, V42, P3559, DOI 10.1007/s11064-017-2403-9
   Rechner AR, 2004, FREE RADICAL BIO MED, V36, P212, DOI 10.1016/j.freeradbiomed.2003.09.022
   Reich SG, 2019, MED CLIN N AM, V103, P337, DOI 10.1016/j.mcna.2018.10.014
   Ren YQ, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20174238
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Ritchie K, 2007, NEUROLOGY, V69, P536, DOI 10.1212/01.wnl.0000266670.35219.0c
   Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674
   RUDOLPHI KA, 1989, NEUROSCI LETT, V103, P275, DOI 10.1016/0304-3940(89)90112-2
   S√§√§ksj√§rvi K, 2008, EUR J CLIN NUTR, V62, P908, DOI 10.1038/sj.ejcn.1602788
   Sachse KT, 2008, J CEREBR BLOOD F MET, V28, P395, DOI 10.1038/sj.jcbfm.9600539
   Saitou K, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10101337
   Sandercock PAG, 2014, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD000029.pub3
   Santos C, 2010, J ALZHEIMERS DIS, V20, PS187, DOI 10.3233/JAD-2010-091387
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Saraj√§rvi T, 2012, J CELL MOL MED, V16, P2754, DOI 10.1111/j.1582-4934.2012.01599.x
   Sasaki S, 2017, PEDIATR RES, V82, P19, DOI 10.1038/pr.2017.70
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Scalbert A, 2000, J NUTR, V130, P2073S, DOI 10.1093/jn/130.8.2073S
   Scapagnini G, 2011, MOL NEUROBIOL, V44, P192, DOI 10.1007/s12035-011-8181-5
   Schapira AH, 2011, MOVEMENT DISORD, V26, P1049, DOI 10.1002/mds.23732
   SCOTT NR, 1984, ANN CLIN BIOCHEM, V21, P120, DOI 10.1177/000456328402100208
   Semerl JS, 2004, CROAT MED J, V45, P775
   Senard JM, 1997, J NEUROL NEUROSUR PS, V63, P584, DOI 10.1136/jnnp.63.5.584
   Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, P0, DOI 10.1101/cshperspect.a006189
   Shan SH, 2019, MED SCI MONITOR, V25, P453, DOI 10.12659/MSM.911166
   Shen WJ, 2012, BRAIN RES BULL, V88, P487, DOI 10.1016/j.brainresbull.2012.04.010
   Siesjo BK, 1996, ACT NEUR S, V66, P8
   Silletta MG, 2007, CIRCULATION, V116, P2944, DOI 10.1161/CIRCULATIONAHA.107.712976
   Silva T, 2014, EXPERT OPIN THER PAT, V24, P1257, DOI 10.1517/13543776.2014.959492
   Simic G, 2016, BIOMOLECULES, V6, P0, DOI 10.3390/biom6010006
   Singh SS, 2020, OXID MED CELL LONGEV, V2020, P0, DOI 10.1155/2020/6571484
   Singh S, 2009, BRAIN RES, V1283, P115, DOI 10.1016/j.brainres.2009.06.002
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   SMITS P, 1985, AM J CARDIOL, V56, P958, DOI 10.1016/0002-9149(85)90412-6
   Song Y, 2006, BRAIN RES, V1085, P57, DOI 10.1016/j.brainres.2006.02.042
   Song Y, 2018, BRAIN RES, V1690, P96, DOI 10.1016/j.brainres.2018.03.006
   Sonk√© B, 2006, BOT J LINN SOC, V151, P425, DOI 10.1111/j.1095-8339.2006.00508.x
   Sonsalla PK, 2012, EXP NEUROL, V234, P482, DOI 10.1016/j.expneurol.2012.01.022
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Strong R, 2000, NEUROPHARMACOLOGY, V39, P515, DOI 10.1016/S0028-3908(99)00156-2
   Sul D, 2009, LIFE SCI, V84, P257, DOI 10.1016/j.lfs.2008.12.001
   SUTHERLAND GR, 1991, NEUROSCIENCE, V42, P171, DOI 10.1016/0306-4522(91)90157-J
   Szwajgier D, 2015, ANN AGR ENV MED, V22, P690, DOI 10.5604/12321966.1185777
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Tan EK, 2007, PHARMACOGENET GENOM, V17, P1001, DOI 10.1097/FPC.0b013e3282f09265
   TANGLIU DD, 1983, J PHARMACOL EXP THER, V224, P180
   Taram F, 2016, BRAIN RES, V1648, P69, DOI 10.1016/j.brainres.2016.07.028
   Tavani A, 2001, EUR J EPIDEMIOL, V17, P1131, DOI 10.1023/A:1021276932160
   Teipel SJ, 2005, BRAIN, V128, P2626, DOI 10.1093/brain/awh589
   Teraoka M, 2012, J CLIN BIOCHEM NUTR, V51, P122, DOI 10.3164/jcbn.D-11-00030
   TERRY RD, 1981, ANN NEUROL, V10, P184, DOI 10.1002/ana.410100209
   Thom M, 2014, NEUROPATH APPL NEURO, V40, P520, DOI 10.1111/nan.12150
   Tohda C, 2005, NEUROSIGNALS, V14, P34, DOI 10.1159/000085384
   TOMBAUGH GC, 1993, J NEUROCHEM, V61, P793, DOI 10.1111/j.1471-4159.1993.tb03589.x
   TRANG JM, 1985, BIOPHARM DRUG DISPOS, V6, P51, DOI 10.1002/bdd.2510060107
   Trevitt J, 2009, PHARMACOL BIOCHEM BE, V94, P24, DOI 10.1016/j.pbb.2009.07.001
   Trinh K, 2010, J NEUROSCI, V30, P5525, DOI 10.1523/JNEUROSCI.4777-09.2010
   Tsai SJ, 2011, EUR J PHARMACOL, V670, P441, DOI 10.1016/j.ejphar.2011.09.171
   Tsai SK, 2006, LIFE SCI, V78, P2758, DOI 10.1016/j.lfs.2005.10.017
   Tu QY, 2008, NEURAL REGEN RES, V3, P1218
   Turan D, 2020, EUR J PHARMACOL, V883, P0, DOI 10.1016/j.ejphar.2020.173342
   Uchiyama T, 2011, J NEUROL NEUROSUR PS, V82, P1382, DOI 10.1136/jnnp.2011.241075
   Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001
   van Gelder BM, 2007, EUR J CLIN NUTR, V61, P226, DOI 10.1038/sj.ejcn.1602495
   van Troostwijk LJAED, 2003, EUR J PHARM SCI, V20, P451, DOI 10.1016/j.ejps.2003.09.010
   van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318
   Vardi N, 2012, J CHEM NEUROANAT, V43, P43, DOI 10.1016/j.jchemneu.2011.09.003
   Aguiar LMV, 2006, PHARMACOL BIOCHEM BE, V84, P415, DOI 10.1016/j.pbb.2006.05.027
   Vauzour D, 2010, ARCH BIOCHEM BIOPHYS, V501, P106, DOI 10.1016/j.abb.2010.03.016
   VISTISEN K, 1991, ADV EXP MED BIOL, V283, P407
   Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033
   Wang XM, 2017, FOOD FUNCT, V8, P2924, DOI 10.1039/c7fo00659d
   Wang YL, 2016, INT J MOL MED, V38, P869, DOI 10.3892/ijmm.2016.2683
   Wardlaw JM, 2005, J NEUROL NEUROSUR PS, V76, P617, DOI 10.1136/jnnp.2004.039982
   Washio T, 2017, PHYSIOL REP, V5, P0, DOI 10.14814/phy2.13288
   Wasim S, 2020, CUREUS J MED SCIENCE, V12, P0, DOI 10.7759/cureus.9578
   Wei ML, 2016, NEUROSCI LETT, V617, P143, DOI 10.1016/j.neulet.2016.02.019
   Wei X, 2008, NEUROSCIENCE, V155, P1098, DOI 10.1016/j.neuroscience.2008.06.056
   White H, 2005, CIRCULATION, V111, P1327, DOI 10.1161/01.CIR.0000157736.19739.D0
   Wong CC, 2010, J NUTR BIOCHEM, V21, P1060, DOI 10.1016/j.jnutbio.2009.09.001
   Wostyn Peter, 2011, INT J ALZHEIMERS DIS, V2011, P617420, DOI 10.4061/2011/617420
   Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026
   Xu K, 2005, PHARMACOL THERAPEUT, V105, P267, DOI 10.1016/j.pharmthera.2004.10.007
   Xu K, 2006, J NEUROSCI, V26, P535, DOI 10.1523/JNEUROSCI.3008-05.2006
   Xu K, 2010, NEUROSCIENCE, V167, P475, DOI 10.1016/j.neuroscience.2010.02.020
   Yang JQ, 2008, CNS NEUROSCI THER, V14, P10, DOI 10.1111/j.1527-3458.2007.00031.x
   Yao J, 2019, BIOFACTORS, V45, P616, DOI 10.1002/biof.1507
   Yiannopoulou KG, 2013, THER ADV NEUROL DISO, V6, P19, DOI 10.1177/1756285612461679
   Yu LQ, 2008, ANN NEUROL, V63, P338, DOI 10.1002/ana.21313
   Yuyama S, 1996, ADV EXP MED BIOL, V398, P599
   YUYAMA S, 1991, ADV EXP MED BIOL, V294, P475
   Zhang J, 2012, STROKE, V43, P1700, DOI 10.1161/STROKEAHA.111.632448
   Zhang J, 2012, J NEUROCHEM, V120, P564, DOI 10.1111/j.1471-4159.2011.07496.x
   Zhang L, 2007, LIFE SCI, V80, P530, DOI 10.1016/j.lfs.2006.09.039
   Zhang W, 2009, DIABETES CARE, V32, P1043, DOI 10.2337/dc08-2251
   Zhang Y, 2019, PHARMACOL RES, V150, P0, DOI 10.1016/j.phrs.2019.104538
   Zhang YS, 2011, J CEREBR BLOOD F MET, V31, P572, DOI 10.1038/jcbfm.2010.127
   Zhao XR, 2010, STROKE, V41, P363, DOI 10.1161/STROKEAHA.109.562900
   Zhao ZH, 2010, PHYTOCHEM REV, V9, P133, DOI 10.1007/s11101-009-9145-5
   Zhou Y, 2006, ACTA PHARMACOL SIN, V27, P1103, DOI 10.1111/j.1745-7254.2006.00406.x
NR 412
TC 133
Z9 136
U1 5
U2 135
PU MDPI
PI BASEL
PA MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN 15
PY 2021
VL 22
IS 1
BP 
EP 
DI 10.3390/ijms22010107
PG 64
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA PQ0FW
UT WOS:000606228100001
PM 33374338
DA 2025-04-28
ER

PT J
AU de Campos, ML
   de Castro, MB
   Campos, AD
   Fernandes, MF
   Conegundes, JLM
   Rodrigues, MN
   M√ºgge, FLB
   da Silva, AM
   Sabarense, CM
   Casta√±on, MCMN
   Andreazzi, AE
   Scio, E
AF de Campos, Mara Lucia
   de Castro, Marina Bento
   Campos, Artur Domingos
   Fernandes, Maria Fernanda
   Mota Conegundes, Jessica Leiras
   Rodrigues, Matheus Nehrer
   Brandao Mugge, Fernanda Lins
   da Silva, Aristobolo Mendes
   Sabarense, Cephora Maria
   Marques Nogueira Castanon, Maria Christina
   Andreazzi, Ana Eliza
   Scio, Elita
TI Antiobesity, hepatoprotective and anti-hyperglycemic effects of a pharmaceutical formulation containing Cecropia pachystachya Trecul in mice fed with a hypercaloric diet
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Cecropia pachystachya; Type 2 diabetes; Obesity; Antioxidant
ID insulin-resistance; adipose-tissue; macrophage infiltration; oxidative stress; chlorogenic acid; liver-disease; weight-loss; long-term; obesity; adipocyte
AB Ethnopharmacological relevance: The leaves of Cecropia pachystachya Tre acute accent cul (Urticaceae), known as embauba, are used as hypoglycemic and for weight reduction in Brazilian traditional medicine. Aim of the study: This study investigated the effects of a pharmaceutical formulation (ECP20) containing C. pachystachya extract on some metabolic alterations caused by a hypercaloric diet in mice. Material and methods: Mice were randomly fed with a standard or hypercaloric diet and orally treated with ECP20 or vehicle for 13 weeks. Subsequently, adiposity, glucose intolerance, and the presence of nonalcoholic fatty liver disease were assessed. Adipose tissue and liver were collected after euthanasia and frozen at-80 degrees C for histological and antioxidant analyzes. The effect of ECP20 on the differentiation of 3T3-L1 pre-adipocytes was also investigated. Results: Animals treated with ECP20 showed less weight gain, reduced glycemia, glucose tolerance restored, and hepatoprotective effect. Also, ECP20 presented significant in vivo antioxidant activity. Treatment of 3T3-L1 preadipocytes with ECP20 did not inhibit cellular differencing. Conclusions: Therefore, ECP20 presented promising effects in the control of obesity and related disorders. Considering that glucose intolerance and hyperglycemia are strong evidence for the development of type 2 diabetes, the findings corroborated the traditional use of C. pachystachya to treat this disease. The chlorogenic acid and the flavonoids orientin and iso-orientin, present in the extract, might be involved in the activities found.
C1 [de Campos, Mara Lucia; de Castro, Marina Bento; Campos, Artur Domingos; Fernandes, Maria Fernanda; Mota Conegundes, Jessica Leiras; Scio, Elita] Univ Fed Juiz de Fora, Inst Biol Sci, Dept Biochem, Lab Bioact Nat Prod, BR-36036900 Juiz De Fora, MG, Brazil.
   [Rodrigues, Matheus Nehrer; Marques Nogueira Castanon, Maria Christina] Univ Fed Juiz de Fora, Inst Biol Sci, Dept Morphol, BR-36036900 Juiz De Fora, MG, Brazil.
   [Brandao Mugge, Fernanda Lins; da Silva, Aristobolo Mendes] Univ Fed Minas Gerais, Inst Biol Sci, Lab Inflammatory Genes, BR-31270901 Belo Horizonte, MG, Brazil.
   [Sabarense, Cephora Maria] Univ Fed Juiz de Fora, Inst Biol Sci, Dept Nutr, BR-36036900 Juiz De Fora, MG, Brazil.
   [Andreazzi, Ana Eliza] Univ Fed Juiz de Fora, Inst Biol Sci, Dept Physiol, BR-36036900 Juiz De Fora, MG, Brazil.
C3 Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora; Universidade Federal de Minas Gerais; Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora
RP Scio, E (corresponding author), Univ Fed Juiz de Fora, Inst Biol Sci, Dept Biochem, Lab Bioact Nat Prod, BR-36036900 Juiz De Fora, MG, Brazil.
EM maralucampos@hotmail.com; marina.bcastro14@gmail.com; arturdcjf@hotmail.com; mf_mariafernanda@hotmail.com; jessicaleiras26@gmail.com; matheusnehrer@hotmail.com; fernandalbm@gmail.com; aristobolo@icb.ufmg.br; cephora.sabarense@ufjf.edu.br; christina.nogueira@terra.com.br; anaelizabio@yahoo.com.br; elitascio887@gmail.com
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [FAPEMIG - APQ-00487-16, APQ 01087-18]
CR Afshin A, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0172277
   Ali AT, 2013, EUR J CELL BIOL, V92, P229, DOI 10.1016/j.ejcb.2013.06.001
   Andrade-Cetto A, 2005, J ETHNOPHARMACOL, V99, P325, DOI 10.1016/j.jep.2005.04.019
   Andrade-Cetto A, 2010, J ETHNOPHARMACOL, V130, P93, DOI 10.1016/j.jep.2010.04.016
   Unknown -, 1985, WHO TECH REP SER, V0, P1
   Arag ~ao DMO, 2015, CECROPIA PACHYSTACHY, V0, P0
   Aragao DMO, 2010, J ETHNOPHARMACOL, V128, P629, DOI 10.1016/j.jep.2010.01.008
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Berg CC, 1990, FLORA NEOTROP, V51, P1
   BERG CC, 2005, FLORA NEOTROPICA MONOGRAPH, V94, P0
   Beutler E, 1975, RED CELL METABOLISM, V2, P160
   Bray GA, 2017, OBES REV, V18, P715, DOI 10.1111/obr.12551
   Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286
   Buege J A, 1978, METHODS ENZYMOL, V52, P302
   Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x
   Caria CREP, 2017, EXP CELL RES, V359, P431, DOI 10.1016/j.yexcr.2017.08.026
   Castro AVB, 2014, ARQ BRAS ENDOCRINOL, V58, P600, DOI 10.1590/0004-2730000003223
   Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762
   Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009
   Cheung BMY, 2013, THER ADV DRUG SAF, V4, P171, DOI 10.1177/2042098613489721
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Consolini AE, 2006, J ETHNOPHARMACOL, V106, P90, DOI 10.1016/j.jep.2005.12.006
   Corbal√°n MS, 2002, CLIN GENET, V61, P305
   da Silva MAB, 2010, REV BRAS FARMACOGN, V20, P549, DOI 10.1590/S0102-695X2010000400014
   Cadena-Zamudio JD, 2019, ACTA BOT MEX, V126, P0, DOI 10.21829/abm126.2019.1361
   Aragao DMD, 2013, PHYTOTHER RES, V27, P926, DOI 10.1002/ptr.4811
   Di Carlo G, 1999, LIFE SCI, V65, P337, DOI 10.1016/S0024-3205(99)00120-4
   Duarte-Alonso A, 2020, J ETHNOPHARMACOL, V261, P0, DOI 10.1016/j.jep.2020.113087
   Faulhaber-Walter R, 2011, DIABETES, V60, P2578, DOI 10.2337/db11-0058
   Filho Ribeiro Mariosa LSS, 2006, ARQ BRAS ENDOCRINOL, V50, P0
   Fraloub JC, 2010, J CLIN BIOCHEM NUTR, V46, P1
   Gaglioti AL, 2014, URTICACEAE NO ESTADO, V0, P0
   Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019
   He XY, 2021, J SCI FOOD AGR, V101, P631, DOI 10.1002/jsfa.10675
   Hollman P C, 1998, ARCH TOXICOL SUPPL, V20, P237
   Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5
   Jeyakumar SM, 2009, NUTR METAB, V6, P0, DOI 10.1186/1743-7075-6-27
   Katan MB, 2009, NEW ENGL J MED, V360, P923, DOI 10.1056/NEJMe0810291
   Klump KL, 2013, INT J EAT DISORDER, V46, P729, DOI 10.1002/eat.22139
   L√™ KA, 2011, DIABETES, V60, P2802, DOI 10.2337/db10-1263
   Lee MJ, 2010, ADIPOSE TISSUE IN HEALTH AND DISEASE, V0, PP283, DOI 10.1002/9783527629527.CH15
   Li YJ, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17111865
   Lorenzi H, 2002, PLANTAS MEDICINAIS N, V0, P118
   Ma XQ, 2015, FRONT ENDOCRINOL, V6, P0, DOI 10.3389/fendo.2015.00001
   Mehra A, 2007, ANAL BIOCHEM, V362, P281, DOI 10.1016/j.ab.2006.12.016
   Nagai S, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10020130
   Ojo O, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11081905
   Pacheco NR, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/301294
   Pascual-Serrano A, 2017, INT J OBESITY, V41, P1246, DOI 10.1038/ijo.2017.90
   Petta S, 2009, DIGEST LIVER DIS, V41, P615, DOI 10.1016/j.dld.2009.01.004
   Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540
   Revilla-Monsalve MC, 2007, J ETHNOPHARMACOL, V111, P636, DOI 10.1016/j.jep.2007.01.014
   Rivera-Mondrag√≥n A, 2017, PHARM BIOL, V55, P1500, DOI 10.1080/13880209.2017.1307421
   Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003
   Rosen ED, 2018, DIABETES, V67, P1923, DOI 10.2337/db18-0537
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, PE207, DOI 10.1152/ajpendo.2002.282.1.E207
   Shawar Said M, 2012, OMAN MED J, V27, P274, DOI 10.5001/omj.2012.69
   Sipe LM, 2017, NUTR DIABETES, V7, P0, DOI 10.1038/nutd.2017.13
   Soraru SB, 1978, PLANTAS MED POPULAR, V0, P76
   Sudhakar M, 2020, J FUNCT FOODS, V74, P0, DOI 10.1016/j.jff.2020.104161
   Sundaram S, 2016, NUTR RES, V36, P603, DOI 10.1016/j.nutres.2016.02.005
   Tanofsky-Kraff M, 2017, J CONSULT CLIN PSYCH, V85, P218, DOI 10.1037/ccp0000153
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937
   Verboven K, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-22962-x
   Videla LA, 2006, TRENDS MOL MED, V12, P555, DOI 10.1016/j.molmed.2006.10.001
   Vincent HK, 2006, INT J OBESITY, V30, P400, DOI 10.1038/sj.ijo.0803177
   WADE GN, 1975, J COMP PHYSIOL PSYCH, V88, P183, DOI 10.1037/h0076186
   WHO Consultation, 2000, WHO TECH REP SER, V894, P1
   WINTERBOURN CC, 1975, J LAB CLIN MED, V85, P337
   Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x
   World Health Organization, 2016, WHO OBES OVERW FACT, V0, P0
   Yoo S, 2018, J OBES METAB SYNDR, V27, P203, DOI 10.7570/jomes.2018.27.4.203
   Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005
   Zheng YX, 2020, J FUNCT FOODS, V64, P0, DOI 10.1016/j.jff.2019.103587
NR 76
TC 6
Z9 6
U1 0
U2 10
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD NOV 15
PY 2021
VL 280
IS 
BP 
EP 
DI 10.1016/j.jep.2021.114418
EA JUL 2021
PG 11
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine
GA WF6JX
UT WOS:000706410800004
PM 34271111
DA 2025-04-28
ER

PT J
AU Torres, A
   Noriega, LG
   Delgadillo-Puga, C
   Tovar, AR
   Navarro-Oca√±a, A
AF Torres, Andrea
   Noriega, Lilia G.
   Delgadillo-Puga, Claudia
   Tovar, Armando R.
   Navarro-Ocana, Arturo
TI Caffeoylquinic Acid Derivatives of Purple Sweet Potato as Modulators of Mitochondrial Function in Mouse Primary Hepatocytes
SO MOLECULES
LA English
DT Article
DE purple sweet potato; CQA-derivatives; maximal respiration; glycolysis; hepatic steatosis
ID fatty liver-disease; antioxidant activity; hepatic steatosis; fleshed potatoes; chlorogenic acid; anthocyanin; obesity; inhibition; metabolism; extraction
AB Owing to their antioxidant properties, caffeoylquinic acid (CQA)-derivatives could potentially improve the impaired metabolism in hepatic cells, however, their effect on mitochondrial function has not been demonstrated yet. Here, we evaluated the impact of three CQA-derivatives extracted from purple sweet potato, namely 5-CQA, 3,4- and 4,5-diCQA, on mitochondrial activity in primary hepatocytes using an extracellular flux analyzer. Notably, an increase of maximal respiration and spare respiratory capacity were observed when 5-CQA and 3,4-diCQA were added to the system indicating the improved mitochondrial function. Moreover, 3,4-diCQA was shown to considerably increase glycolytic reserve which is a measure of cell capability to respond to an energy demand through glycolysis. Conversely, 4,5-diCQA did not modify mitochondrial activity but increased glycolysis at low concentration in primary hepatocytes. All compounds tested improved cellular capacity to oxidize fatty acids. Overall, our results demonstrated the potential of test CQA-derivatives to modify mitochondrial function in hepatic cells. It is especially relevant in case of dysfunctional mitochondria in hepatocytes linked to hepatic steatosis during obesity, diabetes, and metabolic syndrome.
C1 [Torres, Andrea; Navarro-Ocana, Arturo] Univ Nacl Autonoma Mexico, Fac Quim, Dept Alimentos & Biotecnol, Mexico City 04529, DF, Mexico.
   [Noriega, Lilia G.; Tovar, Armando R.] Inst Nacl Ciencias Med Nutr Salvador Zubiran, Dept Fisiol Nutr, Mexico City 14080, DF, Mexico.
   [Delgadillo-Puga, Claudia] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nutr Anim Dr Fernando Perez Gil Romo, Mexico City 14080, DF, Mexico.
C3 Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico
RP Navarro-Oca√±a, A (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Dept Alimentos & Biotecnol, Mexico City 04529, DF, Mexico.
EM andrea_ta5@hotmail.com; lgnoriegal@gmail.com; claudia.delgadillop@incmnsz.mx; armando.tovarp@incmnsz.mx; arturono@unam.mx
FU CONACYT [308249]; project PAPIIT-UNAM [IT202318]
CR BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   Betteridge DJ, 2000, METABOLISM, V49, P3, DOI 10.1016/S0026-0495(00)80077-3
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Burgos G, 2013, J FOOD COMPOS ANAL, V30, P6, DOI 10.1016/j.jfca.2012.12.001
   Cant√≥ C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Che YY, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21121728
   Clifford MN, 2017, NAT PROD REP, V34, P1391, DOI 10.1039/c7np00030h
   Erk T, 2014, EUR J NUTR, V53, P159, DOI 10.1007/s00394-013-0512-z
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Fan SJ, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0051007
   Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Huang WF, 2018, DIABET METAB SYND OB, V11, P357, DOI 10.2147/DMSO.S166728
   Jackson KMP, 2017, MOL NUTR FOOD RES, V61, P0, DOI 10.1002/mnfr.201601118
   Jiang XW, 2017, CELL MOL NEUROBIOL, V37, P499, DOI 10.1007/s10571-016-0387-7
   Kita A, 2013, J FOOD COMPOS ANAL, V32, P169, DOI 10.1016/j.jfca.2013.09.006
   Liu T, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23081988
   Loebenstein G, 2009, P9, V0, P0, DOI DOI 10.1007/978-1-4020-9475-0_2
   MAHMOOD N, 1993, ANTIVIR CHEM CHEMOTH, V4, P235, DOI 10.1177/095632029300400406
   Leal-D√≠az AM, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep34242
   Mart√≠nez-L√≥pez S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Meng XJ, 2019, INT J FOOD SCI TECH, V54, P2887, DOI 10.1111/ijfs.14153
   Mu TH, 2017, SWEET POTATO PROCESSING TECHNOLOGY, V0, PP357, DOI 10.1016/B978-0-12-812871-8.00007-6
   Nicolson GL, 2014, ALTERN THER HEALTH M, V20, P18
   Nugroho A, 2009, ARCH PHARM RES, V32, P1361, DOI 10.1007/s12272-009-2003-6
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Palacios-Gonz√°lez B, 2019, J NUTR BIOCHEM, V68, P59, DOI 10.1016/j.jnutbio.2019.03.012
   Pereira AD, 2003, Z NATURFORSCH C, V58, P590
   Rector RS, 2008, WORLD J GASTROENTERO, V14, P185, DOI 10.3748/wjg.14.185
   Santana-G√°lvez J, 2017, MOLECULES, V22, P0, DOI 10.3390/molecules22030358
   Scarano A, 2018, AGRICULTURE-BASEL, V8, P0, DOI 10.3390/agriculture8070102
   Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304
   Sp√≠nola V, 2017, PHYTOCHEMISTRY, V143, P29, DOI 10.1016/j.phytochem.2017.07.006
   TAGA MS, 1984, J AM OIL CHEM SOC, V61, P928, DOI 10.1007/BF02542169
   Tominaga Kunihiko, 2009, ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE, V14, P142, DOI 10.1007/s12199-008-0074-5
   Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138
   Van den Bossche J, 2015, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/53424
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wang AM, 2018, FOOD CHEM, V260, P124, DOI 10.1016/j.foodchem.2018.03.125
   Wang HL, 2020, INT J BIOL MACROMOL, V148, P324, DOI 10.1016/j.ijbiomac.2020.01.146
   Wianowska D, 2019, PHYTOCHEM REV, V18, P273, DOI 10.1007/s11101-018-9592-y
   Xie MH, 2019, J AGR FOOD CHEM, V67, P171, DOI 10.1021/acs.jafc.8b05444
   Yoshimoto M, 2002, BIOSCI BIOTECH BIOCH, V66, P2336, DOI 10.1271/bbb.66.2336
   Zamora-L√≥pez K, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-71878-y
   Zhang H, 2016, J FUNCT FOODS, V22, P363, DOI 10.1016/j.jff.2016.01.004
   Zhang XY, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0053931
   Zhao JG, 2014, FOOD CHEM, V161, P22, DOI 10.1016/j.foodchem.2014.03.079
NR 47
TC 11
Z9 12
U1 1
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JAN 15
PY 2021
VL 26
IS 2
BP 
EP 
DI 10.3390/molecules26020319
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA PX6FW
UT WOS:000611451000001
PM 33435516
DA 2025-04-28
ER

PT J
AU Mihaylova, D
   Desseva, I
   Popova, A
   Dincheva, I
   Vrancheva, R
   Lante, A
   Krastanov, A
AF Mihaylova, Dasha
   Desseva, Ivelina
   Popova, Aneta
   Dincheva, Ivayla
   Vrancheva, Radka
   Lante, Anna
   Krastanov, Albert
TI GC-MS Metabolic Profile and Œ±-Glucosidase-, Œ±-Amylase-, Lipase-, and Acetylcholinesterase-Inhibitory Activities of Eight Peach Varieties
SO MOLECULES
LA English
DT Article
DE peach; amylase; glucosidase; lipase; acetylcholinesterase; enzyme inhibitory activities; GC-MS; principal component analysis; hierarchical cluster analysis
ID antioxidant property; vegetable consumption; different sensitivity; insulin-resistance; phenolic-compounds; chlorogenic acid; fruit; carotenoids; nectarine; quality
AB The inhibition of certain digestive enzymes by target food matrices represents a new approach in the treatment of socially significant diseases. Proving the ability of fruits to inhibit such enzymes can support the inclusion of specific varieties in the daily diets of patients with diabetes, obesity, Alzheimer's disease, etc., providing them with much more than just valuable micro- and macromolecules. The current study aimed atidentifying and comparing the GC-MS metabolic profiles of eight peach varieties ("Filina", "Ufo 4, "Gergana", "Laskava", "July Lady", "Flat Queen", "Evmolpiya", and "Morsiani 90") grown in Bulgaria (local and introduced) and to evaluate the inhibitory potential of their extracts towards alpha-glucosidase, alpha-amylase, lipase, and acetylcholinesterase. In order to confirm samples' differences or similarities, principal component analysis (PCA) and hierarchical cluster analysis (HCA) were also applied to the identified metabolites. The results provide important insights into the metabolomic profiles of the eight peach varieties and represent a first attempt to characterize the peels of the peach varieties with respect to alpha-glucosidase-, alpha-amylase-, lipase-, and acetylcholinesterase-inhibitory activities. All of the studied peach extracts displayed inhibitory activity towards alpha-glucosidase (IC50: 125-757 mg/mL) and acetylcholinesterase (IC50: 60-739 mg/mL), but none of them affected alpha-amylase activity. Five of the eight varieties showed inhibitory activity towards porcine pancreatic lipase (IC50: 24-167 mg/mL). The obtained results validate the usefulness of peaches and nectarines as valuable sources of natural agents beneficial for human health, although further detailed investigation should be performed in order to thoroughly identify the enzyme inhibitors responsible for each activity.
C1 [Mihaylova, Dasha; Krastanov, Albert] Univ Food Technol, Fac Technol, Dept Biotechnol, Plovdiv 4002, Bulgaria.
   [Desseva, Ivelina; Vrancheva, Radka] Univ Food Technol, Fac Technol, Dept Analyt Chem & Phys Chem, Plovdiv 4002, Bulgaria.
   [Popova, Aneta] Univ Food Technol, Fac Econ, Dept Catering & Tourism, Plovdiv 4002, Bulgaria.
   [Dincheva, Ivayla] Agricultural Acad, AgroBioInst, 8 Dr Tsankov Blvd, Sofia 1164, Bulgaria.
   [Lante, Anna] Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, I-35020 Legnaro, Italy.
C3 University of Food Technology - Bulgaria; University of Food Technology - Bulgaria; University of Food Technology - Bulgaria; Agricultural Academy - Bulgaria; University of Padua
RP Mihaylova, D (corresponding author), Univ Food Technol, Fac Technol, Dept Biotechnol, Plovdiv 4002, Bulgaria.; Desseva, I (corresponding author), Univ Food Technol, Fac Technol, Dept Analyt Chem & Phys Chem, Plovdiv 4002, Bulgaria.
EM dashamihaylova@yahoo.com; ivelina_hristova_vn@abv.bg; popova_aneta@yahoo.com; ivadincheva@yahoo.com; radka_vrancheva@yahoo.com; anna.lante@unipd.it; a_krastanov@uft-plovdiv.bg
FU Ministry of Education and Science Scientific Research Fund, Bulgaria [K P-06-H37/23-2019]
CR Adefegha Stephen A, 2012, JOURNAL OF BASIC AND CLINICAL PHYSIOLOGY AND PHARMACOLOGY, V23, P153, DOI 10.1515/jbcpp-2012-0029
   Akhatou I, 2016, PLANT PHYSIOL BIOCH, V101, P14, DOI 10.1016/j.plaphy.2016.01.016
   Unknown -, 2018, NAT PROD COMMUN, V0, P0
   Unknown -, 2019, INCREASING FRUIT AND VEGETABLE CONSUMPTION TO REDUCE THE RISK OF NONCOMMUNICABLE DISEASES, V0, P0
   Aseervatham GSB, 2016, BIOMED PHARMACOTHER, V82, P54, DOI 10.1016/j.biopha.2016.04.066
   Assaad HI, 2014, SPRINGERPLUS, V3, P0, DOI 10.1186/2193-1801-3-474
   Atta-ur-Rahman, 2001, PURE APPL CHEM, V73, P555, DOI 10.1351/pac200173030555
   Bagdas D, 2020, CURR NEUROPHARMACOL, V18, P216, DOI 10.2174/1570159X17666191021111809
   Omena CMB, 2012, FOOD RES INT, V49, P334, DOI 10.1016/j.foodres.2012.07.010
   Becerra-Tom√°s N, 2021, NUTR METAB CARDIOVAS, V31, P1702, DOI 10.1016/j.numecd.2021.02.007
   Bento C, 2022, FOOD REV INT, V38, P1703, DOI 10.1080/87559129.2020.1837861
   Bento C, 2018, J FUNCT FOODS, V43, P224, DOI 10.1016/j.jff.2018.02.018
   Berger K, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25225224
   Berkov S, 2018, REF SER PHYTOCHEM, V0, PP67, DOI 10.1007/978-3-319-54600-1_12
   Berkov S, 2011, TALANTA, V83, P1455, DOI 10.1016/j.talanta.2010.11.029
   Bhadra S, 2015, CHAPTER 13 EVALUATIO, V0, P273
   Bontpart T, 2016, J EXP BOT, V67, P3537, DOI 10.1093/jxb/erw184
   Bostock RM, 1999, PHYSIOL MOL PLANT P, V54, P37, DOI 10.1006/pmpp.1998.0189
   Bourgaud F, 2001, PLANT SCI, V161, P839, DOI 10.1016/S0168-9452(01)00490-3
   Brown AF, 2014, J AM SOC HORTIC SCI, V139, P676, DOI 10.21273/JASHS.139.6.676
   Budreviciute A, 2020, FRONT PUBLIC HEALTH, V8, P0, DOI 10.3389/fpubh.2020.574111
   Byrne DH, 2009, ACTA HORTIC, V841, P267, DOI 10.17660/ActaHortic.2009.841.32
   Cao SF, 2017, FOOD CHEM, V214, P137, DOI 10.1016/j.foodchem.2016.07.085
   Cevallos-Cevallos JM, 2012, PLANT PHYSIOL BIOCH, V53, P69, DOI 10.1016/j.plaphy.2012.01.010
   Colaric M, 2005, J SCI FOOD AGR, V85, P2611, DOI 10.1002/jsfa.2316
   Commisso M, 2021, BIOLOGY-BASEL, V10, P0, DOI 10.3390/biology10050380
   Dabbou S, 2017, PLANT FOOD HUM NUTR, V72, P103, DOI 10.1007/s11130-016-0585-y
   Dobrev G, 2015, BIOCATAL AGRIC BIOTE, V4, P77, DOI 10.1016/j.bcab.2014.09.011
   Duan YX, 2013, ACTA PHYSIOL PLANT, V35, P707, DOI 10.1007/s11738-012-1111-y
   Famiani F, 2020, FRONT PLANT SCI, V11, P0, DOI 10.3389/fpls.2020.572601
   Ferreira J, 2020, EVID-BASED COMPL ALT, V2020, P0, DOI 10.1155/2020/3825629
   Food and Agriculture Organization, 2003, INCR FRUIT VEG CONS INCR FRUIT VEG CONS, V0, P0
   Guo CT, 2020, INT J FOOD PROP, V23, P1272, DOI 10.1080/10942912.2020.1797782
   Habtemariam S, 2019, MOLECULES, V24, P0, DOI 10.3390/molecules24081519
   Hamade Y, 2013, METABOLISM, V62, P734, DOI 10.1016/j.metabol.2012.10.015
   Ikram MMM, 2020, METABOLITES, V10, P0, DOI 10.3390/metabo10040134
   Infante R, 2011, CHIL J AGR RES, V71, P445, DOI 10.4067/S0718-58392011000300016
   Ingkaninan K, 2003, J ETHNOPHARMACOL, V89, P261, DOI 10.1016/j.jep.2003.08.008
   Iwasaki Y, 2012, METABOLITES, V2, P496, DOI 10.3390/metabo2030496
   Jocken JWE, 2016, INT J OBESITY, V40, P507, DOI 10.1038/ijo.2015.211
   Johnson Elizabeth J, 2002, NUTR CLIN CARE, V5, P56, DOI 10.1046/j.1523-5408.2002.00004.x
   Kabir MT, 2019, CURR PHARM DESIGN, V25, P3519, DOI 10.2174/1381612825666191008103141
   Kazeem MI, 2013, BIOMED RES INT, V2013, P0, DOI 10.1155/2013/527570
   Keutgen AJ, 2008, FOOD CHEM, V107, P1413, DOI 10.1016/j.foodchem.2007.09.071
   Kopka J, 2006, J BIOTECHNOL, V124, P312, DOI 10.1016/j.jbiotec.2005.12.012
   Lara MV, 2020, FRONT PLANT SCI, V11, P0, DOI 10.3389/fpls.2020.562252
   Liang N, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8010016
   Lillo-Carmona V, 2020, METABOLITES, V10, P0, DOI 10.3390/metabo10040154
   Liu H, 2018, J FOOD PROCESS PRES, V42, P0, DOI 10.1111/jfpp.13624
   Liu H, 2015, LWT-FOOD SCI TECHNOL, V63, P1042, DOI 10.1016/j.lwt.2015.04.052
   Liu YJ, 2013, MOL MED REP, V8, P1106, DOI 10.3892/mmr.2013.1652
   Lobbens ESB, 2017, J ETHNOPHARMACOL, V200, P66, DOI 10.1016/j.jep.2017.02.020
   Lombardo VA, 2011, PLANT PHYSIOL, V157, P1696, DOI 10.1104/pp.111.186064
   Martinez-Gonzalez AI, 2017, MOLECULES, V22, P0, DOI 10.3390/molecules22040669
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/801457
   Michailidis M, 2021, HORTICULTURAE, V7, P0, DOI 10.3390/horticulturae7040085
   Mihaylova D, 2021, MOLECULES, V26, P0, DOI 10.3390/molecules26092818
   Mihaylova D, 2021, FOODS, V10, P0, DOI 10.3390/foods10010164
   Mirmiran P, 2009, METABOLISM, V58, P460, DOI 10.1016/j.metabol.2008.11.002
   Muraki I, 2013, BMJ-BRIT MED J, V347, P0, DOI 10.1136/bmj.f5001
   Nakajima K, 2016, WORLD J DIABETES, V7, P112, DOI 10.4239/wjd.v7.i6.112
   Quan NV, 2019, MOLECULES, V24, P0, DOI 10.3390/molecules24030482
   Noori T, 2021, EUR J PHARMACOL, V898, P0, DOI 10.1016/j.ejphar.2021.173974
   Noratto G, 2009, J AGR FOOD CHEM, V57, P5219, DOI 10.1021/jf900259m
   Nowicka P, 2018, PLANT FOOD HUM NUTR, V73, P314, DOI 10.1007/s11130-018-0688-8
   Nowicka P, 2016, J FUNCT FOODS, V25, P397, DOI 10.1016/j.jff.2016.06.024
   Oboh G, 2013, NEUROCHEM RES, V38, P413, DOI 10.1007/s11064-012-0935-6
   Oguntibeju OO, 2013, DIABETES MELLITUS IN, V3, P180
   Olatona FA, 2018, J HEALTH POPUL NUTR, V37, P0, DOI 10.1186/s41043-018-0152-2
   Parashar A, 2010, INT J FRUIT SCI, V10, P425, DOI 10.1080/15538362.2010.530129
   ROBERTSON JA, 1988, HORTSCIENCE, V23, P1032
   Rodr√≠guez-Solana R, 2019, ANTIOXIDANTS-BASEL, V8, P0, DOI 10.3390/antiox8110563
   RYUGO KAY, 1959, PROC AMER SOC HORT SCI, V74, P130
   Saifuddin N, 2008, E-J CHEM, V5, P864, DOI 10.1155/2008/920408
   Saini RK, 2015, FOOD RES INT, V76, P735, DOI 10.1016/j.foodres.2015.07.047
   Santana-G√°lvez J, 2017, MOLECULES, V22, P0, DOI 10.3390/molecules22030358
   Santin M, 2018, POSTHARVEST BIOL TEC, V139, P127, DOI 10.1016/j.postharvbio.2018.02.001
   Sasaki K, 2010, FOOD CHEM, V118, P830, DOI 10.1016/j.foodchem.2009.05.070
   Sochor J, 2011, MOLECULES, V16, P7428, DOI 10.3390/molecules16097428
   Suh SJ, 2006, J MOL NEUROSCI, V29, P101, DOI 10.1385/JMN:29:2:101
   Sultana R, 2020, FOODS, V9, P0, DOI 10.3390/foods9070844
   Sun LJ, 2020, CRIT REV FOOD SCI, V60, P541, DOI 10.1080/10408398.2018.1544883
   Tadera K, 2006, J NUTR SCI VITAMINOL, V52, P149, DOI 10.3177/jnsv.52.149
   Tian Y, 2018, PUBLIC HEALTH NUTR, V21, P756, DOI 10.1017/S136898001700310X
   Torras-Claveria L, 2010, PHYTOCHEM ANALYSIS, V21, P80, DOI 10.1002/pca.1158
   Uriarte-Pueyo I, 2011, CURR MED CHEM, V18, P5289, DOI 10.2174/092986711798184325
   Vendrame S, 2016, ANTIOXIDANTS-BASEL, V5, P0, DOI 10.3390/antiox5040034
   Volpe SL, 2019, ACSMS HEALTH FIT J, V23, P30, DOI 10.1249/FIT.0000000000000474
   Vrancheva R, 2021, PLANTS-BASEL, V10, P0, DOI 10.3390/plants10010094
   Vrancheva RZ, 2020, Z NATURFORSCH C, V75, P451, DOI 10.1515/znc-2020-0058
   Wagner C, 2003, PHYTOCHEMISTRY, V62, P887, DOI 10.1016/S0031-9422(02)00703-3
   Walker R, 2018, HORTICULTURAL REV, V0, P371
   Wang XB, 2020, RSC MED CHEM, V11, P225, DOI 10.1039/c9md00441f
   Watanabe J, 1997, BIOSCI BIOTECH BIOCH, V61, P177, DOI 10.1271/bbb.61.127
   Williams P, 2011, NAT PROD REP, V28, P48, DOI 10.1039/c0np00027b
   World Health Organisation, 2020, NONC DIS PROGR MON 2, V0, P0
   Wu BH, 2012, J AGR SCI-CAMBRIDGE, V150, P53, DOI 10.1017/S0021859611000438
   Yoshioka T, 2004, Z NATURFORSCH C, V59, P509
   Zhang XA, 2019, MOLECULES, V24, P0, DOI 10.3390/molecules24101968
   Zhao CN, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9060598
   Zheleva-Dimitrova DZ, 2013, PHARMACOGN MAG, V9, P109, DOI 10.4103/0973-1296.111251
NR 102
TC 19
Z9 20
U1 5
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JUL 15
PY 2021
VL 26
IS 14
BP 
EP 
DI 10.3390/molecules26144183
PG 23
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA TO1DR
UT WOS:000676662200001
PM 34299456
DA 2025-04-28
ER

PT J
AU Riediger, N
   Dhalla, A
   Cooper, M
   Bombak, A
   Sreeramaiah, H
AF Riediger, Natalie
   Dhalla, Anika
   Cooper, Maureen
   Bombak, Andrea
   Sreeramaiah, Hemalatha
TI A qualitative analysis of the perceived socio-cultural contexts and health concerns of sugar-sweetened beverages among adults studying or working at a post-secondary institution in Dharwad, India
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Sugar-sweetened beverages; Diabetes; India; Health; Nutrition; Health policy; Global health; Stigma
ID risk; transition; nutrition; obesity; stigma; food
AB BackgroundWe sought to explore the perceptions of the socio-cultural contexts and health concerns of consuming sugar-sweetened beverages (SSB) among Indian adults working or studying at a post-secondary institution in Karnataka, India.MethodsWe completed a qualitative study, including 24 semi-structured interviews between 2017 and 2018 at the University of Agricultural Sciences, Dharwad, Karnataka, India. Data were analyzed using thematic content analysis.ResultsOne over-arching theme emerged, westernization and changing perceptions of food, sugar, and health. Participants discussed SSB and associated health concerns in the broad context of westernization and overall economic development in India. Three sub-themes regarding the health perceptions of consuming SSB were: healthy drinks are clean and natural; hydration and energy; and moderation and body weight. Hygienically-prepared beverages were a consistent concern among participants. Juices and beverages, such as tea or coffee, sweetened with jaggery were viewed positively due to their naturalness and lack of processed sugar. Participants perceived SSB as providing hydration and energy, particularly in hot weather. Lastly, if consumed in moderation, SSB were thought to have no direct adverse health consequences. Though some participants noted excessive, 'addictive' consumption would contribute to weight gain and diabetes.ConclusionPerceived health concerns of SSB reflect dominant health issues in India, namely, food insecurity, food safety, and increasingly, diabetes. Policymakers tend to prioritize acute challenges over long-term concerns. As such, the capacity of any policy to address chronic nutritional concerns related to SSB are likely to be muted in the absence of improvements to food safety and security.
C1 [Riediger, Natalie; Dhalla, Anika; Cooper, Maureen] Univ Manitoba, Fac Agr & Food Sci, Dept Food & Human Nutr Sci, Winnipeg, MB, Canada.
   [Riediger, Natalie] Univ Manitoba, Rady Fac Hlth Sci, Dept Community Hlth Sci, Winnipeg, MB, Canada.
   [Bombak, Andrea] Univ New Brunswick, Dept Sociol, Fredericton, NB, Canada.
   [Sreeramaiah, Hemalatha] Univ Agr Sci Dharwad, Food Sci & Technol Dept, Dharwad, Karnataka, India.
C3 University of Manitoba; University of Manitoba; University of New Brunswick
RP Riediger, N (corresponding author), Univ Manitoba, Fac Agr & Food Sci, Dept Food & Human Nutr Sci, Winnipeg, MB, Canada.; Riediger, N (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Community Hlth Sci, Winnipeg, MB, Canada.
EM Natalie.riediger@umanitoba.ca
FU Queen Elizabeth II Diamond Jubilee Scholarship; Mitacs Globalink Research Award in 2018; Queen Elizabeth Scholarship Program; University of Manitoba; CIHR Early Career Investigator Award [155435]
CR Aliferis L, 2014, HERES WHAT WOULD BE, V0, P0
   Unknown -, 2019, LANCET PUBLIC HEALTH, V4, PE168, DOI 10.1016/S2468-2667(19)30045-3
   Unknown -, 2021, SUGARY DRINK TAXES AROUND THE WORLD, V0, P0
   Unknown -, 2015, FISCAL POLICIES FOR DIET AND PREVENTION OF NONCOMMUNICABLE DISEASES, V0, P0
   Arifin B, 2020, QUAL LIFE RES, V29, P109, DOI 10.1007/s11136-019-02299-2
   Bailey C, 2018, J NUTR EDUC BEHAV, V50, P675, DOI 10.1016/j.jneb.2018.03.013
   Basu M, 2020, ENVIRON DEV SUSTAIN, V10, P1, DOI 10.5296/emsd.v10i1.17820
   Birbeck GL, 2019, BMC MED, V17, P0, DOI 10.1186/s12916-019-1282-0
   Biswas S, 2019, BBC NEWS, V0, P0
   Bragg MA, 2017, GLOBALIZATION HEALTH, V13, P0, DOI 10.1186/s12992-017-0303-z
   Brewis A, 2019, LAZY CRAZY DISGUSTIN, V0, P0
   Creswell JW, 2014, FOURTH EDITION. RESEARCH DESIGN: QUALITATIVE, V0, P0
   Diabetes Canada, 2020, SUG DIAB, V0, P0
   Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x
   Finkler K, 2004, SOC SCI MED, V59, P2037, DOI 10.1016/j.socscimed.2004.03.008
   Fletcher J, 2013, PREV CHRONIC DIS, V10, P0, DOI 10.5888/pcd10.120195
   Food and Agriculture Organization of the United Nations, 2021, FOOD BAS DIET GUID I, V0, P0
   Gard M, 2005, OBESITY EPIDEMIC SCI, V0, P0, DOI DOI 10.4324/9780203619308
   Government of UK: HM Revenue & Custom, 2018, CHECK YOUR DRINK IS, V0, P0
   Gulati S, 2014, NUTRIENTS, V6, P5955, DOI 10.3390/nu6125955
   Gulati S, 2013, ANN NUTR METAB, V62, P279, DOI 10.1159/000346554
   Gupta Setu, 2017, INDIAN J COMMUNITY MED, V42, P43, DOI 10.4103/0970-0218.199800
   International Diabetes Foundation,, 2019, IDF DIABETES ATLAS, V0, P0
   International Sugar Organization, 2020, SUG SUG MARK, V0, P0
   John S, 2002, TOBACCO POVERTY OBSE, V0, P0
   Kapoor N, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0237974
   Kato A, 2020, DIABETOL INT, V11, P73, DOI 10.1007/s13340-019-00421-w
   Kuperstein Anna, 2008, J HLTH CARE LAW POLI, V11, P103
   Law C, 2020, J AGR ECON, V71, P118, DOI 10.1111/1477-9552.12322
   Lencucha R, 2019, INT J HEALTH POLICY, V8, P514, DOI 10.15171/ijhpm.2019.56
   LUPTON D, 2016, FOOD, V0, P0
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Marini M, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0083543
   Maru Ami M, 2012, J CONTEMP DENT PRACT, V13, P382
   McCarthy M, 2016, BMJ-BRIT MED J, V355, P0, DOI 10.1136/bmj.i5940
   Mccoy D, 2017, HEALTH ECON POLICY L, V12, P179, DOI 10.1017/S174413311600044X
   Mendenhall E, 2019, LANCET, V393, P741, DOI 10.1016/S0140-6736(19)30310-1
   Miglani Sanjay, 2020, INT J CLIN PEDIATR DENT, V13, P155, DOI 10.5005/jp-journals-10005-1733
   Ministry of Health and Family Welfare, 2011, FOOD SAF STAND PACK, V0, P0
   Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018
   Myers A, 2017, GLOB PUBLIC HEALTH, V12, P98, DOI 10.1080/17441692.2015.1071419
   Pande R, 2020, LANCET PUBLIC HEALTH, V5, PE195, DOI 10.1016/S2468-2667(20)30031-1
   Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491
   Quint B, 2020, TOBACCO FARMERS BODY, V0, P0
   Salda~na J, 2015, THE CODING MANUAL FOR QUALITATIVE RESEARCHERS, V0, P0
   Salmona M, 2015, AUST J MANAGE, V40, P403, DOI 10.1177/0312896214536204
   Saxena NC, 2018, POVERTY, V0, P55, DOI 10.1007/978-981-13-0677-8_4
   Shetty P, 2012, NATURE, V485, PS14, DOI 10.1038/485S14a
   SHRIVASTAVA AK, 2020, SUGAR AND SUGAR DERIVATIVES: CHANGING CONSUMER PREFERENCES, V0, PP1, DOI 10.1007/9789811566639_1
   Singh RB, 1999, INT J CARDIOL, V69, P139, DOI 10.1016/S0167-5273(99)00010-8
   Surendran S, 2020, GLOB FOOD SECUR-AGR, V24, P0, DOI 10.1016/j.gfs.2019.100343
   Valenzuela MJ, 2021, EUR J PUBLIC HEALTH, V31, P122, DOI 10.1093/eurpub/ckaa147
   Vandana K, 2018, INDIAN J DENT RES, V29, P428, DOI 10.4103/ijdr.IJDR_75_17
   Vandevijvere S, 2019, OBES REV, V20, P10, DOI 10.1111/obr.12860
   Walls H, 2019, GLOB FOOD SECUR-AGR, V21, P69, DOI 10.1016/j.gfs.2019.05.005
   Walls HL, 2012, J PUBLIC HEALTH POL, V33, P89, DOI 10.1057/jphp.2011.50
   Wojcicki JM, 2010, PEDIATRICS, V126, PE1617, DOI 10.1542/peds.2010-0461
   Wutich A, 2014, CURR ANTHROPOL, V55, P444, DOI 10.1086/677311
NR 63
TC 2
Z9 2
U1 2
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAY 29
PY 2021
VL 21
IS 1
BP 
EP 
DI 10.1186/s12889-021-11033-y
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA SO6VM
UT WOS:000659112400008
PM 34051790
DA 2025-04-28
ER

PT J
AU Damiri, B
   Khatib, O
   Nazzal, Z
   Sanduka, D
   Igbaria, S
   Thabaleh, A
   Farhoud, A
   Saudi, L
   Belkebir, S
   Al Ali, R
   Alili, M
   Hamdan, M
   Safarini, OA
   Younis, O
AF Damiri, Basma
   Khatib, Omar
   Nazzal, Zaher
   Sanduka, Diala
   Igbaria, Siwar
   Thabaleh, Ammar
   Farhoud, Ahmad
   Saudi, Lubna
   Belkebir, Souad
   Al Ali, Rayyan
   Alili, Mohammed
   Hamdan, Mahmoud
   Safarini, Omar A.
   Younis, Omar
TI Metabolic Syndrome Associated with Tobacco and Caffeine Products Use Among Refugee Adolescents: Risk of Dyslipidemia
SO DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
LA English
DT Article
DE refugee adolescents; metabolic syndrome; tobacco smoking; cognitive enhancers and psychostimulants; dyslipidemia; UNRWA
ID energy drink consumption; high-density-lipoprotein; children; definition; prevalence; predictors; overweight; management; attention; cognition
AB Introduction: Due to their stressful lives, Palestinian refugees are prone to use cognitive enhancers (CE) and psychostimulant substances (PS). Recognising health problems asso-ciated with CE/PS use can indicate how preventive programs should be directed towards adolescents. Unfortunately, research has not thoroughly investigated the health problems related to tobacco and caffeine products, the most socially acceptable CE/PS among Palestinian refugee adolescents. Methodology: In 2021, schoolchildren from five Palestinian refugee camps (N=271) aged 12-<16 years agreed to give blood samples and to be interviewed to address the association between metabolic syndrome (MetS) and tobacco smoking, coffee, energy drinks (ED), black tea, and chocolate consumption. MetS was diagnosed based on International Diabetic Federation Criteria. To address the association, we used binary logistic regression models adjusted to age, gender, BMI, and central obesity. Results: The prevalence of MetS was [17 (6.3%)]; (7.4%) in males, (5.1%) in females. The prevalence of substance use was as follows: ED [163 (48.9%)], coffee [255 (76.6%)], black tea [295 (89.1%)], cigarette [35 (10.5%)], waterpipe [59 (17.7%)], and chocolate [309 (93.6%)], with male predominance. Cigarette smokers have increased central obesity (p-value=0.024), and decreased HDL-cholesterol (p-value=0.015) than non-smokers. Similar results were observed for waterpipe smokers besides the increased levels of trigly-cerides (p-value=0.01). ED consumers have increased central obesity (p-value=0.03) and fast blood sugar (p-value=0.003) than non-consumers. Chocolate consumers have decreased central obesity (p-value=0.008) and increased HDL levels (p-value=0.04) than non-consumers. ED consumers were significantly at higher risk of MetS (OR=9.97, p-value=0.019) than non-consumers and chocolate consumers were at lower risk of MetS (OR=0.14, p-value=0.046) than non-consumers. Waterpipe smokers were at a higher risk of having increased plasma triglycerides than non-consumers (OR=3.4, p-value=0.03). Conclusion: The high prevalence of ED consumption and waterpipe smoking in Palestinian refugee adolescents is problematic. Their use was associated with higher odds of MetS, dyslipidemia, and central obesity, which justifies greater attention.
C1 [Damiri, Basma] An Najah Natl Univ, Med & Hlth Sci Fac, Drug & Toxicol Div, POB 7, Nablus 00970, Palestine.
   [Khatib, Omar; Sanduka, Diala; Igbaria, Siwar; Thabaleh, Ammar; Farhoud, Ahmad; Alili, Mohammed; Safarini, Omar A.; Younis, Omar] An Najah Natl Univ, Dept Med, Med & Hlth Sci Fac, Nablus 00970, Palestine.
   [Nazzal, Zaher; Belkebir, Souad] An Najah Natl Univ, Med & Hlth Sci Fac, Family & Community Med, Nablus 00970, Palestine.
   [Al Ali, Rayyan] An Najah Natl Univ, Inst Forens Med, Med & Hlth Sci Fac, Nablus 00970, Palestine.
   [Hamdan, Mahmoud] Najah Natl Univ, Grad Sch, Med Hlth Sci Fac, Clin Lab Sci Program, Nablus 00970, Palestine.
C3 An Najah National University; An Najah National University; An Najah National University; An Najah National University
RP Damiri, B (corresponding author), An Najah Natl Univ, Med & Hlth Sci Fac, Drug & Toxicol Div, POB 7, Nablus 00970, Palestine.
EM bdamiri@najah.edu
FU Committee Services for Refugee Camps in Nablus
CR Abdelaal M, 2017, ANN TRANSL MED, V5, P0, DOI 10.21037/atm.2017.03.107
   Adil M, 2013, INDO AM J PHARM SCI, V2, P6469
   Al Sabbah H, 2015, MOJ PUBLIC HLTH, V2, P36, DOI https://doi.org/10.15406/mojph.2015.02.00015
   Al Sabbah H, 2009, BMC PUBLIC HEALTH, V9, P0, DOI 10.1186/1471-2458-9-52
   Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Anderson PJ, 2001, INT J OBESITY, V25, P1782, DOI 10.1038/sj.ijo.0801837
   Unknown -, 2006, OB OV, V0, P0
   Unknown -, 2019, KEY SUBSTANCE USE ME, V0, P0
   Aslam Hafiz Muhammad, 2014, INT ARCH MED, V7, P16, DOI 10.1186/1755-7682-7-16
   Balhara Yatan Pal Singh, 2012, INDIAN J ENDOCRINOL METAB, V16, P81, DOI 10.4103/2230-8210.91197
   Barter PJ, 2011, DIABETES METAB J, V35, P101, DOI 10.4093/dmj.2011.35.2.101
   Baspinar B, 2017, FOOD FUNCT, V8, P2089, DOI 10.1039/c7fo00388a
   Benton D, 1998, PERS INDIV DIFFER, V24, P513, DOI 10.1016/S0191-8869(97)00215-8
   Buitrago-Lopez A, 2011, BMJ-BRIT MED J, V343, P0, DOI 10.1136/bmj.d4488
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Campbell B, 2013, J INT SOC SPORT NUTR, V10, P0, DOI 10.1186/1550-2783-10-1
   Cappelletti S, 2015, CURR NEUROPHARMACOL, V13, P71, DOI 10.2174/1570159X13666141210215655
   CDC, 2021, DEF CHILDH WEIGHT ST, V0, P0
   Cobb CO, 2011, NICOTINE TOB RES, V13, P78, DOI 10.1093/ntr/ntq212
   Damiri B, 2020, J CONCUR DISORD, V1, P7
   Damiri B, 2021, PALEST MED PHARM J, V6, P0
   Damiri B, 2018, ANN CLIN LAB RES, V6, P8
   Damiri B, 2021, NEUROPSYCH DIS TREAT, V17, P1633, DOI 10.2147/NDT.S308598
   Damiri B, 2020, DRUG-EDUC PREV POLIC, V27, P173, DOI 10.1080/09687637.2019.1591341
   Damiri B, 2022, INT HEALTH, V14, P339, DOI 10.1093/inthealth/ihz093
   Damiri B, 2018, DIABETES METAB SYND, V12, P343, DOI 10.1016/j.dsx.2017.12.021
   Damiri B, 2018, DIABETOL METAB SYNDR, V10, P0, DOI 10.1186/s13098-018-0337-2
   Damiri BR, 2020, INT J MENT HEALTH AD, V18, P1507, DOI 10.1007/s11469-019-00183-1
   DeBoer MD, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11081788
   Ein√∂ther SJL, 2013, PSYCHOPHARMACOLOGY, V225, P251, DOI 10.1007/s00213-012-2917-4
   Eltahir HM, 2020, ACTA BIOCHIM POL, V67, P79, DOI 10.18388/abp.2020_2914
   Famurewa AC, 2015, JOURNAL OF CHEMICAL AND PHARMACEUTICAL RESEARCH, V7, P363
   Favrod-Coune T, 2010, PHARMACEUTICALS-BASE, V3, P2333, DOI 10.3390/ph3072333
   Fornari E, 2019, FRONT ENDOCRINOL, V10, P0, DOI 10.3389/fendo.2019.00702
   Frati P, 2015, CURR NEUROPHARMACOL, V13, P5, DOI 10.2174/1570159X13666141210221750
   Galimov A, 2020, J PSYCHOPHARMACOL, V34, P221, DOI 10.1177/0269881119895545
   Galimov A, 2019, APPETITE, V139, P172, DOI 10.1016/j.appet.2019.04.016
   Gallimberti L, 2013, EUR J PEDIATR, V172, P1335, DOI 10.1007/s00431-013-2036-1
   Ginsberg HN, 2000, AM J CARDIOL, V86, P0
   GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9
   Grundy SM, 2019, CIRCULATION, V139, PE1082, DOI 10.1161/CIR.0000000000000625
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Hadaegh F, 2009, EAST MEDITERR HEALTH J, V15, P157
   Higgins JP, 2010, MAYO CLIN PROC, V85, P1033, DOI 10.4065/mcp.2010.0381
   Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180
   Iyadurai SJP, 2007, EPILEPSY BEHAV, V10, P504, DOI 10.1016/j.yebeh.2007.01.009
   Kasik√ßioglu E, 2017, ANATOL J CARDIOL, V17, P163, DOI 10.14744/AnatolJCardiol.2017.7575
   Kostovski Marko, 2018, OPEN ACCESS MACED J MED SCI, V6, P511, DOI 10.3889/oamjms.2018.097
   Lanni C, 2008, PHARMACOL RES, V57, P196, DOI 10.1016/j.phrs.2008.02.004
   Mansour B, 2019, EUR J PEDIATR, V178, P649, DOI 10.1007/s00431-019-03342-7
   Marjani A, 2013, J BIOL SCI, V13, P679, DOI 10.3923/ jbs.2013.679.684
   Massad SG, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10081118
   Massad SG, 2016, BMC PUBLIC HEALTH, V16, P0, DOI 10.1186/s12889-016-3472-4
   Mattioli AV, 2016, J CARDIOVASC MED, V17, P902, DOI 10.2459/JCM.0000000000000416
   Musmar SG, 2012, EASTERN MEDITERRANEAN HEALTH JOURNAL, V18, P454
   Nadeem IM, 2021, SPORTS HEALTH, V13, P265, DOI 10.1177/1941738120949181
   National Institute on Drug Abuse (NIDA), 2020, PRINC AD SUBST US DI, V0, P0
   Nazzal Z, 2020, PALEST MED PHARM J, V5, P25
   Nehlig A, 2010, J ALZHEIMERS DIS, V20, PS85, DOI 10.3233/JAD-2010-091315
   NEWCOMB MD, 1988, J COUNS PSYCHOL, V35, P426, DOI 10.1037/0022-0167.35.4.426
   Peacock A, 2013, APPETITE, V64, P1, DOI 10.1016/j.appet.2012.12.021
   Rader DJ, 2014, LANCET, V384, P618, DOI 10.1016/S0140-6736(14)61217-4
   Rogers PJ, 2013, PSYCHOPHARMACOLOGY, V226, P229, DOI 10.1007/s00213-012-2889-4
   Rusted J, 2009, PSYCHOPHARMACOLOGY, V202, P93, DOI 10.1007/s00213-008-1320-7
   Saha SP, 2007, INT J ANGIOL, V16, P77
   Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592
   Stanhope KL, 2016, CRIT REV CL LAB SCI, V53, P52, DOI 10.3109/10408363.2015.1084990
   Trapp G, 2020, NUTR METAB CARDIOVAS, V30, P1679, DOI 10.1016/j.numecd.2020.06.012
   Tucktuck M, 2017, BMC PUBLIC HEALTH, V18, P0, DOI 10.1186/s12889-017-4524-0
   Valentine G, 2018, CURR NEUROPHARMACOL, V16, P403, DOI 10.2174/1570159X15666171103152136
   Wassef B, 2017, WORLD J CARDIOL, V9, P796, DOI 10.4330/wjc.v9.i11.796
   Wolk BJ, 2012, CURR OPIN PEDIATR, V24, P243, DOI 10.1097/MOP.0b013e3283506827
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487
   Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1
NR 75
TC 14
Z9 14
U1 1
U2 4
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-7007
EI 
J9 DIABET METAB SYND OB
JI Diabetes Metab. Syndr. Obes.
PD JUN 15
PY 2021
VL 14
IS 
BP 4121
EP 4133
DI 10.2147/DMSO.S329675
PG 13
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA WB6RW
UT WOS:000703698800001
PM 34616165
DA 2025-04-28
ER

PT J
AU Paz-Graniel, I
   Babio, N
   Becerra-Tom√°s, N
   Toledo, E
   Camacho-Barcia, L
   Corella, D
   Casta√±er-Ni√±o, O
   Romaguera, D
   Vioque, J
   Alonso-G√≥mez, AM
   W√§rnberg, J
   Mart√≠nez, JA
   Serra-Majem, L
   Estruch, R
   Tinahones, FJ
   Fernandez-Aranda, F
   Lapetra, J
   Pint√≥, X
   Tur, JA
   Garc√≠a-Rios, A
   Bueno-Cavanillas, A
   Gaforio, JJ
   Mat√≠a-Mart√≠n, P
   Daimiel, L
   Sanchez, VM
   Vidal, J
   Prieto-Sanchez, L
   Ros, E
   Razquin, C
   Mestres, C
   Sorli, JV
   Cuenca-Royo, AM
   Rios, A
   Torres-Collado, L
   Vaquero-Luna, J
   P√©rez-Farin√≥s, N
   Zulet, MA
   Sanchez-Villegas, A
   Casas, R
   Bernal-Lopez, MR
   Santos-Lozano, JM
   Corbella, X
   Mateos, D
   Buil-Cosiales, P
   Jimenez-Murcia, S
   Fernandez-Carrion, R
   Forcano-Gamazo, L
   L√≥pez, M
   Sempere-Pascual, MA
   Moreno-Rodriguez, A
   Gea, A
   De la Torre-Fornell, R
   Salas-Salvad√≥, J
AF Paz-Graniel, Indira
   Babio, Nancy
   Becerra-Tomas, Nerea
   Toledo, Estefania
   Camacho-Barcia, Lucia
   Corella, Dolores
   Castaner-Nino, Olga
   Romaguera, Dora
   Vioque, Jesus
   Alonso-Gomez, Angel M.
   Warnberg, Julia
   Martinez, J. Alfredo
   Serra-Majem, Luis
   Estruch, Ramon
   Tinahones, Francisco J.
   Fernandez-Aranda, Fernando
   Lapetra, Jose
   Pinto, Xavier
   Tur, Josep A.
   Garcia-Rios, Antonio
   Bueno-Cavanillas, Aurora
   Gaforio, Jose J.
   Matia-Martin, Pilar
   Daimiel, Lidia
   Sanchez, Vicente Martin
   Vidal, Josep
   Prieto-Sanchez, Lucia
   Ros, Emilio
   Razquin, Cristina
   Mestres, Cristina
   Sorli, Jose V.
   Cuenca-Royo, Aida M.
   Rios, Angel
   Torres-Collado, Laura
   Vaquero-Luna, Jessica
   Perez-Farinos, Napoleon
   Zulet, M. Angeles
   Sanchez-Villegas, Almudena
   Casas, Rosa
   Bernal-Lopez, M. Rosa
   Santos-Lozano, Jose Manuel
   Corbella, Xavier
   Mateos, David
   Buil-Cosiales, Pilar
   Jimenez-Murcia, Susana
   Fernandez-Carrion, Rebeca
   Forcano-Gamazo, Laura
   Lopez, Meritxell
   Sempere-Pascual, Miguel Angel
   Moreno-Rodriguez, Anai
   Gea, Alfredo
   De la Torre-Fornell, Rafael
   Salas-Salvado, Jordi
TI Association between coffee consumption and total dietary caffeine intake with cognitive functioning: cross-sectional assessment in an elderly Mediterranean population
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Cognitive impairment; Mini-Mental State Examination; Coffee; Caffeine; PREDIMED-plus
ID physical-activity questionnaire; mini-mental state; older; impairment; benefits; risk; validation; component; dementia; disease
AB Purpose Coffee is rich in compounds such as polyphenols, caffeine, diterpenes, melanoidins and trigonelline, which can stimulate brain activity. Therefore, the possible association of coffee consumption with cognition is of considerable research interest. In this paper, we assess the association of coffee consumption and total dietary caffeine intake with the risk of poor cognitive functioning in a population of elderly overweight/obese adults with metabolic syndrome (MetS). Methods PREDIMED-plus study participants who completed the Mini-Mental State Examination test (MMSE) (n = 6427; mean age = 65 +/- 5 years) or a battery of neuropsychological tests were included in this cross-sectional analysis. Coffee consumption and total dietary caffeine intake were assessed at baseline using a food frequency questionnaire. Logistic regression models were fitted to evaluate the association between total, caffeinated and decaffeinated coffee consumption or total dietary caffeine intake and cognitive impairment. Results Total coffee consumers and caffeinated coffee consumers had better cognitive functioning than non-consumers when measured by the MMSE and after adjusting for potential confounders (OR 0.63; 95% CI 0.44-0.90 and OR 0.56; 95% CI 0.38-0.83, respectively). Results were similar when cognitive performance was measured using the Clock Drawing Test (CDT) and Trail Making Test B (TMT-B). These associations were not observed for decaffeinated coffee consumption. Participants in the highest tertile of total dietary caffeine intake had lower odds of poor cognitive functioning than those in the reference tertile when screened by the MMSE (OR 0.64; 95% CI 0.47-0.87) or other neurophysiological tests evaluating a variety of cognitive domains (i.e., CDT and TMT-A). Conclusions Coffee consumption and total dietary caffeine intake were associated with better cognitive functioning as measured by various neuropsychological tests in a Mediterranean cohort of elderly individuals with MetS.
C1 [Paz-Graniel, Indira; Babio, Nancy; Becerra-Tomas, Nerea; Camacho-Barcia, Lucia; Salas-Salvado, Jordi] Rovira & Virgili Univ, Dept Biochem & Biotechnol, Human Nutr Unit, Reus, Spain.
   [Paz-Graniel, Indira; Babio, Nancy; Becerra-Tomas, Nerea; Camacho-Barcia, Lucia; Salas-Salvado, Jordi] Inst Invest Sanitaria Pere Virgili IISPV, Reus, Spain.
   [Paz-Graniel, Indira; Babio, Nancy; Becerra-Tomas, Nerea; Toledo, Estefania; Camacho-Barcia, Lucia; Corella, Dolores; Castaner-Nino, Olga; Romaguera, Dora; Alonso-Gomez, Angel M.; Warnberg, Julia; Martinez, J. Alfredo; Serra-Majem, Luis; Estruch, Ramon; Tinahones, Francisco J.; Fernandez-Aranda, Fernando; Lapetra, Jose; Pinto, Xavier; Tur, Josep A.; Garcia-Rios, Antonio; Sanchez, Vicente Martin; Ros, Emilio; Razquin, Cristina; Sorli, Jose V.; Cuenca-Royo, Aida M.; Vaquero-Luna, Jessica; Perez-Farinos, Napoleon; Zulet, M. Angeles; Sanchez-Villegas, Almudena; Casas, Rosa; Bernal-Lopez, M. Rosa; Santos-Lozano, Jose Manuel; Mateos, David; Buil-Cosiales, Pilar; Jimenez-Murcia, Susana; Fernandez-Carrion, Rebeca; Forcano-Gamazo, Laura; Moreno-Rodriguez, Anai; Gea, Alfredo; De la Torre-Fornell, Rafael; Salas-Salvado, Jordi] Carlos III Hlth Inst, CIBER Physiol Obes & Nutr CIBEROBN, Madrid, Spain.
   [Becerra-Tomas, Nerea] Univ Valencia, Sch Med, Dept Prevent Med & Publ Hlth, Valencia 46010, Spain.
   [Toledo, Estefania; Razquin, Cristina; Buil-Cosiales, Pilar; Gea, Alfredo] Univ Navarra, Dept Prevent Med & Publ Hlth, IdiSNA, Pamplona, Spain.
   [Corella, Dolores; Sorli, Jose V.; Fernandez-Carrion, Rebeca] Univ Valencia, Dept Prevent Med, Valencia, Spain.
   [Castaner-Nino, Olga; Romaguera, Dora] Hosp del Mar Res Inst IMIM, Cardiovasc Risk & Nutr Res Grp CARIN, Barcelona, Spain.
   [Tur, Josep A.; Rios, Angel; Lopez, Meritxell] Univ Hosp Son Espases, Hlth Res Inst Balear Islands IdISBa, Palma De Mallorca, Spain.
   [Vioque, Jesus; Gaforio, Jose J.; Torres-Collado, Laura; Mateos, David] Carlos III Hlth Inst, CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.
   [Vioque, Jesus; Torres-Collado, Laura] Miguel Hernandez Univ, ISABIAL UMH, Alicante, Spain.
   [Alonso-Gomez, Angel M.; Bueno-Cavanillas, Aurora; Vaquero-Luna, Jessica; Moreno-Rodriguez, Anai] Univ Basque Country UPV EHU, Araba Univ Hosp, Bioaraba Hlth Res Inst, Osakidetza Basque Hlth Serv, Vitoria, Spain.
   [Warnberg, Julia] Univ Malaga, Sch Hlth Sci, Dept Nursing, Inst Invest Biomed Malaga IBIMA, Malaga, Spain.
   [Martinez, J. Alfredo; Zulet, M. Angeles] Univ Navarra, Dept Nutr Food Sci & Physiol, IDISNA, Pamplona, Spain.
   [Martinez, J. Alfredo; Daimiel, Lidia] CSIC, Nutr Genom & Epigen Grp, IMDEA Food, CEI UAM, Madrid, Spain.
   [Serra-Majem, Luis; Sanchez-Villegas, Almudena] Univ Las Palmas Gran Canaria, Res Inst Biomed & Hlth Sci IUIBS, Ctr Hosp Univ Insular Materno Infantil CHUIMI, Prevent Med Serv,Canarian Hlth Serv, Las Palmas Gran Canaria, Spain.
   [Estruch, Ramon; Casas, Rosa] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin, Dept Internal Med, Barcelona, Spain.
   [Tinahones, Francisco J.] Univ Malaga, Virgen Victoria Hosp, Dept Endocrinol, Biomed Res Inst Malaga IBIMA, Malaga, Spain.
   [Fernandez-Aranda, Fernando; Jimenez-Murcia, Susana] Bellvitge Univ Hosp, IDIBELL, Dept Psychiat, Barcelona, Spain.
   [Lapetra, Jose; Santos-Lozano, Jose Manuel] Distrito Sanitario Atenc Primaria Sevilla, Dept Family Med, Res Unit, Seville, Spain.
   [Pinto, Xavier; Corbella, Xavier] Bellvitge Univ Hosp, Internal Med, Lipids & Vasc Risk Unit, Barcelona, Spain.
   [Tur, Josep A.; Mateos, David] Univ Balear Islands, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain.
   [Garcia-Rios, Antonio] Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Dept Internal Med, Cordoba, Spain.
   [Bueno-Cavanillas, Aurora] Univ Granada, Dept Prevent Med, Granada, Spain.
   [Gaforio, Jose J.] Univ Jaen, Dept Ciencias Salud, Ctr Estudios Avanzados Olivar & Aceites Oliva, Jaen, Spain.
   [Matia-Martin, Pilar] San Carlos Clin Hosp IdISSC, Hlth Res Inst, Dept Endocrinol & Nutr, Madrid, Spain.
   [Sanchez, Vicente Martin] Univ Leon, Inst Biomed IBIOMED, Leon, Spain.
   [Vidal, Josep] Carlos III Hlth Inst ISCIII, CIBER Diabet & Associated Metab Dis CIBERDEM, Madrid, Spain.
   [Vidal, Josep] Univ Barcelona, August Pi & Sunyer Biomed Res Inst IDIBAPS, Hosp Clin, Dept Endocrinol, Barcelona, Spain.
   [Prieto-Sanchez, Lucia] Fdn Jimenez Diaz, Dept Endocrinol, Madrid, Spain.
   [Ros, Emilio] August Pi & Sunyer Biomed Res Inst IDIBAPS, Hosp Clin, Dept Endocrinol & Nutr, Lipid Clin, Barcelona, Spain.
   [Mestres, Cristina] Joan XXIII Univ Hosp, Tarragona, Spain.
   [Mestres, Cristina] Horts Miro Hlth Ctr, Reus, Spain.
   [Cuenca-Royo, Aida M.; Forcano-Gamazo, Laura; De la Torre-Fornell, Rafael] Hosp del Mar Res Inst IMIM, Integrat Pharmacol & Syst Neurosci FINS, Barcelona, Spain.
   [Perez-Farinos, Napoleon] Univ Malaga, Sch Med, Dept Publ Hlth, Biomed Res Inst Malaga IBIMA, Malaga, Spain.
   [Zulet, M. Angeles] Univ Navarra, Fac Pharm & Nutr, Ctr Nutr Res, Pamplona, Spain.
   [Bernal-Lopez, M. Rosa] Reg Univ Hosp Malaga, Inst Invest Biomed Malaga IBIMA, Internal Med Dept, Malaga, Spain.
   [Corbella, Xavier] Univ Int Catalunya, Med & Hlth Sci Fac, Barcelona, Spain.
   [Sempere-Pascual, Miguel Angel] Santa Pola Hlth Ctr, Alicante, Spain.
   [Salas-Salvado, Jordi] Sant Joan Univ Hosp, Human Nutr Unit, Reus, Spain.
C3 Universitat Rovira i Virgili; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Valencia; University of Navarra; University of Valencia; Hospital del Mar Research Institute; Hospital del Mar; Hospital Universitari Son Espases; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); University of Basque Country; University Hospital of Araba; Bioaraba Health Research Institute; Universidad de Malaga; Instituto de Investigacion Biomedica de Malaga y Plataforma en Nanomedicina (IBIMA); University of Navarra; Consejo Superior de Investigaciones Cientificas (CSIC); IMDEA Food Institute; Universidad de Las Palmas de Gran Canaria; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidad de Malaga; Instituto de Investigacion Biomedica de Malaga y Plataforma en Nanomedicina (IBIMA); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Universidad de Cordoba; University of Granada; Universidad de Jaen; Universidad de Leon; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital del Mar Research Institute; Hospital del Mar; Instituto de Investigacion Biomedica de Malaga y Plataforma en Nanomedicina (IBIMA); Universidad de Malaga; University of Navarra; Universidad de Malaga; Instituto de Investigacion Biomedica de Malaga y Plataforma en Nanomedicina (IBIMA); Universitat Internacional de Catalunya (UIC)
RP Babio, N; Salas-Salvad√≥, J (corresponding author), Rovira & Virgili Univ, Dept Biochem & Biotechnol, Human Nutr Unit, Reus, Spain.; Babio, N; Salas-Salvad√≥, J (corresponding author), Inst Invest Sanitaria Pere Virgili IISPV, Reus, Spain.; Babio, N; Salas-Salvad√≥, J (corresponding author), Carlos III Hlth Inst, CIBER Physiol Obes & Nutr CIBEROBN, Madrid, Spain.; Salas-Salvad√≥, J (corresponding author), Sant Joan Univ Hosp, Human Nutr Unit, Reus, Spain.
EM nancy.babio@urv.cat; jordi.salas@urv.cat
FU Spanish government's official funding agency for biomedical research, ISCIII, through the Fondo de Investigacion para la Salud (FIS); European Union ERDF/ESF, "A way to make Europe"/"Investing in your future" [PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471]; Special Action Project entitled: Implementacion y evaluacion de una intervencion intensiva sobre la actividad fisica Cohorte PREDIMED-Plus grant; European Research Council [340918]; Recercaixa Grant [2013ACUP00194]; Consejeria de Salud de la Junta de Andalucia [PI0458/2013, PS0358/2016, PI0137/2018]; Generalitat Valenciana [PROMETEO/2017/017]; SEMERGEN grant; European Regional Development Fund [CB06/03]; EU-H2020 Grant (EAT2BENICE/H2020-SFS-2016-2) [728018]; Department of Health of the Generalitat de Catalunya [SLT006/17/00246]; ICREA under the ICREA Academia program; Spanish Ministry of Education, Culture and Sports [FPU 17/01925]; Generalitat de Catalunya's Department of Universities [FI-DGR 2017]; Juan de la Cierva-Formacion [FJC2018-036016-I]; "Miguel Servet Type I" program from the ISCIII-Madrid (Spain) [CP15/00028]; Fondo Europeo de Desarrollo Regional-FEDER;  [PI16/00473];  [PI16/00662];  [PI16/01873];  [PI16/01094];  [PI16/00501];  [PI16/00533];  [PI16/00381];  [PI16/00366];  [PI16/01522];  [PI16/01120];  [PI17/00764];  [PI17/01183];  [PI17/00855];  [PI17/01347];  [PI17/00525];  [PI17/01827];  [PI17/00532];  [PI17/00215];  [PI17/01441];  [PI17/00508];  [PI17/01732];  [PI17/00926];  [PI19/00957];  [PI19/00386];  [PI19/00309];  [PI19/01032];  [PI19/00576];  [PI19/00017];  [PI19/01226];  [PI19/00781];  [PI19/01560];  [PI19/01332]
CR Unknown -, 1999, WAIS 3 ESC INT WECHS, V0, P0
   Aprahamian Ivan, 2009, DEMENT. NEUROPSYCHOL., V3, P74, DOI 10.1590/S1980-57642009DN30200002
   Ara√∫jo LF, 2015, NUTRIENTS, V7, P9590, DOI 10.3390/nu7115487
   Atti AR, 2019, AM J GERIAT PSYCHIAT, V27, P625, DOI 10.1016/j.jagp.2019.01.214
   Basurto-Islas G, 2014, NEUROBIOL AGING, V35, P2701, DOI 10.1016/j.neurobiolaging.2014.06.012
   Benton AL, 1994, MULTILINGUAL APHASIA EXAMINATION, V0, P0
   Berendsen AAM, 2017, J AM MED DIR ASSOC, V18, P427, DOI 10.1016/j.jamda.2016.11.026
   Blesa R, 2001, NEUROPSYCHOLOGIA, V39, P1150, DOI 10.1016/S0028-3932(01)00055-0
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Camfield DA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0082897
   Cao CH, 2011, J ALZHEIMERS DIS, V25, P323, DOI 10.3233/JAD-2011-110110
   Castelli V, 2018, CURR PHARM DESIGN, V24, P227, DOI 10.2174/1381612824666171213100449
   Chu YF, 2012, FOOD CHEM, V135, P2095, DOI 10.1016/j.foodchem.2012.04.148
   Colombo R, 2020, CRIT REV FOOD SCI, V60, P760, DOI 10.1080/10408398.2018.1550384
   Dong X, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12030840
   Driscoll I, 2016, J GERONTOL A-BIOL, V71, P1596, DOI 10.1093/gerona/glw078
   ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966
   Elosua R, 2000, MED SCI SPORT EXER, V32, P1431, DOI 10.1097/00005768-200008000-00011
   Ferreira-P√™go C, 2014, NUTR HOSP, V29, P1171, DOI 10.3305/nh.2014.29.5.7421
   Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   Hajjar I, 2018, J NEUROINFLAMM, V15, P0, DOI 10.1186/s12974-017-1026-z
   Haskell-Ramsay CF, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10101386
   Jackson NHH, 2015, J GERONTOL GERIATR R, V4, P0, DOI 10.4172/2167-7182.1000233
   JARVIS MJ, 1993, PSYCHOPHARMACOLOGY, V110, P45, DOI 10.1007/BF02246949
   Johnson-Kozlow M, 2002, AM J EPIDEMIOL, V156, P842, DOI 10.1093/aje/kwf119
   Konishi Y, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0202247
   Kromhout MA, 2019, EXP GERONTOL, V122, P85, DOI 10.1016/j.exger.2019.04.017
   Llin√†s-Regl√† J, 2017, ASSESSMENT, V24, P183, DOI 10.1177/1073191115602552
   Mancini RS, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00735
   Mart√≠nez-Gonz√°lez MA, 2019, INT J EPIDEMIOL, V48, P387, DOI 10.1093/ije/dyy225
   Mataix Verdu J, 2003, TABLA COMPOSICION AL, V0, P0
   Moreiras O, 2005, TABLAS DE COMPOSICION DE ALIMENTOS, V0, P0
   Navarro AM, 2018, AM J CLIN NUTR, V108, P1113, DOI 10.1093/ajcn/nqy198
   Nissensohn M, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8040232
   Paganini-Hill A, 2011, DEMENT GER COGN D EX, V1, P75, DOI 10.1159/000326781
   Paz-Graniel I, 2020, EUR J NUTR, V59, P1595, DOI 10.1007/s00394-019-02015-3
   Quijano TD, 2004, MED CLIN-BARCELONA, V122, P727, DOI 10.1157/13062190
   Ros E, 2013, CIRCULATION, V128, P553, DOI 10.1161/CIRCULATIONAHA.112.001119
   Salas-Salvad√≥ J, 2019, DIABETES CARE, V42, P777, DOI 10.2337/dc18-0836
   Santos C, 2010, J ALZHEIMERS DIS, V20, PS187, DOI 10.3233/JAD-2010-091387
   Sanz J, 2003, CLINICA Y SALUD, V14, P249
   Schr√∂der H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566
   SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305
   Singh B, 2014, J ALZHEIMERS DIS, V39, P271, DOI 10.3233/JAD-130830
   Sokka T, 2008, CLIN EXP RHEUMATOL, V26, PS35, DOI 10.1161/CIRCULATIONAHA.109.192644
   Solas M, 2017, CURR OPIN PHARMACOL, V37, P87, DOI 10.1016/j.coph.2017.10.005
   WHO, 2019, RISK REDUCTION OF COGNITIVE DECLINE AND DEMENTIA: WHO GUIDELINES, V0, P0
   Wu L, 2017, CLIN NUTR, V36, P730, DOI 10.1016/j.clnu.2016.05.015
   Yates KF, 2012, ARTERIOSCL THROM VAS, V32, P2060, DOI 10.1161/ATVBAHA.112.252759
   Zucconi S, 2013, SUPPORTING PUBLICATIONS EN-394, V0, P0, DOI DOI 10.2903/SP.EFSA.2013.EN
NR 52
TC 19
Z9 19
U1 1
U2 48
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD AUG 15
PY 2021
VL 60
IS 5
BP 2381
EP 2396
DI 10.1007/s00394-020-02415-w
EA OCT 2020
PG 16
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA TI0VN
UT WOS:000583015100002
PM 33125576
DA 2025-04-28
ER

PT J
AU Yoo, HJ
   Yoon, HY
   Yee, J
   Gwak, HS
AF Yoo, Hee-Jeong
   Yoon, Ha-Young
   Yee, Jeong
   Gwak, Hye-Sun
TI Effects of Ephedrine-Containing Products on Weight Loss and Lipid Profiles: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
SO PHARMACEUTICALS
LA English
DT Review
DE mahuang; ephedrine; weight loss; blood pressure; lipid profiles; systematic review; meta-analysis
ID body-mass index; double-blind; dietary-supplements; herbal supplement; caffeine; obesity; efficacy; safety; overweight; placebo
AB Ephedrine, the main active ingredient of mahuang, may lead to weight loss; however, it can also induce cardiovascular side effects. As ephedrine use remains controversial, this study aimed to systematically review previous studies on ephedrine-containing products and perform meta-analysis of the existing evidence on weight, blood pressure (BP), heart rate, and lipid change effects of ephedrine-containing products. We searched for placebo-controlled randomized studies in PubMed, Web of Science, and EMBASE until July 2021 using the following search terms: (ephedr* OR mahuang) AND ( "weight loss " OR obes* OR overweight). Mean differences (MDs) and 95% confidence intervals (CIs) were calculated to evaluate the effects of ephedrine-containing products on weight, BP, heart rate, and lipid profiles. A total of 10 articles were included. Compared with the placebo group, the ephedrine-containing product group was associated with greater weight loss, with an MD of -1.97 kg (95% CI: -2.38, -1.57). In the ephedrine-containing product group, the mean heart rate was 5.76 beats/min higher than in the placebo group (95% CI: 3.42, 8.10), whereas intergroup differences in systolic and diastolic BP were not statistically significant. The ephedrine-containing product group had a significantly higher mean high-density lipoprotein cholesterol level (MD: 2.74 mg/dL; 95% CI: 0.94, 4.55), lower mean low-density lipoprotein cholesterol level (MD: -5.98 mg/dL; 95% CI: -10.97, -0.99), and lower mean triglyceride level (MD: -11.25 mg/dL; 95% CI: -21.83, -0.68) than the placebo group. Compared with placebo, the ephedrine-containing products showed better effects on weight loss and lipid profiles, whereas they caused increased heart rate. The ephedrine-containing products may be beneficial to obese or overweight patients; however, close monitoring is needed, especially heart rate monitoring.
C1 [Yoo, Hee-Jeong; Yoon, Ha-Young; Yee, Jeong; Gwak, Hye-Sun] Ewha Womans Univ, Coll Pharm, Seoul 03760, South Korea.
   [Yoo, Hee-Jeong; Yoon, Ha-Young; Yee, Jeong; Gwak, Hye-Sun] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul 03760, South Korea.
   [Yoo, Hee-Jeong] Natl Med Ctr, Dept Pharm, Seoul 04564, South Korea.
C3 Ewha Womans University; Ewha Womans University; National Medical Center - Korea
RP Yee, J; Gwak, HS (corresponding author), Ewha Womans Univ, Coll Pharm, Seoul 03760, South Korea.; Yee, J; Gwak, HS (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul 03760, South Korea.
EM heejyoo@hanmail.net; hayoungdymphnayoon@gmail.com; jjjhello1@naver.com; hsgwak@ewha.ac.kr
CR Apovian CM, 2015, J CLIN ENDOCR METAB, V100, P342, DOI 10.1210/jc.2014-3415
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   Batsis JA, 2021, OBESITY, V29, P1102, DOI 10.1002/oby.23110
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8
   Bogacka I, 2007, DIABETES CARE, V30, P1179, DOI 10.2337/dc06-1962
   Boozer CN, 2001, INT J OBESITY, V25, P316, DOI 10.1038/sj.ijo.0801539
   Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023
   BUEMANN B, 1994, INT J OBESITY, V18, P329
   Carey AL, 2015, DIABETOLOGIA, V58, P1045, DOI 10.1007/s00125-015-3543-6
   Caterson ID, 2012, DIABETES OBES METAB, V14, P523, DOI 10.1111/j.1463-1326.2011.01554.x
   Coffey CS, 2004, INT J OBESITY, V28, P1411, DOI 10.1038/sj.ijo.0802784
   Daneschvar HL, 2016, AM J MED, V129, P0, DOI 10.1016/j.amjmed.2016.02.009
   De Matteis R, 2002, INT J OBESITY, V26, P1442, DOI 10.1038/sj.ijo.0802148
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, PR77, DOI 10.1152/ajpregu.00832.2005
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Food and Drug Administration HHS, 2004, FED REGIST, V69, P6787
   Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x
   Greenway FL, 2004, OBES RES, V12, P1152, DOI 10.1038/oby.2004.144
   Hackman RM, 2006, INT J OBESITY, V30, P1545, DOI 10.1038/sj.ijo.0803283
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   Harpaz Eynav, 2017, JOURNAL OF BASIC AND CLINICAL PHYSIOLOGY AND PHARMACOLOGY, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073
   Hioki C, 2004, CLIN EXP PHARMACOL P, V31, P614, DOI 10.1111/j.1440-1681.2004.04056.x
   Ingerslev J, 1997, INT J OBESITY, V21, P666, DOI 10.1038/sj.ijo.0800457
   Kalman DS, 2000, CURR THER RES CLIN E, V61, P199, DOI 10.1016/S0011-393X(00)89034-7
   Khera R, 2016, JAMA-J AM MED ASSOC, V315, P2424, DOI 10.1001/jama.2016.7602
   Kopelman P, 2007, OBES REV, V8, P13, DOI 10.1111/j.1467-789X.2007.00311.x
   KRIEGER DR, 1990, T ASSOC AM PHYSICIAN, V103, P307
   Laccourreye O, 2015, EUR ANN OTORHINOLARY, V132, P31, DOI 10.1016/j.anorl.2014.11.001
   Maunder A, 2020, DIABETES OBES METAB, V22, P891, DOI 10.1111/dom.13973
   Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163
   Ogden CL, 2020, JAMA-J AM MED ASSOC, V324, P1208, DOI 10.1001/jama.2020.14590
   Page MJ, 2021, BMJ-BRIT MED J, V372, P0, DOI 10.1136/bmj.n71
   PASQUALI R, 1985, INT J OBESITY, V9, P93
   Persky AM, 2004, BRIT J CLIN PHARMACO, V57, P552, DOI 10.1111/j.1365-2125.2003.02062.x
   Saper RB, 2004, AM FAM PHYSICIAN, V70, P1731
   Schubert MM, 2014, J APPL PHYSIOL, V117, P745, DOI 10.1152/japplphysiol.00570.2014
   Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537
   Song MK, 2012, EXP THER MED, V3, P707, DOI 10.3892/etm.2012.462
   Sterne JAC, 2019, BMJ-BRIT MED J, V366, P0, DOI 10.1136/bmj.l4898
   Tynes JR, 2006, J LEGAL MED, V27, P493, DOI 10.1080/01947640601021113
   VALLERAND AL, 1989, J APPL PHYSIOL, V67, P438, DOI 10.1152/jappl.1989.67.1.438
   Wadden TA, 2004, OBES RES, V12, P151S, DOI 10.1038/oby.2004.282
   Westfall T, 2017, GOODMAN GILMANS: THE PHARMACOLOGICAL BASIS OF THERAPEUTICS, V0, P0
   Wooltorton E, 2002, CAN MED ASSOC J, V166, P633
NR 48
TC 8
Z9 9
U1 0
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD NOV 15
PY 2021
VL 14
IS 11
BP 
EP 
DI 10.3390/ph14111198
PG 11
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA XI0WB
UT WOS:000725842200001
PM 34832979
DA 2025-04-28
ER

PT J
AU Kong, L
   Xu, M
   Qiu, YY
   Liao, MF
   Zhang, QF
   Yang, LC
   Zheng, GD
AF Kong, Li
   Xu, Meng
   Qiu, Yangyang
   Liao, Mingfu
   Zhang, Qingfeng
   Yang, Licong
   Zheng, Guodong
TI Chlorogenic acid and caffeine combination attenuates adipogenesis by regulating fat metabolism and inhibiting adipocyte differentiation in 3T3-L1 cells
SO JOURNAL OF FOOD BIOCHEMISTRY
LA English
DT Article
DE L1 cells; caffeine; chlorogenic acid; differentiation; fat metabolism
ID activated protein-kinase; ampk-dependent pathway; lipid-metabolism; ppar-gamma; c/ebp-alpha; obesity; expression; management; enzymes; target
AB Obesity is a complex disease spreading in the world. In our previous studies, chlorogenic acid (CGA) and caffeine had ever been reported to reduce the body weight gain and fat accumulation in mice. This study investigated the anti-obesity effect of CGA and caffeine on 3T3-L1 cells. According to triglyceride (TG) assay and Oil-Red O staining, 40 mu g/ml CGA and 160 mu g/ml caffeine reduced TG content. Moreover, CGA + caffeine inhibited the mRNA expression of major adipogenic markers, PPAR-gamma 2, and C/EBP alpha in the metaphase and anaphase stages of differentiation induction (Day 2 and 4). CGA + caffeine improved P-AMPK/AMPK accompanied by decreasing the expression of GPDH and FAS to depress the lipid synthesis, increasing the mRNA expression of ACO and CAT to promote fatty acid oxidation and up-regulated the expression of hydrolysis-related enzyme adipose TG lipase (ATGL) and P-HSL/HSL. Furthermore, CGA + caffeine improved the expression of Glut4 which promoted the glucose transport. Taken together, these data demonstrated CGA + caffeine inhibited 3T3-L1 cells differentiation in the middle and late stages and reduced the fat accumulation through AMPK pathway by regulating the fat metabolism-related enzyme in 3T3-L1 cells to attenuates adipogenesis. Practical applications The aim of this study was to elucidate the potential role of chlorogenic acid and caffeine in the treatment of obesity.
C1 [Kong, Li; Xu, Meng; Qiu, Yangyang; Liao, Mingfu; Zhang, Qingfeng; Yang, Licong; Zheng, Guodong] Jiangxi Agr Univ, Sch Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang 330045, Jiangxi, Peoples R China.
C3 Jiangxi Agricultural University
RP Yang, LC; Zheng, GD (corresponding author), Jiangxi Agr Univ, Sch Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang 330045, Jiangxi, Peoples R China.
EM wanttobea@163.com; zrs150716@aliyun.com
FU National Natural Science Foundation of China [81760157, 82060165]
CR Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378
   Catalioto RM, 2013, BIOCHEM PHARMACOL, V86, P508, DOI 10.1016/j.bcp.2013.06.005
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Feng L, 2010, ACTA PHARMACOL SIN, V31, P329, DOI 10.1038/aps.2010.11
   Forbes-Hern√°ndez TY, 2020, FOOD FUNCT, V11, P297, DOI 10.1039/c9fo02285f
   Gowans GJ, 2014, BIOCHEM SOC T, V42, P71, DOI 10.1042/BST20130244
   Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965
   Hardie DG, 2008, INT J OBESITY, V32, PS7, DOI 10.1038/ijo.2008.116
   Hausman D B, 2001, OBES REV, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x
   Hu GL, 2019, FOOD FUNCT, V10, P3113, DOI 10.1039/c9fo00288j
   Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015
   Ruiz-Ojeda FJ, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17071040
   Jeong YU, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21020460
   Karri S, 2019, BIOMED PHARMACOTHER, V110, P224, DOI 10.1016/j.biopha.2018.11.076
   KELLEY DS, 1986, BIOCHEM J, V235, P87, DOI 10.1042/bj2350087
   Kralova E, 2021, J PHARM PHARMACOL, V73, P778, DOI 10.1093/jpp/rgab005
   Lee JW, 2012, J LIPID RES, V53, P1277, DOI 10.1194/jlr.M022897
   Liu JL, 2018, FOOD SCI TECHNOL RES, V24, P903, DOI 10.3136/fstr.24.903
   Luiken JJFP, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165775
   Maki C, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0173264
   Morais S, 2007, PHYSIOL GENOMICS, V28, P239, DOI 10.1152/physiolgenomics.00136.2006
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mouton AJ, 2020, CIRC RES, V126, P789, DOI 10.1161/CIRCRESAHA.119.312321
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Park HJ, 2012, FOOD CHEM, V134, P227, DOI 10.1016/j.foodchem.2012.02.101
   Rao MY, 2019, J DIABETES RES, V2019, P0, DOI 10.1155/2019/5101423
   Reddy MRG, 2016, BBA-MOL CELL BIOL L, V1861, P156, DOI 10.1016/j.bbalip.2015.11.005
   Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Srivastava RAK, 2012, J LIPID RES, V53, P2490, DOI 10.1194/jlr.R025882
   Sun NN, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21101351
   Vazirian M, 2018, FOOD CHEM TOXICOL, V122, P69, DOI 10.1016/j.fct.2018.09.079
   Wang J, 2019, J AGR FOOD CHEM, V67, P14056, DOI 10.1021/acs.jafc.9b05072
   Wang L, 2015, CELL PHYSIOL BIOCHEM, V35, P2285, DOI 10.1159/000374032
   Wang QQ, 2017, CURR PHARM DESIGN, V23, P3677, DOI 10.2174/1381612823666170704125104
   Wang QA, 2014, ADIPOCYTE, V3, P146, DOI 10.4161/adip.27656
   Wang ZY, 2019, J AGR FOOD CHEM, V67, P1092, DOI 10.1021/acs.jafc.8b05281
   World Health Organization, 2020, WHO GLOB INF, V0, P0
   Xu M, 2019, FOOD FUNCT, V10, P7489, DOI 10.1039/c9fo00502a
   Xu Y, 2020, FRONT MICROBIOL, V11, P0, DOI 10.3389/fmicb.2020.00219
   Zhang XM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0070663
   Zhao Y, 2017, EUR J NUTR, V56, P2309, DOI 10.1007/s00394-016-1271-4
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zou TD, 2020, J SCI FOOD AGR, V100, P2389, DOI 10.1002/jsfa.10248
NR 44
TC 29
Z9 30
U1 3
U2 46
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0145-8884
EI 1745-4514
J9 J FOOD BIOCHEM
JI J. Food Biochem.
PD JUL 15
PY 2021
VL 45
IS 7
BP 
EP 
DI 10.1111/jfbc.13795
EA MAY 2021
PG 11
WC Biochemistry & Molecular Biology; Food Science & Technology
SC Biochemistry & Molecular Biology; Food Science & Technology
GA TC4HC
UT WOS:000654042600001
PM 34036605
DA 2025-04-28
ER

PT J
AU Cai, JS
   Liu, SZ
   Li, Y
   Liu, QM
   Xu, M
   Mo, CB
   Mai, TY
   Xu, X
   Tang, X
   Chen, QH
   Nong, CT
   Lu, HX
   He, HY
   Tang, JX
   Zhang, JL
   Wei, CM
   Tan, DC
   Qin, J
   Zhang, ZY
AF Cai, Jiansheng
   Liu, Shuzhen
   Li, You
   Liu, Qiumei
   Xu, Min
   Mo, Chunbao
   Mai, Tingyu
   Xu, Xia
   Tang, Xu
   Chen, Quanhui
   Nong, Chuntao
   Lu, Huaxiang
   He, Haoyu
   Tang, Jiexia
   Zhang, Junling
   Wei, Chunmei
   Tan, Dechan
   Qin, Jian
   Zhang, Zhiyong
TI Effects of Oil Tea on Obesity and Dyslipidemia: A Cross-Sectional Study in China
SO DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
LA English
DT Article
DE abdominal obesity; blood lipid; HDL-C
ID green tea; metabolic syndrome; lipid profile; consumption; fat; caffeine; association; adults; rats; intervention
AB Background: Animal experiments have found that oil tea reduces body weight and improves blood lipid levels. However, the effect of oil tea on human health has not been confirmed yet. This study aims to explore the relationship between oil tea consumption and obesity and dyslipidemia. Methods: In a cross-sectional population study in Guangxi, China, a semi-quantitative questionnaire was used to investigate the oil tea consumed and food consumption frequency in adults aged 30 years and over. Anthropometric variables and serum biochemical indicators were measured. A total of 2001 adults were divided into five groups based on their non-consumption status and quartile of consumption (groups non-drink oil tea, Q1-Q4). Results: The risk of abdominal obesity tended to decrease significantly with increasing consumption of oil tea (P for trend<0.05) in the overall participants (Q3 group, OR = 0.545, 95% CI = 0.336-0.884; Q4 group, OR = 0.520, 95% CI = 0.311-0.871) and in women (Q2 group, OR = 0.502, 95% CI = 0.274-0.920; Q3 group, OR = 0.397, 95% CI = 0.213-0.740; Q4 group, OR = 0.421, 95% CI = 0.228-0.780). Oil tea consumption Q1, Q2, Q3 and Q4 group significantly reduced the risk of abnormal HDL-cholesterol (P < 0.05). Oil tea consumption Q2 group significantly increased the risk of abnormal LDL-cholesterol (OR = 2.600, 95% CI = 1.033-6.546) in women. Oil tea consumption Q1 (OR = 0.081, 95% CI=0.008-0.864) and Q3 (OR = 0.057, 95% CI = 0.004-0.913) groups significantly reduced the risk of abnormal HDL-cholesterol in women. Conclusion: Oil tea consumption may be associated with a low risk of abdominal obesity. High-dose oil tea consumption may be associated with a low risk of abnormal HDL-cholesterol. Prospective studies with large sample sizes would be required to further investigate this association.
C1 [Cai, Jiansheng; Liu, Shuzhen; Liu, Qiumei; Xu, Min; Xu, Xia; Tang, Xu; Chen, Quanhui; Nong, Chuntao; Lu, Huaxiang; He, Haoyu; Zhang, Junling; Wei, Chunmei; Qin, Jian; Zhang, Zhiyong] Guangxi Med Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Shuangyong Rd 22, Nanning 530021, Guangxi, Peoples R China.
   [Cai, Jiansheng] Guilin Med Univ, Guangxi Key Lab Tumor Immunol & Microenvironm Reg, Guilin, Peoples R China.
   [Li, You; Mo, Chunbao; Mai, Tingyu; Lu, Huaxiang; Tan, Dechan; Zhang, Zhiyong] Guilin Med Univ, Sch Publ Hlth, Dept Environm Hlth & Occupat Med, Guilin, Peoples R China.
   [He, Haoyu] Guangxi Med Univ, Affiliated Hosp Stomatol, Qual Management Dept, Nanning, Peoples R China.
   [Tang, Jiexia] Guangxi Ctr Dis Prevent & Control, Nanning, Peoples R China.
C3 Guangxi Medical University; Guilin Medical University; Guilin Medical University; Guangxi Medical University
RP Qin, J; Zhang, ZY (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Shuangyong Rd 22, Nanning 530021, Guangxi, Peoples R China.
EM qinjian@gxmu.edu.cn; rpazz@163.com
FU National Natural Science Foundation of China [81760577, 81560523, 81960583]; Guangxi Science and Technology Development Project [AD17129003, AD18050005]; Natural Science Foundation for Innovation Research Team of Guangxi [2019GXNSFGA245002]; Guangxi Scholarship Fund of Guangxi Education Department of China
CR Bae UJ, 2018, AM J CHINESE MED, V46, P617, DOI 10.1142/s0192415x18500325
   Baladia E, 2014, NUTR HOSP, V29, P479, DOI 10.3305/nh.2014.29.3.7118
   Barba C, 2004, LANCET, V363, P157, DOI 10.1016/s0140-6736(03)15268-3
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Chen LH, 2017, FOOD NUTR RES, V61, P0, DOI 10.1080/16546628.2017.1347480
   Chen YJ, 2019, BMC PUBLIC HEALTH, V19, P0, DOI 10.1186/s12889-019-7633-0
   Chooi YC, 2019, METABOLISM, V92, P6, DOI 10.1016/j.metabol.2018.09.005
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, PR77, DOI 10.1152/ajpregu.00832.2005
   Du P, 2017, J EPIDEMIOL, V27, P282, DOI 10.1016/j.je.2017.03.001
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Erba D, 2005, J NUTR BIOCHEM, V16, P144, DOI 10.1016/j.jnutbio.2004.11.006
   Finkelstein EA, 2009, HEALTH AFFAIR, V28, PW822, DOI 10.1377/hlthaff.28.5.w822
   Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Huang JB, 2018, MOL NUTR FOOD RES, V62, P0, DOI 10.1002/mnfr.201700696
   Huang LH, 2018, BMC COMPLEM ALTERN M, V18, P0, DOI 10.1186/s12906-018-2355-x
   Huang YX, 2014, POPUL HEALTH METR, V12, P0, DOI 10.1186/s12963-014-0028-7
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Jurgens TM, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD008650.pub2
   Lin R, 2018, NUTR RES, V57, P67, DOI 10.1016/j.nutres.2018.05.004
   Liu XD, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0134627
   Maharlouei N, 2019, CRIT REV FOOD SCI, V59, P1753, DOI 10.1080/10408398.2018.1427044
   Micek A, 2018, INT J FOOD SCI NUTR, V69, P358, DOI 10.1080/09637486.2017.1362690
   Nabuco HCG, 2018, EXP GERONTOL, V103, P132, DOI 10.1016/j.exger.2018.01.013
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Ng M, 2014, LANCET, V384, P746
   Pastoriza S, 2017, FOOD FUNCT, V8, P2650, DOI 10.1039/c7fo00611j
   RACOTTA IS, 1994, PHARMACOL BIOCHEM BE, V48, P887, DOI 10.1016/0091-3057(94)90196-1
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Saravanan G, 2014, J SCI FOOD AGR, V94, P2972, DOI 10.1002/jsfa.6642
   Sun Y, 2019, FOOD FUNCT, V10, P3502, DOI 10.1039/C9FO00162J
   Toeller M, 1999, EXP CLIN ENDOCR DIAB, V107, P512, DOI 10.1055/s-0029-1232560
   Uchiyama S, 2011, NUTRITION, V27, P287, DOI 10.1016/j.nut.2010.01.019
   Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9
   Wang CJ, 2018, PSYCHIAT RES, V260, P123, DOI 10.1016/j.psychres.2017.11.052
   Wang J, 2019, J NUTR BIOCHEM, V70, P105, DOI 10.1016/j.jnutbio.2019.05.001
   Wu T, 2018, FOOD NUTR RES, V62, P0, DOI 10.29219/fnr.v62.1599
   Xu RJ, 2012, FOOD CHEM TOXICOL, V50, P2473, DOI 10.1016/j.fct.2011.10.047
   Yang YX, 2009, INGREDIENT LIST CHIN, V6th, P0
   Yi DQ, 2014, BRIT J NUTR, V111, P1421, DOI 10.1017/S0007114513003644
   Zhu ZJ, 2017, FOOD FUNCT, V8, P1680, DOI 10.1039/c7fo00089h
NR 42
TC 5
Z9 5
U1 3
U2 14
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-7007
EI 
J9 DIABET METAB SYND OB
JI Diabetes Metab. Syndr. Obes.
PD JUN 15
PY 2021
VL 14
IS 
BP 3173
EP 3185
DI 10.2147/DMSO.S312280
PG 13
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA TH9TE
UT WOS:000672424900001
PM 34285525
DA 2025-04-28
ER

PT J
AU Guti√©rrez-Esparza, GO
   Ram√≠rez-delReal, TA
   Mart√≠nez-Garc√≠a, M
   V√°zquez, OI
   Vallejo, M
   Hern√°ndez-Torruco, J
AF Gutierrez-Esparza, Guadalupe O.
   Ramirez-delReal, Tania A.
   Martinez-Garcia, Mireya
   Vazquez, Oscar Infante
   Vallejo, Maite
   Hernandez-Torruco, Jose
TI Machine and Deep Learning Applied to Predict Metabolic Syndrome without a Blood Screening
SO APPLIED SCIENCES-BASEL
LA English
DT Article
DE metabolic syndrome; features selection; health parameters; random forest; deep neural networks; C4.5; Mexico City; tlalpan 2020 cohort
ID alcohol-consumption; food patterns; obesity; risk; definition; classification; association; components; diagnosis; health
AB The exponential increase of metabolic syndrome and its association with the risk impact of morbidity and mortality has propitiated the development of tools to diagnose this syndrome early. This work presents a model that is based on prognostic variables to classify Mexicans with metabolic syndrome without blood screening applying machine and deep learning. The data that were used in this study contain health parameters related to anthropometric measurements, dietary information, smoking habit, alcohol consumption, quality of sleep, and physical activity from 2289 participants of the Mexico City Tlalpan 2020 cohort. We use accuracy, balanced accuracy, positive predictive value, and negative predictive value criteria to evaluate the performance and validate different models. The models were separated by gender due to the shared features and different habits. Finally, the highest performance model in women found that the most relevant features were: waist circumference, age, body mass index, waist to height ratio, height, sleepy manner that is associated with snoring, dietary habits related with coffee, cola soda, whole milk, and Oaxaca cheese and diastolic and systolic blood pressure. Men's features were similar to women's; the variations were in dietary habits, especially in relation to coffee, cola soda, flavored sweetened water, and corn tortilla consumption. The positive predictive value obtained was 84.7% for women and 92.29% for men. With these models, we offer a tool that supports Mexicans to prevent metabolic syndrome by gender; it also lays the foundation for monitoring the patient and recommending change habits.
C1 [Gutierrez-Esparza, Guadalupe O.; Ramirez-delReal, Tania A.] Catedra CONACYT Consejo Nacl Ciencia, Ciudad De Mexico 08400, Mexico.
   [Gutierrez-Esparza, Guadalupe O.; Martinez-Garcia, Mireya; Vazquez, Oscar Infante; Vallejo, Maite] Inst Nacl Cardiol Ignacio Chavez, Ciudad De Mexico 14080, Mexico.
   [Ramirez-delReal, Tania A.] Ctr Invest Ciencias Informac Geoespacial, Circuito Tecnopolo Norte 107, Aguascalientes 20313, Aguascalientes, Mexico.
   [Hernandez-Torruco, Jose] Univ Juarez Autonoma Tabasco, Div Acad Ciencias & Tecnol Informac, Cunduacan 86690, Tabasco, Mexico.
C3 National Institute of Cardiology - Mexico; Universidad Juarez Autonoma de Tabasco
RP Vallejo, M (corresponding author), Inst Nacl Cardiol Ignacio Chavez, Ciudad De Mexico 14080, Mexico.; Hern√°ndez-Torruco, J (corresponding author), Univ Juarez Autonoma Tabasco, Div Acad Ciencias & Tecnol Informac, Cunduacan 86690, Tabasco, Mexico.
EM ggutierreze@conacyt.mx; tramirez@centrogeo.edu.mx; mireya.martinez@cardiologia.org.mx; osinfa@yahoo.com; maite.vallejo@cardiologia.org.mx; jose.hernandezt@ujat.mx
FU National Council of Science and Technology (CONACYT, Mexico), Catedras CONACYT [1591]
CR Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Alley DE, 2010, J GERONTOL A-BIOL, V65, P111, DOI 10.1093/gerona/glp177
   Unknown -, 1983, BIOESTADISTICA BASE, V0, P0
   Unknown -, 2003, MANUAL DE USUARIO. SNUT SISTEMA DE EVALUACION DE HABITOS NUTRICIONALES Y CONSUMO DE NUTRIMENTOS, V0, P0
   Barrios M, 2019, DIAGNOSTICS, V9, P0, DOI 10.3390/diagnostics9040192
   Baspinar B, 2017, FOOD FUNCT, V8, P2089, DOI 10.1039/c7fo00388a
   Basu S, 2013, AM J PUBLIC HEALTH, V103, P2071, DOI 10.2105/AJPH.2012.300974
   Bobadilla J, 2012, INFORM PROCESS MANAG, V48, P204, DOI 10.1016/j.ipm.2011.03.007
   Breiman L, 2001, MACHINE LEARNING, V45, P5, DOI 10.1023/A:1010933404324
   Chen Z, 2018, GENOM PROTEOM BIOINF, V16, P451, DOI 10.1016/j.gpb.2018.08.004
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Choe Eun Kyung, 2018, GENOMICS & INFORMATICS, V16, P0
   Chollet F, 2015, KERAS, V0, P0
   Cohen I, 2009, SPEECH PROCESS, V0, PP1, DOI 10.1007/978-3-642-00296-05
   Col√≠n-Ram√≠rez E, 2017, BMJ OPEN, V7, P0, DOI 10.1136/bmjopen-2017-016773
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Elmadhun NY, 2013, CLIN LIPIDOL, V8, P5, DOI 10.2217/CLP.12.82
   Fernandez-Mendoza J, 2017, J AM HEART ASSOC, V6, P0, DOI 10.1161/JAHA.117.005479
   Foster KR, 2014, BIOMED ENG ONLINE, V13, P0, DOI 10.1186/1475-925X-13-94
   GECCO, 2003, P GEN EVO COMP C, V0, P0
   Gertner D, 2018, THUNDERBIRD INT BUS, V60, P161, DOI 10.1002/tie.21888
   Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6
   Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527
   Ho JS, 2008, AM J CARDIOL, V102, P689, DOI 10.1016/j.amjcard.2008.05.010
   Hostmark AT, 2010, APPL PHYSIOL NUTR ME, V35, P635, DOI 10.1139/H10-059
   Hsu C-W, 2003, A PRACTICAL GUIDE TO SUPPORT VECTOR CLASSIFICATION, V0, P0
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Ivanovic D, 2016, J MED SYST, V40, P0, DOI 10.1007/s10916-016-0601-7
   Jain D, 2018, EGYPT INFORM J, V19, P179, DOI 10.1016/j.eij.2018.03.002
   Jia WP, 2013, BIOMED ENVIRON SCI, V26, P947, DOI 10.3967/bes2013.029
   Karegowda AG, 2010, INTERNATIONAL JOURNAL OF INFORMATION TECHNOLOGY AND KNOWLEDGE MANAGEMENT, V2, P271
   Guti√©rrez-Solis AL, 2018, METAB SYNDR RELAT D, V16, P395, DOI 10.1089/met.2017.0157
   Liu Xiaoxuan, 2019, LANCET DIGIT HEALTH, V1, Pe271, DOI 10.1016/S2589-7500(19)30123-2
   Maity NG, 2017, AEROSP CONF PROC, V0, P0
   Marfell-Jones MJ, 2012, INTERNATIONAL STANDARDS FOR ANTHROPOMETRIC ASSESSMENT, V0, P0
   Milei J, 2011, WORLD J CARDIOL, V3, P111, DOI 10.4330/wjc.v3.i4.111
   Moore JX, 2017, PREV CHRONIC DIS, V14, P0, DOI 10.5888/pcd14.160287
   Murguia-Romero Miguel, 2013, ADVANCES IN ARTIFICIAL INTELLIGENCE AND ITS APPLICATIONS. 12TH MEXICAN INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, V0, P464, DOI 10.1007/978-3-642-45114-0_36
   Nambiar L, 2014, J SCI MED SPORT, V18, PE117, DOI 10.1016/j.jsams.2014.11.080
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Oh Eui-Geum, 2007, TAEHAN KANHO HAKHOE CHI, V37, P790
   Panagiotakos DB, 2007, J AM DIET ASSOC, V107, P979, DOI 10.1016/j.jada.2007.03.006
   Porchia LM, 2019, REV PANAM SALUD PUBL, V43, P0, DOI 10.26633/RPSP.2019.9
   Quinlan JR, 1993, C4.5: PROGRAMS FOR MACHINE LEARNING, V0, P0
   Raats MM, 1992, FOOD QUALITY AND PREFERENCE, V3, P89, DOI 10.1016/0950-3293(91)90028-D
   Salas R, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0105581
   Salazar NAS, 2018, REV EXP MED HOSP REG, V4, P56
   Sarebanhassanabadi M, 2018, PUBLIC HEALTH NUTR, V21, P1139, DOI 10.1017/S1368980017003627
   Sethi P, 2010, COMM COM INF SC, V54, P392
   SPRITZER K, 2003, MOS SLEEP SCALE: A MANUAL FOR USE AND SCORING, V0, P1
   Stewart AL, 1992, MEASURING FUNCTIONIN, V0, P0, DOI DOI 10.7249/CB361
   Strobl C, 2008, BMC BIOINFORMATICS, V9, P0, DOI 10.1186/1471-2105-9-307
   Sun K, 2014, CLIN NUTR, V33, P596, DOI 10.1016/j.clnu.2013.10.003
   Troxel WM, 2010, SLEEP, V33, P1633, DOI 10.1093/sleep/33.12.1633
   Tsai SS, 2018, DIABETOL METAB SYNDR, V10, P0, DOI 10.1186/s13098-018-0358-x
   Vrbaski D, 2019, ARTIF INTELL MED, V101, P0, DOI 10.1016/j.artmed.2019.101708
   Wirf√§lt E, 2001, AM J EPIDEMIOL, V154, P1150, DOI 10.1093/aje/154.12.1150
   Worachartcheewan Apilak, 2015, SCIENTIFICWORLDJOURNAL, V2015, P581501, DOI 10.1155/2015/581501
   Wu WT, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0130279
   Yahia N, 2014, DIABETOL METAB SYNDR, V6, P0, DOI 10.1186/1758-5996-6-111
   Zheng Z, 2004, ACM SIGKDD EXPLOR NEWSL, V6, P80, DOI 10.1145/1007730.1007741
   Zou JJ, 2019, J DIABETES RES, V2019, P0, DOI 10.1155/2019/9578391
NR 65
TC 5
Z9 5
U1 2
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2076-3417
J9 APPL SCI-BASEL
JI Appl. Sci.-Basel
PD MAY 15
PY 2021
VL 11
IS 10
BP 
EP 
DI 10.3390/app11104334
PG 18
WC Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied
SC Chemistry; Engineering; Materials Science; Physics
GA ST7EE
UT WOS:000662602100001
DA 2025-04-28
ER

PT J
AU Zhang, Y
   Liu, ZP
   Choudhury, T
   Cornelis, MC
   Liu, WQ
AF Zhang, Yang
   Liu, Zhipeng
   Choudhury, Tasnim
   Cornelis, Marilyn C.
   Liu, Wanqing
TI Habitual coffee intake and risk for nonalcoholic fatty liver disease: a two-sample Mendelian randomization study
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Coffee; Nonalcoholic fatty liver disease (NAFLD); Causal effect; Mendelian randomization; Genome-wide association study (GWAS)
ID consumption; caffeine; obesity; bias
AB Purpose Epidemiological studies support a protective role of habitual coffee and caffeine consumption against the risk of non-alcoholic fatty liver disease (NAFLD). We aimed to investigate the causal relationship between coffee intake and the risk of NAFLD. Methods We performed a two-sample Mendelian randomization (MR) analysis using SNPs associated with habitual coffee intake in a published genome-wide association study (GWAS) as genetic instruments and summary-level data from a published GWAS of NAFLD (1122 cases and 399,900 healthy controls) in the UK Biobank. The causal relationship was estimated with the inverse weighted method using a 4-SNP and 6-SNP instrument based on the single largest non-UK Biobank GWAS (n = 91,462) and meta-analysis (n = 121,524) of GWAS data on habitual coffee intake, respectively. To maximize power, we also used up to 77 SNPs associated with coffee intake at a liberal significance level (p <= 1e-4) as instruments. Results We observed a non-significant trend towards a causal protective effect of coffee intake on NAFLD based upon either the 4-SNP (OR: 0.76; 95% CI 0.51, 1.14,p = 0.19) or 6-SNP genetic instruments (OR: 0.77; 95% CI 0.48, 1.25,p = 0.29). The result also remains non-significant when using the more liberal 77-SNP instrument. Conclusion Our findings do not support a causal relationship between coffee intake and NAFLD risk. However, despite the largest-to-date sample size, the power of this study may be limited by the non-specificity and moderate effect size of the genetic alleles on coffee intake.
C1 [Zhang, Yang; Choudhury, Tasnim; Liu, Wanqing] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Detroit, MI 48202 USA.
   [Liu, Zhipeng] Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.
   [Cornelis, Marilyn C.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Liu, Wanqing] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48202 USA.
   [Liu, Wanqing] Wayne State Univ, Integrat Biosci Ctr, Room 2401,6135 Woodward Ave, Detroit, MI 48202 USA.
C3 Wayne State University; Purdue University System; Purdue University; Northwestern University; Feinberg School of Medicine; Wayne State University; Wayne State University
RP Liu, WQ (corresponding author), Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Detroit, MI 48202 USA.; Liu, WQ (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48202 USA.; Liu, WQ (corresponding author), Wayne State Univ, Integrat Biosci Ctr, Room 2401,6135 Woodward Ave, Detroit, MI 48202 USA.
EM wliu@wayne.edu
FU NIH/NIDDK Grant [R01DK106540]; Office of Vice President for Research of Wayne State University
CR Arauz J, 2017, NUTR RES, V40, P65, DOI 10.1016/j.nutres.2017.03.008
   Bajaj JS, 2018, HEPATOLOGY, V68, P234, DOI 10.1002/hep.29791
   Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965
   Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080
   Burgess S, 2016, GENET EPIDEMIOL, V40, P597, DOI 10.1002/gepi.21998
   Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758
   Carlstr√∂m M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Caro-G√≥mez E, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11030497
   Chen YP, 2019, CLIN NUTR, V38, P2552, DOI 10.1016/j.clnu.2018.11.030
   Choi B, 2017, FOOD SCI BIOTECHNOL, V26, P921, DOI 10.1007/s10068-017-0144-9
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Cornelis MC, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10101343
   Georgiou Andrea N, 2021, INFLAMM BOWEL DIS, V27, P162, DOI 10.1093/ibd/izaa152
   Hosseinabadi S, 2020, COMPLEMENT THER MED, V49, P0, DOI 10.1016/j.ctim.2019.102290
   Jang YJ, 2018, FOOD FUNCT, V9, P1102, DOI 10.1039/c7fo01683b
   Jeznach-Steinhagen A, 2019, MEDICINA-LITHUANIA, V55, P0, DOI 10.3390/medicina55050166
   Jung S, 2017, J MED FOOD, V20, P626
   Liu ZP, 2020, J HEPATOL, V73, P263, DOI 10.1016/j.jhep.2020.03.006
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   Lu H, 2020, MULT SCLER RELAT DIS, V44, P0, DOI 10.1016/j.msard.2020.102300
   Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481
   Metro D, 2017, J CLIN TRANSL ENDOCR, V10, P22, DOI 10.1016/j.jcte.2017.10.001
   Molloy JW, 2012, HEPATOLOGY, V55, P429, DOI 10.1002/hep.24731
   Esp√≠ndola KMM, 2019, FRONT ONCOL, V9, P0, DOI 10.3389/fonc.2019.00541
   Nicolopoulos K, 2020, CLIN NUTR, V39, P3467, DOI 10.1016/j.clnu.2020.03.009
   Nishitsuji K, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-34571-9
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Paternoster L, 2017, PLOS GENET, V13, P0, DOI 10.1371/journal.pgen.1006944
   Perdomo CM, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11030677
   Qian Y, 2020, ANN NEUROL, V87, P525, DOI 10.1002/ana.25693
   Saab S, 2014, LIVER INT, V34, P495, DOI 10.1111/liv.12304
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Seo HY, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10070863
   Shokouh P, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10101547
   Shokouh P, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10010006
   Sidoryk K, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23092199
   Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753
   Storey ML, 2006, J AM DIET ASSOC, V106, P1992, DOI 10.1016/j.jada.2006.09.009
   Su√°rez M, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9101052
   Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03
   Vitaglione P, 2019, J NUTR SCI, V8, P0, DOI 10.1017/jns.2019.10
   Wang TG, 2017, BMC MED, V15, P0, DOI 10.1186/s12916-017-0862-0
   Wijarnpreecha K, 2017, EUR J GASTROEN HEPAT, V29, PE8, DOI 10.1097/MEG.0000000000000776
   Yavorska OO, 2017, INT J EPIDEMIOL, V46, P1734, DOI 10.1093/ije/dyx034
   Zheng Jie, 2017, CURR EPIDEMIOL REP, V4, P330, DOI 10.1007/s40471-017-0128-6
   Zhong VW, 2019, HUM MOL GENET, V28, P2449, DOI 10.1093/hmg/ddz061
   Zhou W, 2018, NAT GENET, V50, P1335, DOI 10.1038/s41588-018-0184-y
NR 48
TC 43
Z9 44
U1 3
U2 23
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD JUN 15
PY 2021
VL 60
IS 4
BP 1761
EP 1767
DI 10.1007/s00394-020-02369-z
EA AUG 2020
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA SF0TU
UT WOS:000563227600001
PM 32856188
DA 2025-04-28
ER

PT J
AU Liu, JY
   He, D
   Xing, YF
   Zeng, W
   Ren, K
   Zhang, C
   Lu, Y
   Yang, S
   Ou, SJ
   Wang, Y
   Xing, XH
AF Liu, Jun-Yu
   He, Dong
   Xing, Yi-Fan
   Zeng, Wen
   Ren, Kai
   Zhang, Chong
   Lu, Yuan
   Yang, Song
   Ou, Shu-Jian
   Wang, Yi
   Xing, Xin-Hui
TI Effects of bioactive components of Pu-erh tea on gut microbiomes and health: A review
SO FOOD CHEMISTRY
LA English
DT Review
DE Pu-erh tea; Bioactive components; Gut microbiomes; Intestinal environment; Quality indicators
ID butyrate-producing bacteria; diet-induced obesity; chain fatty-acids; metabolic syndrome; black tea; fermentation; theabrownin; caffeine; modulation; pathway
AB Pu-erh tea is a post-fermentation tea with unique flavor and multiple health benefits. Due to the various microorganisms involved in the post-fermentation process, Pu-erh tea contains highly complex components, which have rich interactions with the gut microbiomes (GMs). Because the structure and homeostasis of GMs are closely related to human wellness and the various diseases progress, the beneficial effects of Pu-erh tea on GMs have a great potential for application in health care. However, there is no systematic summary of the bioactive components of Pu-erh tea, and their effects on the GMs. Here, we review the current studies on the effects of Pu-erh tea and its bioactive components on the structure of GMs as well as on health improvement, and further discuss the relevant quality indicators. This "components - function - indicators" clue will hopefully stimulate the standardization of Pu-erh tea fermentation process and the development of its functional products.
C1 [Liu, Jun-Yu; Xing, Yi-Fan; Zeng, Wen; Ren, Kai; Zhang, Chong; Lu, Yuan; Wang, Yi; Xing, Xin-Hui] Tsinghua Univ, Dept Chem Engn, Key Lab Ind Biocatalysis, Minist Educ China, Beijing 100084, Peoples R China.
   [Zhang, Chong; Xing, Xin-Hui] Tsinghua Univ, Ctr Synthet & Syst Biol, Beijing 100084, Peoples R China.
   [Xing, Xin-Hui] Tsinghua Shenzhen Int Grad Sch, Inst Biopharmaceut & Hlth Engn, Shenzhen 518055, Peoples R China.
   [Xing, Xin-Hui] Shenzhen Bay Lab, Inst Biomed Hlth Technol & Engn, Shenzhen 518055, Peoples R China.
   [He, Dong] Guangdong Univ Technol, Sch Chem Engn & Light Ind, Guangzhou 510006, Peoples R China.
   [Yang, Song] Qingdao Agr Univ, Sch Life Sci, Shandong Prov Key Lab Appl Mycol, Qingdao 266109, Shandong, Peoples R China.
   [Yang, Song] Qingdao Agr Univ, Qingdao Int Ctr Microbes Utilizing Biogas, Qingdao 266109, Shandong, Peoples R China.
   [Ou, Shu-Jian] Yunnan Shujian Tea Co Ltd, Kunming 650000, Yunnan, Peoples R China.
C3 Tsinghua University; Tsinghua University; Tsinghua Shenzhen International Graduate School; Shenzhen Bay Laboratory; Guangdong University of Technology; Qingdao Agricultural University; Qingdao Agricultural University
RP Wang, Y; Xing, XH (corresponding author), Tsinghua Univ, Dept Chem Engn, Key Lab Ind Biocatalysis, Minist Educ China, Beijing 100084, Peoples R China.
EM liujunyu0306@163.com; hedong86284116@163.com; xingyf18@mails.tsinghua.edu.cn; zengw17@mails.tsinghua.edu.cn; kairenshanxi@126.com; chongzhang@tsinghua.edu.cn; yuanlu@tsinghua.edu.cn; yangsong1209@163.com; oushujian2020@163.com; wangyi671@mail.tsinghua.edu.cn; xhxing@tsinghua.edu.cn
FU Key-Area Research and Development Program of Guangdong Province, China [2019B020210001]; National Key Research Project of Hebei Province, China [20375502D]
CR Ahmed S, 2010, J ETHNOPHARMACOL, V132, P176, DOI 10.1016/j.jep.2010.08.016
   Ananingsih VK, 2013, FOOD RES INT, V50, P469, DOI 10.1016/j.foodres.2011.03.004
   Autenrieth DM, 2017, DEUT MED WOCHENSCHR, V142, P261, DOI 10.1055/s-0042-111608
   Bibb√≤ S, 2016, EUR REV MED PHARMACO, V20, P4742
   BLANCHARD J, 1983, EUR J CLIN PHARMACOL, V24, P93, DOI 10.1007/BF00613933
   BLANCHARD J, 1983, J PHARMACOKINET BIOP, V11, P109, DOI 10.1007/BF01061844
   Bond T, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11102364
   Chen GJ, 2018, MOL NUTR FOOD RES, V62, P0, DOI 10.1002/mnfr.201700485
   Chen GJ, 2018, J AGR FOOD CHEM, V66, P2783, DOI 10.1021/acs.jafc.8b00296
   Chen TT, 2020, CRIT REV FOOD SCI, V60, P2691, DOI 10.1080/10408398.2019.1654430
   Clemente JC, 2018, BMJ-BRIT MED J, V360, P0, DOI 10.1136/bmj.j5145
   CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221
   Deng YT, 2015, FOOD FUNCT, V6, P1539, DOI 10.1039/C4FO01025F
   Ding QZ, 2019, RSC ADV, V9, P2967, DOI 10.1039/c8ra09259a
   Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661
   Dong Fang, 2008, JOURNAL OF CHINESE INSTITUTE OF FOOD SCIENCE AND TECHNOLOGY, V8, P133
   Du WH, 2012, J AGR FOOD CHEM, V60, P10126, DOI 10.1021/jf302426w
   Duncan SH, 2002, APPL ENVIRON MICROB, V68, P5186, DOI 10.1128/AEM.68.10.5186-5190.2002
   Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817
   Fraga CG, 2019, FOOD FUNCT, V10, P514, DOI 10.1039/C8FO01997E
   Gai S, 2005, ACTA BOT YUNN, V27, P572
   Gao XY, 2018, INFECT IMMUN, V86, P0, DOI 10.1128/IAI.00601-17
   Gong JS, 2010, J FOOD SCI, V75, PH182, DOI 10.1111/j.1750-3841.2010.01675.x
   Gu Xiao-Pan, 2018, ZHONGGUO ZHONG YAO ZA ZHI, V43, P2339, DOI 10.19540/j.cnki.cjcmm.20180323.001
   Haas D, 2013, INT J FOOD MICROBIOL, V166, P316, DOI 10.1016/j.ijfoodmicro.2013.07.024
   Henning SM, 2018, EUR J NUTR, V57, P2759, DOI 10.1007/s00394-017-1542-8
   Hetzel M, 2003, EUR J BIOCHEM, V270, P902, DOI 10.1046/j.1432-1033.2003.03450.x
   Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259
   Huang FJ, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-12896-x
   [ËíãÊÖßÈ¢ñ Jiang Huiying], 2018, È£üÂìÅÂ∑•‰∏öÁßëÊäÄ SCIENCE & TECHNOLOGY OF FOOD INDUSTRY, V39, P274
   Jobu K, 2013, FOOD RES INT, V54, P324, DOI 10.1016/j.foodres.2013.07.037
   Kanegae A, 2013, J NAT MED-TOKYO, V67, P652, DOI 10.1007/s11418-012-0704-5
   Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041
   Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746
   Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001
   [ÊùéÊô®Êô® Li ChenChen], 2012, Âåó‰∫¨ÂåñÂ∑•Â§ßÂ≠¶Â≠¶Êä•. Ëá™ÁÑ∂ÁßëÂ≠¶Áâà JOURNAL OF BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY. NATURAL SCIENCE EDITION, V39, P74
   Li XSM, 2017, EUR HEART J, V38, P814, DOI 10.1093/eurheartj/ehw582
   Liang YR, 2005, J SCI FOOD AGR, V85, P381, DOI 10.1002/jsfa.1857
   Liu Y, 2020, MOL NUTR FOOD RES, V64, P0, DOI 10.1002/mnfr.201900943
   Liu YC, 2020, APPL MICROBIOL BIOT, V104, P981, DOI 10.1007/s00253-019-10306-2
   Liu ZB, 2016, FOOD FUNCT, V7, P4869, DOI 10.1039/c6fo01439a
   Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004
   Lu XJ, 2019, J AGR FOOD CHEM, V67, P6978, DOI 10.1021/acs.jafc.8b04909
   Lv HP, 2013, FOOD RES INT, V53, P608, DOI 10.1016/j.foodres.2013.02.043
   Macedo JA, 2012, FOOD CHEM, V133, P358, DOI 10.1016/j.foodchem.2012.01.041
   Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane
   MACFARLANE GT, 1986, J APPL BACTERIOL, V60, P195, DOI 10.1111/j.1365-2672.1986.tb01073.x
   Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106
   Maukonen J, 2006, FEMS MICROBIOL ECOL, V58, P517, DOI 10.1111/j.1574-6941.2006.00179.x
   Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003
   Mohan KVPC, 2007, CELL BIOL INT, V31, P599, DOI 10.1016/j.cellbi.2006.11.034
   Monagas M, 2010, FOOD FUNCT, V1, P233, DOI 10.1039/c0fo00132e
   Morrison M, 2000, FEMS MICROBIOL LETT, V185, P109
   Mosele JI, 2015, MOL NUTR FOOD RES, V59, P1942, DOI 10.1002/mnfr.201500227
   Mukherjee G, 2004, J BASIC MICROB, V44, P42, DOI 10.1002/jobm.200310317
   Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407
   Oi Y, 2012, PHYTOTHER RES, V26, P475, DOI 10.1002/ptr.3602
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646
   Peng CX, 2013, J ANAL APPL PYROL, V104, P226, DOI 10.1016/j.jaap.2013.07.011
   Peng CX, 2013, INT J BIOL MACROMOL, V54, P197, DOI 10.1016/j.ijbiomac.2012.12.021
   Piaopiao L, 2020, FOOD CHEM, V311, P0
   Qin JH, 2012, J AGR FOOD CHEM, V60, P1213, DOI 10.1021/jf204844g
   Quan LH, 2020, GUT, V69, P1239, DOI 10.1136/gutjnl-2019-319114
   Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012
   Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005
   Roda G, 2019, MOLECULES, V24, P0, DOI 10.3390/molecules24030473
   Rothenberg DO, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23051176
   Sandhu KV, 2017, TRANSL RES, V179, P223, DOI 10.1016/j.trsl.2016.10.002
   Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06
   Shanahan F, 2002, BEST PRACT RES CL GA, V16, P915, DOI 10.1053/bega.2002.0342
   Singh R, 2010, LIFE SCI, V86, P907, DOI 10.1016/j.lfs.2010.04.013
   Soni RP, 2015, INT J FOOD FERMENT T, V5, P95, DOI 10.5958/2277-9396.2016.00002.7
   Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413
   Sridharan GV, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6492
   Sung MM, 2017, DIABETES, V66, P418, DOI 10.2337/db16-0680
   Tanaka T, 2012, FOOD CHEM, V134, P276, DOI 10.1016/j.foodchem.2012.02.136
   Tao MK, 2014, NAT PROD COMMUN, V9, P1167
   Thursby E, 2017, BIOCHEM J, V474, P1823, DOI 10.1042/BCJ20160510
   [Áî∞Ê¥ã Tian Yang], 2010, È£üÂìÅÁßëÂ≠¶ FOOD SCIENCE, V31, P20
   Wang JH, 2017, INT J ENV RES PUB HE, V14, P0, DOI 10.3390/ijerph14060555
   Wang K, 2019, CELL REP, V26, P222, DOI 10.1016/j.celrep.2018.12.028
   Wang Q, 2010, T CHINESE SOC AGR EN, V26, P394, DOI 10.3969/j.issn.1002-6819.2010.z1.070
   Wang QP, 2018, LWT-FOOD SCI TECHNOL, V90, P598, DOI 10.1016/j.lwt.2018.01.021
   Wang QP, 2016, J BIOTECHNOL, V231, P250, DOI 10.1016/j.jbiotec.2016.06.010
   Wang QP, 2011, J SCI FOOD AGR, V91, P2412, DOI 10.1002/jsfa.4480
   Wang WN, 2014, FOOD CHEM, V152, P539, DOI 10.1016/j.foodchem.2013.10.117
   Wang XG, 2008, FOOD CHEM, V107, P1086, DOI 10.1016/j.foodchem.2007.09.023
   Wei XY, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-22094-2
   Wulandari RA, 2011, J NAT MED-TOKYO, V65, P594, DOI 10.1007/s11418-011-0515-0
   Xiang L, 2018, MODERN FOOD SCI TECH, V34, P56, DOI 10.13982/j.mfst.1673-9078.2018.04.010
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yang CS, 2018, J FOOD DRUG ANAL, V26, P1, DOI 10.1016/j.jfda.2017.10.010
   Yang DJ, 2006, J CHROMATOGR A, V1119, P277, DOI 10.1016/j.chroma.2005.12.031
   Yang JY, 2017, MUCOSAL IMMUNOL, V10, P104, DOI 10.1038/mi.2016.42
   Yue SJ, 2019, FOOD FUNCT, V10, P7063, DOI 10.1039/c9fo01334b
   Zhang CH, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20205150
   Zhang L, 2019, COMPR REV FOOD SCI F, V18, P1474, DOI 10.1111/1541-4337.12479
   Zhang L, 2013, FOOD RES INT, V53, P600, DOI 10.1016/j.foodres.2013.01.016
   Zhang L, 2011, J AGR FOOD CHEM, V59, P8754, DOI 10.1021/jf2015733
   Zhang T, 2016, INT C APPL BIOT SING, V0, P0
   Zhang YJ, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0157847
   Zhao M, 2019, MSYSTEMS, V4, P0, DOI 10.1128/mSystems.00680-19
   Zhao M, 2013, WORLD J MICROB BIOT, V29, P1877, DOI 10.1007/s11274-013-1351-z
   Zhao ZJ, 2015, INT FOOD RES J, V22, P1240
   Zhao ZJ, 2013, INT J FOOD MICROBIOL, V164, P26, DOI 10.1016/j.ijfoodmicro.2013.03.018
   [ËµµÊåØÂÜõ Zhao Zhenjun], 2012, È£üÂìÅÁßëÂ≠¶ FOOD SCIENCE, V33, P173
   Zhu BL, 2010, PROTEIN CELL, V1, P718, DOI 10.1007/s13238-010-0093-z
   Zhu MZ, 2020, FOOD CHEM, V312, P0, DOI 10.1016/j.foodchem.2019.126043
NR 111
TC 43
Z9 46
U1 17
U2 186
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD AUG 15
PY 2021
VL 353
IS 
BP 
EP 
DI 10.1016/j.foodchem.2021.129439
EA MAR 2021
PG 13
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA SJ4ZA
UT WOS:000655543300007
PM 33743430
DA 2025-04-28
ER

PT J
AU Kim, WJ
   Yu, HS
   Bae, WY
   Ko, KY
   Chang, KH
   Lee, NK
   Paik, HD
AF Kim, Won-Ju
   Yu, Hyung-Seok
   Bae, Won-Young
   Ko, Kyung Yuk
   Chang, Kyung-Hoon
   Lee, Na-Kyoung
   Paik, Hyun-Dong
TI Chrysanthemum indicum suppresses adipogenesis by inhibiting mitotic clonal expansion in 3T3-L1 preadipocytes
SO JOURNAL OF FOOD BIOCHEMISTRY
LA English
DT Article
DE adipogenesis; Akt signaling pathway; Chrysanthemum indicum; ERK 1; 2 signaling pathway; mitotic clonal expansion
ID early-stage; differentiation; extracts; ampk
AB Herbs have been of interest to treat diseases, including obesity, owing to their various bioactive constituents that exhibit therapeutic and prophylactic properties. The present study examined the anti-adipogenic effects and mechanisms of Chrysanthemum indicum aqueous extract (CAE) in 3T3-L1 preadipocytes. CAE comprises 1,3-dicaffeoylquinic acid, chlorogenic acid, kaempferol-3-O-glucoside, caffeic acid, and apigenin, which were corresponded with previous reports. CAE inhibited the accumulation of lipid droplets and significantly alleviated the expression of lipogenesis- and adipogenesis-associated biomarkers. Treatment with CAE inhibited the mitotic clonal expansion (MCE), corroborated by cell cycle arrest at the G(0)/G(1) phase, and mitigated the expression of cell cycle progression-associated proteins and in addition to phosphorylation of MCE-promoting transcription factors. Moreover, CAE downregulated the activation of Akt and extracellular signal-regulated kinase 1/2 signaling pathways. In summary, CAE facilitates adipogenic inhibition during the early phase of differentiation, especially MCE, and its phenolic compounds can contribute to its anti-obesogenic properties. Practical applications Chrysanthemum indicum has been mainly used as traditional herbal tea and drinks. Chrysanthemum indicum aqueous extract (CAE) inhibits adipogenesis by suppressing mitotic clonal expansion during the early phase of differentiation in 3T3-L1 preadipocytes. 1,3-Dicaffeoylquinic acid, chlorogenic acid, kaempferol-3-O-glucoside, caffeic acid, and apigenin were detected in CAE. Based on these findings, CAE can be used as nutraceutical agents for prevention and treatment of obesity.
C1 [Kim, Won-Ju; Yu, Hyung-Seok; Bae, Won-Young; Lee, Na-Kyoung; Paik, Hyun-Dong] Konkuk Univ, Dept Food Sci & Biotechnol Anim Resources, Seoul 05029, South Korea.
   [Ko, Kyung Yuk; Chang, Kyung-Hoon] Natl Inst Food & Drug Safety Evaluat, Osong, South Korea.
   [Chang, Kyung-Hoon] CJ CheilJedang Blossom Pk, Gyeonggi Do, South Korea.
C3 Konkuk University; Ministry of Food & Drug Safety (MFDS), Republic of Korea; National Institute of Food & Drug Safety Evaluation
RP Paik, HD (corresponding author), Konkuk Univ, Dept Food Sci & Biotechnol Anim Resources, Seoul 05029, South Korea.
EM hdpaik@konkuk.ac.kr
CR Abood S, 2018, PHYTOTHER RES, V32, P1583, DOI 10.1002/ptr.6089
   Ahmad B, 2020, FRONT MOL BIOSCI, V7, P0, DOI 10.3389/fmolb.2020.00076
   Bae WY, 2019, BMC COMPLEM ALTERN M, V19, P0, DOI 10.1186/s12906-019-2670-x
   Bae WY, 2019, J FOOD BIOCHEM, V43, P0, DOI 10.1111/jfbc.12785
   Chae SY, 2015, J FUNCT FOODS, V19, P700, DOI 10.1016/j.jff.2015.09.060
   Chang E, 2019, MOLECULES, V24, P0, DOI 10.3390/molecules24061157
   Cheng WM, 2005, J ETHNOPHARMACOL, V101, P334, DOI 10.1016/j.jep.2005.04.035
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi DH, 2020, J MICROBIOL BIOTECHN, V30, P21, DOI 10.4014/jmb.1910.10040
   Feng S, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21101278
   GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3
   Guo L, 2012, CELL DEATH DIFFER, V19, P1917, DOI 10.1038/cdd.2012.75
   Han JH, 2021, J CELL PHYSIOL, V236, P1822, DOI 10.1002/jcp.29964
   Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073
   Hsu CL, 2008, MOL NUTR FOOD RES, V52, P53, DOI 10.1002/mnfr.200890019
   Hsu CL, 2007, J AGR FOOD CHEM, V55, P8404, DOI 10.1021/jf071695r
   Hwang YI, 2019, FOOD SCI BIOTECHNOL, V28, P1577, DOI 10.1007/s10068-019-00668-8
   Jang YJ, 2015, FOOD FUNCT, V6, P2365, DOI 10.1039/c5fo00397k
   Kang HJ, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0061411
   Kim, 2020, ASIAN J BEAUTY COSME, V18, P657, DOI 10.20402/ajbc.2020.0098
   Kim CY, 2020, FOOD SCI BIOTECHNOL, V29, P431, DOI 10.1007/s10068-019-00672-y
   Kim GS, 2012, BMC COMPLEM ALTERN M, V12, P0, DOI 10.1186/1472-6882-12-31
   Kim HS, 2018, FOOD SCI BIOTECHNOL, V27, P451, DOI 10.1007/s10068-017-0253-5
   Lee JH, 2018, J ETHNOPHARMACOL, V222, P61, DOI 10.1016/j.jep.2018.04.020
   Lee JH, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11020269
   Lee MH, 2020, J FOOD BIOCHEM, V44, P0, DOI 10.1111/jfbc.13528
   Merkestein M, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7792
   Muir LA, 2016, OBESITY, V24, P597, DOI 10.1002/oby.21377
   Nepali S, 2018, AM J CHINESE MED, V46, P119, DOI 10.1142/S0192415X18500076
   Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199
   Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200
   Rodgers RJ, 2012, DIS MODEL MECH, V5, P621, DOI 10.1242/dmm.009621
   Shao YH, 2020, AM J CHINESE MED, V48, P871, DOI 10.1142/S0192415X20500421
   Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100
   Torres-Villarreal D, 2019, J PHYSIOL BIOCHEM, V75, P83, DOI 10.1007/s13105-018-0659-4
   Tsuji-Naito K, 2009, FOOD CHEM, V116, P854, DOI 10.1016/j.foodchem.2009.03.042
   Wang DM, 2010, BIOL CELL, V102, P1, DOI 10.1042/BC20090070
   Wu LY, 2010, J MED PLANTS RES, V4, P421
   Yu HS, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12103037
   Ïú§Ïò•Ìù¨, 2007, KOREAN JOURNAL OF FOOD AND COOKERY SCIENCE ÌïúÍµ≠ÏãùÌíàÏ°∞Î¶¨Í≥ºÌïôÌöåÏßÄ, V23, P1
   Zhang T, 2020, FOOD SCI BIOTECHNOL, V29, P1511, DOI 10.1007/s10068-020-00817-4
NR 41
TC 8
Z9 9
U1 9
U2 20
PU WILEY-HINDAWI
PI LONDON
PA ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 0145-8884
EI 1745-4514
J9 J FOOD BIOCHEM
JI J. Food Biochem.
PD SEP 15
PY 2021
VL 45
IS 9
BP 
EP 
DI 10.1111/jfbc.13896
EA AUG 2021
PG 11
WC Biochemistry & Molecular Biology; Food Science & Technology
SC Biochemistry & Molecular Biology; Food Science & Technology
GA UL4DK
UT WOS:000682885000001
PM 34368979
DA 2025-04-28
ER

PT J
AU Epperlein, S
   Gebhardt, C
   Rohde, K
   Chakaroun, R
   Patt, M
   Schamarek, I
   Kralisch, S
   Heiker, JT
   Scholz, M
   Stumvoll, M
   Kovacs, P
   Breitfeld, J
   T√∂njes, A
AF Epperlein, Sarah
   Gebhardt, Claudia
   Rohde, Kerstin
   Chakaroun, Rima
   Patt, Marie
   Schamarek, Imke
   Kralisch, Susan
   Heiker, John T.
   Scholz, Markus
   Stumvoll, Michael
   Kovacs, Peter
   Breitfeld, Jana
   Toenjes, Anke
TI The Effect of FGF21 and Its Genetic Variants on Food and Drug Cravings, Adipokines and Metabolic Traits
SO BIOMEDICINES
LA English
DT Article
DE fibroblast growth factor 21; eating behavior; addictive behavior; adipokines; genetic variation in FGF21
ID growth-factor 21; genome-wide association; self-contained population; serum concentrations; insulin sensitivity; body-weight; glucose; adiponectin; fgf-21; liver
AB Fibroblast growth factor 21 (FGF21) is a regulator of addictive behavior. Increasing evidence suggests an impact of FGF21 on eating behavior, food and drug cravings and on other adipokines like insulin-like growth factor 1 (IGF-1) or adiponectin. We investigated the association of serum FGF21 and genetic variants with aspects of food and drug craving and obesity related metabolic parameters including serum adipokine levels. Standardized questionnaires, blood samples and anthropometric data of the Sorbs cohort (n = 1046) were analyzed using SPSS. For genetic analyses, the FGF21-locus +/- 10 kb was genotyped and analyzed using PLINK. Validation was conducted in a second independent cohort (n = 704). FGF21 was significantly associated with alcohol and coffee consumption, smoking and eating behavior (disinhibition). We confirmed correlations of FGF21 serum levels with IGF-1, adiponectin, pro-enkephalin, adipocyte fatty-acid-binding protein, chemerin and progranulin. FGF21 genetic variants were associated with anthropometric and metabolic parameters, adipokines, food and drug craving while strongest evidence was seen with low-density lipoprotein cholesterol (LDL-C). We highlight the potential role of FGF21 in food and drug cravings and provide new insights regarding the link of FGF21 with other adipokines as well as with metabolic traits, in particular those related to lipid metabolism (LDL-C).
C1 [Epperlein, Sarah; Chakaroun, Rima; Patt, Marie; Schamarek, Imke; Kralisch, Susan; Stumvoll, Michael; Kovacs, Peter; Breitfeld, Jana; Toenjes, Anke] Univ Leipzig, Med Dept Endocrinol Nephrol Rheumatol 3, Med Ctr, D-04103 Leipzig, Germany.
   [Gebhardt, Claudia; Rohde, Kerstin; Heiker, John T.] Univ Leipzig, Helmholtz Inst Metab Obes & Vasc Res HI MAG, Helmholtz Ctr Munich, D-04103 Leipzig, Germany.
   [Gebhardt, Claudia; Rohde, Kerstin; Heiker, John T.] Univ Leipzig, Med Ctr, D-04103 Leipzig, Germany.
   [Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Fac Med, D-04107 Leipzig, Germany.
   [Stumvoll, Michael] Deutsch Zentrum Diabetesforsch, D-85764 Neuherberg, Germany.
C3 Leipzig University; Leipzig University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; Leipzig University
RP Breitfeld, J; T√∂njes, A (corresponding author), Univ Leipzig, Med Dept Endocrinol Nephrol Rheumatol 3, Med Ctr, D-04103 Leipzig, Germany.
EM sarah.epperlein@medizin.uni-leipzig.de; claudia.gebhardt@helmholtz-muenchen.de; kerstin.rohde@helmholtz-muenchen.de; rima.chakaroun@medizin.uni-leipzig.de; marie.patt@medizin.uni-leipzig.de; imke.schamarek@medizin.uni-leipzig.de; susan.kralisch@medizin.uni-leipzig.de; john.heiker@helmholtz-muenchen.de; markus.scholz@imise.uni-leipzig.de; michael.stumvoll@medizin.uni-leipzig.de; peter.kovacs@medizin.uni-leipzig.de; jana.breitfeld@medizin.uni-leipzig.de; anke.toenjes@medizin.uni-leipzig.de
FU Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [209933838-SFB 1052]; DFG Priority Program "Thyroid Transact" [SPP1629, TO 718/2-1]; Deutsches Zentrum fur Diabetesforschung [82DZD06D03]
CR Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393
   Baruch A, 2020, P NATL ACAD SCI USA, V117, P28992, DOI 10.1073/pnas.2012073117
   Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970
   Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684
   Chen C, 2011, DIABETES CARE, V34, P2113, DOI 10.2337/dc11-0294
   Cheng XB, 2011, ENDOCR RES, V36, P142, DOI 10.3109/07435800.2011.558550
   Chu AY, 2013, HUM MOL GENET, V22, P1895, DOI 10.1093/hmg/ddt032
   Clarke TK, 2017, MOL PSYCHIATR, V22, P1376, DOI 10.1038/mp.2017.153
   Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816
   Desai BN, 2017, MOL METAB, V6, P1395, DOI 10.1016/j.molmet.2017.08.004
   Ding RY, 2018, LIPIDS HEALTH DIS, V17, P0, DOI 10.1186/s12944-018-0666-z
   Ebert T, 2018, J CLIN ENDOCR METAB, V103, P1015, DOI 10.1210/jc.2017-02085
   Evangelou E, 2019, NAT HUM BEHAV, V3, P950, DOI 10.1038/s41562-019-0653-z
   Fazeli PK, 2015, J CLIN INVEST, V125, P4601, DOI 10.1172/JCI83349
   Fehrmann RSN, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002197
   Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193
   Frayling TM, 2018, CELL REP, V23, P327, DOI 10.1016/j.celrep.2018.03.070
   Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200
   Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005
   Ge X, 2011, J BIOL CHEM, V286, P34533, DOI 10.1074/jbc.M111.248591
   Heianza Y, 2016, DIABETES CARE, V39, P1909, DOI 10.2337/dc16-1111
   Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006
   Kamizono Y, 2018, MEDICINE, V97, P0, DOI 10.1097/MD.0000000000011947
   Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606
   Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168
   Kim AM, 2017, DIABETES OBES METAB, V19, P1762, DOI 10.1111/dom.13023
   Kralisch S, 2013, J ENDOCRINOL, V216, P135, DOI 10.1530/JOE-12-0367
   Lee Y, 2014, CLIN ENDOCRINOL, V80, P57, DOI 10.1111/cen.12134
   Li G, 2018, EUR NEUROPSYCHOPHARM, V28, P892, DOI 10.1016/j.euroneuro.2018.05.015
   Li HT, 2010, J HEPATOL, V53, P934, DOI 10.1016/j.jhep.2010.05.018
   Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005
   L√∂ffler A, 2017, PUBLIC HEALTH NUTR, V20, P2706, DOI 10.1017/S1368980017001653
   L√∂ffler A, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0133977
   Lundsgaard AM, 2017, MOL METAB, V6, P22, DOI 10.1016/j.molmet.2016.11.001
   Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Minard AY, 2016, CELL REP, V17, P29, DOI 10.1016/j.celrep.2016.08.086
   Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x
   National Center for Biotechnology Information (NCBI), 2020, US ROCKVILLE PIKE, V0, P0
   Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975
   Samms RJ, 2017, J CLIN ENDOCR METAB, V102, P3806, DOI 10.1210/jc.2017-01257
   Santoso P, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep45819
   Schumann G, 2016, P NATL ACAD SCI USA, V113, P14372, DOI 10.1073/pnas.1611243113
   Seberg S, 2018, MOL METAB, V11, P96, DOI 10.1016/j.molmet.2018.03.010
   Soberg S, 2017, CELL METAB, V25, P1045, DOI 10.1016/j.cmet.2017.04.009
   Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6
   STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8
   Talukdar S, 2016, CELL METAB, V23, P427, DOI 10.1016/j.cmet.2016.02.001
   Talukdar S, 2016, CELL METAB, V23, P344, DOI 10.1016/j.cmet.2015.12.008
   Tanaka T, 2013, AM J CLIN NUTR, V97, P1395, DOI 10.3945/ajcn.112.052183
   Tanimura Y, 2016, PHYSIOL REP, V4, P0, DOI 10.14814/phy2.12828
   T√∂njes A, 2012, INT J OBESITY, V36, P766, DOI 10.1038/ijo.2011.162
   T√∂njes A, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004854
   T√∂njes A, 2010, EUR J HUM GENET, V18, P104, DOI 10.1038/ejhg.2009.107
   T√∂njes A, 2009, HUM MOL GENET, V18, P4662, DOI 10.1093/hmg/ddp423
   Verger EO, 2017, J ACAD NUTR DIET, V117, P878, DOI 10.1016/j.jand.2016.10.030
   Wang N, 2018, INFLAMMATION, V41, P73, DOI 10.1007/s10753-017-0665-7
   Wannamethee SG, 2007, INT J OBESITY, V31, P1089, DOI 10.1038/sj.ijo.0803544
   Westhofer J, 1989, FRAGEBOGEN ZUM E VER, V0, P0
   Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797
   Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, PE1105, DOI 10.1152/ajpendo.00348.2009
   Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476
NR 64
TC 10
Z9 10
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2227-9059
J9 BIOMEDICINES
JI Biomedicines
PD APR 15
PY 2021
VL 9
IS 4
BP 
EP 
DI 10.3390/biomedicines9040345
PG 18
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Research & Experimental Medicine; Pharmacology & Pharmacy
GA RQ9ZT
UT WOS:000642770200001
PM 33805553
DA 2025-04-28
ER

PT J
AU Monteiro-Alfredo, T
   Oliveira, S
   Amaro, A
   Rosendo-Silva, D
   Antunes, K
   Pires, AS
   Teixo, R
   Abrantes, AM
   Botelho, MF
   Castelo-Branco, M
   Sei√ßa, R
   Silva, S
   Souza, KD
   Matafome, P
AF Monteiro-Alfredo, Tamaeh
   Oliveira, Sara
   Amaro, Andreia
   Rosendo-Silva, Daniela
   Antunes, Katia
   Pires, Ana Salome
   Teixo, Ricardo
   Abrantes, Ana Margarida
   Botelho, Maria Filomena
   Castelo-Branco, Miguel
   Seica, Raquel
   Silva, Sonia
   de Picoli Souza, Kely
   Matafome, Paulo
TI Hypoglycaemic and Antioxidant Properties of Acrocomia aculeata (Jacq.) Lodd Ex Mart. Extract Are Associated with Better Vascular Function of Type 2 Diabetic Rats
SO NUTRIENTS
LA English
DT Article
DE diabetes; macauba; bocaiuva; vascular function; polyphenols
ID insulin-resistance; oxidative stress; ferulic acid; caffeic acid; coronary-artery; chlorogenic acid; cocos-nucifera; triglycerides; quercetin; complications
AB Oxidative stress is involved in the metabolic dysregulation of type 2 diabetes (DM2). Acrocomia aculeata (Aa) fruit pulp has been described for the treatment of several diseases, and recently we have proved that its leaves have phenolic compounds with a marked antioxidant effect. We aimed to assess whether they can improve metabolic, redox and vascular functions in DM2. Control Wistar (W-Ctrl) and non-obese type 2 diabetic Goto-Kakizaki (GK-Ctrl) rats were treated for 30 days with 200 mg.kg(-1) aqueous extract of Aa (EA-Aa) (Wistar, W-EA-Aa/GK, GK-EA-Aa). EA-Aa was able to reduce fasting glycaemia and triglycerides of GK-EA-Aa by improving proteins related to glucose and lipid metabolism, such as GLUT-4, PPAR gamma, AMPK, and IR, when compared to GK-Ctrl. It also improved viability of 3T3-L1 pre-adipocytes exposed by H2O2. EA-Aa also increased the levels of catalase in the aorta and kidney, reduced oxidative stress and increased relaxation of the aorta in GK-treated rats in relation to GK-Ctrl, in addition to the protective effect against oxidative stress in HMVec-D cells. We proved the direct antioxidant potential of the chemical compounds of EA-Aa, the increase in antioxidant defences in a tissue-specific manner and hypoglycaemic properties, improving vascular function in type 2 diabetes. EA-Aa and its constituents may have a therapeutic potential for the treatment of DM2 complications.
C1 [Monteiro-Alfredo, Tamaeh; Oliveira, Sara; Amaro, Andreia; Rosendo-Silva, Daniela; Seica, Raquel; Matafome, Paulo] Univ Coimbra, Inst Physiol, Fac Med, P-3000548 Coimbra, Portugal.
   [Monteiro-Alfredo, Tamaeh; Oliveira, Sara; Amaro, Andreia; Rosendo-Silva, Daniela; Pires, Ana Salome; Teixo, Ricardo; Abrantes, Ana Margarida; Botelho, Maria Filomena; Silva, Sonia; Matafome, Paulo] Univ Coimbra, Ctr Innovat Biomed & Biotechnol CIBB, Fac Med, Coimbra Inst Clin & Biomed Res iCBR, P-3000548 Coimbra, Portugal.
   [Monteiro-Alfredo, Tamaeh; Oliveira, Sara; Amaro, Andreia; Rosendo-Silva, Daniela; Pires, Ana Salome; Teixo, Ricardo; Abrantes, Ana Margarida; Botelho, Maria Filomena; Matafome, Paulo] Clin Acad Ctr Coimbra, P-3000548 Coimbra, Portugal.
   [Monteiro-Alfredo, Tamaeh; Antunes, Katia; de Picoli Souza, Kely] Fed Univ Grande Dourados, Res Grp Biotechnol & Bioprospecting Appl Metab GE, BR-79825070 Dourados, MS, Brazil.
   [Pires, Ana Salome; Teixo, Ricardo; Abrantes, Ana Margarida; Botelho, Maria Filomena] Univ Coimbra, Inst Biophys, Fac Med, P-3000548 Coimbra, Portugal.
   [Castelo-Branco, Miguel] Univ Coimbra, Inst Biomed Imaging & Life Sci IBILI, Visual Neurosci Lab, Fac Med, P-3000548 Coimbra, Portugal.
   [Castelo-Branco, Miguel] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, IBILI, P-3000548 Coimbra, Portugal.
   [Castelo-Branco, Miguel] Univ Coimbra, Inst Nucl Sci Appl Hlth ICNAS, P-3000548 Coimbra, Portugal.
   [Castelo-Branco, Miguel] Univ Coimbra, Lab Bioestat Med, Fac Med, P-3000548 Coimbra, Portugal.
   [Silva, Sonia] Univ Coimbra, Inst Pharmacol & Expt Therapeut, Fac Med, P-3000548 Coimbra, Portugal.
   [Matafome, Paulo] Inst Politecn Coimbra, Coimbra Hlth Sch ESTeSC, Dept Complementary Sci, P-3000548 Coimbra, Portugal.
C3 Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade Federal da Grande Dourados; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Instituto Politecnico de Coimbra (IPC)
RP Matafome, P (corresponding author), Univ Coimbra, Inst Physiol, Fac Med, P-3000548 Coimbra, Portugal.; Matafome, P (corresponding author), Univ Coimbra, Ctr Innovat Biomed & Biotechnol CIBB, Fac Med, Coimbra Inst Clin & Biomed Res iCBR, P-3000548 Coimbra, Portugal.; Matafome, P (corresponding author), Clin Acad Ctr Coimbra, P-3000548 Coimbra, Portugal.; Matafome, P (corresponding author), Inst Politecn Coimbra, Coimbra Hlth Sch ESTeSC, Dept Complementary Sci, P-3000548 Coimbra, Portugal.
EM tamaehamonteiro@hotmail.com; sara.1996.oliveira@hotmail.com; andreia.amaro15@hotmail.com; daniela.silva26@hotmail.com; avilacatia@hotmail.com; a.salome.pires@gmail.com; ricardo.teixo@gmail.com; margaridaabrantes@gmail.com; mfbotelho@fmed.uc.pt; mcbranco@fmed.uc.pt; rseica@fmed.uc.pt; sonias@ci.uc.pt; kelypicoli@gmail.com; paulo.matafome@uc.pt
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Foundation for Science and Technology (FCT), Portugal [PEst UID/NEU/04539/2013, UID/NEU/04539/2019, PEst UIDB/04539/2020, UIDP/04539/2020]
CR Abdelaziz DHA, 2015, PHARM BIOL, V53, P792, DOI 10.3109/13880209.2014.942790
   Agostini-Costa TD, 2018, J ETHNOPHARMACOL, V224, P202, DOI 10.1016/j.jep.2018.05.035
   Akuodor GC, 2014, J ACUTE DIS, V3, P99, DOI 10.1016/S2221-6189(14)60025-1
   AL-Ishaq RK, 2019, BIOMOLECULES, V9, P0, DOI 10.3390/biom9090430
   Nonato CDA, 2018, PEERJ, V6, P0, DOI 10.7717/peerj.5991
   Unknown -, 2012, THESIS U FEDERAL GRA, V0, P0
   Appeldoorn MM, 2009, J AGR FOOD CHEM, V57, P7693, DOI 10.1021/jf901381x
   Chen L, 2019, TRENDS FOOD SCI TECH, V85, P149, DOI 10.1016/j.tifs.2018.11.026
   Choi S, 2012, KIDNEY RES CLIN PRAC, V31, P227, DOI 10.1016/j.krcp.2012.09.001
   da Silva PVB, 2019, NAT PROD RES, V33, P2413, DOI 10.1080/14786419.2018.1446006
   de Oliveira LM, 2016, VASC PHARMACOL, V81, P69, DOI 10.1016/j.vph.2015.10.010
   Aquino DFD, 2020, J ETHNOPHARMACOL, V253, P0, DOI 10.1016/j.jep.2020.112648
   de Souza FG, 2020, FOOD RES INT, V138, P0, DOI 10.1016/j.foodres.2020.109690
   Egawa T, 2017, PHENOLIC COMPOUNDS, V169, P0, DOI 10.5772/65968
   Eid HM, 2010, BIOCHEM PHARMACOL, V79, P444, DOI 10.1016/j.bcp.2009.08.026
   Fusi F, 2003, EUR J NUTR, V42, P10, DOI 10.1007/s00394-003-0395-5
   Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545
   Ginsberg HN, 2005, ARCH MED RES, V36, P232, DOI 10.1016/j.arcmed.2005.01.005
   Huang DW, 2016, NUTR RES, V36, P150, DOI 10.1016/j.nutres.2015.10.001
   Huang DD, 2020, BIOMED PHARMACOTHER, V125, P0, DOI 10.1016/j.biopha.2019.109767
   Ighodaro OM, 2018, BIOMED PHARMACOTHER, V108, P656, DOI 10.1016/j.biopha.2018.09.058
   Incalza MA, 2018, VASC PHARMACOL, V100, P1, DOI 10.1016/j.vph.2017.05.005
   Khursheed R, 2019, EUR J PHARMACOL, V862, P0, DOI 10.1016/j.ejphar.2019.172625
   King GL, 1996, ENDOCRIN METAB CLIN, V25, P255, DOI 10.1016/S0889-8529(05)70324-8
   Koyama K, 1997, AM J PHYSIOL-ENDOC M, V273, PE708, DOI 10.1152/ajpendo.1997.273.4.E708
   Kraegen EW, 2001, EXP CLIN ENDOCR DIAB, V109, P0
   Lafay S, 2006, BRIT J NUTR, V96, P39, DOI 10.1079/BJN20061714
   Matafome P, 2012, ARCH PHYSIOL BIOCHEM, V118, P58, DOI 10.3109/13813455.2012.658065
   Nunes AA, 2018, PLANT FOOD HUM NUTR, V73, P61, DOI 10.1007/s11130-017-0648-8
   Nunes AA, 2020, J FUNCT FOODS, V75, P0, DOI 10.1016/j.jff.2020.104295
   Papatheodorou K, 2018, J DIABETES RES, V2018, P0, DOI 10.1155/2018/3086167
   Pashikanti S, 2010, FREE RADICAL BIO MED, V48, P656, DOI 10.1016/j.freeradbiomed.2009.11.019
   Prasad CNV, 2010, FEBS LETT, V584, P531, DOI 10.1016/j.febslet.2009.11.092
   Preetha PP, 2013, REV BRAS FARMACOGN, V23, P481, DOI 10.1590/S0102-695X2013005000027
   Renjith RS, 2013, ASIAN PAC J TROP MED, V6, P804, DOI 10.1016/S1995-7645(13)60142-X
   Ribeiro DA, 2014, J ETHNOPHARMACOL, V155, P1522, DOI 10.1016/j.jep.2014.07.042
   Ribeiro JA, 2020, J ETHNOPHARMACOL, V260, P0, DOI 10.1016/j.jep.2020.112547
   Rodrigues T, 2020, PHARMACOL RES, V161, P0, DOI 10.1016/j.phrs.2020.105198
   Santos RX, 2009, J FOOD SCI, V74, PH8, DOI 10.1111/j.1750-3841.2008.00982.x
   Sena CM, 2014, PHYSIOL RES, V63, P189, DOI 10.33549/physiolres.932554
   Shabab S, 2021, J ETHNOPHARMACOL, V265, P0, DOI 10.1016/j.jep.2020.113328
   Shi GJ, 2019, BIOMED PHARMACOTHER, V109, P1085, DOI 10.1016/j.biopha.2018.10.130
   Soares J, 2017, MOL ONCOL, V11, P612, DOI 10.1002/1878-0261.12051
   Sova M, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12082190
   Taubert D, 2002, J CARDIOVASC PHARM, V40, P701, DOI 10.1097/00005344-200211000-00008
   Topakas E, 2003, LEBENSM-WISS TECHNOL, V36, P561, DOI 10.1016/S0023-6438(03)00060-4
   Traka MH, 2011, PLANT CELL, V23, P2483, DOI 10.1105/tpc.111.087916
   Tsuda S, 2012, J NUTR BIOCHEM, V23, P1403, DOI 10.1016/j.jnutbio.2011.09.001
   Winterbone MS, 2009, ATHEROSCLEROSIS, V202, P431, DOI 10.1016/j.atherosclerosis.2008.04.040
   Wu WC, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep41606
   Yang K, 2020, FRONT IMMUNOL, V11, P0, DOI 10.3389/fimmu.2020.580208
   Zhou ZY, 2017, EUR J PHARMACOL, V815, P26, DOI 10.1016/j.ejphar.2017.10.008
   Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599
NR 55
TC 11
Z9 11
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG 15
PY 2021
VL 13
IS 8
BP 
EP 
DI 10.3390/nu13082856
PG 17
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA UH6JE
UT WOS:000690033800001
PM 34445015
DA 2025-04-28
ER

PT J
AU Yang, LC
   Zhu, YP
   Zhong, SS
   Zheng, GD
AF Yang, Licong
   Zhu, Yanping
   Zhong, Shusheng
   Zheng, Guodong
TI Astilbin lowers the effective caffeine dose for decreasing lipid accumulation via activatingAMPKin high-fat diet-induced obese mice
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE astilbin and caffeine combination; obesity; lipid metabolism; AMPK
ID adipose-tissue; metabolism; binding; activation; pathway; lipase; acid; catechins; lipolysis; leaves
AB BACKGROUND Caffeine has an anti-obesity effect, although chronic excessive caffeine consumption also causes caffeinism, which is marked by increased anxiety or depression, amongst other symptoms. The present study aimed to investigate whether the addition of flavonoids such as astilbin can reduce the caffeine dose needed to inhibit obesity. RESULTS ICR mice (n= 80) were fed with normal diet, high-fat diet (HFD), HFD supplemented with astilbin, caffeine, or astilbin + caffeine for 12 weeks. When diets supplemented with astilbin, 0.3 g kg(-1)diet caffeine had the same effect as 0.6 g kg(-1)diet caffeine alone, and 0.6 g kg(-1)diet caffeine combined with astilbin most effectively inhibited HFD-induced obesity. Astilbin improved the anti-obesity effects of caffeine on lipid accumulation via the activation of AMP-activated protein kinase alpha(AMPK alpha). (i) Activated AMPK alpha decreased lipid biosynthesis by suppressing the activity or mRNA expression of 3-hydroxy-3-methylglutaryl-CoA reductase, sterol regulatory element binding protein 1c and its target gene fatty acid synthase. (ii) Activated AMPK alpha also up-regulated lipolysis by enhancing the expression of adipose triglyceride lipase and increasing the phosphorylation of hormone-sensitive lipase. (iii) Finally, activated AMPK alpha increased carnitine acyltransferase and acyl-CoA oxidase activities, which further promoted fatty acid beta-oxidation. CONCLUSION The results obtained in the present study indicate that astilbin may decrease the effective dose of caffeine needed for an anti-obesity effect and also suggest that it suppresses fat accumulation via the activation of AMPK. (c) 2020 Society of Chemical Industry
C1 [Yang, Licong; Zhu, Yanping; Zhong, Shusheng; Zheng, Guodong] Jiangxi Agr Univ, Jiangxi Key Lab Nat Prod & Funct Food, Coll Food Sci & Engn, Nanchang 330045, Jiangxi, Peoples R China.
C3 Jiangxi Agricultural University
RP Zheng, GD (corresponding author), Jiangxi Agr Univ, Jiangxi Key Lab Nat Prod & Funct Food, Coll Food Sci & Engn, Nanchang 330045, Jiangxi, Peoples R China.
EM zrs150716@aliyun.com
FU National Natural Science Foundation of China [81760157, 21701068, 21967010]; Science and Technology Research Projects of the Education Department of Jiangxi Province [GJJ180209]
CR Chen WL, 2012, BIOCHEM PHARMACOL, V84, P522, DOI 10.1016/j.bcp.2012.05.022
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   Deng X, 2015, BBA-MOL CELL BIOL L, V1851, P1521, DOI 10.1016/j.bbalip.2015.08.007
   Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734
   Fern√°ndez-Quintela A, 2016, J PHYSIOL BIOCHEM, V73, P417, DOI 10.1007/s13105-016-0544-y
   Folch JMS, 1957, J BIOL CHEM, V22, P24
   Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200
   Gilliland K, 1983, ADV ALCOHOL SUBST ABUSE, V3, P53
   Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022
   Greenberg JA, 2008, AM J CARDIOL, V102, P1502, DOI 10.1016/j.amjcard.2008.07.046
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hawley Simon A, 2003, J BIOL, V2, P28, DOI 10.1186/1475-4924-2-28
   He ZX, 2015, J TOXICOL SCI, V40, P127, DOI 10.2131/jts.40.127
   Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120
   Huang HQ, 2011, J AGR FOOD CHEM, V59, P4562, DOI 10.1021/jf2002969
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Kim JS, 2017, J FUNCT FOODS, V31, P131, DOI 10.1016/j.jff.2017.01.044
   Landrault N, 2002, J AGR FOOD CHEM, V50, P2046, DOI 10.1021/jf010794g
   Li GS, 2009, PLANTA MED, V75, P1470, DOI 10.1055/s-0029-1185802
   Li M, 1999, BIOCHEM MOL BIOL INT, V47, P63
   Liu SD, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0124951
   Mantovani J, 2011, FEBS LETT, V585, P967, DOI 10.1016/j.febslet.2010.12.015
   Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200
   Moorthy M, 2020, TRENDS FOOD SCI TECH, V99, P634, DOI 10.1016/j.tifs.2020.03.036
   Motoyashiki T, 1998, BIOL PHARM BULL, V21, P517, DOI 10.1248/bpb.21.517
   Mun EC, 2001, GASTROENTEROLOGY, V120, P669, DOI 10.1053/gast.2001.22430
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   National Commission of Chinese Pharmacopoeia, 2010, PHARM PEOPL REP CHIN, VI, P17
   Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013
   Quan HY, 2013, BMB REP, V46, P207, DOI 10.5483/BMBRep.2013.46.4.153
   Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375
   Sharma A, 2020, PHARMACOL RES, V158, P0, DOI 10.1016/j.phrs.2020.104894
   Singh DK, 2006, J PHARMACOL EXP THER, V318, P1020, DOI 10.1124/jpet.106.107144
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Sung SH, 2015, BIOORG MED CHEM LETT, V25, P4648, DOI 10.1016/j.bmcl.2015.08.032
   Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885
   Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161
   Yang J, 2009, J CELL BIOCHEM, V106, P414, DOI 10.1002/jcb.22024
   Yu L, 2014, J AGR FOOD CHEM, V62, P8640, DOI 10.1021/jf501963a
   Yuan ED, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10020187
   Zhang QF, 2013, J AGR FOOD CHEM, V61, P12085, DOI 10.1021/jf404420s
   Zhang QF, 2013, NAT PROD RES, V27, P277, DOI 10.1080/14786419.2012.666747
   Zhao Y, 2017, EUR J NUTR, V56, P2309, DOI 10.1007/s00394-016-1271-4
   Zheng D, 2019, J AGR FOOD CHEM, V67, P5746, DOI 10.1021/acs.jafc.9b00018
   Zheng GD, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0122925
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zheng XC, 2015, J BIOMED SCI, V22, P0, DOI 10.1186/s12929-015-0206-3
   Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747
NR 48
TC 13
Z9 14
U1 1
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD JAN 30
PY 2021
VL 101
IS 2
BP 573
EP 581
DI 10.1002/jsfa.10669
EA AUG 2020
PG 9
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology
SC Agriculture; Chemistry; Food Science & Technology
GA PA4FG
UT WOS:000558899900001
PM 32673411
DA 2025-04-28
ER

PT J
AU Sirotkin, AV
   Kolesarova, A
AF Sirotkin, Alexander, V
   Kolesarova, Adriana
TI The Anti-Obesity and Health-Promoting Effects of Tea and Coffee
SO PHYSIOLOGICAL RESEARCH
LA English
DT Review
DE Obesity; Adipocyte; Tea; Coffee; Metabolism; Food consumption
ID green tea; body-weight; response metaanalysis; metabolic syndrome; antioxidant; mechanisms; obesity; homeostasis; consumption; humans
AB This paper reviews provenance, chemical composition and properties of tea (Camelia sinensis L.) and coffee (Coffee arabica, L. and Coffea caniphora, L.), their general health effects, as well as the currently available knowledge concerning their action on fat storage, physiological mechanisms of their effects, as well as their safety and recommended dosage for treatment of obesity. Both tea and coffee possess the ability to promote health and to prevent, to mitigate and to treat numerous disorders. This ability can be partially due to presence of caffeine in both plants. Further physiological and medicinal effects could be explained by other molecules (theaflavins, catechins, their metabolites and polyphenols in tea and polyphenol chlorogenic acid in coffee). These plants and plant molecules can be efficient for prevention and treatment of numerous metabolic disorders including metabolic syndrome, cardiovascular diseases, type 2 diabetes and obesity. Both plants and their constituents can reduce fat storage through suppression of adipocyte functions, and support of gut microbiota. In addition, tea can prevent obesity via reduction of appetite, food consumption and food absorption in gastrointestinal system and through the changes in fat metabolism.
C1 [Sirotkin, Alexander, V] Constantine Philosopher Univ Nitra, Fac Nat Sci, Nitra, Slovakia.
   [Kolesarova, Adriana] Slovak Univ Agr, Fac Biotechnol & Food Sci, Nitra, Slovakia.
C3 Constantine the Philosopher University in Nitra; Slovak University of Agriculture Nitra
RP Sirotkin, AV (corresponding author), Constantine Philosopher Univ Nitra, Dept Zool & Anthropol, Tr A Hlinku 1, Nitra 94974, Slovakia.
EM asirotkin@ukf.sk
FU Slovak Research and Development Agency (APVV) [APVV-15-0296, APVV-18-0312]; Slovak Grant Agency of the Ministry of Education, Science and Sport; Slovak Academy of Science (VEGA) [VEGA 1/0392/17, VEGA 1/0266/20]
CR Bedrood Z, 2018, PHYTOTHER RES, V32, P1163, DOI 10.1002/ptr.6063
   Bhatti SK, 2013, CURR OPIN CLIN NUTR, V16, P688, DOI 10.1097/MCO.0b013e328365b9a0
   Cao JH, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8120762
   Carlstr√∂m M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   de Roos B, 1999, P NUTR SOC, V58, P551, DOI 10.1017/S0029665199000725
   Dybkowska Ewa, 2017, ROCZ PANSTW ZAKL HIG, V68, P347
   Flanagan J, 2014, PHYTOTHER RES, V28, P946, DOI 10.1002/ptr.5085
   Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073
   Hu J, 2018, REGUL TOXICOL PHARM, V95, P412, DOI 10.1016/j.yrtph.2018.03.019
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Janssens PLHR, 2016, PHYSIOL BEHAV, V162, P83, DOI 10.1016/j.physbeh.2016.01.044
   Karak T, 2017, CRIT REV FOOD SCI, V57, P2996, DOI 10.1080/10408398.2015.1083534
   Li YC, 2016, DIABETES-METAB RES, V32, P2, DOI 10.1002/dmrr.2641
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI 10.1039/C4FO00042K
   Mazzanti G, 2015, ARCH TOXICOL, V89, P1175, DOI 10.1007/s00204-015-1521-x
   Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784
   Mohamed GA, 2014, BULLETIN OF THE FACULTY OF PHARMACY, V0, P0
   Islam MT, 2018, CURR DRUG METAB, V19, P544, DOI 10.2174/1389200219666180302154551
   Odzakovic B, 2016, ACTA SCI POLON-TECHN, V15, P409, DOI 10.17306/J.AFS.2016.4.39
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, P0, DOI 10.1155/2011/382852
   Oz HS, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9060561
   Pan HB, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21121659
   Pan JX, 2018, FOOD SCI BIOTECHNOL, V27, P1311
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Ricci E, 2017, NUTR J, V16, P0, DOI 10.1186/s12937-017-0257-2
   R√≠os-Hoyo A, 2016, CURR OBES REP, V5, P262, DOI 10.1007/s13679-016-0214-y
   Rothenberg DO, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23051176
   Sarri√° B, 2018, EUR J NUTR, V57, P269, DOI 10.1007/s00394-016-1316-8
   Silvester AJ, 2019, J NUTR BIOCHEM, V64, P1, DOI 10.1016/j.jnutbio.2018.09.028
   Singh AK, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10060731
   Skrypnik K, 2017, ACTA SCI POLON-TECHN, V16, P83, DOI 10.17306/J.AFS.2017.0442
   Sung J, 2018, FOOD FUNCT, V9, P6082, DOI 10.1039/c8fo01561a
   Tabrizi R, 2019, CRIT REV FOOD SCI, V59, P2688, DOI 10.1080/10408398.2018.1507996
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Tamura H, 2020, YAKUGAKU ZASSHI, V140, P1351, DOI 10.1248/yakushi.20-00150
   Tang GY, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20246196
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   T√ºrk√∂z√º D, 2017, CRIT REV FOOD SCI, V57, P254, DOI 10.1080/10408398.2014.986672
   Unachukwu UJ, 2010, J FOOD SCI, V75, PC541, DOI 10.1111/j.1750-3841.2010.01705.x
   Unno K, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10101468
   Cisneros LCV, 2017, NUTR HOSP, V34, P731, DOI 10.20960/nh.753
   Willems MET, 2018, INT J SPORT NUTR EXE, V28, P536, DOI 10.1123/ijsnem.2017-0237
   Williamson G, 2011, MOL NUTR FOOD RES, V55, P864, DOI 10.1002/mnfr.201000631
   Xie C, 2018, J HUM HYPERTENS, V32, P83, DOI 10.1038/s41371-017-0007-0
   Xu H, 2018, NEUROPSYCH DIS TREAT, V14, P1795, DOI 10.2147/NDT.S165618
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yang CS, 2018, J FOOD DRUG ANAL, V26, P1, DOI 10.1016/j.jfda.2017.10.010
   Yashin A, 2013, ANTIOXIDANTS-BASEL, V2, P230, DOI 10.3390/antiox2040230
NR 48
TC 54
Z9 56
U1 3
U2 80
PU ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY
PI PRAGUE 4
PA VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC
SN 0862-8408
EI 1802-9973
J9 PHYSIOL RES
JI Physiol. Res.
PD APR 15
PY 2021
VL 70
IS 2
BP 161
EP 168
DI 10.33549/physiolres.934674
PG 8
WC Physiology
SC Physiology
GA TI2AG
UT WOS:000672587800004
PM 33992045
DA 2025-04-28
ER

PT J
AU Leech, RM
   Boushey, CJ
   McNaughton, SA
AF Leech, Rebecca M.
   Boushey, Carol J.
   McNaughton, Sarah A.
TI What do Australian adults eat for breakfast? A latent variable mixture modelling approach for understanding combinations of foods at eating occasions
SO INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY
LA English
DT Article
DE Eating patterns; Dietary patterns; Eating occasions; Breakfast; 24-h recall
ID nutrient intake; cardiovascular-disease; cluster-analysis; meal patterns; diet quality; health; energy; associations; adolescents; consumption
AB Background The patterning of food intake at eating occasions is a poorly understood, albeit important, step towards achieving a healthy dietary pattern. However, to capture the many permutations of food combinations at eating occasions, novel analytic approaches are required. We applied a latent variable mixture modelling (LVMM) approach to understand how foods are consumed in relation to each other at breakfast. Methods Dietary intake at breakfast (n = 8145 occasions) was assessed via 24-h recall during the 2011-12 Australian National Nutrition and Physical Activity Survey (n = 3545 men and n = 4127 women, > 19 y). LVMM was used to determine breakfast food profiles based on 35 food group variables, reflecting compliance with Australian Dietary Guidelines. F and adjusted-chi2 tests assessed differences in timing of consumption and participant characteristics between the breakfast profiles. Regression models, adjusted for covariates, were used to examine associations between breakfast food profiles and objective adiposity measures (BMI and waist circumference). Results Five distinct profiles were found. Three were similar for men and women. These were labelled: "Wholegrain cereals and milks" (men: 16%, women: 17%), "Protein-foods" (men and women: 11%) and "Mixed cereals and milks" (men: 33%, women: 37%). Two "Breads and spreads" profiles were also found that were differentiated by their accompanying beverages (men) or type of grain (women). Profiles were found to vary by timing of consumption, participant characteristics and adiposity indicators. For example, the "Protein-foods" profile occurred more frequently on weekends and after 9 am. Men with a "Bread and spreads (plus tea/coffee)" profile were older (P < 0.001) and had lower income and education levels (P < 0.05), when compared to the other profiles. Women with a "Protein-foods" profile were younger (P < 0.001) and less likely to be married (P < 0.01). Both men and women with a "Wholegrain cereals and milks" profile had the most favourable adiposity estimates (P < 0.05). Conclusions We identified five breakfast food profiles in adults that varied by timing of consumption, participant characteristics and adiposity indicators. LVMM was a useful approach for capturing the complexity of food combinations at breakfast. Future research could collect contextual information about eating occasions to understand the complex factors that influence food choices.
C1 [Leech, Rebecca M.; McNaughton, Sarah A.] Deakin Univ, Inst Phys Act & Nutr IPAN, Sch Exercise & Nutr Sci, Geelong, Vic, Australia.
   [Boushey, Carol J.] Univ Hawaii, Ctr Canc, Epidemiol Program, Honolulu, HI 96822 USA.
C3 Deakin University; Cancer Research Center of Hawaii; University of Hawaii System
RP Leech, RM (corresponding author), Deakin Univ, Inst Phys Act & Nutr IPAN, Sch Exercise & Nutr Sci, Geelong, Vic, Australia.
EM rebecca.leech@deakin.edu.au
FU National Heart Foundation Postdoctoral Research Fellowship [ID102109]; National Health and Medical Research Council [APP1175250]
CR Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8
   Unknown -, 2017, DIET, V0, P0
   Unknown -, 2013, AUSTR DIET GUID, V0, P0
   Unknown -, 2020, SCIENTIFIC REPORT OF THE 2020 DIETARY GUIDELINES ADVISORY COMMITTEE: ADVISORY REPORT TO THE SECRETARY OF AGRICULTURE AND SECRETARY OF HEALTH AND HUMAN SERVICES, V0, P0, DOI DOI 10.52570/DGAC2020
   Australian Bureau of Statistics, 2013, AUSTRALIAN HEALTH SURVEY: USERS GUIDE, V0, P0
   Australian Institute of Health and Welfare, 2003, THE ACTIVE AUSTRALIA SURVEY: A GUIDE AND MANUAL FOR IMPLEMENTATION, V0, P0
   Barr SI, 2013, J NUTR, V143, P86, DOI 10.3945/jn.112.167098
   Benisi-Kohansal S, 2016, ADV NUTR, V7, P1052, DOI 10.3945/an.115.011635
   Blanton CA, 2006, J NUTR, V136, P2594, DOI 10.1093/jn/136.10.2594
   Buttriss JL, 2014, NUTR BULL, V39, P115, DOI 10.1111/nbu.12076
   Chowdhury EA, 2016, AM J CLIN NUTR, V103, P747, DOI 10.3945/ajcn.115.122044
   Chung SJ, 2015, NUTR RES PRACT, V9, P288, DOI 10.4162/nrp.2015.9.3.288
   Dashti HS, 2019, AM J CLIN NUTR, V110, P473, DOI 10.1093/ajcn/nqz076
   Davis KA, 2019, NUTR REV, V77, P388, DOI 10.1093/nutrit/nuy058
   Deshmukh-Taskar P, 2013, PUBLIC HEALTH NUTR, V16, P2073, DOI 10.1017/S1368980012004296
   Deshmukh-Taskar PR, 2010, J AM COLL NUTR, V29, P407, DOI 10.1080/07315724.2010.10719858
   Drewnowski A, 2019, NUTRIENTS, V11, P0
   Everitt BS, 2001, CLUSTER ANALYSIS ARNOLD, V0, PP429, DOI 10.1002/9780470977811
   Food and Agrigulture Organization of the United Nations, 2019, FOOD BAS DIET GUID, V0, P0
   Food Standards Australia New Zealand, 2017, ASS 2011 13 AHS AUST, V0, P0
   Food Standards Australia New Zealand, 2013, AUSNUT 2011 13 AUSTR, V0, P0
   Hearty AP, 2008, AM J CLIN NUTR, V88, P1632, DOI 10.3945/ajcn.2008.26619
   Hruby A, 2020, J GERONTOL A-BIOL, V75, P123, DOI 10.1093/gerona/gly201
   Jackson KA, 2008, EUR J CLIN NUTR, V62, P537, DOI 10.1038/sj.ejcn.1602740
   Jastran MM, 2009, APPETITE, V52, P127, DOI 10.1016/j.appet.2008.09.003
   Kent P, 2014, BMC MED RES METHODOL, V14, P0, DOI 10.1186/1471-2288-14-113
   Keski-Rahkonen A, 2003, EUR J CLIN NUTR, V57, P842, DOI 10.1038/sj.ejcn.1601618
   Khanna Nitin, 2011, ISM, V2011, P375, DOI 10.1109/ISM.2011.68
   Leech RM, 2017, INT J BEHAV NUTR PHY, V14, P0, DOI 10.1186/s12966-016-0459-6
   Leech RM, 2015, AM J CLIN NUTR, V102, P1229, DOI 10.3945/ajcn.115.114660
   Leech RM, 2015, NUTR RES REV, V28, P1, DOI 10.1017/S0954422414000262
   Leech RM, 2014, INT J BEHAV NUTR PHY, V11, P0, DOI 10.1186/1479-5868-11-4
   Lobo AS, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0210425
   Ma Guansheng, 2015, JOURNAL OF ETHNIC FOODS, V2, P195
   McCann SE, 2001, PUBLIC HEALTH NUTR, V4, P989, DOI 10.1079/PHN2001168
   Meiselman HL, 2009, WOODHEAD PUBL FOOD S, V0, PP1, DOI 10.1533/9781845695712
   Monsivais P, 2014, AM J PREV MED, V47, P796, DOI 10.1016/j.amepre.2014.07.033
   Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324
   Mozaffarian D, 2018, TOPICS COMMENTS BE E, V0, P0
   Mozaffarian D, 2018, BMJ-BRIT MED J, V361, P0, DOI 10.1136/bmj.k2392
   Muth√©n B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x
   Muthen LK, 1998, MPLUS USERS GUIDE, V0, P0
   Newby PK, 2004, AM J CLIN NUTR, V80, P759
   ONeil CE, 2014, J ACAD NUTR DIET, V114, PS27, DOI 10.1016/j.jand.2014.08.021
   Pendergast Felicity J, 2017, CURR NUTR REP, V6, P212, DOI 10.1007/s13668-017-0211-0
   Priebe MG, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0164931
   Quatela A, 2017, HEALTHCARE-BASEL, V5, P0, DOI 10.3390/healthcare5030049
   Sarah A - M CNAUGHTON, 2010, AUSTRALASIAN EPIDEMIOLOGIST, V17, P35
   Schulze MB, 2018, BMJ-BRIT MED J, V361, P0, DOI 10.1136/bmj.k2396
   Schwedhelm C, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0202936
   Siega-Riz AM, 2000, PREV MED, V30, P415, DOI 10.1006/pmed.2000.0651
   Smith J, 2018, NUTRIENTS, V10, P0
   Smith KJ, 2010, J AM DIET ASSOC, V110, P1363, DOI 10.1016/j.jada.2010.06.011
   Spence C, 2017, INT J GASTRON FOOD S, V8, P1, DOI 10.1016/j.ijgfs.2017.01.003
   St-Onge MP, 2017, CIRCULATION, V135, PE96, DOI 10.1161/CIR.0000000000000476
   Subar AF, 2015, J NUTR, V145, P2639, DOI 10.3945/jn.115.219634
   USDepartment of Health and Human Services and USDepartment of Agriculture, 2015, 2015 2020 DIET GUID, V8, P0
   Wickrama KK, 2016, HIGHER ORDER GROWTH, V0, P0
   Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S
   Willett WC, 2013, NUTR EPIDEMIOLOGY, V0, P0
   Williams PG, 2014, ADV NUTR, V5, P636S, DOI 10.3945/an.114.006247
   Woolhead C, 2015, AM J CLIN NUTR, V102, P316, DOI 10.3945/ajcn.114.106112
NR 62
TC 4
Z9 4
U1 1
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1479-5868
J9 INT J BEHAV NUTR PHY
JI Int. J. Behav. Nutr. Phys. Act.
PD MAR 25
PY 2021
VL 18
IS 1
BP 
EP 
DI 10.1186/s12966-021-01115-w
PG 16
WC Nutrition & Dietetics; Physiology
SC Nutrition & Dietetics; Physiology
GA RG0YH
UT WOS:000635261300002
PM 33766039
DA 2025-04-28
ER

PT J
AU Kim, SY
   Yoo, DM
   Min, C
   Choi, HG
AF Kim, So Young
   Yoo, Dae Myoung
   Min, Chanyang
   Choi, Hyo Geun
TI Association between Coffee Consumption/Physical Exercise and Gastric, Hepatic, Colon, Breast, Uterine Cervix, Lung, Thyroid, Prostate, and Bladder Cancer
SO NUTRIENTS
LA English
DT Article
DE coffee; cancer; cohort studies; risk factors
ID physical-activity; risk-factors; fatigue; obesity; sleep
AB Although the effects of coffee consumption and physical exercise on the risk of cancer have been suggested, their interactions have not been investigated. The present cross-sectional study aimed to investigate the correlation of coffee consumption and physical exercise with cancer. Participants >= 40 years old in the Korean Genome and Epidemiology Study 2004-2016 were included (n = 162,220). Histories of gastric cancer, hepatic cancer, colon cancer, breast cancer, uterine cervix cancer, lung cancer, thyroid cancer, prostate cancer, and bladder cancer were analyzed according to the coffee consumption groups using logistic regression models. The odds among individuals in the >60 cups/month coffee group were lower for gastric cancer (adjusted odds ratio (aOR) = 0.80 (95% confidence intervals = 0.65-0.98)), hepatic cancer (0.32 (0.18-0.58)), colon cancer (0.53 (0.39-0.72)), breast cancer (0.56 (0.45-0.70)), and thyroid cancer (0.71 (0.59-0.85)) than for individuals in the no coffee group. Physical exercise of >= 150 min/week was correlated with higher odds for gastric cancer (1.18 (1.03-1.36)), colon cancer (1.52 (1.26-1.83)), breast cancer (1.53 (1.35-1.74)), thyroid cancer (1.42 (1.27-1.59)), and prostate cancer (1.61 (1.13-2.28)) compared to no exercise. Coffee consumption and physical exercise showed an interaction in thyroid cancer (p = 0.002). Coffee consumption was related to a decreased risk of gastric cancer, hepatic cancer, colon cancer, breast cancer, and thyroid cancer in the adult population. Physical exercise was positively correlated with gastric cancer, colon cancer, breast cancer, thyroid cancer, and prostate cancer.
C1 [Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam 13496, South Korea.
   [Yoo, Dae Myoung; Min, Chanyang; Choi, Hyo Geun] Hallym Univ, Hallym Data Sci Lab, Coll Med, Anyang 14068, South Korea.
   [Min, Chanyang] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul 08826, South Korea.
   [Choi, Hyo Geun] Hallym Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Anyang 14068, South Korea.
C3 Pochon Cha University; Hallym University; Seoul National University (SNU); Hallym University
RP Choi, HG (corresponding author), Hallym Univ, Hallym Data Sci Lab, Coll Med, Anyang 14068, South Korea.; Choi, HG (corresponding author), Hallym Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Anyang 14068, South Korea.
EM sossi81@hanmail.net; ydm1285@naver.com; joicemin@naver.com; pupen@naver.com
FU National Research Foundation (NRF) of Korea [NRF-2018-R1D1A1A02085328, 2021-R1C1C100498611]; The APC [NRF-2021-R1C1C100498611]
CR Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657
   Alicandro G, 2017, EUR J CANCER PREV, V26, P424, DOI 10.1097/CEJ.0000000000000341
   Bae Jong-Myon, 2020, ASIAN PAC J CANCER PREV, V21, P1177, DOI 10.31557/APJCP.2020.21.5.1177
   Bower JE, 2014, NAT REV CLIN ONCOL, V11, P597, DOI 10.1038/nrclinonc.2014.127
   Brown JC, 2012, COMPR PHYSIOL, V2, P2775, DOI 10.1002/cphy.c120005
   Buldak RJ, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23123309
   Chen XN, 2021, BMJ OPEN, V11, P0, DOI 10.1136/bmjopen-2020-038902
   Dai ZW, 2019, NUTR METAB, V16, P0, DOI 10.1186/s12986-019-0390-3
   Deng YH, 2017, CURR TREAT OPTION ON, V18, P0, DOI 10.1007/s11864-017-0500-2
   Gasscht F, 2015, GENES NUTR, V10, P0, DOI 10.1007/s12263-015-0501-3
   Godos J, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9090950
   Grubben MJAL, 2000, ALIMENT PHARM THER, V14, P1181, DOI 10.1046/j.1365-2036.2000.00826.x
   Han MA, 2017, INT J ENV RES PUB HE, V14, P0, DOI 10.3390/ijerph14020129
   Hayakawa S, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25194553
   Kenfield SA, 2011, J CLIN ONCOL, V29, P726, DOI 10.1200/JCO.2010.31.5226
   Kim Y, 2017, INT J EPIDEMIOL, V46, P0, DOI 10.1093/ije/dyv316
   Ligibel Jennifer A, 2019, AM SOC CLIN ONCOL EDUC BOOK, V39, Pe22, DOI 10.1200/EDBK_237423
   Lim MS, 2017, YONSEI MED J, V58, P1040, DOI 10.3349/ymj.2017.58.5.1040
   Micek A, 2019, INT J FOOD SCI NUTR, V70, P986, DOI 10.1080/09637486.2019.1591352
   Mojica BE, 2018, J FOOD SCI, V83, P1125, DOI 10.1111/1750-3841.14102
   Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548
   Ochiai R, 2018, FOOD SCI NUTR, V6, P2530, DOI 10.1002/fsn3.861
   Parra-Lara LG, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12103028
   Pedersen L, 2016, CELL METAB, V23, P554, DOI 10.1016/j.cmet.2016.01.011
   Poole R, 2017, BMJ-BRIT MED J, V359, P0, DOI 10.1136/bmj.j5024
   S√°nchez-Quesada C, 2020, EUR J NUTR, V59, P3461, DOI 10.1007/s00394-020-02180-w
   Sartini M, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11030694
   Seow WJ, 2020, EUR J NUTR, V59, P3083, DOI 10.1007/s00394-019-02146-7
   Shin S, 2022, INT J EPIDEMIOL, V51, P626, DOI 10.1093/ije/dyab161
   Steck SE, 2020, NAT REV CANCER, V20, P125, DOI 10.1038/s41568-019-0227-4
   Tahbaz R, 2018, CURR OPIN UROL, V28, P62, DOI 10.1097/MOU.0000000000000454
   Tamura T, 2019, NAGOYA J MED SCI, V81, P143, DOI 10.18999/nagjms.81.1.143
   Torquati L, 2018, INT J ENV RES PUB HE, V15, P0, DOI 10.3390/ijerph15091812
   Xie Y, 2016, ASIA PAC J CLIN NUTR, V25, P578, DOI 10.6133/apjcn.092015.07
   Yamagata K, 2018, ANTIOXIDANTS-BASEL, V7, P0, DOI 10.3390/antiox7020026
   YU MC, 1986, JNCI-J NATL CANCER I, V77, P351
   Zhu JJ, 2021, INT J CANCER, V148, P2457, DOI 10.1002/ijc.33445
NR 37
TC 13
Z9 14
U1 4
U2 41
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV 15
PY 2021
VL 13
IS 11
BP 
EP 
DI 10.3390/nu13113927
PG 22
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA ZD4CS
UT WOS:000758148100007
PM 34836181
DA 2025-04-28
ER

PT J
AU Sousa, S
   de Morais, IL
   Albuquerque, G
   Gelormini, M
   Casal, S
   Pinho, O
   Motta, C
   Damasceno, A
   Moreira, P
   Breda, J
   Lunet, N
   Padrao, P
AF Sousa, Sofia
   de Morais, Ines Lanca
   Albuquerque, Gabriela
   Gelormini, Marcello
   Casal, Susana
   Pinho, Olivia
   Motta, Carla
   Damasceno, Albertino
   Moreira, Pedro
   Breda, Joao
   Lunet, Nuno
   Padrao, Patricia
TI A Cross-Sectional Study of the Street Foods Purchased by Customers in Urban Areas of Central Asia
SO NUTRIENTS
LA English
DT Article
DE street food; nutritional value; nutrition transition; central Asia
ID sugar-sweetened beverages; cardiovascular-disease; obesity; weight; sodium; maputo; diet
AB This study aimed to describe street food purchases in cities from Central Asia, considering customers' characteristics and the nutritional composition of the foods and beverages. Cross-sectional studies were conducted in 2016/2017 in Dushanbe (Tajikistan), Bishkek (Kyrgyzstan), Ashgabat (Turkmenistan) and Almaty (Kazakhstan). Direct observation was used to collect data on the purchases made by street food customers, selected by random and systematic sampling. Nutritional composition was estimated using data from chemical analyses, food composition tables or food labels. A total of 714 customers (56.6% females, 55.5% aged degrees 5 years, 23.3% overweight/obese) were observed, who bought 852 foods and beverages, the most frequent being savoury pastries/snacks (23.2%), main dishes (19.0%), sweet pastries/confectionery (17.9%), tea/coffee (11.3%) and soft drinks/juices (9.8%). Fruit was the least purchased food (1.1%). Nearly one-third of customers purchased industrial food items (31.9%). The median energy content of a street food purchase was 529 kcal/serving. Saturated and trans-fat median contents were 4.7 g/serving and 0.36 g/serving (21.4% and 16.5% of maximum daily intake recommendations, respectively). Median sodium and potassium contents were 745 mg/serving (37.3% of maximum recommendation) and 304 mg/serving (8.7% of minimum recommendation), respectively. In general, the purchases observed presented high contents of energy, saturated-fat, trans-fat and sodium, and low levels of potassium. Policies towards the improvement of these urban food environments should be encouraged.
C1 [Sousa, Sofia; Albuquerque, Gabriela; Casal, Susana; Damasceno, Albertino; Moreira, Pedro; Lunet, Nuno; Padrao, Patricia] Univ Porto, EPIUnit Inst Saude Publ, Rua Taipas 135, P-4050600 Porto, Portugal.
   [Sousa, Sofia; Albuquerque, Gabriela; Casal, Susana; Damasceno, Albertino; Moreira, Pedro; Lunet, Nuno; Padrao, Patricia] Lab Invest Integrat & Translac Saude Populac ITR, Rua Taipas 135, P-4050600 Porto, Portugal.
   [Sousa, Sofia; Pinho, Olivia; Moreira, Pedro; Padrao, Patricia] Univ Porto, Fac Ciencias Nutr & Alimentacao, Rua Campo Alegre 823, P-4150180 Porto, Portugal.
   [de Morais, Ines Lanca; Gelormini, Marcello] WHO, Nutr Phys Act & Obes Programme, Reg Off Europe, Div Noncommunicable Dis & Life Course, Marmorvej 51, DK-2100 Copenhagen, Denmark.
   [Casal, Susana; Pinho, Olivia] Univ Porto, Fac Farm, Lab Bromatol & Hidrol, REQUIMTE, Rua D Manuel II, P-4050313 Porto, Portugal.
   [Motta, Carla] Inst Nacl Saude Doutor Ricardo Jorge INSA, Dept Alimentacao & Nutr, Ave Padre Cruz, P-1649016 Lisbon, Portugal.
   [Damasceno, Albertino; Lunet, Nuno] Univ Porto, Dept Ciencias Saude Publ & Forenses & Educ Med, Fac Med, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal.
   [Damasceno, Albertino] Univ Eduardo Mondlane, Fac Med, Ave Salvador Allende 702, Maputo 257, Mozambique.
   [Moreira, Pedro] Univ Porto, Ctr Invest Atividade Fis Saude & Lazer, Rua Dr Placido Costa 91, P-4200450 Porto, Portugal.
   [Breda, Joao] WHO, Reg Off Europe, Marmorvej 51, DK-2100 Copenhagen, Denmark.
C3 Universidade do Porto; Universidade do Porto; World Health Organization; Universidade do Porto; Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade do Porto; Eduardo Mondlane University; Universidade do Porto; World Health Organization
RP Padrao, P (corresponding author), Univ Porto, EPIUnit Inst Saude Publ, Rua Taipas 135, P-4050600 Porto, Portugal.; Padrao, P (corresponding author), Lab Invest Integrat & Translac Saude Populac ITR, Rua Taipas 135, P-4050600 Porto, Portugal.; Padrao, P (corresponding author), Univ Porto, Fac Ciencias Nutr & Alimentacao, Rua Campo Alegre 823, P-4150180 Porto, Portugal.
EM sofia.sousa@ispup.up.pt; inesbolm@gmail.com; gabriela.albuquerque@ispup.up.pt; marcello.gelormini@gmail.com; sucasal@ff.up.pt; oliviapinho@fcna.up.pt; carla.motta@insa.min-saude.pt; tino_7117@hotmail.com; pedromoreira@fcna.up.pt; rodriguesdasilvabred@who.int; nlunet@med.up.pt; patriciapadrao@fcna.up.pt
FU World Health Organization Europe [2015/591370-0, 2017/698514]; Ministry of Health of the Russian Federation; FCT (Fundacao para a Ciencia e Tecnologia-Ministerio da Ciencia, Tecnologia e Ensino Superior) [UID/QUI/50006/2020, UIDB/04750/2020]; FCT [SFRH/BD/130650/2017, SFRH/BD/118630/2016]; Human Capital Operational Programme of the European Social Fund (POCH/FSE); Funda√ß√£o para a Ci√™ncia e a Tecnologia [SFRH/BD/130650/2017, UIDB/04750/2020] Funding Source: FCT
CR Abrahale K, 2019, J HUM NUTR DIET, V32, P152, DOI 10.1111/jhn.12604
   Albuquerque G, 2020, FOOD SCI NUTR, V8, P5309, DOI 10.1002/fsn3.1753
   Albuquerque G, 2019, BRIT J NUTR, V122, P1052, DOI 10.1017/S0007114519001892
   Unknown -, 2019, TURKMENISTAN: EMPLOYMENT IN AGRICULTURE, V0, P0
   Unknown -, 2018, KEY FACTS, V0, P0
   AOAC, 2000, OFF METH AN AOAC INT, V0, P0
   DElia L, 2011, J AM COLL CARDIOL, V57, P1210, DOI 10.1016/j.jacc.2010.09.070
   Louzada MLD, 2018, PUBLIC HEALTH NUTR, V21, P94, DOI 10.1017/S1368980017001434
   de Morais IL, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10010098
   de Souza RJ, 2015, BMJ-BRIT MED J, V351, P0, DOI 10.1136/bmj.h3978
   Eurasian Economic Commission, 2011, 0242011 TP TC EUR EC, V0, P0
   Fellows P, 2012, SELLING STREET SNACK, V0, P0
   Food and Agriculture Organization, 2019, EUR CENTR AS REG OV, V0, P0
   Food and Agriculture Organization, 1989, 46 FAO, V0, P0
   Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x
   Gupta V, 2016, J NUTR EDUC BEHAV, V48, P269, DOI 10.1016/j.jneb.2015.11.006
   Harris CV, 2008, INT J OBESITY, V32, P336, DOI 10.1038/sj.ijo.0803704
   Hussain T, 2001, FOOD COMPOSITION TABLE FOR PAKISTAN, V0, P0
   Juul F, 2018, BRIT J NUTR, V120, P90, DOI 10.1017/S0007114518001046
   Kelly M, 2016, EATING, V0, P83, DOI 10.1007/978-3-319-42468-29
   Kurlansky Mark, 2003, SALT WORLD HIST, V0, P0
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Lunet N, 2019, FEEDCITIES PROJECT-A COMPREHENSIVE CHARACTERIZATION OF THE STREET FOOD ENVIRONMENT IN CITIES, V0, P0
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107
   Nago ES, 2010, BRIT J NUTR, V103, P281, DOI 10.1017/S0007114509991668
   Namugumya BS, 2012, PUBLIC HEALTH NUTR, V15, P1503, DOI 10.1017/S1368980011002710
   Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Popkin BM, 2011, P NUTR SOC, V70, P82, DOI 10.1017/S0029665110003903
   Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7
   Poti JM, 2017, CURR OBES REP, V6, P420, DOI 10.1007/s13679-017-0285-4
   Rauber F, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10050587
   Sousa Sofia, 2019, NUTRITION AND HEALTH (BICESTER), V25, P37, DOI 10.1177/0260106018816427
   Sousa S, 2018, J PUBLIC HEALTH-UK, V40, P659, DOI 10.1093/pubmed/fdx113
   Steele EM, 2017, POPUL HEALTH METR, V15, P0, DOI 10.1186/s12963-017-0119-3
   Steyn NP, 2014, PUBLIC HEALTH NUTR, V17, P1363, DOI 10.1017/S1368980013001158
   Uauy R, 2009, EUR J CLIN NUTR, V63, PS68, DOI 10.1038/ejcn.2009.15
   United Nations, 2013, URB CENTR AS CHALL I, V0, P0
   Whelton PK, 2012, CIRCULATION, V126, P2880, DOI 10.1161/CIR.0b013e318279acbf
   WHO, 2003, WHO TECH REP SER, V916, P1
   WHO, 2012, GUIDELINE: SODIUM INTAKE FOR ADULTS AND CHILDREN, V0, P0
   WHO Europe, 2020, TACKL NONC DIS UKR 2, V45, P0, DOI 10.2900/112339
   World Health Organization, 2015, EL T FATS EUR POL BR, V0, P0
   World Health Organization, 2019, FEEDCITIES PROJ FOOD, V0, P0
   World Health Organization, 2017, CRAVEN COUNTY PROFIL, V0, P0
   World Health Organization, 2012, POTASSIUM INTAKE FOR ADULTS AND CHILDREN, V0, P0
NR 51
TC 6
Z9 7
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT 15
PY 2021
VL 13
IS 10
BP 
EP 
DI 10.3390/nu13103651
PG 16
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA WU2UK
UT WOS:000716405100001
PM 34684652
DA 2025-04-28
ER

PT J
AU Zheng, YL
   Choi, YH
   Lee, JH
   Lee, SY
   Kang, IJ
AF Zheng, Yulong
   Choi, Yoon-Hee
   Lee, Ji-Hyun
   Lee, So-Yeon
   Kang, Il-Jun
TI Anti-Obesity Effect of Erigeron annuus (L.) Pers. Extract Containing Phenolic Acids
SO FOODS
LA English
DT Article
DE C57BL/6J mice; high-fat diet; anti-obesity; AMPK pathway; phenolic acid; Erigeron annuus (L.) Pers
ID activated protein-kinase; ampk activation; antioxidant property; red ginseng; metabolism; identification; glycation; flowers; obesity; target
AB Erigeron annuus (L.) Pers. water extract (EAW) was investigated for its anti-obesity effects in C57BL/6J mice on a high-fat diet. Mice were divided into groups fed normal and high-fat diets (ND and HFD, respectively), and HFD mice were treated with EAW (50, 100, and 200 mg/kg/day) for 8 weeks. Inhibition of HFD-induced obesity by EAW was evaluated using biochemical parameters, immunohistochemistry, real-time PCR, and immunoblot assay. EAW supplementation significantly diminished the final body weight, adipose tissue size, and epididymal adipose tissue volume compared with mice with obesity induced by HFD (p < 0.05 for all). EAW also decreased serum triglyceride (TG) and LDL-cholesterol (LDL-c) levels in obese mice. EAW attenuated HFD-induced obesity by down-regulating C/EBP alpha, PPAR gamma, and SREBP-1c to suppress adipogenesis. Moreover, this study indicated that EAW activates the AMPK pathway and increases ACC phosphorylation and downstream CPT1 expression in HFD-induced obese mice. Furthermore, several phenolic acids with anti-obesity properties have been identified in EAW, including quinic acid, caffeic acid, chlorogenic acid, and 3,4-dicaffeoylquinic acid. Based on these data, EAW has anti-obesity effects in vivo, which indicates that it is an excellent candidate for the development of anti-obesity functional foods.
C1 [Zheng, Yulong; Lee, Ji-Hyun; Lee, So-Yeon; Kang, Il-Jun] Hallym Univ, Dept Food Sci & Nutr, Chunchon 24252, South Korea.
   [Zheng, Yulong; Lee, Ji-Hyun; Lee, So-Yeon; Kang, Il-Jun] Hallym Univ, Korean Inst Nutr, Chunchon 24252, South Korea.
   [Choi, Yoon-Hee] Hallym Polytech Univ, Dept Food & Nutr, Chunchon 24210, South Korea.
C3 Hallym University; Hallym University
RP Kang, IJ (corresponding author), Hallym Univ, Dept Food Sci & Nutr, Chunchon 24252, South Korea.; Kang, IJ (corresponding author), Hallym Univ, Korean Inst Nutr, Chunchon 24252, South Korea.
EM zyl1994@naver.com; cyh@hsc.ac.kr; leejihyun@hallym.ac.kr; syeon300@hallym.ac.kr; ijkang@hallym.ac.kr
FU Hallym University Research Fund [HRF-202010-003]
CR Ahmad B, 2020, FRONT MOL BIOSCI, V7, P0, DOI 10.3389/fmolb.2020.00076
   Bertrand L, 2006, AM J PHYSIOL-HEART C, V291, PH239, DOI 10.1152/ajpheart.01269.2005
   Coughlan KA, 2014, DIABET METAB SYND OB, V7, P241, DOI 10.2147/DMSO.S43731
   Duangjai Acharaporn, 2018, KOBE J MED SCI, V64, P0
   Durazzo A, 2017, FOODS, V6, P0, DOI 10.3390/foods6030017
   Fathoni A, 2017, AIP CONF PROC, V1862, P0, DOI 10.1063/1.4991183
   Felipe DF, 2014, MOLECULES, V19, P15720, DOI 10.3390/molecules191015720
   Foretz M, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19092826
   Ha JH, 2016, INT J MOL MED, V37, P816, DOI 10.3892/ijmm.2016.2484
   Hardie DG, 2014, PHYSIOLOGY, V29, P99, DOI 10.1152/physiol.00050.2013
   Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95
   Jang DS, 2008, ARCH PHARM RES, V31, P900, DOI 10.1007/s12272-001-1244-z
   Jeong CH, 2011, CHIN MED-UK, V6, P0, DOI 10.1186/1749-8546-6-25
   Jo MJ, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/297427
   Kang JG, 2012, DIABETES METAB J, V36, P13, DOI 10.4093/dmj.2012.36.1.13
   Kim J, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0159990
   Kim Y, 2018, J AM SOC NEPHROL, V29, P1108, DOI 10.1681/ASN.2017060627
   Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218
   Lee HJ, 2006, BIOTECHNOL BIOPROC E, V11, P13, DOI 10.1007/BF02931862
   Li SS, 2016, J CHROMATOGR SCI, V54, P1225, DOI 10.1093/chromsci/bmw055
   Liao CC, 2013, J AGR FOOD CHEM, V61, P11082, DOI 10.1021/jf4026647
   Lindholm CR, 2013, J PHYSIOL BIOCHEM, V69, P165, DOI 10.1007/s13105-012-0199-2
   Liu YF, 2017, EVID-BASED COMPL ALT, V2017, P0, DOI 10.1155/2017/8943059
   Longo M, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20092358
   Nazaruk J, 2009, MOLECULES, V14, P2458, DOI 10.3390/molecules14072458
   Nigro E, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/658913
   Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Qu Q, 2016, CELL DEATH DIS, V7, P0, DOI 10.1038/cddis.2016.132
   Randy A, 2016, J FUNCT FOODS, V27, P1, DOI 10.1016/j.jff.2016.08.050
   Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702
   Simirgiotis MJ, 2015, MOLECULES, V20, P11490, DOI 10.3390/molecules200611490
   Srivastava RAK, 2012, J LIPID RES, V53, P2490, DOI 10.1194/jlr.R025882
   Sudhakar M, 2020, J FUNCT FOODS, V74, P0, DOI 10.1016/j.jff.2020.104161
   Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x
   Xu X, 2013, SEMIN LIVER DIS, V33, P301, DOI 10.1055/s-0033-1358523
   Yoo NH, 2008, J NAT PROD, V71, P713, DOI 10.1021/np070489a
   Zaha VG, 2012, CIRC RES, V111, P800, DOI 10.1161/CIRCRESAHA.111.255505
   Zheng YL, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12092744
   Zheng Y, 2020, J MED FOOD, V23, P215, DOI 10.1089/jmf.2019.4660
NR 40
TC 11
Z9 12
U1 5
U2 23
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2304-8158
J9 FOODS
JI Foods
PD JUN 15
PY 2021
VL 10
IS 6
BP 
EP 
DI 10.3390/foods10061266
PG 13
WC Food Science & Technology
SC Food Science & Technology
GA TA0SJ
UT WOS:000666964900001
PM 34199426
DA 2025-04-28
ER

PT J
AU Graneri, LT
   Mamo, JCL
   D'Alonzo, Z
   Lam, V
   Takechi, R
AF Graneri, Liam T.
   Mamo, John C. L.
   D'Alonzo, Zachary
   Lam, Virginie
   Takechi, Ryusuke
TI Chronic Intake of Energy Drinks and Their Sugar Free Substitution Similarly Promotes Metabolic Syndrome
SO NUTRIENTS
LA English
DT Article
DE energy drinks; artificial sweetener; metabolic syndrome; cholesterol; triglycerides; blood glucose; insulin; body fat; brown adipose tissue
ID biological risk-factors; insulin sensitivity; decaffeinated coffee; diabetes-mellitus; caffeine intake; dietary-intake; taurine; resistance; secretion; obesity
AB Energy drinks containing significant quantities of caffeine, taurine and sugar are increasingly consumed, particularly by adolescents and young adults. The putative effects of chronic ingestion of either standard energy drink, Mother(TM) (ED), or its sugar-free formulation (sfED) on metabolic syndrome were determined in wild-type C57BL/6J mice, in comparison to a soft drink, Coca-Cola (SD), a Western-styled diet enriched in saturated fatty acids (SFA), and a combination of SFA + ED. Following 13 weeks of intervention, mice treated with ED were hyperglycaemic and hypertriglyceridaemic, indicating higher triglyceride glucose index, which was similar to the mice maintained on SD. Surprisingly, the mice maintained on sfED also showed signs of insulin resistance with hyperglycaemia, hypertriglyceridaemia, and greater triglyceride glucose index, comparable to the ED group mice. In addition, the ED mice had greater adiposity primarily due to the increase in white adipose tissue, although the body weight was comparable to the control mice receiving only water. The mice maintained on SFA diet exhibited significantly greater weight gain, body fat, cholesterol and insulin, whilst blood glucose and triglyceride concentrations remained comparable to the control mice. Collectively, these data suggest that the consumption of both standard and sugar-free forms of energy drinks induces metabolic syndrome, particularly insulin resistance.
C1 [Graneri, Liam T.; Mamo, John C. L.; D'Alonzo, Zachary; Lam, Virginie; Takechi, Ryusuke] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA 6845, Australia.
   [Graneri, Liam T.; D'Alonzo, Zachary] Curtin Univ, Fac Hlth Sci, Curtin Med Sch, Perth, WA 6845, Australia.
   [Mamo, John C. L.; Lam, Virginie; Takechi, Ryusuke] Curtin Univ, Fac Hlth Sci, Sch Populat Hlth, Perth, WA 6845, Australia.
C3 Curtin University; Curtin University; Curtin University
RP Takechi, R (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA 6845, Australia.; Takechi, R (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Populat Hlth, Perth, WA 6845, Australia.
EM Liam.graneri@postgrad.curtin.edu.au; j.mamo@curtin.edu.au; Zachary.dalonzo@postgrad.curtin.edu.au; Virginie.Lam@curtin.edu.au; R.Takechi@curtin.edu.au
CR Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004
   Alperet DJ, 2020, AM J CLIN NUTR, V111, P448, DOI 10.1093/ajcn/nqz306
   Rosales-G√≥mez CA, 2018, BIOMED RES INT, V2018, P0, DOI 10.1155/2018/1345282
   Bian XM, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0178426
   Boden G, 2001, DIABETES, V50, P1612, DOI 10.2337/diabetes.50.7.1612
   Brons C, 2004, EUR J CLIN NUTR, V58, P1239, DOI 10.1038/sj.ejcn.1601955
   Chang YH, 2012, INT J OBESITY, V36, P993, DOI 10.1038/ijo.2011.168
   Clark KS, 2019, CLIN EXP PHARMACOL P, V46, P475, DOI 10.1111/1440-1681.13065
   DALY JW, 1983, CELL MOL NEUROBIOL, V3, P69, DOI 10.1007/BF00734999
   Dewar L, 2017, DIAB MET SYND CLIN R, V11, PS631, DOI 10.1016/j.dsx.2017.04.017
   Du Y, 2005, EUR J EPIDEMIOL, V20, P311, DOI 10.1007/s10654-004-7536-x
   Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911
   Emanuela F, 2012, J NUTR METAB, V2012, P0, DOI 10.1155/2012/476380
   Farouque HMO, 2000, AUST NZ J MED, V30, P351, DOI 10.1111/j.1445-5994.2000.tb00837.x
   Ferreira SE, 2004, PHYSIOL BEHAV, V82, P841, DOI 10.1016/S0031-9384(04)00284-7
   Finnegan D, 2003, NUTRITION BULLETIN, V28, P147, DOI 10.1046/j.1467-3010.2003.00345.x
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817
   Gomez R, 2018, BIOMED PHARMACOTHER, V103, P1028, DOI 10.1016/j.biopha.2018.04.131
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Guo JX, 2017, LIPIDS HEALTH DIS, V16, P0, DOI 10.1186/s12944-017-0444-3
   Hartley T R, 2001, J CLIN HYPERTENS (GREENWICH), V3, P354, DOI 10.1111/j.1524-6175.2001.00478.x
   Hartley TR, 2000, HYPERTENSION, V36, P137, DOI 10.1161/01.HYP.36.1.137
   Hosoi T, 2014, NEUROSCI LETT, V569, P23, DOI 10.1016/j.neulet.2014.03.053
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Kim KS, 2012, EXP MOL MED, V44, P665, DOI 10.3858/emm.2012.44.11.075
   LAmoreaux WJ, 2010, J BIOMED SCI, V17, P0, DOI 10.1186/1423-0127-17-S1-S11
   Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, PH2031, DOI 10.1152/ajpheart.01058.2004
   Lee AH, 2016, NUTR DIABETES, V6, P0, DOI 10.1038/nutd.2016.19
   Lenters-Westra E, 2010, CLIN CHEM, V56, P44, DOI 10.1373/clinchem.2009.130641
   Lertrit A, 2018, NUTRITION, V55-56, P125, DOI 10.1016/j.nut.2018.04.001
   Lewis GF, 1996, DIABETES CARE, V19, P390, DOI 10.2337/diacare.19.4.390
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Malaisse WJ, 1998, CELL SIGNAL, V10, P727, DOI 10.1016/S0898-6568(98)00017-5
   Mitani T, 2017, J NUTR SCI VITAMINOL, V63, P331, DOI 10.3177/jnsv.63.331
   Panek-Shirley LM, 2018, J ACAD NUTR DIET, V118, P1832, DOI 10.1016/j.jand.2018.05.015
   Parhofer KG, 2015, DIABETES METAB J, V39, P353, DOI 10.4093/dmj.2015.39.5.353
   Petersen KF, 2006, AM J MED, V119, P10S, DOI 10.1016/j.amjmed.2006.01.009
   Piao S, 2011, J CLIN BIOCHEM NUTR, V49, P50, DOI 10.3164/jcbn.10-120
   Rahiman F, 2014, J IMMUNOASSAY IMMUNOCHEM, V35, P26, DOI 10.1080/15321819.2013.784197
   Reis CEG, 2018, BRIT J NUTR, V119, P1029, DOI 10.1017/S000711451800034X
   Ribeiro RA, 2018, AMINO ACIDS, V50, P1511, DOI 10.1007/s00726-018-2650-3
   Sandireddy R, 2014, INT J ENDOCRINOL, V2014, P0, DOI 10.1155/2014/674987
   Santos RD, 2018, AMINO ACIDS, V50, P469, DOI 10.1007/s00726-017-2533-z
   Sarkar P, 2017, FOOD CHEM TOXICOL, V110, P109, DOI 10.1016/j.fct.2017.10.022
   Schaffer SW, 2000, AMINO ACIDS, V18, P305, DOI 10.1007/PL00010320
   Seidel U, 2019, MOL NUTR FOOD RES, V63, P0, DOI 10.1002/mnfr.201800569
   Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592
   Sun TT, 2014, CELL BIOL INT, V38, P1183, DOI 10.1002/cbin.10321
   Sylvetsky AC, 2020, MOL NUTR FOOD RES, V64, P0, DOI 10.1002/mnfr.201901166
   Tamer F, 2020, FOOD CHEM TOXICOL, V135, P0, DOI 10.1016/j.fct.2019.110914
   Tey SL, 2017, EUR J CLIN NUTR, V71, P1129, DOI 10.1038/ejcn.2017.37
   Trapp GSA, 2014, DRUG ALCOHOL DEPEN, V134, P30, DOI 10.1016/j.drugalcdep.2013.09.006
   Umemura T, 2006, AM J CARDIOL, V98, P1538, DOI 10.1016/j.amjcard.2006.06.058
   Velickovic K, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-45540-1
   Wedick NM, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-93
   Wu LF, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15904
   Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390
   Xydakis AM, 2004, J CLIN ENDOCR METAB, V89, P2697, DOI 10.1210/jc.2003-031826
   Yu H, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25746
NR 61
TC 8
Z9 9
U1 2
U2 34
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD APR 15
PY 2021
VL 13
IS 4
BP 
EP 
DI 10.3390/nu13041202
PG 16
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA RR9HM
UT WOS:000643400100001
PM 33917297
DA 2025-04-28
ER

PT J
AU Yim, HR
   Yun, HJ
   Lee, JH
AF Yim, Hui-Rang
   Yun, Hyun Ju
   Lee, Jee Hye
TI An Investigation on Korean Adolescents' Dietary Consumption: Focused on Sociodemographic Characteristics, Physical Health, and Mental Health
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE adolescents; dietary intake; sociodemographic characteristics; physical health; mental health
ID fast-food consumption; socioeconomic-status; university-students; sedentary behaviors; vegetable intake; eating habits; sugar intake; weight-gain; children; obesity
AB The promotion of healthful dietary intake in adolescents is an important public health concern, as obesity is on the rise among adolescents. The current study aimed to determine the association between sociodemographic characteristics and dietary intake (breakfast, vegetables, milk, fruits, fast food, carbohydrate beverages, and caffeine beverages) and to examine the influences of physical and mental health on dietary intake. A nationally representative sample of 187,622 adolescents who attended middle and high schools and participated in the Korean Youth Risk Behavior Survey (2015, 2017, and 2019) was used. The results showed a decrease in breakfast, vegetable, milk, and fruit consumption and an increase in the obesity rate from 2015 to 2019. There was a significant association between dietary intake and gender, economic status, BMI, and academic achievement. Multiple logistic regression analysis results revealed that the consumption of breakfast, vegetables, milk, and fruit were associated with greater odds of having enough sleep. Fast food intake was shown to be a significant risk factor for depression with an odds ratio of 1.204 (95% CI = 1.169-1.239), and carbonated beverage consumption was shown to be a significant risk factor for stress with an odds ratio of 1.042 (95% CI = 1.030-1.054). These results provide fundamental data that can be used to develop an effective nutrition intervention program or nutrition policy for adolescents or school food service programs.
C1 [Yim, Hui-Rang] Kyungsung Univ, Dept Food & Nutr, Coll Life & Hlth Sci, 309 Suyeong Ro, Busan 48434, South Korea.
   [Yun, Hyun Ju; Lee, Jee Hye] Univ Ulsan, Coll Human Ecol, Dept Food & Nutr, 93 Daehak Ro, Ulsan 44610, South Korea.
C3 Kyungsung University; University of Ulsan
RP Lee, JH (corresponding author), Univ Ulsan, Coll Human Ecol, Dept Food & Nutr, 93 Daehak Ro, Ulsan 44610, South Korea.
EM hrlim@ks.ac.kr; goidcat@ulsan.ac.kr; lljh2000@ulsan.ac.kr
FU University of Ulsan
CR Amahmid O, 2020, INT J HEALTH PROMOT, V58, P242, DOI 10.1080/14635240.2019.1685399
   Arganini C, 2012, PUBLIC HEALTH - SOCIAL AND BEHAVIORAL HEALTH, V0, P83
   Arria AM, 2014, NUTR REV, V72, P87, DOI 10.1111/nure.12129
   Baldasso JG, 2016, REV NUTR, V29, P65, DOI 10.1590/1678-98652016000100007
   Barbosa VC, 2014, CIENC SAUDE COLETIVA, V19, P173, DOI 10.1590/1413-81232014191.0446
   Blundell JE, 2003, P NUTR SOC, V62, P651, DOI 10.1079/PNS2003286
   Burrows T, 2017, J HUM NUTR DIET, V30, P117, DOI 10.1111/jhn.12407
   Burton-Freeman B, 2000, J NUTR, V130, P272S, DOI 10.1093/jn/130.2.272S
   Cartwright M, 2003, HEALTH PSYCHOL, V22, P362, DOI 10.1037/0278-6133.22.4.362
   Das JK, 2017, ANN NY ACAD SCI, V1393, P21, DOI 10.1111/nyas.13330
   Drewnowski A, 2004, AM J CLIN NUTR, V79, P6
   Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326
   Epstein LH, 2001, OBES RES, V9, P171, DOI 10.1038/oby.2001.18
   Errisuriz VL, 2016, EAT BEHAV, V22, P211, DOI 10.1016/j.eatbeh.2016.06.008
   Finlayson G, 2009, PHYSIOL BEHAV, V97, P62, DOI 10.1016/j.physbeh.2009.02.002
   Gillman MW, 2001, PREV MED, V32, P295, DOI 10.1006/pmed.2000.0812
   Ha K, 2016, NUTR RES PRACT, V10, P537, DOI 10.4162/nrp.2016.10.5.537
   Harada Tetsuo, 2007, JOURNAL OF PHYSIOLOGICAL ANTHROPOLOGY, V26, P201, DOI 10.2114/jpa2.26.201
   Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847
   Hong SA, 2017, CHILD ADOL PSYCH MEN, V11, P0, DOI 10.1186/s13034-017-0194-z
   Huang CJ, 2010, INT J OBESITY, V34, P720, DOI 10.1038/ijo.2009.285
   ÏñëÏòÅÎ™®, 2014, YAKHAK HOEJI ÏïΩ Ìïô Ìöå ÏßÄ, V58, P387
   Hwang JiYun Hwang JiYun, 2009, KOREAN JOURNAL OF NUTRITION, V42, P171, DOI 10.4163/kjn.2009.42.2.171
   Iannotti RJ, 2013, PEDIATRICS, V132, P606, DOI 10.1542/peds.2013-1488
   Inglis V, 2005, APPETITE, V45, P334, DOI 10.1016/j.appet.2005.05.003
   J√§√§skel√§inen A, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-321
   Jang HanByul Jang HanByul, 2011, KOREAN JOURNAL OF NUTRITION, V44, P416, DOI 10.4163/kjn.2011.44.5.416
   Jeffery RW, 2009, APPETITE, V52, P238, DOI 10.1016/j.appet.2008.08.008
   Jeong JH, 2001, J KOREAN HOME EC ASS, V39, P111
   Jung BokMi Jung BokMi, 2003, KOREAN JOURNAL OF COMMUNITY NUTRITION, V8, P129
   Kaushik JS, 2011, INDIAN PEDIATR, V48, P97, DOI 10.1007/s13312-011-0035-8
   KHIDI (Korea Health Industry Development Institute), 2015, SUG DAT COMP COMM CO, V0, P0
   Kim HyeSoo Kim HyeSoo, 2014, JOURNAL OF NUTRITION AND HEALTH, V47, P134, DOI 10.4163/jnh.2014.47.2.134
   ÍπÄÏû¨Íµ¨, 2012, JOURNAL OF COACHING DEVELOPMENT ÏΩîÏπ≠Îä•Î†•Í∞úÎ∞úÏßÄ, V14, P115
   Kim SeolA Kim SeolA, 2008, KOREAN JOURNAL OF NUTRITION, V41, P786
   Kinard BR, 2012, INT J CONSUM STUD, V36, P23, DOI 10.1111/j.1470-6431.2011.01005.x
   Korea Consumer Agency, 2013, SURV SAF EN DRINK CO, V0, P0
   Korea Consumer Agency, 2013, EN DRINK CAFF CONT M, V0, P0
   Kwon YS, 2018, ASIA PAC J CLIN NUTR, V27, P217, DOI 10.6133/apjcn.032017.09
   Lambert J, 2004, BRIT J NUTR, V92, PS147, DOI 10.1079/BJN20041160
   Lee CY, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8090567
   Lee MyoungSook Lee MyoungSook, 2018, JOURNAL OF NUTRITION AND HEALTH, V51, P455
   Lien L, 2007, PUBLIC HEALTH NUTR, V10, P422, DOI 10.1017/S1368980007258550
   Lim HJ, 2018, J ACAD NUTR DIET, V118, P1228, DOI 10.1016/j.jand.2017.08.001
   Lluch A, 1998, EUR J CLIN NUTR, V52, P300, DOI 10.1038/sj.ejcn.1600555
   Lobstein T, 2003, OBES REV, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x
   Loprinzi PD, 2014, MAYO CLIN PROC, V89, P190, DOI 10.1016/j.mayocp.2013.09.018
   Marques-Vidal P, 2006, INT J OBESITY, V30, P88, DOI 10.1038/sj.ijo.0803045
   Marshall TA, 2013, J AM DENT ASSOC, V144, P1148, DOI 10.14219/jada.archive.2013.0033
   MFDS (Ministry of Food and Drug Safety), 2017, CHECK OUT PHRAS CONT, V0, P0
   Michael SL, 2020, PREV MED REP, V19, P0, DOI 10.1016/j.pmedr.2020.101153
   Moreno-G√≥mez C, 2012, PUBLIC HEALTH NUTR, V15, P2131, DOI 10.1017/S1368980012000080
   Mullie P, 2010, EUR J CLIN NUTR, V64, P231, DOI 10.1038/ejcn.2009.145
   Niemeier HM, 2006, J ADOLESCENT HEALTH, V39, P842, DOI 10.1016/j.jadohealth.2006.07.001
   Noonan RJ, 2018, INT J ENV RES PUB HE, V15, P0, DOI 10.3390/ijerph15061224
   Ock SM, 2002, J KOREAN ACAD FAM ME, V23, P905
   Oddy WH, 2009, BMJ-BRIT MED J, V339, P0, DOI 10.1136/bmj.b5268
   OECD, 2017, RES PROGR INT STUD A, V0, P0
   Oliver G, 2000, PSYCHOSOM MED, V62, P853, DOI 10.1097/00006842-200011000-00016
   Paans NPG, 2019, APPETITE, V134, P103, DOI 10.1016/j.appet.2018.12.030
   Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x
   Patrick K, 2004, ARCH PEDIAT ADOL MED, V158, P385, DOI 10.1001/archpedi.158.4.385
   Rhew I, 2007, CONTEMP CLIN TRIALS, V28, P472, DOI 10.1016/j.cct.2007.01.002
   Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965
   Schutz Y, 2000, ENERGY SUBSTRATE BAL, V10, P137
   Shahar D, 2005, NUTRITION, V21, P559, DOI 10.1016/j.nut.2004.09.018
   Shim JS, 2019, NUTR RES PRACT, V13, P134, DOI 10.4162/nrp.2019.13.2.134
   Steptoe A, 2002, PREV MED, V35, P97, DOI 10.1006/pmed.2002.1048
   Story M, 2002, J AM DIET ASSOC, V102, PS40, DOI 10.1016/S0002-8223(02)90421-9
   Teegarden SL, 2008, PHYSIOL BEHAV, V93, P713, DOI 10.1016/j.physbeh.2007.11.030
   Wardle J, 2001, J EPIDEMIOL COMMUN H, V55, P185, DOI 10.1136/jech.55.3.185
   WesterterpPlantenga MS, 1997, PHYSIOL BEHAV, V62, P1345, DOI 10.1016/S0031-9384(97)00353-3
   Whitaker KM, 2014, NUTR RES, V34, P294, DOI 10.1016/j.nutres.2014.01.007
   Wijnhoven TMA, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-806
   WURTMAN JJ, 1993, J AFFECT DISORDERS, V29, P183, DOI 10.1016/0165-0327(93)90032-F
   Yoo JS, 2008, J NUTR HLTH, V41, P818
   Yoo JiYeon Yoo JiYeon, 2009, KOREAN JOURNAL OF COMMUNITY NUTRITION, V14, P147
NR 77
TC 9
Z9 9
U1 1
U2 23
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD SEP 15
PY 2021
VL 18
IS 18
BP 
EP 
DI 10.3390/ijerph18189773
PG 14
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational Health
GA UX2HV
UT WOS:000700667600001
PM 34574695
DA 2025-04-28
ER

PT J
AU Bagheri, A
   Hashemi, R
   Heshmat, R
   Motlagh, AD
   Esmaillzadeh, A
AF Bagheri, Amir
   Hashemi, Rezvan
   Heshmat, Ramin
   Motlagh, Ahmadreza Dorosty
   Esmaillzadeh, Ahmad
TI Patterns of Nutrient Intake in Relation to Sarcopenia and Its Components
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE nutrient patterns; sarcopenia; muscle mass; muscle strength; gait speed
ID skeletal-muscle mass; dietary patterns; older-adults; handgrip strength; national-health; grip strength; gait speed; associations; consensus; obesity
AB Background: Despite the associations between individual nutrients and sarcopenia, we are aware of no information about the link between patterns of nutrient intake and odds of sarcopenia and its components. The present study aimed to examine the association between nutrient-based dietary patterns and sarcopenia and its components among the Iranian adult population. Methods: In this population-based, cross-sectional study, we enrolled 300 elderly adults (150 men and 150 women) aged >= 55 years by using a cluster random sampling method. Dietary intakes of the study population were assessed using a validated food frequency questionnaire. Principal component analysis was conducted to derive nutrient patterns based on a daily intake of 33 nutrients. Muscle mass, muscle strength, and gait speed were measured according to standard methods. Sarcopenia and its components were defined based on the European Working Group on Sarcopenia. Results: Three major nutrient-based dietary patterns were identified: (1) the "pro-vit pattern" that was high in pantothenic (B5), cobalamin (B12), calcium, protein, phosphor, riboflavin (B2), zinc, cholesterol, saturated fat, folate, niacin (B3), selenium, vitamin D, vitamin K, and vitamin A; (2) the "anti-inflammatory" pattern, which was rich in polyunsaturated fat, monounsaturated fat, copper, vitamin E, omega-3, magnesium, iron, pyridoxine (B6), sodium, and caffeine; and (3) the "carbo-vit" patternm which is characterized by high intake of fructose, glucose, dietary fiber, biotin, potassium, thiamin (B1), vitamin C, and chromium. After adjusting for confounders, subjects in the top tertile of the anti-inflammatory pattern had lower odds of sarcopenia (OR 0.25; 95% CI 0.10-0.63) and low muscle strength (OR: 0.46; 95% CI: 0.22-0.96) than those in the bottom tertile. Greater adherence to the carbo-vit pattern was inversely associated with the odds of low gait speed (OR: 0.46; 95% CI: 0.235-0.93). Conclusion: Major nutrient-based dietary patterns were significantly associated with sarcopenia and its components. Further studies are required to confirm our findings.
C1 [Bagheri, Amir; Motlagh, Ahmadreza Dorosty; Esmaillzadeh, Ahmad] Univ Tehran Med Sci, Dept Community Nutr, Sch Nutrit Sci & Dietet, Tehran, Iran.
   [Hashemi, Rezvan] Univ Tehran Med Sci, Ziaeian Hosp, Dept Geriatr Med, Tehran, Iran.
   [Heshmat, Ramin] Univ Tehran Med Sci, Chron Dis Res Ctr CDRC, Endocrinol & Metab Populat Sci Inst, Tehran, Iran.
   [Esmaillzadeh, Ahmad] Univ Tehran Med Sci, Endocrinol & Metab Mol Cellular Sci Inst, Obes & Eating Habits Res Ctr, Tehran, Iran.
   [Esmaillzadeh, Ahmad] Isfahan Univ Med Sci, Dept Community Nutr, Esfahan, Iran.
C3 Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Isfahan University of Medical Sciences
RP Esmaillzadeh, A (corresponding author), Univ Tehran Med Sci, Dept Community Nutr, Sch Nutrit Sci & Dietet, Tehran, Iran.; Hashemi, R (corresponding author), Univ Tehran Med Sci, Ziaeian Hosp, Dept Geriatr Med, Tehran, Iran.; Esmaillzadeh, A (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Mol Cellular Sci Inst, Obes & Eating Habits Res Ctr, Tehran, Iran.; Esmaillzadeh, A (corresponding author), Isfahan Univ Med Sci, Dept Community Nutr, Esfahan, Iran.
EM r_hashemi@tums.ac.ir; a-esmaillzadeh@tums.ac.ir
FU Tehran Endocrine and Metabolism Research Center; Tehran University of Medical Science
CR Bagheri A, 2020, NUTR J, V19, P0, DOI 10.1186/s12937-020-00649-2
   Beaudart C, 2019, AGING CLIN EXP RES, V31, P815, DOI 10.1007/s40520-019-01186-7
   Bibiloni MD, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9070704
   Bloom I, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10030308
   Carmeli E, 2002, EXP GERONTOL, V37, P477, DOI 10.1016/S0531-5565(01)00220-0
   Chan R, 2016, J AM MED DIR ASSOC, V17, P336, DOI 10.1016/j.jamda.2015.12.004
   Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025
   Committee IR., 2005, GUIDELINES DATA PROC, V0, P0
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   De Stefani E, 2008, ANTICANCER RES, V28, P2499
   Edefonti V, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12061584
   Flood A, 2014, CLIN NUTR, V33, P106, DOI 10.1016/j.clnu.2013.03.003
   Gedmantaite A, 2020, MECH AGEING DEV, V189, P0, DOI 10.1016/j.mad.2020.111269
   Granic A, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11040745
   Granic A, 2020, CLIN NUTR, V39, P166, DOI 10.1016/j.clnu.2019.01.009
   Hashemi R, 2012, J DIABETES METAB DIS, V11, P0, DOI 10.1186/2251-6581-11-23
   HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214
   Iwasaki Y, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11050990
   Ji C, 2018, LIPIDS HEALTH DIS, V17, P0, DOI 10.1186/s12944-018-0734-4
   Jochem C, 2019, J AM MED DIR ASSOC, V20, P1213, DOI 10.1016/j.jamda.2019.05.015
   Kim MK, 2011, J CLIN ENDOCR METAB, V96, P3250, DOI 10.1210/jc.2011-1602
   Kim M, 2019, INT J ENV RES PUB HE, V16, P0, DOI 10.3390/ijerph16091491
   Li SX, 2018, PEDIATR DIABETES, V19, P375, DOI 10.1111/pedi.12596
   Mahan LK, 2016, KRAUSES FOOD AND THE NUTRITION CARE PROCESS-E-BOOK, V0, P1370
   McClure R, 2019, CLIN NUTR ESPEN, V32, P33, DOI 10.1016/j.clnesp.2019.05.009
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   Merkies ISJ, 2000, MUSCLE NERVE, V23, P1393, DOI 10.1002/1097-4598(200009)23:9<1393::AID-MUS10>3.0.CO;2-O
   Mirmiran P, 2010, PUBLIC HEALTH NUTR, V13, P654, DOI 10.1017/S1368980009991698
   Mohseni R, 2017, AGING CLIN EXP RES, V29, P1241, DOI 10.1007/s40520-016-0721-4
   Morley JE, 2004, CYTOKINE-RELATED AGING PROCESS, V0, P0
   Newby PK, 2004, NUTR REV, V62, P177, DOI 10.1301/rn.2004.may.177-203
   Peel NM, 2019, J GERONTOL A-BIOL, V74, P943, DOI 10.1093/gerona/gly140
   Perera S, 2016, J GERONTOL A-BIOL, V71, P63, DOI 10.1093/gerona/glv126
   Rondanelli M, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/524948
   Salehi-Abargouei A, 2019, CLIN NUTR, V38, P940, DOI 10.1016/j.clnu.2018.02.002
   Salehi-Abargouei A, 2016, EUR J NUTR, V55, P505, DOI 10.1007/s00394-015-0867-4
   Schaap LA, 2006, AM J MED, V119, P0, DOI 10.1016/j.amjmed.2005.10.049
   Scott D, 2010, J AM GERIATR SOC, V58, P2129, DOI 10.1111/j.1532-5415.2010.03147.x
   Shafiee G, 2019, J DIABETES METAB DIS, V18, P665, DOI 10.1007/s40200-019-00452-9
   Smith GI, 2015, AM J CLIN NUTR, V102, P115, DOI 10.3945/ajcn.114.105833
   ter Borg S, 2016, J AM MED DIR ASSOC, V17, P393, DOI 10.1016/j.jamda.2015.12.015
   Thomas DR, 2007, CLIN NUTR, V26, P389, DOI 10.1016/j.clnu.2007.03.008
   Veronese N, 2018, J AM MED DIR ASSOC, V19, P981, DOI 10.1016/j.jamda.2018.06.007
   Willett W, 2012, NUTR EPIDEMIOLOGY, VThird, P0, DOI 10.1093/acprof:oso/9780199754038.001.0001
NR 44
TC 16
Z9 17
U1 2
U2 27
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
EI 
J9 FRONT NUTR
JI Front. Nutr.
PD APR 27
PY 2021
VL 8
IS 
BP 
EP 
DI 10.3389/fnut.2021.645072
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA RZ8WY
UT WOS:000648881600001
PM 33987198
DA 2025-04-28
ER

PT J
AU Greenberg, JA
   Neuhouser, ML
   Tinker, LF
   Lane, DS
   Paskett, ED
   Van Horn, LV
   Wassertheil-Smoller, S
   Shikany, JM
   Qi, LH
   Sealy-Jefferson, S
   Manson, JE
AF Greenberg, James A.
   Neuhouser, Marian L.
   Tinker, Lesley F.
   Lane, Dorothy S.
   Paskett, Electra D.
   Van Horn, Linda V.
   Wassertheil-Smoller, Sylvia
   Shikany, James M.
   Qi, Lihong
   Sealy-Jefferson, Shawnita
   Manson, JoAnn E.
TI Chocolate Candy and Incident Invasive Cancer Risk in the Women's Health Initiative: An Observational Prospective Analysis
SO JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS
LA English
DT Article
DE Women's Health Initiative; Chocolate consumption; Invasive cancer; Invasive colorectal cancer; Obesity
ID cardiovascular-disease; oxidative stress; cocoa; consumption; flavonoids; coffee; foods; fat
AB Background Laboratory and animal studies suggest an inverse association between chocolate consumption and the risk of cancer. Epidemiological studies have yielded inconsistent evidence. Objective To assess the association of chocolate candy consumption with incident, invasive total, breast, colorectal, and lung cancers in a large cohort of postmenopausal American women. Design Prospective cohort study with a mean 14.8-year follow-up. Chocolate candy intake was assessed by food frequency questionnaire. Invasive cancer events were assessed by physician adjudication. Participants/setting The Women's Health Initiative Study enrolled 161,808 postmenopausal women at 40 clinical centers nationwide between 1993 and 1998. Of these women, 114,281 with plausible food frequency or biometric data and no missing data on chocolate candy exposure were selected for analysis. Main outcome measures Cancer risk in quartiles of chocolate candy consumption with the first quartile as referent. Statistical analyses Multivariable Cox regression was used to calculate hazard ratios and 95% confidence intervals. Results There were 16,164 documented incident invasive cancers, representing an incidence rate of 17.0 per 100 participants and 12.3 per 1000 person years during follow-up among participants without any preexisting cancers or missing outcome data. There were no statistically significant associations for total invasive cancer (P-linear = .47, P-curvature = .14), or invasive breast cancer (P-linear = .77, P-curvature = .26). For colorectal cancer P-linear was .02, P-curvature was .03, and compared with women eating a 1 oz (28.4 g) chocolate candy serving <1 time per month, the hazard ratio for >= 1.5 times/ wk was 1.18 (95% confidence interval: 1.04-1.35). This result may be attributable to the excess adiposity associated with frequent chocolate candy consumption. Conclusions In the Women's Health Initiative, there was no significant association between chocolate candy consumption and invasive total or breast cancer. There was a modest 18% higher risk of invasive colorectal cancer for women who ate chocolate candy at least 1.5 times/wk. These results require confirmation.
C1 [Greenberg, James A.] CUNY Brooklyn Coll, Dept Hlth & Nutr Sci, 2900 Bedford Ave, Brooklyn, NY 11210 USA.
   [Neuhouser, Marian L.; Tinker, Lesley F.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA USA.
   [Lane, Dorothy S.] SUNY Stony Brook, Sch Med, Dept Family Populat & Prevent Med, Stony Brook, NY 11794 USA.
   [Paskett, Electra D.] Ohio State Univ, Canc Res, Dept Internal Med, Div Canc Prevent & Control,Coll Med,Comprehens Ca, Columbus, OH 43210 USA.
   [Sealy-Jefferson, Shawnita] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA.
   [Van Horn, Linda V.] Northwestern Univ, Nutr, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Wassertheil-Smoller, Sylvia] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.
   [Shikany, James M.] Univ Alabama Birmingham, Cardiovasc Dis, Div Prevent Med, Sch Med, Birmingham, AL USA.
   [Shikany, James M.] Univ Alabama Birmingham, Sch Med, Div Prevent Med, Res, Birmingham, AL USA.
   [Qi, Lihong] Univ Calif Davis, Dept Publ Hlth Sci, Sch Med, Davis, CA 95616 USA.
   [Manson, JoAnn E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.
C3 City University of New York (CUNY) System; Brooklyn College (CUNY); Fred Hutchinson Cancer Center; State University of New York (SUNY) System; Stony Brook University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Northwestern University; Feinberg School of Medicine; Yeshiva University; Montefiore Medical Center; Albert Einstein College of Medicine; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Davis; Harvard University; Harvard Medical School; Harvard University Medical Affiliates; Brigham & Women's Hospital
RP Greenberg, JA (corresponding author), CUNY Brooklyn Coll, Dept Hlth & Nutr Sci, 2900 Bedford Ave, Brooklyn, NY 11210 USA.
EM jamesg@brooklyn.cuny.edu
FU National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI), US Department of Health and Human Services [HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, HHSN268201600004C, HHSN268201100001C]; NIH/NHLBI, the Women's Health Initiative program [HHSN268201100001C]; Mars Symbioscience; NIH/NHLBI, US Department of Health and Human Services [HHSN268201100046C]; Stony Brook WHI Center grant, NHLBI [NO1-WH-42115]
CR Allison, 2010, SURVIVAL ANAL USING, V0, P175
   Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
   Martin MA, 2013, FOOD CHEM TOXICOL, V56, P336, DOI 10.1016/j.fct.2013.02.020
   Mart√≠n MA, 2010, J NUTR BIOCHEM, V21, P196, DOI 10.1016/j.jnutbio.2008.10.009
   Unknown -, 2001, B WORLD HEALTH ORGAN, V79, P373, DOI 10.1001/jama.2013.281053
   Arts ICW, 2001, INT J CANCER, V92, P298, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1187>3.0.CO;2-8
   Bayard Vicente, 2007, INT J MED SCI, V4, P53
   Boutron-Ruault MC, 1999, EUR J CANCER PREV, V8, P229, DOI 10.1097/00008469-199906000-00011
   Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222
   Curb JD, 2003, ANN EPIDEMIOL, V13, PS122, DOI 10.1016/S1047-2797(03)00048-6
   Ellinger S, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8060321
   Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829
   Giannandrea F, 2009, INT J ENV RES PUB HE, V6, P568, DOI 10.3390/ijerph6020578
   Greenberg JA, 2015, OBESITY, V23, P677, DOI 10.1002/oby.20983
   Gu YY, 2014, EUR J NUTR, V53, P149, DOI 10.1007/s00394-013-0510-1
   Harrell FE, 2015, SPRINGER SER STAT, V0, P0, DOI DOI 10.1007/978-3-319-19425-7
   Heiss C, 2010, EUR HEART J, V31, P2583, DOI 10.1093/eurheartj/ehq332
   Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5
   Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849
   Knuiman MW, 1998, ANN EPIDEMIOL, V8, P56, DOI 10.1016/S1047-2797(97)00107-5
   Langer RD, 2003, ANN EPIDEMIOL, V13, PS107, DOI 10.1016/S1047-2797(03)00047-4
   Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602
   Lemeshow L, 1999, APPL SURVIVAL ANAL R, V0, P205
   Maskarinec G, 2009, NUTR CANCER, V61, P573, DOI 10.1080/01635580902825662
   McKelvey W, 2000, EPIDEMIOLOGY, V11, P469, DOI 10.1097/00001648-200007000-00018
   PANNELLI F, 1989, EUR J EPIDEMIOL, V5, P392, DOI 10.1007/BF00144843
   Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6
   Ramiro E, 2005, BRIT J NUTR, V93, P859, DOI 10.1079/BJN20051443
   Rodr√≠guez-Ramiro I, 2011, MOL NUTR FOOD RES, V55, P1895, DOI 10.1002/mnfr.201100363
   SELIGSON FH, 1994, AM J CLIN NUTR, V60, P1060S, DOI 10.1093/ajcn/60.6.1060S
   Spadafranca A, 2010, BRIT J NUTR, V103, P1008, DOI 10.1017/S0007114509992698
   Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159
   Steinberg FM, 2003, J AM DIET ASSOC, V103, P215, DOI 10.1053/jada.2003.50028
   von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120
   Zhou A, 2019, AM J CLIN NUTR, V109, P509, DOI 10.1093/ajcn/nqy297
NR 35
TC 6
Z9 6
U1 1
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 2212-2672
EI 2212-2680
J9 J ACAD NUTR DIET
JI J. Acad. Nutr. Diet.
PD FEB 15
PY 2021
VL 121
IS 2
BP 314
EP +
DI 10.1016/j.jand.2020.06.014
EA JAN 2021
PG 17
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA PW1EK
UT WOS:000610419300014
PM 32763064
DA 2025-04-28
ER

PT J
AU Torres-Collado, L
   Compa√±-Gabucio, LM
   Gonz√°lez-Palacios, S
   Notario-Barandiaran, L
   Oncina-C√°novas, A
   Vioque, J
   Garc√≠a-de la Hera, M
AF Torres-Collado, Laura
   Maria Compan-Gabucio, Laura
   Gonzalez-Palacios, Sandra
   Notario-Barandiaran, Leyre
   Oncina-Canovas, Alejandro
   Vioque, Jesus
   Garcia-de la Hera, Manuela
TI Coffee Consumption and All-Cause, Cardiovascular, and Cancer Mortality in an Adult Mediterranean Population
SO NUTRIENTS
LA English
DT Article
DE coffee; caffeinated; decaffeinated; mortality; cardiovascular disease; cancer
ID risk; metaanalysis; association; caffeine; disease; diet; agreement; adherence; survival; obesity
AB We assessed the association between usual coffee consumption and all-cause, cardiovascular (CV), and cancer mortality in an adult population in Spain, taking into account both the amount and type of coffee consumed. We used baseline data on coffee consumption and other personal variables, and the number of deaths during an 18-year follow-up period, for 1567 participants aged 20 years and older from the Valencia Nutrition Study in Spain. Total, caffeinated, and decaffeinated coffee consumption was assessed using a validated food frequency questionnaire. Cox regression models were used to estimate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs). During the 18-year follow-up period, 317 died; 115 due to CV disease and 82 due to cancer. Compared with no-consumption, the consumption of <= 1 cup per day and >1 cup per day of coffee was associated with a lower risk of all-cause mortality, HR = 0.73 (95% CI: 0.56-0.97) and HR 0.56 (95% CI: 0.41-0.77), respectively. A lower cancer mortality was observed among drinkers of more than 1 cup per day compared with nondrinkers, HR 0.41 (95% CI 0.20-0.86). Regarding the type of coffee, only the overall consumption of caffeinated coffee was associated with lower all-cause mortality at 12 and 18 years of follow-up, HR = 0.66 (95% CI:0.46-0.94) and HR = 0.59 (95% CI: 0.44-0.79), respectively. In conclusion, this study suggests that the moderate consumption of coffee, particularly caffeinated coffee (range 1-6.5 cups per day), is associated with a lower all-cause and cancer mortality after a long follow-up period. No significant association was found between coffee consumption and CVD mortality.
C1 [Torres-Collado, Laura; Maria Compan-Gabucio, Laura; Gonzalez-Palacios, Sandra; Notario-Barandiaran, Leyre; Oncina-Canovas, Alejandro; Vioque, Jesus; Garcia-de la Hera, Manuela] ISABIAL UMH, Inst Invest Sanitaria & Biomed Alicante, Alicante 03010, Spain.
   [Torres-Collado, Laura; Maria Compan-Gabucio, Laura; Gonzalez-Palacios, Sandra; Notario-Barandiaran, Leyre; Oncina-Canovas, Alejandro; Vioque, Jesus; Garcia-de la Hera, Manuela] Univ Miguel Hernandez UMH, Dept Salud Publ Hist Ciencia & Ginecol, Unidad Epidemiol Nutr, Alicante 03550, Spain.
   [Torres-Collado, Laura; Maria Compan-Gabucio, Laura; Gonzalez-Palacios, Sandra; Notario-Barandiaran, Leyre; Oncina-Canovas, Alejandro; Vioque, Jesus; Garcia-de la Hera, Manuela] Inst Salud Carlos III, CIBER Epidemiol & Salud Publ CIBERESP, Madrid 28034, Spain.
C3 General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III
RP Vioque, J (corresponding author), ISABIAL UMH, Inst Invest Sanitaria & Biomed Alicante, Alicante 03010, Spain.; Vioque, J (corresponding author), Univ Miguel Hernandez UMH, Dept Salud Publ Hist Ciencia & Ginecol, Unidad Epidemiol Nutr, Alicante 03550, Spain.; Vioque, J (corresponding author), Inst Salud Carlos III, CIBER Epidemiol & Salud Publ CIBERESP, Madrid 28034, Spain.
EM l.torres@umh.es; lcompan@umh.es; sandra.gonzalezp@umh.es; lnotario@umh.es; aoncina@umh.es; vioque@umh.es; manoli@umh.es
FU Direccion General de Salud Publica, Generalitat Valenciana 1994; Fondo Investigacion Sanitaria [FIS 00/0985]; Instituto de Salud Carlos III; FEDER funds [FIS PI13/00654]
CR Bravi F, 2017, EUR J CANCER PREV, V26, P368, DOI 10.1097/cej.0000000000000252
   Buckland G, 2009, AM J EPIDEMIOL, V170, P1518, DOI 10.1093/aje/kwp282
   BUSH TL, 1989, AM J PUBLIC HEALTH, V79, P1554, DOI 10.2105/AJPH.79.11.1554
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Caini S, 2017, EUR J NUTR, V56, P1, DOI 10.1007/s00394-016-1253-6
   Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dinu M, 2018, EUR J CLIN NUTR, V72, P30, DOI 10.1038/ejcn.2017.58
   G√∂kcen BB, 2019, CRIT REV FOOD SCI, V59, P336, DOI 10.1080/10408398.2017.1369391
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2017, AM J EPIDEMIOL, V185, P1304, DOI 10.1093/aje/kww207
   Grosso G, 2017, PUBLIC HEALTH NUTR, V20, P82, DOI 10.1017/S1368980016001749
   Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2
   Gunter MJ, 2017, ANN INTERN MED, V167, P236, DOI 10.7326/M16-2945
   Happonen P, 2008, BRIT J NUTR, V99, P1354, DOI 10.1017/S0007114507871650
   HARLOW SD, 1989, AM J EPIDEMIOL, V129, P233, DOI 10.1093/oxfordjournals.aje.a115129
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Je Y, 2014, BRIT J NUTR, V111, P1162, DOI 10.1017/S0007114513003814
   Kim Y, 2019, EUR J EPIDEMIOL, V34, P731, DOI 10.1007/s10654-019-00524-3
   LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158
   Liu JX, 2013, MAYO CLIN PROC, V88, P1066, DOI 10.1016/j.mayocp.2013.06.020
   Liu QP, 2016, NUTRITION, V32, P628, DOI 10.1016/j.nut.2015.11.015
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI 10.1039/C4FO00042K
   Machado-Fragua MD, 2019, EUR J NUTR, V58, P1415, DOI 10.1007/s00394-018-1664-7
   Malerba S, 2013, EUR J EPIDEMIOL, V28, P527, DOI 10.1007/s10654-013-9834-7
   Navarro AM, 2018, AM J CLIN NUTR, V108, P1113, DOI 10.1093/ajcn/nqy198
   Palatini P, 2016, INT J CARDIOL, V212, P131, DOI 10.1016/j.ijcard.2016.03.006
   Palma I, 2008, TABLAS DE COMPOSICIN DE ALIMENTOS POR MEDIDAS CASERAS DE CONSUMO HABITUAL EN ESPAA. CENTRE DENSENYAMENT SUPERIOR DE NUTRICI I DIETTICA (CESNID), V0, P0
   Park SY, 2017, ANN INTERN MED, V167, P228, DOI 10.7326/M16-2472
   Penolazzi B, 2012, APPETITE, V58, P971, DOI 10.1016/j.appet.2012.02.001
   Poole R, 2017, BMJ-BRIT MED J, V359, P0, DOI 10.1136/bmj.j5024
   Quiles J, 1998, MED CLIN-BARCELONA, V110, P319
   Ruggiero E, 2021, J NUTR, V151, P395, DOI 10.1093/jn/nxaa365
   Sado J, 2019, CIRC J, V83, P757, DOI 10.1253/circj.CJ-18-0618
   Sado J, 2017, CANCER SCI, V108, P2079, DOI 10.1111/cas.13328
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Torres-Collado L, 2019, EUR J NUTR, V58, P2439, DOI 10.1007/s00394-018-1796-9
   TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457
   Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039
   USDepartment of Agriculture ARS USDA Nutrient Data Laboratory, 2008, USDA NAT NUTR DAT ST, V0, P0
   Vioque J, 1991, EUROPEAN JOURNAL OF CANCER PREVENTION, V1, P19
   WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086
   Wu L, 2017, CLIN NUTR, V36, P730, DOI 10.1016/j.clnu.2016.05.015
   Yamagata K, 2018, ANTIOXIDANTS-BASEL, V7, P0, DOI 10.3390/antiox7020026
   Yu XF, 2011, BMC CANCER, V11, P0, DOI 10.1186/1471-2407-11-96
NR 47
TC 18
Z9 18
U1 0
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD APR 15
PY 2021
VL 13
IS 4
BP 
EP 
DI 10.3390/nu13041241
PG 13
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA RR9PZ
UT WOS:000643422200001
PM 33918797
DA 2025-04-28
ER

PT J
AU Paluch, E
   Okinczyc, P
   Zwyrzykowska-Wodzinska, A
   Szperlik, J
   Zarowska, B
   Duda-Madej, A
   Babelewski, P
   Wlodarczyk, M
   Wojtasik, W
   Kupczynski, R
   Szumny, A
AF Paluch, Emil
   Okinczyc, Piotr
   Zwyrzykowska-Wodzinska, Anna
   Szperlik, Jakub
   Zarowska, Barbara
   Duda-Madej, Anna
   Babelewski, Przemyslaw
   Wlodarczyk, Maciej
   Wojtasik, Wioleta
   Kupczynski, Robert
   Szumny, Antoni
TI Composition and Antimicrobial Activity of Ilex Leaves Water Extracts
SO MOLECULES
LA English
DT Article
DE Ilex; antimicrobial activity; biofilm; HPLC; DAD; MS; polyphenols; yerba mate
ID yerba mate; st-hil.; antifungal activity; phenolic-compounds; aqueous extract; paraguariensis; identification; antioxidant; constituents; plants
AB Plants from the Ilex genus are known for properties such as antimicrobial and anti-inflammatory activity, can act as antiobesity agents and thus can be helpful in medicine. Some holly species, such as Ilex paraguariensis (widely known in the form of popular beverage: yerba mate), have been investigated, while others have been partially researched or remain unknown. Therefore, we performed qualitative and quantitative phytochemical analyses and screened antimicrobial properties of lesser-studied species (I. aquifolium L., I. aquifolium 'Argentea Marginata' and I. x meserveae 'Blue Angel'). I. paraguariensis was used as a standard species for comparison purposes. Investigations were performed on water extracts due to their expected activity and composition. Antimicrobial research included evaluating minimal inhibitory, bactericidal (Staphylococcus aureus and Escherichia coli) and fungicidal concentration (Candida albicans, Alternaria alternata, Fusarium oxysporum, and Aspergillus niger) of extracts. The influence of the extracts on the production, eradication, and viability of bacterial biofilms was also analysed. It was established that Ilex paraguariensis possesses the richest profile of hydroxycinnamic acids derivatives in terms of component concentration and diversity. Ilex spp., especially I. x meserveae, contain a slightly higher amount of flavonoids and more different flavonoid derivatives than I. paraguariensis. However, the strongest antibacterial activity was shown by I. aquifolium L. and its cultivar 'Argentea Marginata' in terms of minimal inhibitory, bactericidal and fungicidal concentration, and biofilm assays. Extracts from both species significantly reduced the biofilm viability of S. aureus as well, which may be of use in the production of multicomponent lavaseptics, antiseptics, diuretics (supporting urinary tract infection therapy) and, due to their action on fungi, additives to growth media for specific fungi. The significant content of saponins enables Ilex extracts to be used as natural emulsifiers, for example, in cosmetics. Moreover, relatively high chlorogenic acid and rutin content may suggest use of Ilex spp. to treat obesity, digestive problems, in chemoprevention, and as preservatives in the food industry.
C1 [Paluch, Emil; Duda-Madej, Anna] Wroclaw Med Univ, Fac Med, Dept Microbiol, Chalubinskiego 4, PL-50376 Wroclaw, Poland.
   [Okinczyc, Piotr; Wlodarczyk, Maciej] Wroclaw Med Univ, Dept Pharmacognosy & Herbal Med, Borowska 211a, PL-50556 Wroclaw, Poland.
   [Zwyrzykowska-Wodzinska, Anna; Kupczynski, Robert] Wroclaw Univ Environm & Life Sci, Dept Environm Hyg & Anim Welf, Chelmonskiego 38C, PL-51630 Wroclaw, Poland.
   [Szperlik, Jakub] Univ Wroclaw, Fac Biol Sci, Lab Tissue Culture Bot Garden, Sienkiewicza 23, PL-50525 Wroclaw, Poland.
   [Zarowska, Barbara] Wroclaw Univ Environm & Life Sci, Dept Biotechnol & Food Microbiol, Chelmonskiego 37, PL-51630 Wroclaw, Poland.
   [Babelewski, Przemyslaw] Wroclaw Univ Environm & Life Sci, Dept Hort, Grunwaldzki 24A, PL-50375 Wroclaw, Poland.
   [Wojtasik, Wioleta] Univ Wroclaw, Fac Biotechnol, Przybyszewskiego 63-77, PL-51148 Wroclaw, Poland.
   [Szumny, Antoni] Wroclaw Univ Environm & Life Sci, Dept Chem, Norwida 25, PL-50375 Wroclaw, Poland.
C3 Wroclaw Medical University; Wroclaw Medical University; Wroclaw University of Environmental & Life Sciences; University of Wroclaw; Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences; University of Wroclaw; Wroclaw University of Environmental & Life Sciences
RP Okinczyc, P (corresponding author), Wroclaw Med Univ, Dept Pharmacognosy & Herbal Med, Borowska 211a, PL-50556 Wroclaw, Poland.; Babelewski, P (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Hort, Grunwaldzki 24A, PL-50375 Wroclaw, Poland.
EM emil.paluch@umed.wroc.pl; piotr.okinczyc@umw.edu.pl; anna.zwyrzykowska@upwr.edu.pl; jakub.szperlik@uwr.edu.pl; barbara.zarowska@upwr.edu.pl; anna.duda-madej@umw.edu.pl; przemyslaw.babelewski@upwr.edu.pl; maciej.wlodarczyk@umw.edu.pl; wioleta.wojtasik@uwr.edu.pl; robert.kupczynski@upwr.edu.pl; antoni.szumny@upwr.edu.pl
CR ALIKARIDIS F, 1987, J ETHNOPHARMACOL, V20, P121, DOI 10.1016/0378-8741(87)90084-5
   Unknown -, 2012, METH DIL ANT SUSC TE, V0, P0
   Balzan S, 2013, FITOTERAPIA, V86, P115, DOI 10.1016/j.fitote.2013.02.008
   Bastos DHM, 2007, MED AROMAT PLANT SCI BIOTECHNOL, V1, P37
   Bracesco N, 2011, J ETHNOPHARMACOL, V136, P378, DOI 10.1016/j.jep.2010.06.032
   Bravo L, 2007, FOOD RES INT, V40, P393, DOI 10.1016/j.foodres.2006.10.016
   Burris KP, 2011, J FOOD SCI, V76, PM456, DOI 10.1111/j.1750-3841.2011.02255.x
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cordova V, 2019, ACTIVIDAD ANTIBIOFIL, V0, P0
   Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002
   Cadiz-Gurrea MD, 2013, FOOD RES INT, V50, P197, DOI 10.1016/j.foodres.2012.09.038
   El-Hawiet AM, 2010, REV BRAS FARMACOGN, V20, P860, DOI 10.1590/S0102-695X2010005000047
   Evens ZN, 2012, WEST J EMERG MED, V13, P538, DOI 10.5811/westjem.2012.8.12572
   Fang ZX, 2007, FOOD CHEM, V100, P845, DOI 10.1016/j.foodchem.2005.09.024
   Filip R, 2010, PHYTOTHER RES, V24, P715, DOI 10.1002/ptr.3004
   Fleck JD, 2019, MOLECULES, V24, P0, DOI 10.3390/molecules24010171
   Grujic N, 2012, MOLECULES, V17, P2518, DOI 10.3390/molecules17032518
   Guo Long, 2015, CHIN J NAT MED, V13, P711, DOI 10.1016/S1875-5364(15)30071-6
   Hao DC, 2013, ACTA PHARM SIN B, V3, P8, DOI 10.1016/j.apsb.2012.12.008
   Haraguchi H, 1999, PHYTOTHER RES, V13, P151, DOI 10.1002/(SICI)1099-1573(199903)13:2<151::AID-PTR391>3.0.CO;2-C
   Heck CI, 2007, J FOOD SCI, V72, PR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Hoffmann K, 2003, PUBLIC HEALTH NUTR, V6, P765, DOI 10.1079/PHN2003500
   Jaiswal R, 2014, J AGR FOOD CHEM, V62, P9252, DOI 10.1021/jf501210s
   Jaiswal R, 2014, PHYTOCHEMISTRY, V106, P141, DOI 10.1016/j.phytochem.2014.07.018
   Kanchanapoom T, 2002, PHYTOCHEMISTRY, V61, P461, DOI 10.1016/S0031-9422(02)00140-1
   Karunanidhi A, 2013, BIOMED RES INT, V2013, P0, DOI 10.1155/2013/392058
   Khoza BS, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/914759
   Kolderman E, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0121835
   Kolodziejczyk-Czepas J, 2018, J PHARM PHARMACOL, V70, P413, DOI 10.1111/jphp.12872
   Kujawska M, 2018, EVID-BASED COMPL ALT, V2018, P0, DOI 10.1155/2018/6849317
   Kuropka P, 2021, FOODS, V10, P0, DOI 10.3390/foods10040818
   Legay S, 2016, NEW PHYTOL, V212, P977, DOI 10.1111/nph.14170
   LEVIN DA, 1976, AM NAT, V110, P261, DOI 10.1086/283063
   Li Jun-min, 2006, ZHEJIANG DA XUE XUE BAO YI XUE BAN, V35, P273
   L√≥pez-Cobo A, 2016, LWT-FOOD SCI TECHNOL, V73, P505, DOI 10.1016/j.lwt.2016.06.049
   Lu√≠s A, 2014, BIOFOULING, V30, P69, DOI 10.1080/08927014.2013.845878
   Marksa M, 2020, IND CROP PROD, V145, P0, DOI 10.1016/j.indcrop.2020.112123
   Martinez MAD, 1997, BIOCHEM SYST ECOL, V25, P619, DOI 10.1016/S0305-1978(97)00054-9
   Mateos R, 2018, FOOD CHEM, V241, P232, DOI 10.1016/j.foodchem.2017.08.085
   Matic IZ, 2013, PHYTOTHER RES, V27, P852, DOI 10.1002/ptr.4807
   Mazur M, 2019, CHIL J AGR RES, V79, P316, DOI 10.4067/S0718-58392019000200316
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/801457
   Noureddine T, 2018, J INFECT DEV COUNTR, V12, P712, DOI 10.3855/jidc.10380
   Okinczyc P, 2021, BIOMOLECULES, V11, P0, DOI 10.3390/biom11010068
   Ouyang MA, 2001, CHINESE J CHEM, V19, P885
   Paluch E, 2020, APPL MICROBIOL BIOT, V104, P1871, DOI 10.1007/s00253-020-10349-w
   Paluch E, 2018, COLLOID SURFACE B, V164, P34, DOI 10.1016/j.colsurfb.2018.01.020
   Paluch E, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-88244-1
   Peres RG, 2013, MOLECULES, V18, P3859, DOI 10.3390/molecules18043859
   Piecuch A, 2016, J APPL MICROBIOL, V121, P682, DOI 10.1111/jam.13204
   Martin JGP, 2013, REV ARGENT MICROBIOL, V45, P93, DOI 10.1016/S0325-7541(13)70006-3
   Ruhal R, 2021, MICROBIOL RES, V251, P0, DOI 10.1016/j.micres.2021.126829
   Salejda AM, 2021, J FOOD QUALITY, V2021, P0, DOI 10.1155/2021/8848279
   Luis AFS, 2019, BRAZ J PHARM SCI, V55, P0, DOI 10.1590/s2175-97902019000217615
   Shimoyama AT, 2013, N-S ARCH PHARMACOL, V386, P5, DOI 10.1007/s00210-012-0807-2
   Tirloni CAS, 2018, J MED FOOD, V21, P1276, DOI 10.1089/jmf.2018.0010
   SPRAY M, 1981, AGR HIST REV, V29, P97
   Takahashi M, 2014, J AOAC INT, V97, P1195, DOI 10.5740/jaoacint.13-038
   UEDA K, 1983, CHEM LETT, V0, PP149, DOI 10.1246/cl.1983.149
   Verderosa AD, 2019, FRONT CHEM, V7, P0, DOI 10.3389/fchem.2019.00824
   WALD A, 1976, GASTROENTEROLOGY, V71, P738
   WEST LG, 1977, PHYTOCHEMISTRY, V16, P1846, DOI 10.1016/0031-9422(71)85115-4
   WILLEMS M, 1988, PHYTOCHEMISTRY, V27, P1852, DOI 10.1016/0031-9422(88)80458-8
   Wismer T, 2013, SMALL ANIMAL TOXICOLOGY, V3rd, P0
   Wu Y, 2000, LETT APPL MICROBIOL, V30, P468, DOI 10.1046/j.1472-765X.2000.00748.x
   Zain N, 2013, J OIL PALM RES, V25, P58
   Zheleva-Dimitrova D, 2020, PROCESS BIOCHEM, V96, P202, DOI 10.1016/j.procbio.2020.06.002
   Zhou CH, 2018, EVID-BASED COMPL ALT, V2018, P0, DOI 10.1155/2018/8936307
   Zhou J, 2019, J AGR FOOD CHEM, V67, P5405, DOI 10.1021/acs.jafc.8b05062
   Zhou SX, 2012, CHIN J NAT MEDICINES, V10, P84, DOI 10.3724/SP.J.1009.2012.00084
   Zhu LL, 2018, J HEPATO-BIL-PAN SCI, V25, P195, DOI 10.1002/jhbp.537
   Ziaee A, 2009, BASIC CLIN PHARMACOL, V104, P253, DOI 10.1111/j.1742-7843.2008.00368.x
   Zwyrzykowska A, 2015, OPEN CHEM, V13, P1303, DOI 10.1515/chem-2015-0142
NR 73
TC 24
Z9 24
U1 3
U2 32
PU MDPI
PI BASEL
PA MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND
SN 
EI 1420-3049
J9 MOLECULES
JI Molecules
PD DEC 15
PY 2021
VL 26
IS 24
BP 
EP 
DI 10.3390/molecules26247442
PG 35
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA XX8UC
UT WOS:000736562200001
PM 34946528
DA 2025-04-28
ER

PT J
AU Otton, R
   Petrovic, N
   Cannon, B
   Nedergaard, J
AF Otton, Rosemari
   Petrovic, Natasa
   Cannon, Barbara
   Nedergaard, Jan
TI On the Validity of Adipogenic Cell Lines as Model Systems for Browning Processes: In Authentic Brown, Brite/Beige, and White Preadipocytes, There is No Cell-Autonomous Thermogenic Recruitment by Green Tea Compounds
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE thermogenesis; adipogenesis; polyphenols; PPAR gamma; green tea (Camellia sinensis L.)
ID adipose-tissue; ppar-gamma; uncoupling protein-1; weight-loss; caffeine; beige; adipocytes; activation; competent; induction
AB The potential ability of nutritional compounds to induce or enhance the browning of adipocytes has attracted large interest as a workable means of combatting the obesity epidemic. Green tea compounds are discussed as such inducers of an enhanced thermogenic capacity and activity. However, the cell-autonomous effects of green tea compounds on adipocytes have until now only been demonstrated in adipogenic cell lines (3T3-L1 and 3T3-F442A), i.e., cells of undefined tissue lineage. In this study, we examine the ability of green tea compounds to cell-autonomously induce thermogenic recruitment in authentic brown and brite/beige adipocytes in vitro. In primary brown adipocytes, the green tea compounds suppressed basal UCP1 gene expression, and there was no positive interaction between the compounds and adrenergic stimulation. In white adipocytes, green tea compounds decreased both basal and norepinephrine-induced UCP1 mRNA levels, and this was associated with the suppression of cell differentiation, indicated by reduced lipogenic gene expression and lipid accumulation. A lack of interaction between rosiglitazone and green tea compounds suggests that the green tea compounds do not directly interact with the PPAR gamma pathway. We conclude that there is a negative effect of the green tea compounds on basal UCP1 gene expression, in both brown and white primary adipocytes, in contrast to the positive effects earlier reported from studies in adipogenic cell lines. We posit that the epigenetic status of the adipogenic cell lines is fundamentally different from that of genuine brown and white adipocytes, reflected, e.g., in several-thousand-fold differences in UCP1 gene expression levels. Thus, results obtained with adipogenic cell lines cannot unreservedly be extrapolated as being relevant for authentic effects in brown and white adipocytes. We suggest that this conclusion can be of general concern for studies attempting to establish physiologically relevant cell-autonomous effects.
C1 [Otton, Rosemari] Cruzeiro Univ, Interdisciplinary Post Grad Programme Hlth Sci, Sao Paulo, Brazil.
   [Otton, Rosemari; Petrovic, Natasa; Cannon, Barbara; Nedergaard, Jan] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden.
C3 Universidade Cruzeiro do Sul; Stockholm University
RP Otton, R (corresponding author), Cruzeiro Univ, Interdisciplinary Post Grad Programme Hlth Sci, Sao Paulo, Brazil.; Otton, R (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden.
EM rosemari.otton@cruzeirodosul.edu.br
FU Sao Paulo Research Foundation (FAPESP) [2019/19049-6]; Magnus Bergvalls Stiftelse; Carl Tryggers Stiftelse; Swedish Science Research Council
CR Abreu-Vieira G, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8433
   Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9
   Barber√° MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200
   Bolin AP, 2020, J NUTR BIOCHEM, V83, P0, DOI 10.1016/j.jnutbio.2020.108429
   Bolin AP, 2020, J NUTR BIOCHEM, V78, P0, DOI 10.1016/j.jnutbio.2019.108322
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Cannon B, 2001, METHODS MOL BIOL, V155, P213
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   de Jong JMA, 2018, ADIPOCYTE, V7, P166, DOI 10.1080/21623945.2018.1479578
   Djeridane A, 2006, FOOD CHEM, V97, P654, DOI 10.1016/j.foodchem.2005.04.028
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Ferreira LT, 2020, J FUNCT FOODS, V64, P0, DOI 10.1016/j.jff.2019.103679
   FoellmiAdams LA, 1996, BIOCHEM PHARMACOL, V52, P693, DOI 10.1016/0006-2952(96)00345-0
   Golzarand M, 2018, J FUNCT FOODS, V46, P320, DOI 10.1016/j.jff.2018.04.002
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816
   Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007
   Kim HS, 2019, CHEM BIODIVERS, V16, P0, DOI 10.1002/cbdv.201900347
   Kraus NA, 2016, ADIPOCYTE, V5, P351, DOI 10.1080/21623945.2016.1240137
   KUUSELA P, 1986, LIFE SCI, V38, P589, DOI 10.1016/0024-3205(86)90052-4
   Lee MS, 2017, FOOD NUTR RES, V61, P0, DOI 10.1080/16546628.2017.1325307
   Merlin J, 2018, CELL SIGNAL, V42, P54, DOI 10.1016/j.cellsig.2017.09.023
   Mi YS, 2018, FOOD FUNCT, V9, P3374, DOI 10.1039/c8fo00167g
   Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, PE444, DOI 10.1152/ajpendo.00691.2006
   Nomura S, 2008, J NUTR BIOCHEM, V19, P840, DOI 10.1016/j.jnutbio.2007.11.005
   Petrovic N, 2008, AM J PHYSIOL-ENDOC M, V295, PE287, DOI 10.1152/ajpendo.00035.2008
   Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942
   Sadie-Van Gijsen H, 2019, J CELL PHYSIOL, V234, P2399, DOI 10.1002/jcp.27266
   Saito M, 2020, FRONT ENDOCRINOL, V11, P0, DOI 10.3389/fendo.2020.00222
   Saito Masayuki, 2015, ADV FOOD NUTR RES, V76, P1, DOI 10.1016/bs.afnr.2015.07.002
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Silvester AJ, 2019, J NUTR BIOCHEM, V64, P1, DOI 10.1016/j.jnutbio.2018.09.028
   Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034
   Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949
   Yoneshiro T, 2017, AM J CLIN NUTR, V105, P873, DOI 10.3945/ajcn.116.144972
   Zhou JH, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10111681
NR 37
TC 3
Z9 3
U1 1
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
EI 
J9 FRONT NUTR
JI Front. Nutr.
PD AUG 17
PY 2021
VL 8
IS 
BP 
EP 
DI 10.3389/fnut.2021.715859
PG 15
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA UM0VN
UT WOS:000693058400001
PM 34485365
DA 2025-04-28
ER

PT J
AU Moedinger, Y
   Schoen, C
   Wilhelm, M
   Pickel, C
   Grothe, T
AF Modinger, Yvonne
   Schon, Christiane
   Wilhelm, Manfred
   Pickel, Christina
   Grothe, Torsten
TI A Food Supplement with Antioxidative Santa Herba Extract Modulates Energy Metabolism and Contributes to Weight Management
SO JOURNAL OF MEDICINAL FOOD
LA English
DT Article
DE body composition; energy metabolism; flavonoids; obesity
ID plasma abnormality; adenosine receptors; eriodictyol; caffeine; behavior; obesity
AB The plant Santa herba (Eriodictyon californicum) contains high flavonoids, thus potentially exerting beneficial effects in context of obesity, often accompanied by inflammation and metabolic imbalance. The study assessed the impact of Santa herba on oxidative stress, energy metabolism, weight reduction, and eating behavior, combining in vitro models with clinical data. Santa herba binding of the adenosine receptor A2A (ADORA2A) was assessed using a radioligand binding assay. A Caenorhabditis elegans model was used to determine mobility boosting effects, and Santa herba oxygen radical absorbance capacity (ORAC) values were determined in comparison to antioxidative plants. Clinical data, that is, body weight and appetite-related parameters, were obtained from overweight and obese women receiving either Santa herba or placebo for 12 weeks. Results showed that Santa herba extract binds to ADORA2A, stimulates C. elegans motility (+7.5%) and locomotion, and yields high antioxidative capacities (ORAC: 819 trolox equivalent). Clinical data, obtained from 24 overweight and 25 obese women (mean: 47.5 years), demonstrated a reduced body weight (P = .042) and body fat (P = .044), and by trend reduced leptin levels (P = .065) in women with obesity after Santa herba consumption compared to placebo. In conclusion, Santa herba extract has energizing and antioxidative properties and may aid in weight management of people with obesity. ClinicalTrials.gov Identifier: NCT03853603.
C1 [Modinger, Yvonne; Schon, Christiane] BioTeSys GmbH, Baden Baden, Germany.
   [Wilhelm, Manfred] Ulm Univ Appl Sci, Dept Math Nat & Econ Sci, Baden Baden, Germany.
   [Pickel, Christina; Grothe, Torsten] Mibelle Grp Biochem, Bolimattstr 1, CH-5033 Buchs, Aargau, Switzerland.
RP Grothe, T (corresponding author), Mibelle Grp Biochem, Bolimattstr 1, CH-5033 Buchs, Aargau, Switzerland.
EM torsten.grothe@mibellegroup.com
CR Bean LJ, 1972, TEMALPAKH: CAHUILLA INDIAN KNOWLEDGE AND USAGE OF PLANTS, V0, P0
   Bertoia ML, 2016, BMJ-BRIT MED J, V352, P0, DOI 10.1136/bmj.i17
   Bucolo C, 2012, BIOCHEM PHARMACOL, V84, P88, DOI 10.1016/j.bcp.2012.03.019
   Castro JP, 2016, BIOL CHEM, V397, P709, DOI 10.1515/hsz-2015-0305
   Dallas C, 2014, PHYTOTHER RES, V28, P212, DOI 10.1002/ptr.4981
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Eisenstein A, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21207470
   El Yacoubi M, 2000, BRIT J PHARMACOL, V129, P1465, DOI 10.1038/sj.bjp.0703170
   Farzaei MH, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20194957
   Fischer W, 2019, REDOX BIOL, V21, P0, DOI 10.1016/j.redox.2018.101089
   FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x
   Habtemariam S, 2012, PHARM BIOL, V50, P1519, DOI 10.3109/13880209.2012.688838
   Hofmann J, 2020, CHEM-EUR J, V26, P7299, DOI 10.1002/chem.202001264
   Hossain MK, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17040569
   Hunot C, 2016, APPETITE, V105, P356, DOI 10.1016/j.appet.2016.05.024
   Kwon EY, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20051227
   Ley JP, 2005, J AGR FOOD CHEM, V53, P6061, DOI 10.1021/jf0505170
   Marranzano M, 2018, INT J FOOD SCI NUTR, V69, P1020, DOI 10.1080/09637486.2018.1452900
   Marseglia L, 2015, INT J MOL SCI, V16, P378, DOI 10.3390/ijms16010378
   Maslov LN, 2019, J CLIN TRANSL ENDOCR, V15, P1, DOI 10.1016/j.jcte.2018.11.001
   Mokdad-Bzeouich I, 2016, CELL STRESS CHAPERON, V21, P773, DOI 10.1007/s12192-016-0702-8
   Moore M, 2003, MEDICINAL PLANTS OF THE MOUNTAIN WEST, V0, P0
   Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002
   Park SJ, 2020, J MED FOOD, V23, P335, DOI 10.1089/jmf.2019.4649
   Parrinello CM, 2015, AM HEART J, V170, P380, DOI 10.1016/j.ahj.2015.04.017
   Shi XP, 2012, MOLECULES, V17, P12868, DOI 10.3390/molecules171112868
   Testa R, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8050310
   Timbrook Janice, 2007, CHUMASH ETHNOBOTANY, V0, P0
   Urushihata T, 2016, BIOSCI BIOTECH BIOCH, V80, P1990, DOI 10.1080/09168451.2016.1191327
   Varani K, 1996, BRIT J PHARMACOL, V117, P1693, DOI 10.1111/j.1476-5381.1996.tb15341.x
   Vernarelli JA, 2017, NUTR DIABETES, V7, P0, DOI 10.1038/nutd.2017.22
   Yamashita M, 2016, J NUTR SCI VITAMINOL, V62, P249, DOI 10.3177/jnsv.62.249
   Zhao BB, 2003, J NEUROSCI, V23, P5319
NR 33
TC 5
Z9 5
U1 2
U2 13
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-620X
EI 1557-7600
J9 J MED FOOD
JI J. Med. Food
PD NOV 1
PY 2021
VL 24
IS 11
BP 1235
EP 1242
DI 10.1089/jmf.2021.0016
EA JUL 2021
PG 8
WC Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics
SC Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics
GA A4BH6
UT WOS:000672883900001
PM 34255555
DA 2025-04-28
ER

PT J
AU Choi, M
   Mukherjee, S
   Yun, JW
AF Choi, Minji
   Mukherjee, Sulagna
   Yun, Jong Won
TI Trigonelline induces browning in3T3-L1white adipocytes
SO PHYTOTHERAPY RESEARCH
LA English
DT Article
DE anti-obesity; beige adipocyte; fat browning; obesity; trigonelline
ID nicotinic-acid; white fat; lipid-accumulation; natural-products; niacin; coffee; differentiation; energy; assay
AB Trigonelline, a major alkaloid component of fenugreek, has been demonstrated to have several biological activities, including antidiabetic and anticancer effects. This study aimed to examine the possible application of trigonelline as an anti-obesity compound based on an investigation of its enhancement of lipid catabolism and induction of browning in white adipocytes. Trigonelline induces browning of 3T3-L1 white adipocytes by enhancing the expressions of brown-fat signature proteins and genes as well as beige-specific genes, includingCd137,Cited1,Tbx1, andTmem26. Trigonelline also improves lipid metabolism in white adipocytes by decreasing adipogenesis and lipogenesis as well as promotes lipolysis and fatty acid oxidation. Moreover, trigonelline increases the expression ofCox4,Nrf1, andTfamgenes that are responsible for mitochondrial biogenesis. Mechanistic studies revealed that the browning effect of trigonelline in 3T3-L1 white adipocytes is mediated by activating beta 3-AR and inhibiting PDE4, thereby stimulating the p38 MAPK/ATF-2 signaling pathway. Considering its high bioavailability in humans and the results of this study, trigonelline may have potential as an anti-obesity compound.
C1 [Choi, Minji; Mukherjee, Sulagna; Yun, Jong Won] Daegu Univ, Dept Biotechnol, Gyongsan 38453, Gyeongbuk, South Korea.
C3 Daegu University
RP Yun, JW (corresponding author), Daegu Univ, Dept Biotechnol, Gyongsan 38453, Gyeongbuk, South Korea.
EM jwyun@daegu.ac.kr
FU National Research Foundation of Korea [2019R1A2C2002163]
CR Allred KF, 2009, J NUTR, V139, P1833, DOI 10.3945/jn.109.108001
   Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378
   Azhar Y, 2016, NUTR METAB, V13, P0, DOI 10.1186/s12986-016-0150-6
   Cheng ZX, 2013, CHIN J NAT MEDICINES, V11, P164, DOI 10.1016/S1875-5364(13)60044-8
   Christian M, 2017, ENDOCRIONOLOGIST, V126, P15
   Concha F, 2019, REV ENDOCR METAB DIS, V20, P161, DOI 10.1007/s11154-019-09495-y
   Costa MC, 2020, J NUTR BIOCHEM, V76, P0, DOI 10.1016/j.jnutbio.2019.108303
   de Jong JMA, 2017, AM J PHYSIOL-ENDOC M, V312, PE508, DOI 10.1152/ajpendo.00437.2016
   GRANNEMAN JG, 1995, CELL SIGNAL, V7, P9, DOI 10.1016/0898-6568(94)00066-K
   Heinrich M, 2020, J ETHNOPHARMACOL, V246, P0, DOI 10.1016/j.jep.2019.112230
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hirakawa N, 2005, BIOSCI BIOTECH BIOCH, V69, P653, DOI 10.1271/bbb.69.653
   Ilavenil S, 2014, PHYTOMEDICINE, V21, P758, DOI 10.1016/j.phymed.2013.11.007
   Izzo AA, 2020, BRIT J PHARMACOL, V177, P2169, DOI 10.1111/bph.15054
   Jang MH, 2020, EUR J NUTR, V59, P3503, DOI 10.1007/s00394-020-02184-6
   Jang MH, 2018, BIOTECHNOL BIOPROC E, V23, P617, DOI 10.1007/s12257-018-0434-y
   Jeremic N, 2017, J CELL PHYSIOL, V232, P61, DOI 10.1002/jcp.25450
   Jiang YW, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.30329
   Kang NH, 2020, PFLUG ARCH EUR J PHY, V472, P583, DOI 10.1007/s00424-020-02380-7
   Li D, 2010, WORLD J GASTROENTERO, V16, P2378, DOI 10.3748/wjg.v16.i19.2378
   Mele L, 2017, ADV NUTR, V8, P694, DOI 10.3945/an.117.015792
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mukherjee S, 2020, BIOTECHNOL BIOPROC E, V25, P29, DOI 10.1007/s12257-020-0023-8
   Mushtaq S, 2018, EXCLI J, V17, P420, DOI 10.17179/excli2018-1174
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI 10.3233/BIO-2009-1083
   Petropoulos GA, 2002, MED AROM PLANTS, V11, P1
   Sharma L, 2018, FOOD CHEM TOXICOL, V121, P283, DOI 10.1016/j.fct.2018.09.011
   Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362
   Silvester AJ, 2019, J NUTR BIOCHEM, V64, P1, DOI 10.1016/j.jnutbio.2018.09.028
   Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5
   Subramanian SP, 2014, BIOMED. PREVEN. NUTRIT, V4, P475, DOI 10.1016/j.bionut.2014.07.001
   Trugo L C, 2003, ENCYCLOPEDIA OF FOOD SCIENCES AND NUTRITION, V3, P1498
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Wanders D, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0071285
   Ye LY, 2019, FASEB J, V33, P4765, DOI 10.1096/fj.201801951R
   Yoshinari O, 2010, CURR MED CHEM, V17, P2196, DOI 10.2174/092986710791299902
   Yoshinari O, 2009, BIOSCI BIOTECH BIOCH, V73, P1033, DOI 10.1271/bbb.80805
   Zeman M, 2015, MED SCI MONITOR, V21, P2156, DOI 10.12659/MSM.893619
   Zhang DF, 2015, ASIAN PAC J TROP MED, V8, P639, DOI 10.1016/j.apjtm.2015.07.012
   Zhang JM, 2018, PHYSIOL RES, V67, P347, DOI 10.33549/physiolres.933650
   Zhang X, 2018, CELL REP, V24, P3180, DOI 10.1016/j.celrep.2018.08.055
   Zhou J, 2012, CURR MED CHEM, V19, P3523, DOI 10.2174/092986712801323171
   Zhou JY, 2012, EVID-BASED COMPL ALT, V2012, P0, DOI 10.1155/2012/164219
   Zhou JY, 2013, FUND CLIN PHARMACOL, V27, P279, DOI 10.1111/j.1472-8206.2011.01022.x
NR 44
TC 39
Z9 42
U1 3
U2 44
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD FEB 15
PY 2021
VL 35
IS 2
BP 1113
EP 1124
DI 10.1002/ptr.6892
EA OCT 2020
PG 12
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA QL6VR
UT WOS:000574896200001
PM 33015893
DA 2025-04-28
ER

PT J
AU Marty, L
   Evans, R
   Sheen, F
   Humphreys, G
   Jones, A
   Boyland, E
   Robinson, E
AF Marty, Lucile
   Evans, Rebecca
   Sheen, Florence
   Humphreys, Gabrielle
   Jones, Andrew
   Boyland, Emma
   Robinson, Eric
TI The energy and nutritional content of snacks sold at supermarkets and coffee shops in the UK
SO JOURNAL OF HUMAN NUTRITION AND DIETETICS
LA English
DT Article
DE coffee shop; energy content; nutritional quality; snacking; supermarket
ID dietary-intake; obesity; meal; behaviors; density; costs
AB Background Snacking is associated with a higher daily energy intake and dietary guidelines recommend snacks of no more than 200 kcal for adults and 100 kcal for children. The present study examines the energy content, nutritional quality and price of single-serving snack food products sold by major supermarket and coffee shop chains in the UK. Methods Energy content, nutritional content and price of single-serving snack products were recorded in 2019 via the websites of 14 major chains (seven supermarkets; seven coffee shops). Results The mean energy content of all eligible snack products (n = 2283) was 186 kcal [95% confidence interval (CI) = 182-190]. The mean energy content of the snack products sold at coffee shops (n = 379; 282 kcal [95% CI = 269-295]) was significantly higher than the energy content of the snack products sold at supermarkets (n = 1904; 167 kcal [95% CI = 164-170]). Seventy nine % of supermarket snacks exceeded energy recommendations for children and 32% for adults. In coffee shops, 91% exceeded recommendations for children and 73% for adults. Forty one % of snacks were high in fat, 42% were high in saturated fat, 39% were high in sugar and 7% were high in salt. Cheaper snack products were more likely to be of lower nutritional quality. Conclusions The high proportion of snack products that do not meet public health recommendations for energy content may contribute to the association between snacking and increased energy intake. Public health measures to increase the availability and reduce the price of snack products that meet public health energy content recommendations may reduce population-level obesity.
C1 [Marty, Lucile; Evans, Rebecca; Sheen, Florence; Humphreys, Gabrielle; Jones, Andrew; Boyland, Emma; Robinson, Eric] Univ Liverpool, Dept Psychol, Eleanor Rathbone Bldg,Bedford St South, Liverpool L69 7ZA, Merseyside, England.
C3 University of Liverpool
RP Marty, L; Robinson, E (corresponding author), Univ Liverpool, Dept Psychol, Eleanor Rathbone Bldg,Bedford St South, Liverpool L69 7ZA, Merseyside, England.
EM lucile.marty@liv.ac.uk; eric.robinson@liv.ac.uk
CR Adams J, 2015, INT J BEHAV NUTR PHY, V12, P0, DOI 10.1186/s12966-015-0210-8
   Amies-Cull B, 2019, BMJ-BRIT MED J, V365, P0, DOI 10.1136/bmj.l1417
   Unknown -, 2020, PUBLIC HEALTH ENGLAND BEYOND THE DATA: UNDERSTANDING THE IMPACT OF COVID 19 ON BAME GROUPS, V0, P0
   Unknown -, 2015, SUGAR REDUCTION: FROM EVIDENCE TO ACTION, V0, P0
   Unknown -, 2017, SALT REDUCTION TARGETS FOR 2017, V0, P0
   Unknown -, 2018, SUGAR REDUCTION AND WIDER REFORMULATION PROGRAMME: PROGRESS REPORT TOWARDS 5% AND NEXT STEPS, V0, P0
   Askew K, 2019, FOOD NAVIGATOR, V0, P0
   Casazza K, 2015, CRIT REV FOOD SCI, V55, P2014, DOI 10.1080/10408398.2014.922044
   Chamontin A, 2003, APPETITE, V41, P21, DOI 10.1016/S0195-6663(03)00036-9
   Department of Health, 2016, GUIDE TO CREATING A FRONT OF PACK (FOP) NUTRITION LABEL FOR PRE-PACKED PRODUCTS SOLD THROUGH RETAIL OUTLETS, V0, P0
   Drewnowski A, 2005, J NUTR, V135, P900, DOI 10.1093/jn/135.4.900
   Drewnowski A, 2004, AM J CLIN NUTR, V79, P6
   Duffey KJ, 2013, EUR J CLIN NUTR, V67, P868, DOI 10.1038/ejcn.2013.60
   French SA, 2003, J NUTR, V133, P841S, DOI 10.1093/jn/133.3.841S
   Green H, 2017, JOURNAL OF NUTRITION & INTERMEDIARY METABOLISM, V9, P1, DOI 10.1016/j.jnim.2017.07.001
   Hassen WS, 2018, NUTR J, V17, P0, DOI 10.1186/s12937-018-0336-z
   Hollands GJ, 2019, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD012573.pub3
   Jumpertz R, 2013, OBESITY, V21, P164, DOI 10.1002/oby.20185
   Kant AK, 2018, PHYSIOL BEHAV, V193, P270, DOI 10.1016/j.physbeh.2018.03.022
   Kant AK, 2015, J ACAD NUTR DIET, V115, P50, DOI 10.1016/j.jand.2014.06.354
   Kantar Worldpanel, 2019, GROCERY MARKET SHARE, V0, P0
   Kerver JM, 2006, J AM DIET ASSOC, V106, P46, DOI 10.1016/j.jada.2005.09.045
   Larson NI, 2016, J NUTR, V146, P1348, DOI 10.3945/jn.116.230334
   Maillot M, 2007, J NUTR, V137, P1815, DOI 10.1093/jn/137.7.1815
   Marshall D, 2003, FOOD QUAL PREFER, V14, P53, DOI 10.1016/S0950-3293(02)00015-0
   Marty L, 2020, INT J BEHAV NUTR PHY, V17, P0, DOI 10.1186/s12966-020-0922-2
   Muc M, 2019, BMJ OPEN, V9, P0, DOI 10.1136/bmjopen-2019-029679
   Murakami K, 2017, NUTR J, V16, P0, DOI 10.1186/s12937-017-0283-0
   Murakami K, 2016, BRIT J NUTR, V116, P1479, DOI 10.1017/S0007114516003573
   Ng M, 2014, LANCET, V384, P746
   Ovaskainen ML, 2006, EUR J CLIN NUTR, V60, P494, DOI 10.1038/sj.ejcn.1602343
   Piernas C, 2010, J NUTR, V140, P325, DOI 10.3945/jn.109.112763
   Robinson E, 2019, BMC PUBLIC HEALTH, V19, P0, DOI 10.1186/s12889-019-7017-5
   Robinson E, 2018, BMJ-BRIT MED J, V363, P0, DOI 10.1136/bmj.k4982
   Statista, 2019, MARKET SHARE GROCERY, V0, P0
   Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595
   Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1
   Theis DRZ, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0222773
   Vandevijvere S, 2015, B WORLD HEALTH ORGAN, V93, P446, DOI 10.2471/BLT.14.150565
   Wadhera D, 2012, APPETITE, V58, P882, DOI 10.1016/j.appet.2012.02.006
NR 40
TC 4
Z9 4
U1 2
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0952-3871
EI 1365-277X
J9 J HUM NUTR DIET
JI J. Hum. Nutr. Diet.
PD DEC 15
PY 2021
VL 34
IS 6
BP 1035
EP 1041
DI 10.1111/jhn.12880
EA APR 2021
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA WX8YQ
UT WOS:000643743900001
PM 33899984
DA 2025-04-28
ER

PT J
AU Ghattamaneni, NKR
   Brown, L
AF Ghattamaneni, Naga K. R.
   Brown, Lindsay
TI Functional foods from the tropics to relieve chronic normobaric hypoxia
SO RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
LA English
DT Article
DE Obesity; Inflammatory bowel disease; Chronic hypoxia; Tropical foods
ID induced metabolic syndrome; sodium-induced colitis; inflammatory-bowel-disease; jaboticaba peel powder; high-carbohydrate; antioxidant activity; chlorogenic acid; insulin-resistance; inducible factor; adipose-tissue
AB Functional foods with antioxidant and anti-inflammatory properties are regarded as a complementary therapy to improve chronic diseases such as obesity and inflammatory bowel disease (IBD). Obesity is a chronic low-grade inflammatory state leading to organ damage with increased risk of common diseases including cardiovascular and metabolic disease, non-alcoholic fatty liver disease, osteoarthritis and some cancers. IBD is a chronic intestinal inflammation categorised as Crohn's disease and ulcerative colitis depending on the location of inflammation. These inflammatory states are characterised by normobaric hypoxia in adipose and intestinal tissues, respectively. Tropical foods especially from Australia and South America are discussed in this review to show their potential in attenuation of these chronic diseases. The phytochemicals from these foods have antioxidant and anti-inflammatory activities to reduce chronic normobaric hypoxia in the tissues. These health benefits of the tropical foods are relevant not only for health economy but also in providing a global solution by improving the sustainability of their cultivation and assisting the local economies.
C1 [Ghattamaneni, Naga K. R.; Brown, Lindsay] Univ Southern Queensland, Funct Foods Res Grp, Ipswich, Qld 4305, Australia.
   [Ghattamaneni, Naga K. R.; Brown, Lindsay] Univ Southern Queensland, Sch Hlth & Wellbeing, Ipswich, Qld 4305, Australia.
C3 University of Southern Queensland; University of Southern Queensland
RP Brown, L (corresponding author), Univ Southern Queensland, Sch Hlth & Wellbeing, Ipswich, Qld 4305, Australia.
EM lindsaybrown1952@gmail.com
CR Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
   Ahluwalia B, 2018, SCAND J GASTROENTERO, V53, P379, DOI 10.1080/00365521.2018.1447597
   Alam MA, 2014, ADV NUTR, V5, P404, DOI 10.3945/an.113.005603
   Alam MA, 2013, NUTRIENTS, V5, P637, DOI 10.3390/nu5030637
   Arias-Reyes C, 2020, RESP PHYSIOL NEUROBI, V277, P0, DOI 10.1016/j.resp.2020.103443
   Azuma T, 2013, J NUTR, V143, P827, DOI 10.3945/jn.113.174508
   Bagattoli PCD, 2016, INDIAN J PHARM SCI, V78, P34, DOI 10.4103/0250-474X.180239
   Barreca D, 2017, BIOFACTORS, V43, P495, DOI 10.1002/biof.1363
   Barthel C, 2015, NUTR J, V14, P0, DOI 10.1186/s12937-015-0070-8
   Bhandarkar NS, 2020, FASEB J, V34, P4783, DOI 10.1096/fj.201902416RR
   Bhandarkar NS, 2019, J FUNCT FOODS, V57, P141, DOI 10.1016/j.jff.2019.04.003
   Bhandarkar NS, 2019, NUTR RES, V62, P78, DOI 10.1016/j.nutres.2018.11.002
   Bhaswant M, 2019, J FUNCT FOODS, V56, P119, DOI 10.1016/j.jff.2019.03.011
   Bhaswant M, 2015, PHARMACOL RES, V102, P208, DOI 10.1016/j.phrs.2015.10.006
   Mariano LNB, 2016, PHARM BIOL, V54, P1697, DOI 10.3109/13880209.2015.1123279
   Bonacorsi C, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/851621
   Brown E, 2018, J PHYSIOL-LONDON, V596, P2985, DOI 10.1113/JP274350
   Brown L, 2015, OBES REV, V16, P914, DOI 10.1111/obr.12313
   Bumrungpert A, 2010, J NUTR, V140, P842, DOI 10.3945/jn.109.120022
   Burke AC, 2018, J LIPID RES, V59, P1714, DOI 10.1194/jlr.M087387
   Moura MHC, 2018, FOOD RES INT, V107, P48, DOI 10.1016/j.foodres.2018.01.071
   Carvalho DV, 2019, FOOD FUNCT, V10, P1671, DOI 10.1039/C8FO01575A
   Cazarin CBB, 2014, EXP BIOL MED, V239, P542, DOI 10.1177/1535370214525306
   Chae HS, 2017, J MED FOOD, V20, P727, DOI 10.1089/jmf.2017.3944
   Chaen Y, 2019, NUTR RES, V64, P82, DOI 10.1016/j.nutres.2019.01.004
   Chen PS, 2020, J BIOMED SCI, V27, P0, DOI 10.1186/s12929-020-00658-7
   Chowdhury R, 2012, CHEM RES TOXICOL, V25, P2194, DOI 10.1021/tx300274a
   Com√≠n-Anduix B, 2002, J BIOL CHEM, V277, P46408, DOI 10.1074/jbc.M206150200
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   da Silva-Maia JK, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11112776
   De Leo M, 2020, PLANTA MED, V86, P180, DOI 10.1055/a-1070-9325
   de Rosso VV, 2008, J FOOD COMPOS ANAL, V21, P291, DOI 10.1016/j.jfca.2008.01.001
   Dias FM, 2014, LIPIDS HEALTH DIS, V13, P0, DOI 10.1186/1476-511X-13-24
   Dragano NRV, 2013, BRIT J NUTR, V110, P447, DOI 10.1017/S0007114512005090
   du Preez R, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12040931
   Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283
   Espey MG, 2013, FREE RADICAL BIO MED, V55, P130, DOI 10.1016/j.freeradbiomed.2012.10.554
   Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3
   Fang HY, 2012, FOOD CHEM TOXICOL, V50, P4042, DOI 10.1016/j.fct.2012.08.037
   Fanning KJ, 2014, J SCI FOOD AGR, V94, P2137, DOI 10.1002/jsfa.6591
   Fl√ºck K, 2016, MUCOSAL IMMUNOL, V9, P379, DOI 10.1038/mi.2015.67
   Garcia JC, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0113510
   Garz√≥n GA, 2009, J FOOD SCI, V74, PC227, DOI 10.1111/j.1750-3841.2009.01092.x
   Geserick M, 2018, NEW ENGL J MED, V379, P1303, DOI 10.1056/NEJMoa1803527
   Ghattamaneni NKR, 2020, EUR J NUTR, V59, P2905, DOI 10.1007/s00394-019-02130-1
   Ghattamaneni NKR, 2019, J FUNCT FOODS, V56, P194, DOI 10.1016/j.jff.2019.01.028
   Ghattamaneni NKR, 2019, PHARMACOL REP, V71, P149, DOI 10.1016/j.pharep.2018.10.006
   Glover LE, 2017, ANN AM THORAC SOC, V14, PS233, DOI 10.1513/AnnalsATS.201608-610MG
   Goossens GH, 2012, CURR OPIN CLIN NUTR, V15, P539, DOI 10.1097/MCO.0b013e328358fa87
   Gutierrez-Orozco F, 2014, MOL NUTR FOOD RES, V58, P1226, DOI 10.1002/mnfr.201300771
   Gutierrez-Orozco F, 2013, J AGR FOOD CHEM, V61, P3891, DOI 10.1021/jf4004434
   Hellwig-B√ºrgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567
   Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009
   Impellizzeri D, 2015, CLIN NUTR, V34, P1146, DOI 10.1016/j.clnu.2014.11.012
   International Coffee Organization, 2020, TOTAL PRODUCTION BY ALL EXPORTING COUNTRIES (IN THOUSAND 60 KG BAGS), V0, P0
   John OD, 2020, FOOD FUNCT, V11, P6946, DOI 10.1039/D0FO01133A
   John OD, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21010272
   John OD, 2019, J FUNCT FOODS, V56, P204, DOI 10.1016/j.jff.2019.03.018
   John OD, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10101425
   Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108
   Karczewski J, 2018, EUR CYTOKINE NETW, V29, P83, DOI 10.1684/ecn.2018.0415
   Ke ZL, 2020, J NUTR BIOCHEM, V83, P0, DOI 10.1016/j.jnutbio.2020.108426
   Khamthong N, 2017, NAT PROD COMMUN, V12, P453
   Kim DH, 2015, INT J ONCOL, V47, P2226, DOI 10.3892/ijo.2015.3200
   Konczak I, 2009, HEALTH BENEFITS OF AUSTRALIAN NATIVE FOODS: AN EVALUATION OF HEALTH-ENHANCING PROPERTIES, V0, P0
   Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130
   Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012
   Lenquiste SA, 2019, FOOD RES INT, V120, P880, DOI 10.1016/j.foodres.2018.11.053
   Li QY, 2015, EUR J PHARMACOL, V751, P81, DOI 10.1016/j.ejphar.2015.01.046
   Lim V, 2020, METABOLITES, V10, P0, DOI 10.3390/metabo10030114
   Lisk C, 2013, FREE RADICAL BIO MED, V63, P264, DOI 10.1016/j.freeradbiomed.2013.05.024
   Liu CQ, 2015, CANCER LETT, V362, P8, DOI 10.1016/j.canlet.2015.03.019
   Losso JN, 2005, J AGR FOOD CHEM, V53, P3751, DOI 10.1021/jf0479719
   Lu Y, 2018, BRIT J PHARMACOL, V175, P1085, DOI 10.1111/bph.14150
   Magee EA, 2005, NUTR J, V4, P0, DOI 10.1186/1475-2891-4-7
   Matafome P, 2015, CURR MED CHEM, V22, P2417, DOI 10.2174/0929867322666150209155633
   McGarry T, 2018, FREE RADICAL BIO MED, V125, P15, DOI 10.1016/j.freeradbiomed.2018.03.042
   Mehl F, 2014, FOOD CHEM, V143, P325, DOI 10.1016/j.foodchem.2013.07.125
   Morrow NM, 2020, J LIPID RES, V61, P387, DOI 10.1194/jlr.RA119000542
   Musumeci L, 2020, NAT PROD RES, V34, P122, DOI 10.1080/14786419.2019.1601196
   Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501
   Nangaku M, 2008, CHINESE MED J-PEKING, V121, P257
   Netzel M, 2006, J AGR FOOD CHEM, V54, P9820, DOI 10.1021/jf0622735
   Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0
   ONeil CE, 2012, NUTR J, V11, P0, DOI 10.1186/1475-2891-11-107
   Omidi-Ardali H, 2019, INFLAMMOPHARMACOLOGY, V27, P1265, DOI 10.1007/s10787-019-00581-w
   Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013
   Panchal SK, 2012, J NUTR, V142, P1026, DOI 10.3945/jn.111.157263
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Panchal SK, 2011, J NUTR, V141, P1062, DOI 10.3945/jn.111.137877
   Panchal SK, 2011, J CARDIOVASC PHARM, V57, P51, DOI 10.1097/FJC.0b013e3181feb90a
   Panelli MF, 2018, ANTIOXIDANTS-BASEL, V7, P0, DOI 10.3390/antiox7090120
   Parhiz H, 2015, PHYTOTHER RES, V29, P323, DOI 10.1002/ptr.5256
   Pierson JT, 2012, MOL NUTR FOOD RES, V56, P357, DOI 10.1002/mnfr.201100441
   Poole R, 2017, BMJ-BRIT MED J, V359, P0, DOI 10.1136/bmj.j5024
   Rajendran P, 2014, CLIN CHIM ACTA, V436, P332, DOI 10.1016/j.cca.2014.06.004
   Rangel-Huerta OD, 2015, J NUTR, V145, P1808, DOI 10.3945/jn.115.213660
   Richard NA, 2012, AVIAT SPACE ENVIR MD, V83, P677, DOI 10.3357/ASEM.3182.2012
   San Martin R, 2017, OBESITY FACTS, V10, P363, DOI 10.1159/000477461
   Sato M, 2019, J NUTR SCI VITAMINOL, V65, P19, DOI 10.3177/jnsv.65.19
   Shah Yatrik M, 2016, MOL CELL PEDIATR, V3, P1, DOI 10.1186/s40348-016-0030-1
   Shin HS, 2015, FOOD CHEM, V168, P167, DOI 10.1016/j.foodchem.2014.06.100
   Siracusa R, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12030834
   Stiehl DP, 2002, FEBS LETT, V512, P157, DOI 10.1016/S0014-5793(02)02247-0
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Teixeira N, 2019, FOOD RES INT, V119, P325, DOI 10.1016/j.foodres.2019.01.058
   Terrazas PM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0076485
   Titto M, 2020, RESP PHYSIOL NEUROBI, V274, P0, DOI 10.1016/j.resp.2019.103336
   Treml B, 2020, INT J ENV RES PUB HE, V17, P0, DOI 10.3390/ijerph17145239
   Tsai ML, 2014, MOL NUTR FOOD RES, V58, P1820, DOI 10.1002/mnfr.201400149
   Villafuerte FC, 2016, HIGH ALT MED BIOL, V17, P61, DOI 10.1089/ham.2016.0031
   Vukelic I, 2018, FOOD CHEM TOXICOL, V121, P140, DOI 10.1016/j.fct.2018.08.061
   Ward ZJ, 2019, NEW ENGL J MED, V381, P2440, DOI 10.1056/NEJMsa1909301
   West JB, 2017, NEW ENGL J MED, V376, P1965, DOI 10.1056/NEJMra1612008
   Wilkins MR, 2015, CIRCULATION, V131, P582, DOI 10.1161/CIRCULATIONAHA.114.006977
   Wright EK, 2018, MED J AUSTRALIA, V209, P318, DOI 10.5694/mja17.01001
   Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010
   Yang YH, 2019, MEDICINE, V98, P0, DOI 10.1097/MD.0000000000015795
   Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, PE1118, DOI 10.1152/ajpendo.00435.2007
   Zhang ZR, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9060588
   Zimna A, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/549412
   Zou Z, 2016, FOOD CHEM, V196, P885, DOI 10.1016/j.foodchem.2015.09.072
   Zubieta-Calleja G, 2017, BLDE UNIVERSITY JOURNAL OF HEALTH SCIENCES, V2, P80
NR 123
TC 2
Z9 2
U1 1
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1569-9048
EI 1878-1519
J9 RESP PHYSIOL NEUROBI
JI Respir. Physiol. Neuro.
PD APR 15
PY 2021
VL 286
IS 
BP 
EP 
DI 10.1016/j.resp.2020.103599
PG 9
WC Physiology; Respiratory System
SC Physiology; Respiratory System
GA TT7CX
UT WOS:000680503600008
PM 33333240
DA 2025-04-28
ER

PT J
AU Basora, J
   Villalobos, F
   Pallej√†-Mill√°n, M
   Babio, N
   Goday, A
   Zome√±o, MD
   Pint√≥, X
   Sacanella, E
   Salas-Salvad√≥, J
AF Basora, Josep
   Villalobos, Felipe
   Palleja-Millan, Meritxell
   Babio, Nancy
   Goday, Albert
   Dolores Zomeno, Maria
   Pinto, Xavier
   Sacanella, Emilio
   Salas-Salvado, Jordi
TI Deprivation Index and Lifestyle: Baseline Cross-Sectional Analysis of the PREDIMED-Plus Catalonia Study
SO NUTRIENTS
LA English
DT Article
DE deprivation index; lifestyle; diet; physical activity
ID physical-activity questionnaire; mediterranean diet adherence; socioeconomic deprivation; patterns; health; associations; population; validation; inequality; validity
AB This baseline cross-sectional analysis from data acquired in a sub-sample of the PREDIMED-Plus study participants aimed to evaluate the relation between the Composite Socioeconomic Index (CSI) and lifestyle (diet and physical activity). This study involved 1512 participants (759 (52.2%) women) between 55 and 80 years with overweight/obesity and metabolic syndrome assigned to 137 primary healthcare centers in Catalonia, Spain. CSI and lifestyle (diet and physical activity) were assessed. Multiple linear regression or multinomial regression were applied to the data. Cluster analysis was performed to identify dietary patterns. The multiple linear regression model showed that a high deprivation index was related to a higher consumption of refined cereals (11.98 g/d, p-value = 0.001) and potatoes (6.68 g/d, p-value = 0.001), and to a lower consumption of fruits (-17.52 g/d, p-value = 0.036), and coffee and tea (-8.03 g/d, p-value = 0.013). Two a posteriori dietary patterns were identified by cluster analysis and labeled as "healthy " and "unhealthy ". In addition, the multinomial regression model showed that a high deprivation index was related to an unhealthy dietary pattern and low physical activity (OR 1.42 [95% CI 1.06-1.89]; p-value < 0.05). In conclusion, a high deprivation index was related to an unhealthy lifestyle (diet and physical activity) in PREDIMED-Plus study participants.</p>
C1 [Basora, Josep] Fundacio Inst Univ Recerca Atencio Primaria Salut, Barcelona 08007, Spain.
   [Basora, Josep; Babio, Nancy; Salas-Salvado, Jordi] Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Unitat Nutr Humana, Reus 43201, Spain.
   [Basora, Josep; Babio, Nancy; Goday, Albert; Dolores Zomeno, Maria; Pinto, Xavier; Sacanella, Emilio; Salas-Salvado, Jordi] Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid 28029, Spain.
   [Villalobos, Felipe; Palleja-Millan, Meritxell] Fundacio Inst Univ Recerca Atencio Primaria Salut, Unitat Suport Recerca Tarragona Reus, Reus 43202, Spain.
   [Babio, Nancy; Salas-Salvado, Jordi] Hosp Univ San Joan Reus, Inst Invest Sanitaria Pere & Virgili IISPV, Reus 43204, Spain.
   [Goday, Albert] Hosp Mar, Serv Endocrinol, Barcelona 08003, Spain.
   [Goday, Albert; Dolores Zomeno, Maria] Hosp Mar Med Res Inst IMIM, Cardiovasc Risk & Nutr Res Grp, Barcelona 08003, Spain.
   [Goday, Albert] Univ Autonoma Barcelona, Dept Med, Barcelona 08193, Spain.
   [Dolores Zomeno, Maria] Univ Ramon Llull, Nutr Humana & Dietet, Fac Ciencies Salut Blanquerna, Barcelona 08022, Spain.
   [Pinto, Xavier] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Internal Med, Lipid Unit, Lhospitalet De Llobregat 08908, Spain.
   [Sacanella, Emilio] Hosp Clin Barcelona, Dept Internal Med, Barcelona 08036, Spain.
   [Sacanella, Emilio] Univ Barcelona, Sch Med, Barcelona 08036, Spain.
C3 Universitat Rovira i Virgili; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Hospital del Mar Research Institute; Hospital del Mar; Hospital del Mar Research Institute; Hospital del Mar; Autonomous University of Barcelona; Universitat Ramon Llull; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona
RP Basora, J (corresponding author), Fundacio Inst Univ Recerca Atencio Primaria Salut, Barcelona 08007, Spain.; Basora, J; Babio, N (corresponding author), Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Unitat Nutr Humana, Reus 43201, Spain.; Basora, J; Babio, N (corresponding author), Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid 28029, Spain.; Babio, N (corresponding author), Hosp Univ San Joan Reus, Inst Invest Sanitaria Pere & Virgili IISPV, Reus 43204, Spain.
EM jbasora@idiapjgol.org; fvillalobos@idiapjgol.info; mpalleja@idiapjgol.info; nancy.babio@urv.cat; agoday@parcdesalutmar.cat; mzomeno@imim.es; xpinto@bellvitgehospital.cat; esacane@clinic.cat; jordi.salas@urv.cat
FU Strategic Plan of Research and Innovation in Health (PERIS) [P17/084]; official Spanish Institutions for funding scientific biomedical research; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERObn); Instituto de Salud Carlos III (ISCIII); Fondo de Investigacion para la Salud (FIS) [PI13/01123, PI17/00215, PI13/00233, PI13/02184, PI14/00728, PI16/01094, PI16/00501, PI16/00381, PI19/01226, P119/00017, PI19/00576, PI19/01032, PI20/00339]; Especial Action Project entitled Implementacion y evaluacion de una intervencion intensiva sobre la actividad fisica; European Research Council [340918]; Recercaixa [2013ACUP00194]; ICREA
CR Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8
   Algren MH, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0139297
   Beaulac J, 2009, PREV CHRONIC DIS, V6, P0
   Beck KL, 2018, EUR J NUTR, V57, P1421, DOI 10.1007/s00394-017-1421-3
   Black JL, 2008, NUTR REV, V66, P2, DOI 10.1111/j.1753-4887.2007.00001.x
   CARSTAIRS V R M, 1990, HEALTH BULLETIN (EDINBURGH), V48, P162
   Caspi CE, 2012, HEALTH PLACE, V18, P1172, DOI 10.1016/j.healthplace.2012.05.006
   Chastin SFM, 2015, INT J BEHAV NUTR PHY, V12, P0, DOI 10.1186/s12966-015-0292-3
   Cipri√°n D, 2013, NUTR HOSP, V28, P1741, DOI 10.3305/nh.2013.28.5.6758
   COCKERHAM WC, 1993, SOCIOL QUART, V34, P413, DOI 10.1111/j.1533-8525.1993.tb00119.x
   Colls C, 2020, GAC SANIT, V34, P44, DOI 10.1016/j.gaceta.2018.07.015
   Contoyannis P, 2004, J HEALTH ECON, V23, P965, DOI 10.1016/j.jhealeco.2004.02.001
   Darin-Mattsson A, 2017, INT J EQUITY HEALTH, V16, P0, DOI 10.1186/s12939-017-0670-3
   Ek S, 2015, HEALTH PROMOT INT, V30, P736, DOI 10.1093/heapro/dat063
   ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966
   Elosua R, 2000, MED SCI SPORT EXER, V32, P1431, DOI 10.1097/00005768-200008000-00011
   Fern√°ndez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837
   Foster HME, 2018, LANCET PUBLIC HEALTH, V3, PE576, DOI 10.1016/S2468-2667(18)30200-7
   Garc√≠a-Alt√©s A, 2018, J EPIDEMIOL COMMUN H, V72, P871, DOI 10.1136/jech-2018-210817
   Groth MV, 2001, EUR J CLIN NUTR, V55, P959, DOI 10.1038/sj.ejcn.1601251
   Guthold R, 2018, LANCET GLOB HEALTH, V6, PE1077, DOI 10.1016/S2214-109X(18)30357-7
   Jones A, 2009, PREV MED, V49, P500, DOI 10.1016/j.ypmed.2009.10.012
   Kesse-Guyot E, 2009, EUR J CLIN NUTR, V63, P521, DOI 10.1038/sj.ejcn.1602978
   Kurotani K, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11092194
   Lachowycz K, 2014, SOC SCI MED, V107, P9, DOI 10.1016/j.socscimed.2014.02.023
   Lakshman R, 2011, J PUBLIC HEALTH-UK, V33, P234, DOI 10.1093/pubmed/fdq072
   Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519
   Maksimov S, 2020, INT J ENV RES PUB HE, V17, P0, DOI 10.3390/ijerph17010328
   Marques-Vidal P, 2018, BMC PUBLIC HEALTH, V18, P0, DOI 10.1186/s12889-018-5045-1
   Martinez-Beneito MA, 2021, INT J ENV RES PUB HE, V18, P0, DOI 10.3390/ijerph18115664
   Mart√≠nez-Gonz√°lez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745
   Mart√≠nez-Gonz√°lez MA, 2019, INT J EPIDEMIOL, V48, P387, DOI 10.1093/ije/dyy225
   Martinez-Lacoba R, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0227620
   Mumme K, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12113425
   Northstone K, 2010, EUR J CLIN NUTR, V64, P978, DOI 10.1038/ejcn.2010.102
   Ochieng Bertha M N, 2006, BR J COMMUNITY NURS, V11, P78
   Papier K, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9111173
   P√©rez-Tepayo S, 2020, NUTR J, V19, P0, DOI 10.1186/s12937-020-00568-2
   S√°nchez-Villegas A, 2003, EUR J CLIN NUTR, V57, P285, DOI 10.1038/sj.ejcn.1601528
   Schr√∂der H, 2021, CLIN NUTR, V40, P4971, DOI 10.1016/j.clnu.2021.06.030
   Schr√∂der H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566
   TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341
   van Lenthe FJ, 2005, SOC SCI MED, V60, P763, DOI 10.1016/j.socscimed.2004.06.013
   Wang J, 2019, INT J ENV RES PUB HE, V16, P0, DOI 10.3390/ijerph16020281
   Wardle J, 2004, ANN BEHAV MED, V27, P107, DOI 10.1207/s15324796abm2702_5
   WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366
   Willett WC, 2013, NUTRITIONAL EPIDEMIOLOGY, V0, P0
   Xiao Q, 2018, PREV MED, V111, P14, DOI 10.1016/j.ypmed.2018.02.011
NR 48
TC 7
Z9 8
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT 15
PY 2021
VL 13
IS 10
BP 
EP 
DI 10.3390/nu13103408
PG 15
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA WN0MO
UT WOS:000711471200001
PM 34684409
DA 2025-04-28
ER

PT J
AU Huang, LC
   Lyu, Q
   Zheng, WY
   Yang, Q
   Cao, G
AF Huang, Lichuang
   Lyu, Qiang
   Zheng, Wanying
   Yang, Qiao
   Cao, Gang
TI Traditional application and modern pharmacological research of Eucommia ulmoides Oliv.
SO CHINESE MEDICINE
LA English
DT Review
ID ovx-induced osteoporosis; neuronal cell-death; antioxidant activity; geniposidic acid; rat plasma; hypolipidemic action; alzheimers-disease; oxidative stress; chlorogenic acid; aldose reductase
AB As a Traditional Chinese Medicine, Eucommia ulmoides Oliv. has been used for the treatment of various diseases since ancient times, involving lumbar pain, knee pain, osteoporosis, hepatoprotection, paralysis, intestinal haemorrhoids, vaginal bleeding, abortion, spermatorrhoea, foot fungus, anti-aging etc. With the developing discovery of E. ulmoides extracts and its active components in various pharmacological activities, E. ulmoides has gained more and more attention. Up to now, E. ulmoides has been revealed to show remarkable therapeutic effects on hypertension, hyperglycemia, diabetes, obesity, osteoporosis, Parkinson's disease, Alzheimer's disease, sexual dysfunction. E. ulmoides has also been reported to possess antioxidant, anti-inflammatory, neuroprotective, anti-fatigue, anti-aging, anti-cancer and immunoregulation activities etc. Along these lines, this review summarizes the traditional application and modern pharmacological research of E. ulmoides, providing novel insights of E. ulmoides in the treatment of various diseases.
C1 [Huang, Lichuang; Lyu, Qiang; Zheng, Wanying; Yang, Qiao; Cao, Gang] Zhejiang Chinese Med Univ, Sch Pharm, 548 Binwen Rd, Hangzhou 310053, Peoples R China.
C3 Zhejiang Chinese Medical University
RP Cao, G (corresponding author), Zhejiang Chinese Med Univ, Sch Pharm, 548 Binwen Rd, Hangzhou 310053, Peoples R China.
EM caogang33@163.com
FU National Natural Science Foundation of China [81973481, 81922073]; Traditional Chinese Medicine Key Scientific Research Fund Project of Zhejiang Province [Q2019J02, 2021ZZ009]; Program of China [2017YFE0191500]
CR Armstrong MJ, 2020, JAMA-J AM MED ASSOC, V323, P548, DOI 10.1001/jama.2019.22360
   Chen SY, 2019, NEUROCHEM RES, V44, P472, DOI 10.1007/s11064-018-2700-y
   Chen YS, 2021, J ETHNOPHARMACOL, V272, P0, DOI 10.1016/j.jep.2021.113920
   Choi MS, 2008, AM J CHINESE MED, V36, P81, DOI 10.1142/S0192415X08005606
   Cuzzocrea S, 2001, PHARMACOL REV, V53, P135
   Dai XP, 2013, FOOD CHEM, V139, P563, DOI 10.1016/j.foodchem.2013.02.006
   Ding YX, 2015, J ASIAN NAT PROD RES, V17, P867, DOI 10.1080/10286020.2015.1039999
   Ding ZJ, 2020, EVID-BASED COMPL ALT, V2020, P0, DOI 10.1155/2020/6432173
   Do MH, 2018, NUTRIENTS, V10, P3
   Dotan Y, 2004, PROG LIPID RES, V43, P200, DOI 10.1016/j.plipres.2003.10.001
   Du KZ, 2020, J SEP SCI, V43, P799, DOI 10.1002/jssc.201900910
   Duan MX, 2019, J PHARMACOL EXP THER, V371, P348, DOI 10.1124/jpet.119.259069
   Fitzgerald KA, 2020, CELL, V180, P1044, DOI 10.1016/j.cell.2020.02.041
   Fu C, 2020, INT IMMUNOPHARMACOL, V84, P0, DOI 10.1016/j.intimp.2020.106547
   Fu H, 2019, EVID-BASED COMPL ALT, V2019, P0, DOI 10.1155/2019/1782953
   Fujikawa T, 2012, J NUTR SCI, V1, P0, DOI 10.1017/jns.2012.12
   Fujikawa T, 2010, BRIT J NUTR, V104, P1868, DOI 10.1017/S0007114510002965
   Fujiwara A, 2016, PHYTOCHEMISTRY, V122, P139, DOI 10.1016/j.phytochem.2015.11.017
   Gao WD, 2020, BIOMED RES INT, V2020, P0, DOI 10.1155/2020/1860637
   Gonz√°lez A, 2020, CELL METAB, V31, P472, DOI 10.1016/j.cmet.2020.01.015
   Gonz√°lez-Muniesa P, 2017, NAT REV DIS PRIMERS, V3, P0, DOI 10.1038/nrdp.2017.34
   Goyal MM, 2010, PROTEIN CELL, V1, P888, DOI 10.1007/s13238-010-0113-z
   Gu JA, 2011, J ETHNOPHARMACOL, V133, P6, DOI 10.1016/j.jep.2010.08.055
   Guo H, 2015, BMC COMPLEM ALTERN M, V15, P0, DOI 10.1186/s12906-015-0675-7
   Ha H, 2003, ARCH PHARM RES, V26, P929, DOI 10.1007/BF02980202
   Habtemariam S, 2018, BIOMEDICINES, V6, P0, DOI 10.3390/biomedicines6020039
   Hao S, 2016, PHARM BIOL, V54, P251, DOI 10.3109/13880209.2015.1029054
   He TF, 2019, MOL MED REP, V20, P1499, DOI 10.3892/mmr.2019.10396
   He XR, 2014, J ETHNOPHARMACOL, V151, P78, DOI 10.1016/j.jep.2013.11.023
   Hirata T, 2011, BIOORG MED CHEM LETT, V21, P1786, DOI 10.1016/j.bmcl.2011.01.060
   Ho JN, 2005, BIOL PHARM BULL, V28, P1244, DOI 10.1248/bpb.28.1244
   Hong YK, 2013, CARBOHYD POLYM, V92, P1761, DOI 10.1016/j.carbpol.2012.11.015
   Horii Y, 2010, NEUROSCI LETT, V479, P181, DOI 10.1016/j.neulet.2010.05.030
   Hsieh CL, 2000, LIFE SCI, V66, P1387, DOI 10.1016/S0024-3205(00)00450-1
   Hu RZ, 2020, J ANIM SCI BIOTECHNO, V11, P0, DOI 10.1186/s40104-020-00492-9
   Hu WC, 2014, CHEM-BIOL INTERACT, V224, P108, DOI 10.1016/j.cbi.2014.10.011
   Hua HM, 2002, J ASIAN NAT PROD RES, V4, P201, DOI 10.1080/10286020290023997
   Huang Q, 2021, NAT PROD RES, V35, P3376, DOI 10.1080/14786419.2019.1700250
   Huang YX, 2014, CHIN J NAT MEDICINES, V12, P469, DOI 10.1016/S1875-5364(14)60073-X
   Hung MY, 2006, FOOD CHEM TOXICOL, V44, P1424, DOI 10.1016/j.fct.2006.03.009
   Hussain T, 2020, TOXICOL IN VITRO, V62, P0, DOI 10.1016/j.tiv.2019.104674
   Jiang S, 2020, J ANIM PHYSIOL AN N, V104, P1085, DOI 10.1111/jpn.13235
   Jin CF, 2013, INT J ENDOCRINOL, V2013, P0, DOI 10.1155/2013/751854
   Jin X, 2010, J ETHNOPHARMACOL, V128, P672, DOI 10.1016/j.jep.2010.02.019
   Jing X, 2015, EVID-BASED COMPL ALT, V2015, P0, DOI 10.1155/2015/987973
   Kim JY, 2015, PHYTOTHER RES, V29, P148, DOI 10.1002/ptr.5195
   Kim MC, 2012, AM J CHINESE MED, V40, P135, DOI 10.1142/S0192415X12500115
   Koh W, 2017, J ETHNOPHARMACOL, V209, P255, DOI 10.1016/j.jep.2017.08.001
   Kwon SH, 2016, BIOMOL THER, V24, P268, DOI 10.4062/biomolther.2015.150
   Kwon SH, 2014, J ETHNOPHARMACOL, V152, P173, DOI 10.1016/j.jep.2013.12.048
   Kwon SH, 2012, J ETHNOPHARMACOL, V142, P337, DOI 10.1016/j.jep.2012.04.010
   Kwon SH, 2011, NEUROSCI LETT, V487, P123, DOI 10.1016/j.neulet.2010.10.042
   Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705
   Lee GH, 2019, NUTRIENTS, V11, P2
   Lee HY, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0081349
   Lee MK, 2005, DIABETES RES CLIN PR, V67, P22, DOI 10.1016/j.diabres.2004.05.013
   Lee MK, 2005, J MED FOOD, V8, P86, DOI 10.1089/jmf.2005.8.86
   Lei S, 2021, PINORESINOL DIGLUCOS, V0, P0
   Li CX, 2019, EUR J PHARMACOL, V854, P224, DOI 10.1016/j.ejphar.2019.04.021
   Li CP, 2016, NEUROL SCI, V37, P755, DOI 10.1007/s10072-016-2491-3
   Li CJ, 2012, MOLECULES, V17, P13960, DOI 10.3390/molecules171213960
   Li L, 2012, J ETHNOPHARMACOL, V139, P454, DOI 10.1016/j.jep.2011.11.032
   Li N, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/7480512
   Li N, 2018, FRONT PHARMACOL, V9, P0, DOI 10.3389/fphar.2018.00854
   Li Q, 2017, BIOMATERIALS, V148, P54, DOI 10.1016/j.biomaterials.2017.09.028
   Li Q, 2017, CARBOHYD POLYM, V169, P304, DOI 10.1016/j.carbpol.2017.04.034
   Li Q, 2016, ACS MACRO LETT, V5, P617, DOI 10.1021/acsmacrolett.6b00182
   Li Y, 2011, PHYTOTHER RES, V25, P1895, DOI 10.1002/ptr.3543
   Li YM, 1999, BIOL PHARM BULL, V22, P941, DOI 10.1248/bpb.22.941
   Li YM, 1998, BIOL PHARM BULL, V21, P1306, DOI 10.1248/bpb.21.1306
   Li YM, 1999, BIOL PHARM BULL, V22, P582, DOI 10.1248/bpb.22.582
   Li YJ, 2016, EUR J DRUG METAB PH, V41, P595, DOI 10.1007/s13318-015-0282-5
   Li ZY, 2013, AM J CHINESE MED, V41, P801, DOI 10.1142/S0192415X13500547
   Lin J, 2011, J ZHEJIANG UNIV-SC B, V12, P47, DOI 10.1631/jzus.B1000057
   Liu B, 2016, CELL PHYSIOL BIOCHEM, V39, P2044, DOI 10.1159/000447900
   Liu C, 2020, CHINA J CHIN MAT MED, V45, P3
   Liu HW, 2018, ANIM SCI J, V89, P888, DOI 10.1111/asj.12998
   [ÂàòÊîÄÂ≥∞ Liu Panfeng], 2020, ÁîüÊÄÅÂ≠¶Êä• ACTA ECOLOGICA SINICA, V40, P5674
   Liu WZ, 2015, REV NEUROSCIENCE, V26, P371, DOI 10.1515/revneuro-2015-0005
   Luo JY, 2009, J ENZYM INHIB MED CH, V24, P1280, DOI 10.3109/14756360902829741
   Luo LF, 2010, J ETHNOPHARMACOL, V129, P238, DOI 10.1016/j.jep.2010.03.019
   Luo XM, 2020, REGUL TOXICOL PHARM, V118, P0, DOI 10.1016/j.yrtph.2020.104811
   Ma B, 2019, PHYTOMEDICINE, V64, P0, DOI 10.1016/j.phymed.2019.153057
   Ma ZG, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/6053727
   Ma ZG, 2016, BRIT J PHARMACOL, V173, P1502, DOI 10.1111/bph.13449
   Marini JC, 2017, NAT REV DIS PRIMERS, V3, P0, DOI 10.1038/nrdp.2017.52
   Meng YY, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/7901735
   Nathan DM, 2015, JAMA-J AM MED ASSOC, V314, P1052, DOI 10.1001/jama.2015.9536
   Neri-Numa IA, 2020, FOOD RES INT, V134, P0, DOI 10.1016/j.foodres.2020.109252
   Niu HS, 2016, DRUG DES DEV THER, V10, P971, DOI 10.2147/DDDT.S98558
   Niu YM, 2020, INT J BIOL MACROMOL, V155, P911, DOI 10.1016/j.ijbiomac.2019.11.049
   Pan YL, 2014, AM J CHINESE MED, V42, P143, DOI 10.1142/S0192415X14500104
   Park SA, 2006, J MED FOOD, V9, P474, DOI 10.1089/jmf.2006.9.474
   Park SA, 2006, J ETHNOPHARMACOL, V107, P412, DOI 10.1016/j.jep.2006.03.034
   Qi SS, 2019, BIOL TRACE ELEM RES, V187, P172, DOI 10.1007/s12011-018-1362-6
   Qiu YL, 2018, BIOMED PHARMACOTHER, V106, P192, DOI 10.1016/j.biopha.2018.05.070
   Ramasamy R, 2010, CIRC RES, V106, P1449, DOI 10.1161/CIRCRESAHA.109.213447
   Shan M, 2017, MOLECULES, V22, P10, DOI 10.14348/molcells.2017.2311
   Shao P, 2015, J FOOD SCI TECH MYS, V52, P4925, DOI 10.1007/s13197-014-1571-8
   Shchepotin B M, 1983, VRACH DELO, V0, P30
   Shen BY, 2019, J CELL MOL MED, V23, P4063, DOI 10.1111/jcmm.14293
   Sheng CJ, 2019, EUR J PHARMACOL, V854, P28, DOI 10.1016/j.ejphar.2019.03.058
   Sheng YW, 2014, CHEM REV, V114, P3854, DOI 10.1021/cr4005296
   Sierksma A, 2020, SCIENCE, V370, P61, DOI 10.1126/science.abb8575
   Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037
   SIH CJ, 1976, J AM CHEM SOC, V98, P5412, DOI 10.1021/ja00433a070
   Taams LS, 2020, J EXP MED, V217, P0, DOI 10.1084/jem.20192048
   Takamura C, 2007, J NAT PROD, V70, P1312, DOI 10.1021/np0780046
   Takeuchi Y, 2020, IMMUNOL REV, V294, P164, DOI 10.1111/imr.12841
   Wang H, 2020, J NEUROINFLAMM, V17, P0, DOI 10.1186/s12974-020-01863-9
   Wang JL, 2012, J ETHNOPHARMACOL, V139, P337, DOI 10.1016/j.jep.2011.10.037
   Wang JY, 2019, CHINESE MED J-PEKING, V132, P319, DOI 10.1097/CM9.0000000000000066
   Wang JY, 2018, EVID-BASED COMPL ALT, V2018, P0, DOI 10.1155/2018/7379893
   Wang JY, 2016, J ETHNOPHARMACOL, V194, P609, DOI 10.1016/j.jep.2016.10.038
   Wang YS, 2019, ONCOTARGETS THER, V12, P5515, DOI 10.2147/OTT.S210497
   Wei XN, 2021, J AGR FOOD CHEM, V69, P3797, DOI 10.1021/acs.jafc.0c07560
   Wu D, 2018, MOLECULES, V23, P8
   Wu JM, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21030260
   Wu QQ, 2018, BRIT J PHARMACOL, V175, P1548, DOI 10.1111/bph.14164
   Xiang Y, 2004, J STRUCT BIOL, V148, P86, DOI 10.1016/j.jsb.2004.04.002
   Xiao DF, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/9719618
   Xiao Y, 2018, PLANTA MED, V84, P91, DOI 10.1055/s-0043-118663
   Xu W, 2012, BIOMED CHROMATOGR, V26, P1066, DOI 10.1002/bmc.1748
   Xu ZS, 2010, J AGR FOOD CHEM, V58, P7289, DOI 10.1021/jf100304t
   Yan JK, 2019, NAT PROD RES, V33, P1162, DOI 10.1080/14786419.2018.1462181
   Yan JK, 2017, FITOTERAPIA, V116, P121, DOI 10.1016/j.fitote.2016.12.001
   Yan JK, 2017, J NAT MED-TOKYO, V71, P780, DOI 10.1007/s11418-017-1102-9
   Yang G, 2015, CHEM BIODIVERS, V12, P538, DOI 10.1002/cbdv.201400376
   Yang J, 2003, LIFE SCI, V73, P3245, DOI 10.1016/j.lfs.2003.06.011
   Yang Z, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/4327901
   Yen GC, 1998, J AGR FOOD CHEM, V46, P3952, DOI 10.1021/jf9800458
   Yin F, 2010, BIOL PHARM BULL, V33, P1841, DOI 10.1248/bpb.33.1841
   Zeida A, 2019, CHEM REV, V119, P10829, DOI 10.1021/acs.chemrev.9b00371
   Zeng XC, 2020, FITOTERAPIA, V140, P0, DOI 10.1016/j.fitote.2019.104443
   Zhang L, 2013, ASIAN PAC J TROP MED, V6, P673, DOI 10.1016/S1995-7645(13)60117-0
   Zhang Q, 2014, J BIOSCI BIOENG, V118, P45, DOI 10.1016/j.jbiosc.2013.12.009
   Zhang Q, 2013, MOLECULES, V18, P1857, DOI 10.3390/molecules18021857
   Zhang R, 2009, BONE, V45, P553, DOI 10.1016/j.bone.2008.08.127
   Zhang R, 2014, J ETHNOPHARMACOL, V155, P104, DOI 10.1016/j.jep.2014.04.031
   Zhang Wan-hong, 2005, ZHONGHUA NAN KE XUE, V11, P309
   Zhang Wan-Hong, 2006, ZHONGHUA NAN KE XUE, V12, P466
   Zhang WP, 2012, AM J CHINESE MED, V40, P735, DOI 10.1142/S0192415X12500553
   Zhao X, 2020, FOOD SCI NUTR, V8, P4897, DOI 10.1002/fsn3.1779
   Zhou YX, 2019, EVID-BASED COMPL ALT, V2019, P0, DOI 10.1155/2019/4925682
   Zhou YQ, 2009, ENVIRON TOXICOL PHAR, V28, P342, DOI 10.1016/j.etap.2009.05.012
   Zhou ZJZ, 2020, EUR J PHARMACOL, V869, P0, DOI 10.1016/j.ejphar.2019.172857
   Zhua YL, 2018, NEUROREPORT, V29, P1075, DOI 10.1097/WNR.0000000000001075
NR 147
TC 68
Z9 75
U1 25
U2 168
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1749-8546
EI 
J9 CHIN MED-UK
JI Chin. Med.
PD AUG 6
PY 2021
VL 16
IS 1
BP 
EP 
DI 10.1186/s13020-021-00482-7
PG 26
WC Integrative & Complementary Medicine; Pharmacology & Pharmacy
SC Integrative & Complementary Medicine; Pharmacology & Pharmacy
GA TY6NP
UT WOS:000683899400001
PM 34362420
DA 2025-04-28
ER

PT J
AU Siqueira, JH
   Santana, NMT
   Pereira, TSS
   Moreira, AD
   Bense√±or, IM
   Barreto, SM
   Velasquez-Melendez, G
   Molina, MDB
AF Siqueira, Jordana Herzog
   Teixeira Santana, Nathalia Miguel
   Silva Pereira, Taisa Sabrina
   Moreira, Alexandra Dias
   Bensenor, Isabela Martins
   Barreto, Sandhi Maria
   Velasquez-Melendez, Gustavo
   Bisi Molina, Maria del Carmen
TI Consumption of alcoholic and non-alcoholic beverages: ELSA-Brasil results
SO CIENCIA & SAUDE COLETIVA
LA English
DT Article
DE Soft Drinks; Fruit Juices; Artificial Sweeteners; Alcoholic Beverages
ID sweetened beverages; glycemic load; risk; food; obesity; disease; health; metaanalysis; mortality; wine
AB The study aims to describe the consumption of alcoholic and non-alcoholic beverages according to sociodemographic, health and location variables. Cross-sectional study with ELSA-Brasil data (2008-2010). A questionnaire was used to collect sociodemographic, food, health data and anthropometry. Descriptive analysis and association with variables of interest were carried out. In the sample, 8% of the total caloric value comes from non-alcoholic beverages (5.6%: sugary drinks), and 4% from alcoholic beverages (2.7%: beer). Consumers of unsweetened and artificially sweetened beverages reported moderate/strong physical activity, former smokers and higher education. The opposite was true for sugary drinks. Eutrophic people reported higher consumption of sugary drinks and those obese, artificially sweetened and beer. Alcohol consumption varied with age (young: beer; elderly: wine/spirits) and education (low education: beer/spirits; higher education: wine). Coffee, natural juice and soda were the most consumed non-alcoholic beverages and beer was the most prevalent alcoholic beverage. Consumption variation was observed according to geographic location. The consumption of sugary and alcoholic beverages is high in Brazil and public health strategies are required.
C1 [Siqueira, Jordana Herzog; Bisi Molina, Maria del Carmen] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Av Marechal Campos 1468, BR-29047105 Vitoria, ES, Brazil.
   [Teixeira Santana, Nathalia Miguel] Inst Fed Educ Ciencia & Tecnol Espirito Santo, Campus Santa Teresa, ES, Brazil.
   [Silva Pereira, Taisa Sabrina] Univ Amer Puebla, Dept Ciencias Saude, San Andres Cholula, Cholula, Brazil.
   [Moreira, Alexandra Dias; Velasquez-Melendez, Gustavo] Univ Fed Minas Gerais, Dept Enfermagem Maternoinfantil & Saude Publ, Escola Enfermagem, Belo Horizonte, MG, Brazil.
   [Bensenor, Isabela Martins] Univ Sao Paulo, Fac Med, Dept Clin Med, Sao Paulo, SP, Brazil.
   [Barreto, Sandhi Maria] Univ Fed Minas Gerais, Fac Med, Dept Med Prevent & Social, Belo Horizonte, MG, Brazil.
C3 Universidade Federal do Espirito Santo; Instituto Federal do Espirito Santo (IFES); Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Universidade Federal de Minas Gerais
RP Siqueira, JH (corresponding author), Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Av Marechal Campos 1468, BR-29047105 Vitoria, ES, Brazil.
EM jordana.herzog@gmail.com
CR Aguiar DRD, 2009, STRUCTURAL CHANGES F, V0, P151
   Unknown -, 2025, USE OF LOWER-SODIUM SALT SUBSTITUTES2025, V0, P0
   Unknown -, 2010, EC BRAS PERSP, V0, P0
   Unknown -, 2010, PESQ ORC FAM 2008 20, V0, P0
   Bezerra Ilana Nogueira, 2013, REV SAUDE PUBLICA, V47 Suppl 1, P200S, DOI 10.1590/S0034-89102013000700006
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Martins APB, 2013, REV SAUDE PUBL, V47, P656, DOI 10.1590/S0034-8910.2013047004968
   Chiva-Blanch G, 2013, ALCOHOL ALCOHOLISM, V48, P270, DOI 10.1093/alcalc/agt007
   Claro RM, 2012, AM J PUBLIC HEALTH, V102, P178, DOI 10.2105/AJPH.2011.300313
   DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229
   Fernandes I, 2017, MOLECULES, V22, P0, DOI 10.3390/molecules22020292
   Figueiredo N, 2018, PUBLIC HEALTH NUTR, V21, P3307, DOI 10.1017/S1368980018002161
   Fitzpatrick L, 2003, J BONE MINER RES, V18, P1570, DOI 10.1359/jbmr.2003.18.9.1570
   Griswold MG, 2018, LANCET, V392, P1015, DOI 10.1016/S0140-6736(18)31310-2
   Haseeb S, 2017, CIRCULATION, V136, P1434, DOI 10.1161/CIRCULATIONAHA.117.030387
   Imamura F, 2015, BMJ-BRIT MED J, V351, P0, DOI 10.1136/bmj.h3576
   Institute for Health Metrics and Evaluation, 2013, GLOBAL BURDEN DIS CO, V0, P0
   Interministerial Food and Nutrition Security Chamber, 2015, BRAZ COMM UN DEC ACT, V0, P0
   Johnson RK, 2018, CIRCULATION, V138, PE126, DOI 10.1161/CIR.0000000000000569
   Knott CS, 2015, BMJ-BRIT MED J, V350, P0, DOI 10.1136/BMJ.h384
   Krenz M, 2012, J MOL CELL CARDIOL, V52, P93, DOI 10.1016/j.yjmcc.2011.10.011
   Levy-Costa RB, 2005, REV SAUDE PUBL, V39, P530, DOI 10.1590/S0034-89102005000400003
   Livesey G, 2013, AM J CLIN NUTR, V97, P584, DOI 10.3945/ajcn.112.041467
   Machado Ie, 2018, REV BRAS EPIDEMIOL, V20, P408
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Matsudo V, 2011, ATIVIDADE FISICA SAU, V6, P5
   Mill JG, 2013, REV SAUDE PUBL, V47, P54, DOI 10.1590/S0034-8910.2013047003851
   Molina Maria Del Carmen Bisi, 2013, CAD SAUDE PUBLICA, V29, P379, DOI 10.1590/S0102-311X2013000600024
   Monteiro CA, 2012, PLOS MED, V9, P0, DOI 10.1371/journal.pmed.1001252
   Monteiro CA, 2008, REV SAUDE PUBL, V42, P582, DOI 10.1590/S0034-89102008000400002
   Mossavar-Rahmani Y, 2019, STROKE, V50, P555, DOI 10.1161/STROKEAHA.118.023100
   Muhlack E, 2018, BMC PUBLIC HEALTH, V18, P0, DOI 10.1186/s12889-018-5948-x
   Mukamal KJ, 2005, CIRCULATION, V112, P1406, DOI 10.1161/CIRCULATIONAHA.105.537704
   Neves Alice Cristina Medeiros das, 2010, CAD. SA√öDE P√öBLICA, V26, P2379, DOI 10.1590/S0102-311X2010001200016
   Pan American Health Organization (PAHO), 2015, REGIONAL STATUS REPORT ON ALCOHOL AND HEALTH IN THE AMERICAS, V0, P0
   Pearlman Michelle, 2017, CURR GASTROENTEROL REP, V19, P64, DOI 10.1007/s11894-017-0602-9
   Pereira RA, 2015, PUBLIC HEALTH NUTR, V18, P1164, DOI 10.1017/S1368980014001657
   Pereira RA, 2014, PUBLIC HEALTH NUTR, V17, P113, DOI 10.1017/S1368980012004892
   Piano MR, 2017, ALCOHOL RES-CURR REV, V38, P219
   Rivera JA, 2008, SALUD PUBLICA MEXICO, V50, P173, DOI 10.1590/S0036-36342008000200011
   Roerecke M, 2018, J AM HEART ASSOC, V7, P0, DOI 10.1161/JAHA.117.008202
   Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027
   Shearer J, 2016, REV ENDOCR METAB DIS, V17, P179, DOI 10.1007/s11154-016-9372-1
   Souza AD, 2013, REV SAUDE PUBL, V47, PS190, DOI 10.1590/S0034-89102013000700005
   Stanhope KL, 2012, ANNU REV MED, V63, P329, DOI 10.1146/annurev-med-042010-113026
   Stockwell T, 2000, INT GUID MON ALC CON, V0, P0
   Stockwell T, 2016, J STUD ALCOHOL DRUGS, V77, P185, DOI 10.15288/jsad.2016.77.185
   Temple NJ, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10010039
   Traversy G, 2015, CURR OBES REP, V4, P122, DOI 10.1007/s13679-014-0129-4
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, V0, P1
   WHO Consultation, 2000, WHO TECH REP SER, V894, P1
   Willett W, 2002, AM J CLIN NUTR, V76, P274S, DOI 10.1093/ajcn/76.1.274S
NR 52
TC 3
Z9 3
U1 2
U2 22
PU ABRASCO -  Brazilian Association of Collective Health
PI RIO DE JANEIRO
PA Ave Brasil 4365, Campus da Fundacao Oswaldo Cruz (Fiocruz)  Predio do CEPI  DSS  Manguinhos, RIO DE JANEIRO, Rio de Janeiro, BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD AUG 15
PY 2021
VL 26
IS 
BP 3825
EP 3837
DI 10.1590/1413-81232021269.2.30682019
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA UK3PE
UT WOS:000691884100041
PM 34468676
DA 2025-04-28
ER

PT J
AU Mwafi, NR
   Al-Rawashdeh, IM
   Al-Kubaisy, WAQ
   Ezzat, WR
   Al-Qazaqi, RA
   Salameh, MH
AF Mwafi, Nesrin Riad
   Al-Rawashdeh, Israa Mohammad
   Al-Kubaisy, Waqar Abdul-Qahar
   Ezzat, Waleed Rifaat
   Al-Qazaqi, Raghad Abdelqader
   Salameh, Mohamed Hashem
TI Prevalence and factors related to obesity and fast food consumption among Mutah University students, Jordan
SO JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION
LA English
DT Article
DE Fast food; Physical exercise; University students; Body mass index; Cross-sectional study
ID risk
AB Objective:To identify the prevalence and factors related to obesity and fast food consumption among university students. Methods: The cross-sectional study was conducted at Mutah University, Al-Karak governorate in southern Jordan, from January to April, 2019, and comprised students recruited from different faculties. Data was collected using a structured, validated questionnaire. Height and weight were measured for body mass index calculation. Data was analysed using SPSS 23. Results: Of the 503 students, 278(55.3%) were females. The overall mean age of the sample was 21.62 +/- 2.22 years (range: 19-39 years). Fast food consumption was >= 2 times/week for 299(59.4%) students. The prevalence was significantly higher among students spending >= 21 Jordanian dinar per week (p=0.020) and those who were not performing physical exercise (p=0.025). Significant correlations were found between fast food consumption and fried potato (p<0.001), processed meat products (p<0.001), coffee (p=0.006) and candies (p=0.039). No significant relation was found between fast food consumption and body mass index, religion, gender, field of study or living away from family (p>0.05). The most common reason for consumption was shortage of time 115(38.5%); lunch time was the most preferred time 210(70.2%); 97(32.4%) students were willing to read the nutrient information; and 211(70.5%) were interested in choosing healthy meals. Conclusion: The prevalence of fast food consumption among university students was found to be high.
C1 [Mwafi, Nesrin Riad] Mutah Univ, Dept Biochem & Mol Biol, Al Karak, Jordan.
   [Al-Rawashdeh, Israa Mohammad; Al-Kubaisy, Waqar Abdul-Qahar] Mutah Univ, Dept Publ Hlth & Community Med, Al Karak, Jordan.
   [Ezzat, Waleed Rifaat] Mutah Univ, Dept Physiol & Pathol, Al Karak, Jordan.
   [Al-Qazaqi, Raghad Abdelqader; Salameh, Mohamed Hashem] Mutah Univ, Al Karak, Jordan.
C3 Mutah University; Mutah University; Mutah University; Mutah University
RP Mwafi, NR (corresponding author), Mutah Univ, Dept Biochem & Mol Biol, Al Karak, Jordan.
EM drnesrin@mutah.edu.jo
CR al-Jadid R, 2018, THE JORDAN TIMES, V0, P0
   Al-Otaibi HH, 2015, PAKISTAN JOURNAL OF NUTRITION, V14, P511
   Alfawaz HA, 2012, PAKISTAN JOURNAL OF NUTRITION, V11, P406
   Alsabieh M, 2019, HELIYON, V5, P0, DOI 10.1016/j.heliyon.2019.e01566
   Anderson B, 2011, PREV CHRONIC DIS, V8, P0
   Bipasha MS, 2014, SOUTH EAST ASIA J. PUBLIC HEALTH, V3, P61, DOI 10.3329/SEAJPH.V3I1.17713
   Deivanai DP, 2016, IOSR J BUSINESS MANA, V18, P20
   Department of StatisticsJordan, 2019, EMPL COMP EMPL SURV, V0, P0
   El-Gilany AHAF, 2016, TAF PREVENTIVE MEDICINE BULLETIN, V15, P440
   El-Qudah JM, 2014, WORLD APPLIED SCIENCES JOURNAL, V29, P1213
   Fryar Cheryl D, 2018, NCHS DATA BRIEF, V0, P1
   Goon S, 2014, EUROPEAN JOURNAL OF PREVENTATIVE MEDICINE, V2, P99, DOI 10.11648/J.EJPM.20140206.14
   Gosliner W, 2011, J SCHOOL HEALTH, V81, P146, DOI 10.1111/j.1746-1561.2010.00573.x
   Greenwood DC, 2014, BRIT J NUTR, V112, P725, DOI 10.1017/S0007114514001329
   Health Promotion Administration, 2020, BODY MASS INDEX AS ASSESSED USING EFFECT SIZE, V0, P0
   Jaworowska A, 2013, NUTR REV, V71, P310, DOI 10.1111/nure.12031
   Kayisoglu S, 2014, ACTA ALIMENT HUNG, V43, P53, DOI 10.1556/AAlim.43.2014.1.6
   Salameh P, 2014, FRONT PUBLIC HEALTH, V2, P0, DOI 10.3389/fpubh.2014.00185
   Shaban L, 2019, INT J PREVENTIVE MED, V10, P0, DOI 10.4103/ijpvm.IJPVM_480_18
   Shah T, 2014, J CLIN DIAGN RES, V8, PCC5, DOI 10.7860/JCDR/2014/7908.4351
   Sharifirad G, 2013, J OBES, V2013, P0, DOI 10.1155/2013/147589
   Tayyem Reema F, 2018, ASIAN PAC J CANCER PREV, V19, P261, DOI 10.22034/APJCP.2018.19.1.261
   WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, V0, P1
   Xi B, 2015, BRIT J NUTR, V113, P709, DOI 10.1017/S0007114514004383
   Younis FH, 2019, JOURNAL OF REGENERATIVE BIOLOGY MEDICINE, V1, P1, DOI 10.37191/Mapsci-2582-385X-1(1)-005
NR 26
TC 10
Z9 11
U1 1
U2 8
PU PAKISTAN MEDICAL ASSOC
PI KARACHI
PA PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN
SN 0030-9982
EI 
J9 J PAK MED ASSOC
JI J. Pak. Med. Assoc.
PD JUN 15
PY 2021
VL 71
IS 6
BP 1608
EP 1612
DI 10.47391/JPMA.274
PG 5
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA SS5DR
UT WOS:000661775200005
PM 34111082
DA 2025-04-28
ER

PT J
AU Anton-Paduraru, DT
   Gotca, I
   Mocanu, V
   Popescu, V
   Iliescu, ML
   Miftode, EG
   Boiculese, VL
AF Anton-Paduraru, Dana-Teodora
   Gotca, Ioan
   Mocanu, Veronica
   Popescu, Veronica
   Iliescu, Maria-Liliana
   Miftode, Egidia-Gabriela
   Boiculese, Vasile-Lucian
TI Assessment of Eating Habits and Perceived Benefits of Physical Activity and Body Attractiveness among Adolescents from Northeastern Romania
SO APPLIED SCIENCES-BASEL
LA English
DT Article
DE adolescent; eating habits; perceived benefits of physical activity; perceived body attractiveness
ID school-aged children; nutritional-status; dietary habits; behavior; validity
AB The purpose of this paper was to present the results of the evaluation of 1320 adolescents from 4 high schools in Iasi, Romania regarding their eating habits and perceived benefits of physical activity and body attractiveness after they completed an anonymous questionnaire. The data analysis was performed using IBM SPSS version 18. The analysis of the nutritional status showed that over 70% of adolescents were of a normal weight. Most of them (63.56%) consumed 3-4 meals/day, with breakfast being the most skipped meal (60.53%). Compared with the boys, the girls consumed fewer whole grains, dairy products, and meat, but the girls consumed fruits and vegetables in approximately the same percentage. The adolescents studied consumed more fruits than vegetables, but the servings of fruits and vegetables consumed were not sufficient in the diets of many adolescents (39.31%). Among the adolescents, 5.68% consumed at least 2 alcoholic drinks daily, and 37.87% consumed caffeine products one or more times per week. Among the boys, 95.20% practiced regular physical activity, and 97.20% of the girls considered that the right nutrition plays a role in the prevention of obesity. The study of the self-perception profile showed that 89.8% of boys and 79.5% of girls considered that they had attractive bodies. According to the BMI, 86.7% of normal-weight adolescents and 84.8% of underweight adolescents considered themselves as having attractive bodies, while this was only considered by 73.5% of overweight and 56.7% of obese adolescents. It is necessary to introduce nutritional education in schools for the improvement of eating habits in children and adolescents. More studies are needed to appreciate the social behaviors (e.g., food intake, physical activity, and recreation time) and then develop interventions and national health programs to promote a healthy lifestyle, particularly healthy eating habits.
C1 [Anton-Paduraru, Dana-Teodora] Grigore T Popa Univ Med & Pharm, Dept Mother & Child Med, 16 Univ St, Iasi 700115, Romania.
   [Gotca, Ioan; Mocanu, Veronica] Grigore T Popa Univ Med & Pharm, Dept Morphofunct Sci 2, 16 Univ St, Iasi 700115, Romania.
   [Popescu, Veronica] Alexandru Ioan Cuza Univ, Fac Phys Educ & Sport, Iasi 700554, Romania.
   [Iliescu, Maria-Liliana; Boiculese, Vasile-Lucian] Grigore T Popa Univ Med & Pharm, Dept Prevent Med & Interdisciplinar, 16 Univ St, Iasi 700115, Romania.
   [Miftode, Egidia-Gabriela] Grigore T Popa Univ Med & Pharm, Dept Med Sci 2, 16 Univ St, Iasi 700115, Romania.
C3 Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy; Alexandru Ioan Cuza University; Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy
RP Gotca, I; Mocanu, V (corresponding author), Grigore T Popa Univ Med & Pharm, Dept Morphofunct Sci 2, 16 Univ St, Iasi 700115, Romania.
EM dana.anton@umfiasi.ro; ioan.gotca@umfiasi.ro; veronica.mocanu@umfiasi.ro; veronica.popescu@uaic.ro; maria.iliescu@umfiasi.ro; egidia.miftode@umfiasi.ro; vasile.boiculese@umfiasi.ro
CR Agofure O, 2021, PAN AFR MED J, V38, P0, DOI 10.11604/pamj.2021.38.32.15824
   Amos PM, 2012, SAGE OPEN, V2, P0, DOI 10.1177/2158244012468140
   Unknown -, 2010, DIETARY GUIDELINES FOR AMERICANS, V0, P0
   Baric IC, 2000, FOOD TECHNOL BIOTECH, V38, P217
   Bazhan M, 2013, J PARAMED SCI, V4, P93
   Castaneda-Sanchez O, 2008, ARCHIVOS MEDICINA FA, V10, P7
   Citozi R, 2013, JOURNAL OF HUMAN SPORT AND EXERCISE, V8, P0
   Drenowatz C, 2018, ANN CLIN NUTR, V2, P1010
   Fortes LD, 2013, REV NUTR, V26, P529, DOI 10.1590/S1415-52732013000500004
   Gill F, 2016, INT J NUTR FOOD SCI, V4, P304, DOI 10.11648/j.ijnfs.20160504.21
   Graur M, 2006, ROMANIAN GUIDE HLTH, V0, P0
   Ilas S, 2016, STATUS NUTR ED PRESC, V0, P0
   Lago RR, 2016, ADOLESCENCIA SAUDE, V13, P98
   Lestari S, 2018, P INT C SCI TECHN EN, V0, P0
   Lindwall M, 2011, PSYCHOL HEALTH MED, V16, P115, DOI 10.1080/13548506.2010.521567
   Rodrigues PRM, 2017, NUTRITION, V42, P114, DOI 10.1016/j.nut.2017.03.011
   Mizia S, 2021, INT J ENV RES PUB HE, V18, P0, DOI 10.3390/ijerph18083996
   Musaiger AO, 2011, FOOD NUTR RES, V55, P0, DOI 10.3402/fnr.v55i0.7122
   Onyiriuka A, 2013, SRI LANKA J CHILD HEALTH, V42, P20
   P√©rez-Rodrigo C, 2015, NUTR HOSP, V31, P76, DOI 10.3305/nh.2015.31.sup3.8755
   Roura E, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0159962
   Samuelson G, 2000, EUR J CLIN NUTR, V54, PS21, DOI 10.1038/sj.ejcn.1600980
   Sarkar M, 2015, IOSR J DENT MED SCI, V14, P6
   Schr√∂der H, 2012, PUBLIC HEALTH NUTR, V15, P618, DOI 10.1017/S1368980011001923
   Silva FA, 2017, J PEDIAT-BRAZIL, V93, P79, DOI 10.1016/j.jped.2016.04.008
   Stoian AP, 2018, J MIND MED SCI, V5, P85, DOI 10.22543/7674.51.P8592
   Story M, 2005, GUIDELINES ADOLESC NUTR SERV, V9, P19
   Vereecken CA, 2005, BRIT J NUTR, V94, P423, DOI 10.1079/BJN20051513
   Vizbaraite D, 2011, BALTIC J SPORT HEALTH SCI, V2, P52, DOI 10.33607/bjshs.v2i81.331
   zkan BA, 2020, PROG NUTR, V22, P0
NR 31
TC 5
Z9 5
U1 0
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2076-3417
J9 APPL SCI-BASEL
JI Appl. Sci.-Basel
PD NOV 15
PY 2021
VL 11
IS 22
BP 
EP 
DI 10.3390/app112211042
PG 10
WC Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied
SC Chemistry; Engineering; Materials Science; Physics
GA XF2VZ
UT WOS:000723935100001
DA 2025-04-28
ER

PT J
AU Li, J
   Chen, QY
   Zhai, XM
   Wang, D
   Hou, YJ
   Tang, M
AF Li, Jie
   Chen, Qiyang
   Zhai, Xiuming
   Wang, Dan
   Hou, Yujia
   Tang, Min
TI Green tea aqueous extract (GTAE) prevents high-fat diet-induced obesity by activating fat browning
SO FOOD SCIENCE & NUTRITION
LA English
DT Article
DE BAT; browning; green tea; Ing-WAT; low-grade systemic inflammation; obesity
ID kappa-b activation; adipose-tissue; nonalcoholic steatohepatitis; insulin-resistance; metabolic syndrome; mice; catechins; expression; inflammation; overweight
AB Adipose browning leads to increased energy expenditure and reduced adiposity and has, therefore, become an attractive therapeutic strategy for obesity. In this study, we elucidated the effect of green tea aqueous extract (GTAE) on the browning of inguinal white adipose tissue (Ing-WAT) and brown adipose tissue (BAT) in high-fat diet (HFD)-fed mice. The main phytochemical components identified in GTAE through high-performance liquid chromatography (HPLC) included (-)-gallocatechin, (-)-epigallocatechin, (-)-catechin, (-)-epigallocatechin-3-gallate, caffeine, (-)-epicatechin, (-)-gallocatechin gallate, and (-)-epicatechin-3-gallate. Daily supplementation with 1% GTAE for 12 weeks markedly reduced bodyweight gain, systemic inflammation, oxidative stress, and improved insulin resistance. Additionally, histological analysis revealed that dietary supplementation with 1% GTAE reversed HFD-induced adipocyte size and hepatic steatosis. These effects were associated with activation of browning in the Ing-WAT and BAT, which mediate systemic metabolic dysfunction in HFD-fed mice. Taken together, our data support the use of GTAE, a natural product, for the attenuation of obesity through the activation of fat browning.
C1 [Li, Jie; Zhai, Xiuming; Hou, Yujia; Tang, Min] Chongqing Acad Agr Sci, Res Inst Tea, Chongqing 402160, Peoples R China.
   [Chen, Qiyang; Wang, Dan] Southwest Univ, Coll Hort & Landscape Architecture, Chongqing, Peoples R China.
C3 Chongqing Academy of Agricultural Sciences; Southwest University - China
RP Hou, YJ; Tang, M (corresponding author), Chongqing Acad Agr Sci, Res Inst Tea, Chongqing 402160, Peoples R China.
EM 564661213@qq.com; tangmin945@163.com
FU Natural Science Foundation Project of Chongqing Science and Technology Bureau of Yongchuan District [2019nb0103]; Chongqing Science and Technology Commission Basic and Frontier Research Project [cstc2019jcyj-msxmX0553]
CR Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
   Asghar A, 2017, CELL IMMUNOL, V315, P18, DOI 10.1016/j.cellimm.2017.03.001
   Azhar Y, 2016, NUTR METAB, V13, P0, DOI 10.1186/s12986-016-0150-6
   Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204
   Bartelt A, 2012, CURR OPIN LIPIDOL, V23, P190, DOI 10.1097/MOL.0b013e328352dcef
   Bolin AP, 2020, J NUTR BIOCHEM, V83, P0, DOI 10.1016/j.jnutbio.2020.108429
   Bolin AP, 2020, J NUTR BIOCHEM, V78, P0, DOI 10.1016/j.jnutbio.2019.108322
   Bostr√∂m P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   Chou YC, 2018, J AGR FOOD CHEM, V66, P9697, DOI 10.1021/acs.jafc.8b02719
   Cohen P, 2015, DIABETES, V64, P2346, DOI 10.2337/db15-0318
   Cunha CA, 2013, MEDIAT INFLAMM, V2013, P0, DOI 10.1155/2013/635470
   Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780
   Dey P, 2019, J NUTR BIOCHEM, V67, P78, DOI 10.1016/j.jnutbio.2019.01.017
   Gao WQ, 2018, BIOMED PHARMACOTHER, V103, P637, DOI 10.1016/j.biopha.2018.04.043
   Hayat K, 2015, CRIT REV FOOD SCI, V55, P939, DOI 10.1080/10408398.2012.678949
   Bautista RJH, 2019, BIOMED PHARMACOTHER, V111, P503, DOI 10.1016/j.biopha.2018.12.108
   Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x
   Kim SH, 2016, DIABETES METAB J, V40, P12, DOI 10.4093/dmj.2016.40.1.12
   Li JH, 2018, J NUTR BIOCHEM, V53, P58, DOI 10.1016/j.jnutbio.2017.10.016
   Li JH, 2017, J NUTR BIOCHEM, V41, P34, DOI 10.1016/j.jnutbio.2016.12.007
   Li Y, 2020, J NUTR BIOCHEM, V78, P0, DOI 10.1016/j.jnutbio.2019.108324
   Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, V0, PP1, DOI 10.1596/978-0-8213-6262-4
   Ma H, 2020, J FUNCT FOODS, V75, P0, DOI 10.1016/j.jff.2020.104279
   Marinovic MP, 2015, TOXICOL IN VITRO, V29, P1766, DOI 10.1016/j.tiv.2015.07.014
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McMillan AC, 2015, CURR OPIN ENDOCRINOL, V22, P347, DOI 10.1097/MED.0000000000000191
   Morgen CS, 2014, NAT REV ENDOCRINOL, V10, P513, DOI 10.1038/nrendo.2014.124
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Neyrinck AM, 2017, J NUTR BIOCHEM, V49, P15, DOI 10.1016/j.jnutbio.2017.07.008
   Nomura S, 2008, J NUTR BIOCHEM, V19, P840, DOI 10.1016/j.jnutbio.2007.11.005
   Okla M, 2017, ADV NUTR, V8, P473, DOI 10.3945/an.116.014332
   Ozguven S, 2016, EUR J NUCL MED MOL I, V43, P355, DOI 10.1007/s00259-015-3166-7
   Poekes L, 2015, CLIN SCI, V129, P933, DOI 10.1042/CS20150339
   Ren J, 2021, PHYSIOL REV, V101, P1745, DOI 10.1152/physrev.00030.2020
   Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869
   Sae-Tan S, 2015, J FUNCT FOODS, V14, P210, DOI 10.1016/j.jff.2015.01.036
   Sampath C, 2017, BIOMED PHARMACOTHER, V87, P73, DOI 10.1016/j.biopha.2016.12.082
   Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643
   Sidossis LS, 2015, CELL METAB, V22, P219, DOI 10.1016/j.cmet.2015.06.022
   Dinh TC, 2019, DIAB MET SYND CLIN R, V13, P1667, DOI 10.1016/j.dsx.2019.03.021
   Vasileva LV, 2020, PHARMACOL RES, V156, P0, DOI 10.1016/j.phrs.2020.104760
   Wang GX, 2015, TRENDS ENDOCRIN MET, V26, P231, DOI 10.1016/j.tem.2015.03.002
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Zhu J, 2020, J FUNCT FOODS, V64, P0, DOI 10.1016/j.jff.2019.103621
NR 48
TC 4
Z9 5
U1 3
U2 31
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2048-7177
EI 
J9 FOOD SCI NUTR
JI Food Sci. Nutr.
PD DEC 15
PY 2021
VL 9
IS 12
BP 6548
EP 6558
DI 10.1002/fsn3.2580
EA OCT 2021
PG 11
WC Food Science & Technology
SC Food Science & Technology
GA XM1DN
UT WOS:000704204900001
PM 34925784
DA 2025-04-28
ER

PT J
AU Nerurkar, PV
   Gandhi, K
   Chen, JJ
AF Nerurkar, Pratibha, V
   Gandhi, Krupa
   Chen, John J.
TI Correlations between Coffee Consumption and Metabolic Phenotypes, Plasma Folate, and Vitamin B12: NHANES 2003 to 2006
SO NUTRIENTS
LA English
DT Article
DE coffee; metabolic healthy obesity; metabolically healthy phenotype; metabolically unhealthy phenotypes
ID total homocysteine concentrations; randomized controlled-trial; all-cause mortality; body-mass index; healthy obesity; follow-up; serum-cholesterol; normal-weight; risk; caffeine
AB Metabolic syndrome (MetS) is prevalent not only among the overweight and obese but also normal weight individuals, and the phenotype is referred to as a metabolically unhealthy phenotype (MUHP). Besides normal weight individuals, overweight/obese individuals are also protected from MetS, and the phenotype is known as a metabolically healthy phenotype (MHP). Epidemiological studies indicate that coffee and micronutrients such as plasma folate or vitamin B12 (vit. B12) are inversely associated with MetS. However, correlations among coffee consumption metabolic phenotypes, plasma folate, and vit. B12 remain unknown. Our objective was to investigate the correlation between coffee consumption, metabolic phenotypes, plasma folate, and vit. B12 as well as to understand associations between plasma folate, vit. B12, and metabolic phenotypes. Associations among coffee consumption metabolic phenotypes, plasma folate, and vit. B12 were assessed in a cross-sectional study of 2201 participants, 18 years or older, from 2003-2004 and 2005-2006 National Health and Nutrition Examination Surveys (NHANES). MUHP was classified as having > three metabolic abnormalities. Coffee consumption was not associated with metabolic phenotypes, but negatively correlated with several metabolic variables, including BMI (p < 0.001). Plasma folate was positively associated with MUHP (p < 0.004), while vit. B12 was inversely associated with MUHP (p < 0.035). Our results suggest the potential protective impact of coffee on individual components of MetS and indicate a positive correlation between coffee consumption and MUHP among overweight individuals. Identifying possible dietary factors may provide practical and low-cost dietary intervention targets, specifically for early intervention. Larger and randomized intervention studies and prospective longitudinal studies are required to further evaluate these associations.
C1 [Nerurkar, Pratibha, V] Univ Hawaii Manoa, Coll Trop Agr & Human Resources CTAHR, Dept Mol Biosci & Bioengn MBBE, Lab Metab Disorders & Alternat Med, Honolulu, HI 96822 USA.
   [Gandhi, Krupa] Thomas Jefferson Univ Hosp, Div Biostat, Philadelphia, PA 19107 USA.
   [Chen, John J.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Quantitat Hlth Sci, Honolulu, HI 96813 USA.
C3 University of Hawaii System; University of Hawaii Manoa; Thomas Jefferson University; University of Hawaii System; University of Hawaii Manoa
RP Nerurkar, PV (corresponding author), Univ Hawaii Manoa, Coll Trop Agr & Human Resources CTAHR, Dept Mol Biosci & Bioengn MBBE, Lab Metab Disorders & Alternat Med, Honolulu, HI 96822 USA.
EM pratibha@hawaii.edu; krupa.gandhi@jefferson.edu; jjchen@hawaii.edu
FU Agriculture and Food Research Initiative, National Institute of Food and Agriculture, USDA [HAW05023-R, HAW00598-H, W3122, W4122, HAW00526-H, 2004-34135-15182]; National Institute of Health (NIH) [U54MD007601]
CR Al-khalidi B, 2019, CLIN NUTR, V38, P820, DOI 10.1016/j.clnu.2018.02.025
   Baspinar B, 2017, FOOD FUNCT, V8, P2089, DOI 10.1039/c7fo00388a
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Bidel Siamak, 2013, EUR ENDOCRINOL, V9, P99, DOI 10.17925/EE.2013.09.02.99
   Bird JK, 2015, J NUTR, V145, P79, DOI 10.3945/jn.114.199117
   Calcaterra V, 2019, MED PRIN PRACT, V28, P48, DOI 10.1159/000494138
   Choi MK, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-1166
   Corr√™a TAF, 2013, NUTRITION, V29, P977, DOI 10.1016/j.nut.2013.01.003
   CURB JD, 1986, AM J EPIDEMIOL, V123, P648, DOI 10.1093/oxfordjournals.aje.a114284
   DAVIS BR, 1988, AM J EPIDEMIOL, V128, P124, DOI 10.1093/oxfordjournals.aje.a114935
   Davis J, 2013, ETHNIC DIS, V23, P65
   De Lorenzo A, 2017, OBES RES CLIN PRACT, V11, P315, DOI 10.1016/j.orcp.2016.08.009
   de Winter M, 2018, J DIABETES RES, V2018, P0, DOI 10.1155/2018/7496768
   DESAI HG, 1973, GASTROENTEROLOGY, V65, P694
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009
   Esposito F, 2003, ALIMENT PHARM THER, V17, P595, DOI 10.1046/j.1365-2036.2003.01429.x
   Esteghamati A, 2014, DIABETES METAB, V40, P347, DOI 10.1016/j.diabet.2014.02.007
   Flores-Guerrero JL, 2020, JAMA NETW OPEN, V3, P0, DOI 10.1001/jamanetworkopen.2019.19274
   Gon√ßalves CG, 2016, NUTRITION, V32, P14, DOI 10.1016/j.nut.2015.07.010
   Grubben MJ, 2000, AM J CLIN NUTR, V71, P480
   Hall YN, 2011, ETHNIC DIS, V21, P40
   Han LY, 2017, AM J CLIN NUTR, V106, P1321, DOI 10.3945/ajcn.117.156232
   Harpaz Eynav, 2017, JOURNAL OF BASIC AND CLINICAL PHYSIOLOGY AND PHARMACOLOGY, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035
   Heinzle S, 2016, PEDIATR OBES, V11, P425, DOI 10.1111/ijpo.12083
   Hosseinpanah F, 2014, EUR J CLIN NUTR, V68, P295, DOI 10.1038/ejcn.2013.142
   Kanth V V Ravi, 2011, J CARDIOVASC DIS RES, V2, P156, DOI 10.4103/0975-3583.85262
   Karelis AD, 2014, DIABETES METAB, V40, P319, DOI 10.1016/j.diabet.2014.03.001
   Karelis AD, 2004, DIABETES OBES METAB, V6, P456, DOI 10.1111/j.1462-8902.2004.00377.x
   Kawada T, 2019, INT J FOOD SCI NUTR, V70, P651, DOI 10.1080/09637486.2018.1563878
   Kim AN, 2020, INT J ENV RES PUB HE, V17, P0, DOI 10.3390/ijerph17155379
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kim JW, 2015, MEDICINE, V94, P0, DOI 10.1097/MD.0000000000002335
   Kim K, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0167007
   Kim YH, 2018, J EXERC REHABIL, V14, P183, DOI 10.12965/jer.1836074.037
   Kim Y, 2018, BRIT J NUTR, V120, P1279, DOI 10.1017/S0007114518002635
   Komorita Y, 2020, BMJ OPEN DIAB RES CA, V8, P0, DOI 10.1136/bmjdrc-2020-001252
   Koyama T, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12103090
   Lee J, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9121340
   Lee WY, 2005, DIABETES RES CLIN PR, V67, P70, DOI 10.1016/j.diabres.2004.05.006
   Lin HL, 2017, MEDICINE, V96, P0, DOI 10.1097/MD.0000000000008838
   Loftfield E, 2016, J NUTR, V146, P1762, DOI 10.3945/jn.116.233940
   Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452
   Mendes MD, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0200701
   Messier V, 2010, OBESITY, V18, P911, DOI 10.1038/oby.2009.364
   Miranda AM, 2021, INT J FOOD SCI NUTR, V72, P794, DOI 10.1080/09637486.2020.1862069
   Miranda AM, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9030276
   Mirmiran P, 2020, INT J FOOD SCI NUTR, V71, P891, DOI 10.1080/09637486.2020.1746955
   Islam MT, 2018, CURR DRUG METAB, V19, P544, DOI 10.2174/1389200219666180302154551
   Mu√±oz-Garach A, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8060320
   Mursu J, 2005, FREE RADICAL BIO MED, V38, P527, DOI 10.1016/j.freeradbiomed.2004.11.025
   Nieber K, 2017, PLANTA MED, V83, P1256, DOI 10.1055/s-0043-115007
   Nygard O, 1997, AM J CLIN NUTR, V65, P136, DOI 10.1093/ajcn/65.1.136
   OKeefe JH, 2018, PROG CARDIOVASC DIS, V61, P38, DOI 10.1016/j.pcad.2018.02.002
   Olthof MR, 2001, AM J CLIN NUTR, V73, P532
   Panagiotakos DB, 2004, HEART VESSELS, V19, P280, DOI 10.1007/s00380-004-0779-3
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Paramsothy P, 2009, METABOLISM, V58, P212, DOI 10.1016/j.metabol.2008.09.016
   Rehm CD, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12082463
   Robertson TM, 2015, BRIT J NUTR, V114, P1218, DOI 10.1017/S0007114515002640
   Ruggiero E, 2021, J NUTR, V151, P395, DOI 10.1093/jn/nxaa365
   Sakamaki T, 2021, PUBLIC HEALTH, V191, P23, DOI 10.1016/j.puhe.2020.10.021
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213
   Song F, 2016, NFS JOURNAL, V4, P9
   Tan LJ, 2021, NUTRIENTS, V13, P0, DOI 10.3390/nu13030920
   Teramoto M, 2021, STROKE, V52, P957, DOI 10.1161/STROKEAHA.120.032273
   Mart√≠nez-Larrad MT, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0106641
   Thomas DR, 2020, CURR DEV NUTR, V4, P0, DOI 10.1093/cdn/nzz142
   Tian DD, 2019, CTS-CLIN TRANSL SCI, V12, P39, DOI 10.1111/cts.12598
   Tomiyama AJ, 2016, INT J OBESITY, V40, P883, DOI 10.1038/ijo.2016.17
   Ulvik A, 2008, CLIN CHEM, V54, P1489, DOI 10.1373/clinchem.2008.103465
   Urgert R, 2000, AM J CLIN NUTR, V72, P1107
   Urgert R, 1997, ANNU REV NUTR, V17, P305, DOI 10.1146/annurev.nutr.17.1.305
   Van Dam RM, 2004, DIABETES CARE, V27, P2990, DOI 10.2337/diacare.27.12.2990
   Verhoef P, 2002, AM J CLIN NUTR, V76, P1244, DOI 10.1093/ajcn/76.6.1244
   Vollset SE, 2000, AM J CLIN NUTR, V71, P403
   Wang TG, 2017, BMC MED, V15, P0, DOI 10.1186/s12916-017-0862-0
   Waskiewicz A, 2010, KARDIOL POL, V68, P275
   Watanabe T, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11071617
   WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698
   Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617
   Yamagata K, 2018, ANTIOXIDANTS-BASEL, V7, P0, DOI 10.3390/antiox7020026
   Yoshihara T, 2019, J PHARMACOL SCI, V139, P209, DOI 10.1016/j.jphs.2019.01.006
   Zhou A, 2019, AM J CLIN NUTR, V109, P509, DOI 10.1093/ajcn/nqy297
NR 87
TC 12
Z9 12
U1 1
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD APR 15
PY 2021
VL 13
IS 4
BP 
EP 
DI 10.3390/nu13041348
PG 18
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA RR8LT
UT WOS:000643343600001
PM 33919513
DA 2025-04-28
ER

PT J
AU de Ara√∫jo, FF
   Farias, DD
   Neri-Numa, IA
   Pastore, GM
AF de Araujo, Fabio Fernandes
   Farias, David de Paulo
   Neri-Numa, Iramaia Angelica
   Pastore, Glaucia Maria
TI Polyphenols and their applications: An approach in food chemistry and innovation potential
SO FOOD CHEMISTRY
LA English
DT Review
DE Phenolic compounds; Flavonoids; Phenolic acids; Anthocyanins; Tannins; Health benefits; Technological applications
ID chlorogenic acid; antioxidant activity; gallic acid; in-vitro; caffeic acid; dietary polyphenols; phenolic-compounds; oxidative stress; gelatin films; ellagic acid
AB Polyphenols are compounds naturally present in fruits and vegetables that are gaining more and more attention due to their therapeutic effects and their potential technological applications. In this review, we intend to demonstrate the importance of some phenolic compounds, addressing their biological effects and potential for applications in various industrial fields. The intake of these compounds in appropriate concentrations can present promising effects in the prevention of diseases such as diabetes, obesity, Parkinson's, Alzheimer's, and others. They can also be used to improve the physicochemical properties of starch, in the preservation of foods, as natural dyes, prebiotic ingredients, hydrogels and nanocomplexes. In addition, these compounds have potential for innovation in the most diverse technological fields, including organic fine chemistry, basic materials chemistry, pharmaceuticals, food chemistry, chemical engineering, etc.
C1 [de Araujo, Fabio Fernandes; Farias, David de Paulo; Neri-Numa, Iramaia Angelica; Pastore, Glaucia Maria] Univ Estadual Campinas, Fac Food Engn, Dept Food Sci, Bioflavors & Bioact Cpds Lab, Rua Monteiro Lobato 80, BR-13083862 Campinas, SP, Brazil.
C3 Universidade Estadual de Campinas
RP de Ara√∫jo, FF; Farias, DD (corresponding author), Univ Estadual Campinas, Fac Food Engn, Dept Food Sci, Bioflavors & Bioact Cpds Lab, Rua Monteiro Lobato 80, BR-13083862 Campinas, SP, Brazil.
EM fabio.fernandesn18@gmail.com; farias.davidp@gmail.com
FU National Council for Scientific and Technological Development, CNPq-Brazil [406820/2018-0]; Sao Paulo Research Foundation, FAPESP-Brazil [2015/50333-1]; Coordination for the Improvement of Higher Education Personnel, CAPES-Brazil [001]; CNPq [160639/2017-4]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [15/50333-1] Funding Source: FAPESP
CR Adami R, 2019, J SUPERCRIT FLUID, V143, P82, DOI 10.1016/j.supflu.2018.07.020
   Addepalli V, 2018, BIOMED PHARMACOTHER, V108, P1517, DOI 10.1016/j.biopha.2018.09.179
   Agunloye OM, 2019, BIOMED PHARMACOTHER, V109, P450, DOI 10.1016/j.biopha.2018.10.044
   Ali F, 2019, NEUROSCI LETT, V692, P90, DOI 10.1016/j.neulet.2018.10.053
   Unknown -, 2008, OFFICIAL JOURNAL OF THE EUROPEAN UNION, V16, P0
   Bakoyiannis I, 2019, BIOMED PHARMACOTHER, V109, P1488, DOI 10.1016/j.biopha.2018.10.086
   Barauna SC, 2018, METAB BRAIN DIS, V33, P1985, DOI 10.1007/s11011-018-0306-3
   Sanchez MB, 2017, BIOMED PHARMACOTHER, V94, P169, DOI 10.1016/j.biopha.2017.07.086
   Bener M, 2010, IND CROP PROD, V32, P499, DOI 10.1016/j.indcrop.2010.06.020
   Bhandarkar NS, 2019, NUTR RES, V62, P78, DOI 10.1016/j.nutres.2018.11.002
   Bondonno NP, 2020, CLIN NUTR, V39, P141, DOI 10.1016/j.clnu.2019.01.004
   Cano A, 2020, FOOD HYDROCOLLOID, V100, P0, DOI 10.1016/j.foodhyd.2019.105443
   Cao Z, 2018, J CELL PHYSIOL, V233, P2332, DOI 10.1002/jcp.26105
   Carloni P, 2013, FOOD RES INT, V53, P900, DOI 10.1016/j.foodres.2012.07.057
   Cassidy A, 2018, MOL ASPECTS MED, V61, P76, DOI 10.1016/j.mam.2017.05.002
   Castello F, 2018, ARCH BIOCHEM BIOPHYS, V646, P1, DOI 10.1016/j.abb.2018.03.021
   Catroux P, 2001, NO TITLE CAPTURED, V0, Patent No. [ES2225548T3., 2225548T3]
   Chaitanya LG, 2014, RESEARCH JOURNAL OF CHEMICAL SCIENCES, V4, P87
   Chatham LA, 2020, FOOD CHEM, V310, P0, DOI 10.1016/j.foodchem.2019.125734
   Chen GL, 2019, FOOD CHEM, V277, P706, DOI 10.1016/j.foodchem.2018.11.040
   Chen JY, 2018, BMC CANCER, V18, P0, DOI 10.1186/s12885-018-4231-y
   Chen L, 2019, TRENDS FOOD SCI TECH, V85, P149, DOI 10.1016/j.tifs.2018.11.026
   Chen TT, 2019, MOL NUTR FOOD RES, V63, P0, DOI 10.1002/mnfr.201801064
   Chen X, 2018, FOOD RES INT, V114, P30, DOI 10.1016/j.foodres.2018.07.062
   Cladis DP, 2020, FOOD CHEM TOXICOL, V139, P0, DOI 10.1016/j.fct.2020.111254
   Czubinski J, 2019, FOOD RES INT, V116, P1126, DOI 10.1016/j.foodres.2018.09.057
   Dasgupta F, 2013, NO TITLE CAPTURED, V0, Patent No. [US8513374B2., 8513374]
   de Ara√∫jo FF, 2019, FOOD RES INT, V121, P57, DOI 10.1016/j.foodres.2019.03.018
   de la Rosa LA, 2019, POSTHARVEST PHYSIOLOGY AND BIOCHEMISTRY OF FRUITS AND VEGETABLES, V0, PP253, DOI 10.1016/B978-0-12-813278-4.00012-9
   Decker KJ, 2018, CAN POLYPHENOLS SERV, V0, P0
   Del Bo C, 2019, CHEM-BIOL INTERACT, V300, P49, DOI 10.1016/j.cbi.2019.01.002
   Ding XQ, 2019, BIOMED PHARMACOTHER, V110, P85, DOI 10.1016/j.biopha.2018.11.018
   Du J, 2019, INT J BIOL MACROMOL, V132, P1193, DOI 10.1016/j.ijbiomac.2019.04.046
   Ebrahimi I, 2016, COLOR TECHNOL, V132, P162, DOI 10.1111/cote.12204
   Edwards M, 2015, J AGR FOOD CHEM, V63, P2423, DOI 10.1021/jf5041993
   El SN, 2012, COMPR REV FOOD SCI F, V11, P2, DOI 10.1111/j.1541-4337.2011.00167.x
   Mu√±oz AE, 2020, LWT-FOOD SCI TECHNOL, V128, P0, DOI 10.1016/j.lwt.2020.109457
   Fan SL, 2018, LIFE SCI, V207, P205, DOI 10.1016/j.lfs.2018.06.006
   Fang ZX, 2018, FOOD CHEM, V260, P90, DOI 10.1016/j.foodchem.2018.04.005
   Farias DD, 2019, TRENDS FOOD SCI TECH, V93, P23, DOI 10.1016/j.tifs.2019.09.004
   Farias DD, 2020, FOOD CHEM, V306, P0, DOI 10.1016/j.foodchem.2019.125630
   Farrag Y, 2018, INT J BIOL MACROMOL, V118, P2201, DOI 10.1016/j.ijbiomac.2018.07.087
   Fei JL, 2019, BIOMED PHARMACOTHER, V109, P1586, DOI 10.1016/j.biopha.2018.09.161
   Ferreira LP, 2017, IND CROP PROD, V97, P599, DOI 10.1016/j.indcrop.2016.12.064
   Fikry EM, 2019, BIOMED PHARMACOTHER, V110, P878, DOI 10.1016/j.biopha.2018.12.041
   Frauches NS, 2016, BRIT J PHARM RES, V12, P0, DOI 10.9734/BJPR/2016/26782
   Ganeshpurkar A, 2018, INT IMMUNOPHARMACOL, V54, P261, DOI 10.1016/j.intimp.2017.11.022
   Garrido EMPJ, 2018, FOOD CHEM, V254, P260, DOI 10.1016/j.foodchem.2018.02.007
   Ge J, 2018, FOOD HYDROCOLLOID, V74, P23, DOI 10.1016/j.foodhyd.2017.07.029
   Gibson GR, 2017, NAT REV GASTRO HEPAT, V14, P491, DOI 10.1038/nrgastro.2017.75
   Gowd V, 2019, TRENDS FOOD SCI TECH, V93, P81, DOI 10.1016/j.tifs.2019.09.005
   Gu RX, 2018, BIOMED PHARMACOTHER, V105, P491, DOI 10.1016/j.biopha.2018.05.158
   Gunm L, 2018, GUT BOOSTING POTENTI, V0, P0
   Heleno SA, 2015, FOOD CHEM, V173, P501, DOI 10.1016/j.foodchem.2014.10.057
   Huang BX, 2018, J FUNCT FOODS, V45, P452, DOI 10.1016/j.jff.2018.04.018
   Hytti M, 2017, J NUTR BIOCHEM, V42, P37, DOI 10.1016/j.jnutbio.2016.12.014
   Iglesias-Carres L, 2019, FOOD CHEM, V299, P0, DOI 10.1016/j.foodchem.2019.125092
   Jiang J, 2018, FOOD CHEM, V268, P334, DOI 10.1016/j.foodchem.2018.06.015
   Jiang L, 2020, MATER DESIGN, V192, P0, DOI 10.1016/j.matdes.2020.108674
   Jiao XY, 2019, J NUTR BIOCHEM, V64, P88, DOI 10.1016/j.jnutbio.2018.07.008
   Kaewprachu P, 2018, FOOD PACKAGING SHELF, V18, P173, DOI 10.1016/j.fpsl.2018.10.011
   Kfoury M, 2019, FOOD CHEM, V278, P163, DOI 10.1016/j.foodchem.2018.11.055
   Khoo HE, 2017, FOOD NUTR RES, V61, P1, DOI 10.1080/16546628.2017.1361779
   Kumari M, 2012, RES J RECENT SCI, V1, P1
   Landete JM, 2011, FOOD RES INT, V44, P1150, DOI 10.1016/j.foodres.2011.04.027
   Li PP, 2019, FOOD HYDROCOLLOID, V92, P208, DOI 10.1016/j.foodhyd.2019.02.002
   Li XH, 2019, CARBOHYD POLYM, V207, P160, DOI 10.1016/j.carbpol.2018.11.084
   Links MR, 2015, J FUNCT FOODS, V12, P55, DOI 10.1016/j.jff.2014.11.003
   Liu B, 2017, DYES PIGMENTS, V142, P32, DOI 10.1016/j.dyepig.2017.03.023
   Liu J, 2018, INT J BIOL MACROMOL, V116, P1011, DOI 10.1016/j.ijbiomac.2018.05.149
   Liu J, 2018, INT J BIOL MACROMOL, V114, P130, DOI 10.1016/j.ijbiomac.2018.03.101
   Loi M, 2018, FOOD RES INT, V106, P763, DOI 10.1016/j.foodres.2018.01.050
   L√≥pez CJ, 2019, FOOD CHEM, V275, P426, DOI 10.1016/j.foodchem.2018.09.099
   Neto ML, 2018, SPECTROCHIM ACTA A, V193, P249, DOI 10.1016/j.saa.2017.12.036
   Lukic I, 2019, FOOD CHEM, V300, P0, DOI 10.1016/j.foodchem.2019.125251
   Mahobiya A, 2018, PHARMACOL REP, V70, P863, DOI 10.1016/j.pharep.2018.03.006
   G√≥mez-Caravaca AM, 2014, POLYPHENOLS IN PLANTS: ISOLATION, V0, P37, DOI 10.1016/B978-0-12-397934-6.00003-6
   Mazed MA, 2009, NO TITLE CAPTURED, V0, Patent No. [US8017147B2, 8017147]
   Mendoz J, 2018, DYES PIGMENTS, V151, P321, DOI 10.1016/j.dyepig.2018.01.007
   Mocciaro G, 2019, J FUNCT FOODS, V63, P0, DOI 10.1016/j.jff.2019.103576
   Molino S, 2018, J FUNCT FOODS, V49, P188, DOI 10.1016/j.jff.2018.07.056
   Murakami A, 2014, ARCH BIOCHEM BIOPHYS, V557, P3, DOI 10.1016/j.abb.2014.04.018
   Netke S, 2008, NO TITLE CAPTURED, V0, Patent No. [AU2003235762B2., 2003235762]
   Oracz J, 2019, FOOD RES INT, V115, P135, DOI 10.1016/j.foodres.2018.08.028
   Orbit, 2020, QUEST NEW PORT PAT D, V0, P0
   Park S, 2019, J NUTR BIOCHEM, V63, P87, DOI 10.1016/j.jnutbio.2018.09.024
   Park YS, 2015, FOOD RES INT, V74, P37, DOI 10.1016/j.foodres.2015.04.021
   Phan K, 2020, DYES PIGMENTS, V176, P0, DOI 10.1016/j.dyepig.2019.108180
   Rashid S, 2018, J MED FOOD, V21, P390, DOI 10.1089/jmf.2017.0078
   Rodriguez-Amaya DB, 2019, FOOD RES INT, V124, P200, DOI 10.1016/j.foodres.2018.05.028
   Rui LY, 2017, CARBOHYD POLYM, V170, P206, DOI 10.1016/j.carbpol.2017.04.076
   Santana AL, 2018, J FUNCT FOODS, V47, P457, DOI 10.1016/j.jff.2018.05.048
   Santos S, 2018, NUTR METAB CARDIOVAS, V28, P1188, DOI 10.1016/J.NUMECD.2018.06.019
   Saulite L, 2019, PHYTOMEDICINE, V53, P86, DOI 10.1016/j.phymed.2018.09.029
   Sganzerla WG, 2020, INT J BIOL MACROMOL, V147, P295, DOI 10.1016/j.ijbiomac.2020.01.074
   Sharma D, 2019, BIOMED PHARMACOTHER, V109, P1610, DOI 10.1016/j.biopha.2018.10.195
   Shi J, 2020, IND CROP PROD, V145, P0, DOI 10.1016/j.indcrop.2020.112130
   Shirmohammadli Y, 2018, IND CROP PROD, V126, P316, DOI 10.1016/j.indcrop.2018.10.034
   Singh S, 2019, PHYTOMEDICINE, V55, P92, DOI 10.1016/j.phymed.2018.07.009
   Skrovankova S, 2015, INT J MOL SCI, V16, P24673, DOI 10.3390/ijms161024673
   Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336
   Thilavech T, 2018, J FUNCT FOODS, V49, P258, DOI 10.1016/j.jff.2018.08.034
   Uranga J, 2018, FOOD HYDROCOLLOID, V84, P313, DOI 10.1016/j.foodhyd.2018.06.018
   Urbatzka R, 2018, EUR J MED CHEM, V151, P272, DOI 10.1016/j.ejmech.2018.03.036
   Vilela C, 2017, FOOD HYDROCOLLOID, V73, P120, DOI 10.1016/j.foodhyd.2017.06.037
   Vinha AF, 2018, POLYPHENOLS: PROPERTIES, V0, P0
   Vuolo MM, 2019, BIOACTIVE COMPOUNDS: HEALTH BENEFITS AND POTENTIAL APPLICATIONS, V0, PP33, DOI 10.1016/B978-0-12-814774-0.00002-5
   Xing J, 2019, INT IMMUNOPHARMACOL, V66, P146, DOI 10.1016/j.intimp.2018.11.016
   Yang H, 2019, CHEM-BIOL INTERACT, V297, P44, DOI 10.1016/j.cbi.2018.10.016
   Yu M, 2019, NEUROBIOL DIS, V124, P67, DOI 10.1016/j.nbd.2018.11.009
   Zaitone SA, 2019, PHARMACOL REP, V71, P32, DOI 10.1016/j.pharep.2018.08.004
   Zhang JJ, 2019, FOOD CHEM, V272, P306, DOI 10.1016/j.foodchem.2018.08.041
   Zhang XK, 2018, FOOD RES INT, V106, P568, DOI 10.1016/j.foodres.2017.12.054
   Zhao YJ, 2019, J SUPERCRIT FLUID, V143, P97, DOI 10.1016/j.supflu.2018.07.025
   Zheleva-Dimitrova D, 2019, FOOD CHEM TOXICOL, V134, P0, DOI 10.1016/j.fct.2019.110841
   Zhou BH, 2019, FOOD CHEM TOXICOL, V123, P16, DOI 10.1016/j.fct.2018.10.036
   Zhu L, 2019, INT IMMUNOPHARMACOL, V67, P129, DOI 10.1016/j.intimp.2018.11.049
   Zou B, 2014, J FUNCT FOODS, V11, P330, DOI 10.1016/j.jff.2014.10.016
NR 118
TC 287
Z9 293
U1 53
U2 899
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD FEB 15
PY 2021
VL 338
IS 
BP 
EP 
DI 10.1016/j.foodchem.2020.127535
PG 15
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA OE5GW
UT WOS:000580559700098
PM 32798817
DA 2025-04-28
ER

PT J
AU Zou, HY
   Ye, HQ
   Kamaraj, R
   Zhang, TH
   Zhang, J
   Pavek, P
AF Zou, Haoyang
   Ye, Haiqing
   Kamaraj, Rajamanikkam
   Zhang, Tiehua
   Zhang, Jie
   Pavek, Petr
TI A review on pharmacological activities and synergistic effect of quercetin with small molecule agents
SO PHYTOMEDICINE
LA English
DT Review
DE Quercetin; Pharmacological activities; Synergistic effect; Combination therapy
ID primary liver-cancer; cell-cycle arrest; oxidative stress; flavonoid quercetin; enhanced inhibition; plant flavonoids; tumor-growth; in-vitro; combination; resveratrol
AB Background: Quercetin is a natural flavonoid, which widely exists in nature, such as tea, coffee, apples, and onions. Numerous studies have showed that quercetin has multiple biological activities such as anti-oxidation, anti-inflammatory, and anti-aging. Hence, quercetin has a significant therapeutic effect on cancers, obesity, diabetes, and other diseases. In the past decades, a large number of studies have shown that quercetin combined with other agents can significantly improve the overall therapeutic effect, compared to single use. Purpose: This work reviews the pharmacological activities of quercetin and its derivatives. In addition, this work also summarizes both in vivo and in vitro experimental evidence for the synergistic effect of quercetin against cancers and metabolic diseases. Methods: An extensive systematic search for pharmacological activities and synergistic effect of quercetin was performed considering all the relevant literatures published until August 2021 through the databases including NCBI PubMed, Scopus, Web of Science, and Google Scholar. The relevant literatures were extracted from the databases with following keyword combinations: "pharmacological activities" OR "biological activities" OR "synergistic effect" OR "combined" OR "combination" AND "quercetin" as well as free-text words. Results: Quercetin and its derivatives possess multiple pharmacological activities including anti-cancer, antioxidant, anti-inflammatory, anti-cardiovascular, anti-aging, and neuroprotective activities. In addition, the synergistic effect of quercetin with small molecule agents against cancers and metabolic diseases has also been confirmed. Conclusion: Quercetin cooperates with agents to improve the therapeutic effect by regulating signal molecules and blocking cell cycle. Synergistic therapy can reduce the dose of agents and avoid the possible toxic and side effects in the treatment process. Although quercetin treatment has some potential side effects, it is safe under the expected use conditions. Hence, quercetin has application value and potential strength as a clinical drug. Furthermore, quercetin, as the main effective therapeutic ingredient in traditional Chinese medicine, may effectively treat and prevent coronavirus disease 2019 (COVID-19).
C1 [Zou, Haoyang; Ye, Haiqing; Zhang, Tiehua; Zhang, Jie] Jilin Univ, Coll Food Sci & Engn, Changchun 130062, Peoples R China.
   [Kamaraj, Rajamanikkam; Pavek, Petr] Charles Univ Prague, Fac Pharm, Dept Pharmacol & Toxicol, Heyrovskeho 1203, CZ-50005 Hradec Kralove, Czech Republic.
C3 Jilin University; Charles University Prague
RP Zhang, J (corresponding author), Jilin Univ, Coll Food Sci & Engn, Changchun 130062, Peoples R China.; Pavek, P (corresponding author), Charles Univ Prague, Fac Pharm, Dept Pharmacol & Toxicol, Heyrovskeho 1203, CZ-50005 Hradec Kralove, Czech Republic.
EM zhangjie83@jlu.edu.cn; petr.pavek@faf.cuni.cz
FU National Natural Science Foundation of China [31972160]; Science and Technology Development Project Foundation of Jilin Province [20200201204JC]; Student Project of Charles University [SVV 260 549]
CR Abdel-Diam MM, 2019, ENVIRON SCI POLLUT R, V26, P3659, DOI 10.1007/s11356-018-3907-9
   Aeschbacher H U, 1982, NUTR CANCER, V4, P90, DOI 10.1080/01635588209513744
   Al Humayed S, 2019, ULTRASTRUCT PATHOL, V43, P162, DOI 10.1080/01913123.2019.1680585
   Amanzadeh E, 2019, REV NEUROSCIENCE, V30, P555, DOI 10.1515/revneuro-2018-0080
   Andres S, 2018, MOL NUTR FOOD RES, V62, P0, DOI 10.1002/mnfr.201700447
   Ansari MA, 2009, J NUTR BIOCHEM, V20, P269, DOI 10.1016/j.jnutbio.2008.03.002
   Aoyagi T, 2015, WORLD J GASTRO ONCOL, V7, P17, DOI 10.4251/wjgo.v7.i4.17
   Aranaz P, 2020, FOOD FUNCT, V11, P4512, DOI 10.1039/d0fo00504e
   Arias N, 2016, EUR J NUTR, V55, P341, DOI 10.1007/s00394-015-0854-9
   Ayissi VBO, 2014, MOL NUTR FOOD RES, V58, P22, DOI 10.1002/mnfr.201300195
   Azevedo MI, 2013, MOL PAIN, V9, P0, DOI 10.1186/1744-8069-9-53
   Babenkova IV, 2018, B EXP BIOL MED+, V165, P347, DOI 10.1007/s10517-018-4167-x
   Bachevski D, 2020, DERMATOL THER, V33, P0, DOI 10.1111/dth.13780
   Baksi R, 2018, BIOMED PHARMACOTHER, V106, P1513, DOI 10.1016/j.biopha.2018.07.106
   Baran I, 2014, LEUKEMIA RES, V38, P836, DOI 10.1016/j.leukres.2014.04.010
   Bester L, 2014, J MED IMAG RADIAT ON, V58, P341, DOI 10.1111/1754-9485.12163
   Bischoff SC, 2008, CURR OPIN CLIN NUTR, V11, P733, DOI 10.1097/MCO.0b013e32831394b8
   BJELDANES LF, 1977, SCIENCE, V197, P577, DOI 10.1126/science.327550
   Bosch FX, 2004, GASTROENTEROLOGY, V127, PS5, DOI 10.1053/j.gastro.2004.09.011
   Brito AF, 2016, NUTR CANCER, V68, P250, DOI 10.1080/01635581.2016.1145245
   CARIA H, 1995, MUTAT RES-GENET TOX, V343, P85, DOI 10.1016/0165-1218(95)90075-6
   Carrasco-Pozo C, 2019, J MED FOOD, V22, P753
   Carrasco-Torres G, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/2734976
   Carullo G, 2017, FUTURE MED CHEM, V9, P79, DOI 10.4155/fmc-2016-0186
   Chen FY, 2015, MOL MED REP, V11, P341, DOI 10.3892/mmr.2014.2734
   Chen LC, 2016, INT J NANOMED, V11, P1557, DOI 10.2147/IJN.S103681
   Chondrogianni N, 2010, EXP GERONTOL, V45, P763, DOI 10.1016/j.exger.2010.07.001
   Chuang CH, 2019, CHEM-BIOL INTERACT, V306, P54, DOI 10.1016/j.cbi.2019.04.006
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   Coldiron AD, 2002, J BIOCHEM MOL TOXIC, V16, P197, DOI 10.1002/jbt.10035
   Coldman AJ, 2003, CAN MED ASSOC J, V168, P31
   Dajas F, 2012, J ETHNOPHARMACOL, V143, P383, DOI 10.1016/j.jep.2012.07.005
   Das N, 2013, FOOD FUNCT, V4, P889, DOI 10.1039/c3fo30241e
   Del Follo-Martinez A, 2013, NUTR CANCER, V65, P494, DOI 10.1080/01635581.2012.725194
   Deng X, 2021, J ETHNOPHARMACOL, V278, P0
   Desrini S, 2017, BANGLADESH J MED SCI, V16, P91, DOI 10.3329/bjms.v16i1.31139
   DiLoreto R, 2015, MOL BIOL CELL, V26, P4524, DOI 10.1091/mbc.E14-06-1084
   DUNNICK JK, 1992, FUND APPL TOXICOL, V19, P423, DOI 10.1016/0272-0590(92)90181-G
   Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127
   Elkady MA, 2019, HUM EXP TOXICOL, V38, P1283, DOI 10.1177/0960327119865588
   Ferry DR, 1996, CLIN CANCER RES, V2, P659
   Geng LL, 2019, PROTEIN CELL, V10, P417, DOI 10.1007/s13238-018-0567-y
   Ghosh A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0057735
   H√§drich G, 2016, PHARM RES-DORDR, V33, P983, DOI 10.1007/s11095-015-1844-6
   HARDIGREE AA, 1978, MUTAT RES, V58, P231, DOI 10.1016/0165-1218(78)90014-9
   Hashemzaei M, 2017, ONCOL REP, V38, P819, DOI 10.3892/or.2017.5766
   Heng HHQ, 2010, J CELL BIOCHEM, V109, P1072, DOI 10.1002/jcb.22497
   Herm√°nkov√° E, 2019, FREE RADICAL BIO MED, V143, P240, DOI 10.1016/j.freeradbiomed.2019.08.001
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Hsieh TC, 2009, ANTICANCER RES, V29, P4025
   Jaishree V, 2020, BIOMED PHARMACOTHER, V130, P0, DOI 10.1016/j.biopha.2020.110561
   Jakaria M, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8111789
   Jalili-Baleh L, 2018, EUR J MED CHEM, V152, P570, DOI 10.1016/j.ejmech.2018.05.004
   Jiang ML, 2019, J DRUG DELIV SCI TEC, V54, P0, DOI 10.1016/j.jddst.2019.101316
   Khurana S, 2013, NUTRIENTS, V5, P3779, DOI 10.3390/nu5103779
   Kleemann R, 2011, ATHEROSCLEROSIS, V218, P44, DOI 10.1016/j.atherosclerosis.2011.04.023
   Langner E, 2019, J FOOD BIOCHEM, V43, P0, DOI 10.1111/jfbc.12802
   Leng EN, 2018, BMC COMPLEM ALTERN M, V18, P0, DOI 10.1186/s12906-018-2189-6
   Leng Y, 2021, FOOD CHEM TOXICOL, V155, P0, DOI 10.1016/j.fct.2021.112413
   Lespade L, 2016, CHEM PHYS, V475, P32, DOI 10.1016/j.chemphys.2016.06.006
   Li W, 2014, ONCOL REP, V31, P117, DOI 10.3892/or.2013.2811
   Li YY, 2014, ACTA BIOCH BIOPH SIN, V46, P460, DOI 10.1093/abbs/gmu023
   Lin CF, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21030334
   Liu RH, 2004, J NUTR, V134, P3479S, DOI 10.1093/jn/134.12.3479S
   Liu S, 2020, MOL PHARMACEUT, V17, P1415, DOI 10.1021/acs.molpharmaceut.0c00138
   Lu J, 2018, MED SCI MONITOR, V24, P2583, DOI 10.12659/MSM.906172
   Luo ED, 2020, CHIN MED-UK, V15, P0, DOI 10.1186/s13020-020-00317-x
   Luo JM, 2017, FOOD RES INT, V100, P579, DOI 10.1016/j.foodres.2017.07.019
   Ma ZS, 2004, INT J ONCOL, V24, P1297
   Magar RT, 2020, J MICROBIOL BIOTECHN, V30, P11, DOI 10.4014/jmb.1907.07003
   Mansourizadeh F, 2020, COLLOID SURFACE B, V191, P0, DOI 10.1016/j.colsurfb.2020.110982
   Maurya Vimal K, 2020, VIRUSDISEASE, V31, P179, DOI 10.1007/s13337-020-00598-8
   Mbikay M, 2014, FEBS OPEN BIO, V4, P755, DOI 10.1016/j.fob.2014.08.003
   Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201
   Mehrbod P, 2021, BIOMOLECULES, V11, P0, DOI 10.3390/biom11010010
   Mertens-Talcott SU, 2005, CANCER LETT, V218, P141, DOI 10.1016/j.canlet.2004.06.007
   Miclea I, 2015, BULLETIN OF UNIVERSITY OF AGRICULTURAL SCIENCES AND VETERINARY MEDICINE CLUJ-NAPOCA. ANIMAL SCIENCE AND BIOTECHNOLOGIES, V72, P182
   Miltonprabu S, 2017, FOOD CHEM TOXICOL, V108, P365, DOI 10.1016/j.fct.2016.08.034
   Mukhopadhyay P, 2015, RSC ADV, V5, P97547, DOI 10.1039/c5ra18896b
   Noh HJ, 2014, J MED FOOD, V17, P550
   Okamoto T, 2005, INT J MOL MED, V16, P275
   Ortega MG, 2010, ARCH BIOCHEM BIOPHYS, V498, P105, DOI 10.1016/j.abb.2010.04.014
   Park HJ, 2008, J MED FOOD, V11, P773, DOI 10.1089/jmf.2008.0077
   Patel RV, 2018, EUR J MED CHEM, V155, P889, DOI 10.1016/j.ejmech.2018.06.053
   Pham TND, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20174293
   Prabu SM, 2011, EUR REV MED PHARM, V14, P903
   Quagliariello V, 2016, J CELL PHYSIOL, V231, P1784, DOI 10.1002/jcp.25283
   Rauf A, 2018, PHYTOTHER RES, V32, P2109, DOI 10.1002/ptr.6155
   Redondo A, 2012, FREE RADICAL RES, V46, P619, DOI 10.3109/10715762.2012.660527
   Refat MS, 2021, PLOS ONE, V16, P0, DOI 10.1371/journal.pone.0246265
   Ren KW, 2017, INT J ONCOL, V50, P1299, DOI 10.3892/ijo.2017.3886
   Ren L, 2021, FOOD CHEM, V340, P0, DOI 10.1016/j.foodchem.2020.127933
   RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2
   Rubio S, 2007, CARCINOGENESIS, V28, P2105, DOI 10.1093/carcin/bgm131
   Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010
   SAHU RK, 1981, MUTAT RES, V89, P69, DOI 10.1016/0165-1218(81)90132-4
   Sahyon HA, 2019, PHARM CHEM J+, V53, P803, DOI 10.1007/s11094-019-02083-z
   Sargiacomo C, 2020, AGING-US, V12, P6511, DOI 10.18632/aging.103001
   Schlachterman A, 2008, TRANSL ONCOL, V1, P19, DOI 10.1593/tlo.07100
   Serri C, 2019, J CELL PHYSIOL, V234, P4959, DOI 10.1002/jcp.27297
   Serwer P, 2018, MED HYPOTHESES, V110, P60, DOI 10.1016/j.mehy.2017.11.001
   Shao Y, 2016, RSC ADV, V6, P12235, DOI 10.1039/c5ra16493a
   Sharma A, 2018, PHARM PAT ANAL, V7, P15, DOI 10.4155/ppa-2017-0030
   Shi GJ, 2019, BIOMED PHARMACOTHER, V109, P1085, DOI 10.1016/j.biopha.2018.10.130
   Shi YX, 2019, ONCOL LETT, V18, P153, DOI 10.3892/ol.2019.10299
   Shih YL, 2010, J AGR FOOD CHEM, V58, P235, DOI 10.1021/jf9031684
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   Spencer JPE, 2003, BIOCHEM J, V372, P173, DOI 10.1042/BJ20021972
   Srivastava Rakesh K, 2011, FRONT BIOSCI (ELITE ED), V3, P515, DOI 10.2741/e266
   Staedler D, 2011, CANCER CHEMOTH PHARM, V68, P1161, DOI 10.1007/s00280-011-1596-x
   Suganthy N, 2016, BIOMED PHARMACOTHER, V84, P892, DOI 10.1016/j.biopha.2016.10.011
   Takahama U, 2011, FOOD CHEM, V126, P1808, DOI 10.1016/j.foodchem.2010.12.009
   TEOFILI L, 1992, LEUKEMIA RES, V16, P497, DOI 10.1016/0145-2126(92)90176-8
   Tohge T, 2017, J EXP BOT, V68, P4013, DOI 10.1093/jxb/erx177
   Vijg J, 2005, ANNU REV MED, V56, P193, DOI 10.1146/annurev.med.56.082103.104617
   Wang GD, 2013, ONCOL REP, V30, P357, DOI 10.3892/or.2013.2469
   Wang PW, 2015, MOL NUTR FOOD RES, V59, P250, DOI 10.1002/mnfr.201400558
   Wang PW, 2014, J NUTR BIOCHEM, V25, P73, DOI 10.1016/j.jnutbio.2013.09.005
   Wang PW, 2012, NUTR CANCER, V64, P580, DOI 10.1080/01635581.2012.661514
   Wang YP, 2021, FOOD FUNCT, V12, P2468, DOI 10.1039/d0fo02894k
   Wong MY, 2010, ANTI-CANCER DRUG, V21, P401, DOI 10.1097/CAD.0b013e328336e940
   Yang FY, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0128277
   Yang H, 2019, FEBS J, V286, P5030, DOI 10.1111/febs.15172
   Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003
   Yang ML, 2020, IND CROP PROD, V143, P0, DOI 10.1016/j.indcrop.2019.05.082
   YEH YA, 1995, LIFE SCI, V57, P1285, DOI 10.1016/0024-3205(95)02085-W
   Yohanathan L, 2019, SURG ONCOL CLIN N AM, V28, P229, DOI 10.1016/j.soc.2018.11.003
   Zhang J, 2020, EFOOD, V1, P392
   Zhang J, 2021, FOOD CHEM TOXICOL, V155, P0, DOI 10.1016/j.fct.2021.112379
   Zhang TH, 2020, FOOD CHEM TOXICOL, V135, P0, DOI 10.1016/j.fct.2019.111017
   Zhang TH, 2020, CRIT REV FOOD SCI, V60, P94, DOI 10.1080/10408398.2018.1514580
   Zhao JQ, 2021, FOOD CHEM TOXICOL, V155, P0, DOI 10.1016/j.fct.2021.112411
   Zhao L, 2017, EXP THER MED, V14, P5942, DOI 10.3892/etm.2017.5331
   Zhao L, 2017, FOOD FUNCT, V8, P4644, DOI 10.1039/C7FO01383C
   Zhou J, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0172838
   Zhou J, 2016, ONCOL LETT, V12, P516, DOI 10.3892/ol.2016.4639
   Zhou MM, 2012, J PROTEOME RES, V11, P4961, DOI 10.1021/pr3004826
NR 137
TC 118
Z9 121
U1 30
U2 188
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0944-7113
EI 1618-095X
J9 PHYTOMEDICINE
JI Phytomedicine
PD NOV 15
PY 2021
VL 92
IS 
BP 
EP 
DI 10.1016/j.phymed.2021.153736
EA SEP 2021
PG 10
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine
GA WB8NI
UT WOS:000703823800021
PM 34560520
DA 2025-04-28
ER

PT J
AU James, JE
AF James, Jack E.
TI Maternal caffeine consumption and pregnancy outcomes: a narrative review with implications for advice to mothers and mothers-to-be
SO BMJ EVIDENCE-BASED MEDICINE
LA English
DT Review
DE behavioral medicine; child health; policy; substance-related disorders; women&apos; s health
ID for-gestational-age; birth-weight; dose-response; childhood leukemia; preterm birth; withdrawal symptoms; coffee consumption; parental smoking; beverage intake; healthy-adults
AB Objectives Caffeine is a habit-forming substance consumed daily by the majority of pregnant women. Accordingly, it is important that women receive sound evidence-based advice about potential caffeine-related harm. This narrative review examines evidence of association between maternal caffeine consumption and negative pregnancy outcomes, and assesses whether current health advice concerning maternal caffeine consumption is soundly based. Methods Database searches using terms linking caffeine and caffeinated beverages to pregnancy outcomes identified 1261 English language peer-reviewed articles. Screening yielded a total of 48 original observational studies and meta-analyses of maternal caffeine consumption published in the past two decades. The articles reported results for one or more of six major categories of negative pregnancy outcomes: miscarriage, stillbirth, low birth weight and/or small for gestational age, preterm birth, childhood acute leukaemia, and childhood overweight and obesity. Results Of 42 separate sets of findings reported in 37 observational studies, 32 indicated significantly increased caffeine-related risk and 10 suggested no or inconclusive associations. Caffeine-related increased risk was reported with moderate to high levels of consistency for all pregnancy outcomes except preterm birth. Of 11 studies reporting 17 meta-analyses, there was unanimity among 14 analyses in finding maternal caffeine consumption to be associated with increased risk for the four outcome categories of miscarriage, stillbirth, low birth weight and/or small for gestational age, and childhood acute leukaemia. The three remaining meta-analyses were also unanimous in reporting absence of a reliable association between maternal caffeine consumption and preterm birth. No meta-analyses were identified for childhood overweight and obesity, although four of five original observational studies reported significant associations linking maternal caffeine consumption to that outcome category. Conclusions The substantial majority finding from observational studies and meta-analyses is that maternal caffeine consumption is reliably associated with major negative pregnancy outcomes. Reported findings were robust to threats from potential confounding and misclassification. Among both observational studies and meta-analyses, there were frequent reports of significant dose-response associations suggestive of causation, and frequent reports of no threshold of consumption below which associations were absent. Consequently, current evidence does not support health advice that assumes 'moderate' caffeine consumption during pregnancy is safe. On the contrary, the cumulative scientific evidence supports pregnant women and women contemplating pregnancy being advised to avoid caffeine.
C1 [James, Jack E.] Reykjavik Univ, Psychol, IS-101 Reykjavik, Iceland.
C3 Reykjavik University
RP James, JE (corresponding author), Reykjavik Univ, Psychol, IS-101 Reykjavik, Iceland.
EM jack@ru.is
CR ALDRIDGE A, 1981, SEMIN PERINATOL, V5, P310
   American College of Obstetricians and Gynecologists, 2016, COMM OP MOD CAFF CON, V0, P0
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V0, P0
   Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792
   Bech BH, 2007, BMJ-BRIT MED J, V334, P409, DOI 10.1136/bmj.39062.520648.BE
   Bech BH, 2006, INT J EPIDEMIOL, V35, P948, DOI 10.1093/ije/dyl116
   Bech Bodil Hammer, 2015, JOURNAL OF CAFFEINE RESEARCH, V5, P65, DOI 10.1089/jcr.2015.0001
   Bonaventure A, 2013, CANCER CAUSE CONTROL, V24, P783, DOI 10.1007/s10552-013-0161-9
   Boylan SM, 2013, MATERN CHILD HLTH J, V17, P601, DOI 10.1007/s10995-012-1034-7
   Boylan S, 2008, BMJ-BRIT MED J, V337, P0, DOI 10.1136/bmj.a2332
   Bracken MB, 2003, AM J EPIDEMIOL, V157, P456, DOI 10.1093/aje/kwf220
   BRAZIER JL, 1981, SEMIN PERINATOL, V5, P315
   Buscariollo DL, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0087547
   CARTER AJ, 1995, J PHARMACOL EXP THER, V273, P637
   Chen LW, 2019, AM J CLIN NUTR, V109, P1648, DOI 10.1093/ajcn/nqz019
   Chen LW, 2018, AM J CLIN NUTR, V108, P1301, DOI 10.1093/ajcn/nqy219
   Chen LW, 2016, PUBLIC HEALTH NUTR, V19, P1233, DOI 10.1017/S1368980015002463
   Chen LW, 2014, BMC MED, V12, P0, DOI 10.1186/s12916-014-0174-6
   Cheng J, 2014, AM J OBSTET GYNECOL, V210, P0, DOI 10.1016/j.ajog.2013.09.026
   Chiaffarino F, 2006, EUR J CLIN NUTR, V60, P610, DOI 10.1038/sj.ejcn.1602358
   Clausson B, 2002, AM J EPIDEMIOL, V155, P429, DOI 10.1093/aje/155.5.429
   Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503
   Curtin SallyC, 2013, PREGNANCY RATES FOR U.S. WOMEN CONTINUE TO DROP, V0, P0
   Darakjian LI, 2019, MOL PHARMACEUT, V16, P1340, DOI 10.1021/acs.molpharmaceut.8b01276
   Demortain D, 2018, PERV POW CORP AUTH P, V0, P0
   DK L, 2015, INT J OBESITY, V39, P658
   Doepker C, 2016, ANNU REV FOOD SCI T, V7, P117, DOI 10.1146/annurev-food-041715-033243
   Doepker C, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10101536
   DUMAS M, 1982, DEV PHARMACOL THERAP, V4, P182, DOI 10.1159/000457375
   DUNLOP M, 1981, BIOL NEONATE, V39, P178
   Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31
   EFSA, 2016, EFSA J, V14, P0, DOI 10.2903/j.efsa.2016.4552
   Ewing AC, 2017, MATERN CHILD HLTH J, V21, P786, DOI 10.1007/s10995-016-2165-z
   dos Santos MKF, 2018, N-S ARCH PHARMACOL, V391, P1301, DOI 10.1007/s00210-018-1570-9
   Fernandes O, 1998, REPROD TOXICOL, V12, P435, DOI 10.1016/S0890-6238(98)00024-0
   Ferr√© S, 2016, PSYCHOPHARMACOLOGY, V233, P1963, DOI 10.1007/s00213-016-4212-2
   FRANCHETTI P, 1994, J MED CHEM, V37, P2970, DOI 10.1021/jm00044a018
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   FUJII T, 1972, TOXICOL APPL PHARM, V22, P449, DOI 10.1016/0041-008X(72)90252-9
   Fulgoni VL, 2015, AM J CLIN NUTR, V101, P1081, DOI 10.3945/ajcn.113.080077
   Gal√©ra C, 2016, BIOL PSYCHIAT, V80, P720, DOI 10.1016/j.biopsych.2015.08.034
   GARRETT BE, 1994, PHARMACOL BIOCHEM BE, V47, P89, DOI 10.1016/0091-3057(94)90115-5
   Gaskins AJ, 2018, EUR J NUTR, V57, P107, DOI 10.1007/s00394-016-1301-2
   Giannelli M, 2003, PAEDIATR PERINAT EP, V17, P316, DOI 10.1046/j.1365-3016.2003.00523.x
   GILBERT EF, 1973, J REPROD FERTIL, V34, P495, DOI 10.1530/jrf.0.0340495
   Goyan J, 1980, FOOD DRUG ADM NEWS R, V0, PP80
   Greenhalgh S, 2019, PERSPECT BIOL MED, V62, P131, DOI 10.1353/pbm.2019.0007
   Greenhalgh S, 2019, BMJ-BRIT MED J, V364, P0, DOI 10.1136/bmj.k5050
   Greenwood DC, 2014, EUR J EPIDEMIOL, V29, P725, DOI 10.1007/s10654-014-9944-x
   Greenwood DC, 2010, EUR J EPIDEMIOL, V25, P275, DOI 10.1007/s10654-010-9443-7
   Grimm H-U, 2016, INT FOOD LAW POLICY, V0, P3
   HADEED A, 1993, CLIN PEDIATR, V32, P45, DOI 10.1177/000992289303200108
   HORNING MG, 1975, LIFE SCI, V16, P651, DOI 10.1016/0024-3205(75)90343-4
   Hoyert Donna L, 2016, NATL VITAL STAT REP, V65, P1
   Hoyt AT, 2014, MATERN CHILD HLTH J, V18, P1540, DOI 10.1007/s10995-013-1397-4
   Hunger SP, 2015, NEW ENGL J MED, V373, P1541, DOI 10.1056/NEJMra1400972
   Jahanfar S, 2015, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD006965.pub4
   James J, 1997, UNDERSTANDING CAFFEI, V0, P0
   James J E, 1985, REV ENVIRON HEALTH, V5, P151
   James JE, 1991, CAFFEINE HLTH, V0, P0
   James JE, 1998, NEUROPSYCHOBIOLOGY, V38, P32, DOI 10.1159/000026514
   JAMES JE, 1994, ADDICTION, V89, P1595, DOI 10.1111/j.1360-0443.1994.tb03760.x
   James JE, 2002, ADDICTION, V97, P1251, DOI 10.1046/j.1360-0443.2002.00146.x
   Juliano LM, 2004, PSYCHOPHARMACOLOGY, V176, P1, DOI 10.1007/s00213-004-2000-x
   Karalexi MA, 2019, CANCER EPIDEMIOL, V62, P0, DOI 10.1016/j.canep.2019.101581
   Khoury J C, 2004, J MATERN FETAL NEONATAL MED, V15, P44, DOI 10.1080/14767050310001650716
   KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8
   Klebanoff MA, 2002, AM J EPIDEMIOL, V155, P32, DOI 10.1093/aje/155.1.32
   Klebanoff MA, 2015, EPIDEMIOLOGY, V26, P185, DOI 10.1097/EDE.0000000000000220
   KNUTTI R, 1981, EUR J CLIN PHARMACOL, V21, P121, DOI 10.1007/BF00637512
   Kobayashi S, 2019, PAEDIATR PERINAT EP, V33, P185, DOI 10.1111/ppe.12551
   Lane JD, 2002, PSYCHOSOM MED, V64, P595, DOI 10.1097/01.PSY.0000021946.90613.DB
   LEBLANC J, 1994, CAN J PHYSIOL PHARM, V72, P113, DOI 10.1139/y94-018
   Lehtonen A, 2021, EUR J NUTR, V60, P193, DOI 10.1007/s00394-020-02231-2
   Leviton A, 2002, FOOD CHEM TOXICOL, V40, P1271, DOI 10.1016/S0278-6915(02)00092-3
   LEVITON A, 1988, J REPROD MED, V33, P175
   LEVITON A, 1984, CAFFEINE PERSPECTIVE, V0, P188
   Leviton A, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10091152
   Li J, 2015, INT J GYNECOL OBSTET, V130, P116, DOI 10.1016/j.ijgo.2015.03.033
   Li J, 2015, TOXICOL APPL PHARM, V284, P345, DOI 10.1016/j.taap.2015.03.002
   LIEBERMAN HR, 1987, PSYCHOPHARMACOLOGY, V92, P308, DOI 10.1007/BF00210835
   MacDonald R, 2001, BRIT MED J, V322, P576, DOI 10.1136/bmj.322.7286.576
   Martin JA, 2017, BIRTHS FINAL DATA 20, V66, P0
   Martin Joyce A, 2018, NATL VITAL STAT REP, V67, P1
   Maslova E, 2010, AM J CLIN NUTR, V92, P1120, DOI 10.3945/ajcn.2010.29789
   Matijasevich A, 2006, PAEDIATR PERINAT EP, V20, P100, DOI 10.1111/j.1365-3016.2006.00706.x
   McCoy GM, 2019, MED HLTH SCI COMMONS, V0, P0
   MCGOWAN JD, 1988, SOUTH MED J, V81, P1092, DOI 10.1097/00007611-198809000-00006
   Menegaux F, 2007, PAEDIATR PERINAT EP, V21, P293, DOI 10.1111/j.1365-3016.2007.00824.x
   MEYER LC, 1994, PAEDIATR PERINAT EP, V8, P145, DOI 10.1111/j.1365-3016.1994.tb00445.x
   Milne E, 2018, CANCER CAUSE CONTROL, V29, P539, DOI 10.1007/s10552-018-1024-1
   Milne E, 2011, CANCER CAUSE CONTROL, V22, P207, DOI 10.1007/s10552-010-9688-1
   Modzelewska D, 2019, BMC PREGNANCY CHILDB, V19, P0, DOI 10.1186/s12884-019-2215-9
   National Health Service, 2018, SHOULD I LIM CAFF PR, V0, P0
   Okubo H, 2015, NUTR RES, V35, P309, DOI 10.1016/j.nutres.2015.02.009
   Orsi L, 2015, CANCER CAUSE CONTROL, V26, P1003, DOI 10.1007/s10552-015-0593-5
   Papadopoulou E, 2018, BMJ OPEN, V8, P0, DOI 10.1136/bmjopen-2017-018895
   PARSONS WD, 1981, J PEDIATR-US, V98, P640, DOI 10.1016/S0022-3476(81)80784-6
   PEARLMAN SA, 1989, DEV PHARMACOL THERAP, V12, P65, DOI 10.1159/000480966
   Peck JD, 2010, FOOD CHEM TOXICOL, V48, P2549, DOI 10.1016/j.fct.2010.06.019
   Pendergrast Mark, 1999, UNCOMMON GROUNDS HIS, V0, P0
   PhillipsBute BG, 1997, PHYSIOL BEHAV, V63, P35, DOI 10.1016/S0031-9384(97)00384-3
   Purdue-Smithe AC, 2019, FERTIL STERIL, V112, PE27, DOI 10.1016/j.fertnstert.2019.07.203
   RALL T W, 1990, P618, V0, P0
   RESCH BA, 1983, AM J OBSTET GYNECOL, V146, P231, DOI 10.1016/0002-9378(83)91070-0
   Rhee J, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0132334
   Rivkees SA, 2011, PEDIATR RES, V69, P271, DOI 10.1203/PDR.0b013e31820efbcf
   Santos I S, 1998, CAD SAUDE PUBLICA, V14, P523, DOI 10.1590/S0102-311X1998000300009
   Sapra Katherine J, 2017, REPROD SCI, V24, P502, DOI 10.1177/1933719116654994
   Sasaki S, 2017, PEDIATR RES, V82, P19, DOI 10.1038/pr.2017.70
   Savitz DA, 2008, EPIDEMIOLOGY, V19, P55, DOI 10.1097/EDE.0b013e31815c09b9
   Sengpiel V, 2013, BMC MED, V11, P0, DOI 10.1186/1741-7015-11-42
   Shrestha B, 2017, PEDIATR NEONATOL, V58, P391, DOI 10.1016/j.pedneo.2016.10.003
   Smit HJ, 2000, PSYCHOPHARMACOLOGY, V152, P167, DOI 10.1007/s002130000506
   SOMANI SM, 1988, INT J CLIN PHARM TH, V26, P521
   Stefanidou EM, 2011, EUR J OBSTET GYN R B, V158, P220, DOI 10.1016/j.ejogrb.2011.04.024
   Stein Z, 1991, EPIDEMIOLOGY, V2, P163
   Strassheim H, 2019, BEHAVIOURAL POLICIES FOR HEALTH PROMOTION AND DISEASE PREVENTION, V0, P73
   THAYER PS, 1973, TOXICOL APPL PHARM, V25, P169, DOI 10.1016/S0041-008X(73)80003-1
   Thomopoulos TP, 2015, CANCER EPIDEMIOL, V39, P1047, DOI 10.1016/j.canep.2015.08.009
   US Food and Drug Administration (FDA), 2024, SPILLING THE BEANS: HOW MUCH CAFFEINE IS TOO MUCH?, V0, P0
   VANTHOFF W, 1982, LANCET, V1, P1020
   Voerman E, 2016, OBESITY, V24, P1170, DOI 10.1002/oby.21466
   Wen WQ, 2001, EPIDEMIOLOGY, V12, P38, DOI 10.1097/00001648-200101000-00008
   Weng XP, 2008, AM J OBSTET GYNECOL, V198, P0, DOI 10.1016/j.ajog.2007.10.803
   Wikoff D, 2017, FOOD CHEM TOXICOL, V109, P585, DOI 10.1016/j.fct.2017.04.002
   Wisborg K, 2003, BRIT MED J, V326, P420, DOI 10.1136/bmj.326.7386.420
   Wu YM, 2015, TOXICOL APPL PHARM, V289, P109, DOI 10.1016/j.taap.2015.09.007
   Xu D, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044497
   Yu T, 2016, J CLIN PHARMACOL, V56, P590, DOI 10.1002/jcph.632
   Zeltner Thomas, 2000, TOBACCO COMPANY STRATEGIES TO UNDERMINE TOBACCO CONTORL ACTIVITIES AT THE WORLD HEALTH ORGANIZATION: A REPORT OF THE COMMITTEE OF EXPERTS ON TOBACCO INDUSTRY DOCUMENTS, V0, P0
NR 132
TC 44
Z9 45
U1 1
U2 17
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2515-446X
EI 2515-4478
J9 BMJ EVID-BASED MED
JI BMJ Evid.-Based Med.
PD JUN 15
PY 2021
VL 26
IS 3
BP 114
EP +
DI 10.1136/bmjebm-2020-111432
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA SK8QI
UT WOS:000656481900015
PM 32843532
DA 2025-04-28
ER

PT J
AU Park, JS
   Kwon, J
   Choi, HJ
   Lee, C
AF Park, Joon Seok
   Kwon, Jieun
   Choi, Hyung Jin
   Lee, Changhyun
TI Clinical effectiveness of liraglutide on weight loss in South Koreans First real-world retrospective data on Saxenda in Asia
SO MEDICINE
LA English
DT Article
DE liraglutide; obesity; weight loss; body mass index; treatment outcome
ID body-composition; glp-1 analog; 3.0 mg; management; obese; maintenance; appetite
AB Among Asian countries, South Korea was the first to approve liraglutide as a treatment for obesity. Thus, the clinical effectiveness of liraglutide has not been studied in Asian populations. In this study, we retrospectively analyzed obese patients [body mass index (BMI) >27 kg/m(2)] who were treated with liraglutide between March 2018 and March 2019 in a single clinic. Weight, BMI, HbA1c, and clinical data were collected before liraglutide treatment. Changes in body weight and composition and their relationships with clinical variables were examined at re-prescription dates within 30, 60, 90, and 180 days. A total of 169 subjects were studied. The average age was 41.5 years, and 42% of the subjects were male. The average weight was 85.2 kg, and the average BMI was 30.8 kg/m(2). Weight reduction was significant (-5.5 +/- 3.4 kg, 30 days: -3.2 +/- 1.8 kg, 60 days: -4.5 +/- 2.3 kg, 90 days: -6.3 +/- 2.6 kg, 180 days: -7.8 +/- 3.5 kg) during the follow-up period and increased with longer treatment time (P < .001). The percentages of subjects that showed >= 5% and >= 10% body weight reduction were 62.1% and 17.2%, respectively. In the body composition analysis, skeletal muscle weight loss was -3.56 +/- 29.7%, which was significantly smaller than fat weight loss of -11.06 +/- 10.4% (P = .03). Weight loss was not significantly related to age, sex, baseline BMI, baseline HbA1c, smoking status, alcohol consumption, coffee intake. In conclusion, Liraglutide treatment led to meaningful weight loss in South Korean patients, and fat mass reduction was prominent during treatment. Furthermore, liraglutide showed greater clinical effectiveness with longer treatment time.
C1 [Park, Joon Seok; Choi, Hyung Jin] Seoul Natl Univ, Coll Med, Seoul, South Korea.
   [Park, Joon Seok; Kwon, Jieun; Lee, Changhyun] Seoul Happiness Clin Internal Med, 88 Jungjaro, Sungnam Si 13612, South Korea.
C3 Seoul National University (SNU)
RP Lee, C (corresponding author), Seoul Happiness Clin Internal Med, 88 Jungjaro, Sungnam Si 13612, South Korea.
EM mdchlee@gmail.com
FU National Research Foundation of Korea (NRF) - Korean Government [MIST] [NRF-2018R1A5A2025964]; Creative-Pioneering Researchers Program through Seoul National University (SNU) The Seoul National University Hospital Medical Research Collaborating Center (SNUH MRCC)
CR Bray GA, 2013, OBESITY, V21, P893, DOI 10.1002/oby.20394
   Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726
   Dombrowski S U, 2014, BMJ, V348, Pg2646, DOI 10.1136/bmj.g2646
   Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3
   Fan JG, 2017, J HEPATOL, V67, P862, DOI 10.1016/j.jhep.2017.06.003
   Fujioka K, 2016, OBESITY, V24, P2278, DOI 10.1002/oby.21629
   Gorgojo-Mart√≠nez JJ, 2019, INT J CLIN PRACT, V73, P0, DOI 10.1111/ijcp.13399
   Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009
   Ishii Satoshi, 2019, J CLIN MED RES, V11, P219, DOI 10.14740/jocmr3647
   Jerlhag E, 2018, NEUROPHARMACOLOGY, V136, P343, DOI 10.1016/j.neuropharm.2018.01.013
   Lin KJ, 2016, CLIN PHARMACOL THER, V100, P147, DOI 10.1002/cpt.359
   Lykkegaard K, 2008, SCHIZOPHR RES, V103, P94, DOI 10.1016/j.schres.2008.05.011
   Mancini MC, 2017, DIABETOL METAB SYNDR, V9, P0, DOI 10.1186/s13098-017-0242-0
   Oh TJ, 2019, J OBES METAB SYNDR, V28, P158
   Pasto R, 2019, CURR PHARM DESIGN, V25, P1783, DOI 10.2174/1381612825666190701155737
   Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P11, DOI 10.1056/NEJMoa1411892
   Poobalan AS, 2007, OBES REV, V8, P503, DOI 10.1111/j.1467-789X.2007.00393.x
   Rondanelli M, 2016, PATIENT PREFER ADHER, V10, P407, DOI 10.2147/PPA.S97383
   Saltiel AR, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aad1811
   Scott LJ, 2015, DRUGS, V75, P899, DOI 10.1007/s40265-015-0408-8
   van Can J, 2014, INT J OBESITY, V38, P784, DOI 10.1038/ijo.2013.162
   Wadden TA, 2013, INT J OBESITY, V37, PS1, DOI 10.1038/ijo.2013.89
   Wharton S, 2019, OBESITY, V27, P917, DOI 10.1002/oby.22462
   WHO, 2004, LANCET, V363, P902, DOI 10.1016/S0140-6736(03)15268-3
   Wing RR, 2005, AM J CLIN NUTR, V82, P222S, DOI 10.1093/ajcn/82.1.222S
   Wright F, 2013, J HEALTH PSYCHOL, V18, P574, DOI 10.1177/1359105312451865
   Yang SW, 2018, J EXERC REHABIL, V14, P621, DOI 10.12965/jer.1836284.142
NR 27
TC 18
Z9 19
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD JAN 15
PY 2021
VL 100
IS 2
BP 
EP 
DI 10.1097/MD.0000000000023780
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA PZ5VL
UT WOS:000612807900010
PM 33466127
DA 2025-04-28
ER

PT J
AU Ruiz-Torres, K
   De los R√≠os, DLH
   Virgen-Carrillo, CA
   Pineda-Lozano, JE
   Moreno, AGM
AF Ruiz-Torres, Karina
   Hernandez de los Rios, Diana Laura
   Alejandrina Virgen-Carrillo, Carmen
   Elizabeth Pineda-Lozano, Jessica
   Martinez Moreno, Alma Gabriela
TI Abstract: Chronic caffeine administration prevents postprandial glucose disturbance in rats
SO ARCHIVOS LATINOAMERICANOS DE NUTRICION
LA English
DT Article
DE caffeine; cafeteria diet; metabolic syndrome; postprandial glucose; rats
ID high-fat diet; metabolic syndrome; cafeteria diet; consumption; obesity; foods; model
AB Introduction: Chronic caffeine administration prevents postprandial glucose disturbance in rats. The increase in caffeine consumption is not debatable, this is how his research has become extensive in his different fields. Objective. To analyze the effects of chronic administration of caffeine in rats fed a cafeteria diet, by evaluating consumption, anthropometric and biochemical indices. Previous studies refer to administering caffeine in diets high in carbohydrates and / or in fat that induce obesity or symptoms of metabolic syndrome. Material and methods. The cafeteria diet is a dietary model equivalent to the characteristics of the typical western diet that causes metabolic syndrome in humans. In this research, chronic intraperitoneal administration of caffeine was performed for 8 weeks to adult male Wistar rats fed a cafeteria diet. Given the little evidence about the biological and behavioral effects of the chronic administration of this substance against a cafeteria diet model, consumption, anthropometric and biochemical parameters were evaluated. Results. After eight weeks it was found that the cafeteria diet given to the controls caused abnormalities associated with the metabolic syndrome; regarding the administration of caffeine in the rats fed this diet, the treatment turned out to be a protective factor in postprandial glucose, but not in the alteration of glucose tolerance or lipid profile. Conclusions. Caffeine allowed to protect postprandial glucose levels at the end of the experiment and a decrease in body weight and food consumption only in the first week. However, no significant improvements were seen in lipid profile, adiposity, glucose tolerance, and plasma glucose.
C1 [Ruiz-Torres, Karina; Hernandez de los Rios, Diana Laura] Univ Juarez Estado Durango, Fac Med & Nutr, Av Univ & Fanny Anitua S-N, Durango 34000, Dgo, Mexico.
   [Alejandrina Virgen-Carrillo, Carmen; Elizabeth Pineda-Lozano, Jessica; Martinez Moreno, Alma Gabriela] Univ Guadalajara, Inst Invest Comportamiento Alimentario & Nutr, Av Enrique Arreola Silva 883, Cd Guzman 49000, Jalisco, Mexico.
C3 Universidad Juarez del Estado de Durango; Universidad de Guadalajara
RP Moreno, AGM (corresponding author), Univ Guadalajara, Inst Invest Comportamiento Alimentario & Nutr, Av Enrique Arreola Silva 883, Cd Guzman 49000, Jalisco, Mexico.
EM alma.martinez@cusur.udg.mx
CR Ezquerra EA, 2008, REV ESP CARDIOL, V61, P752, DOI 10.1016/S1885-5857(08)60212-1
   Unknown -, 2002, NUTR TODAY, V37, P26, DOI 10.1097/00017285-200201000-00009, 10.1097/00017285-200201000-00009
   Bolles RC, 2006, TEORIA MOTIVACION, V0, P0
   CHAPMAN DG, 1959, CAN J BIOCHEM PHYS, V37, P679
   Che BQ, 2012, NEUROTOXICOLOGY, V33, P1248, DOI 10.1016/j.neuro.2012.07.004
   Clark KS, 2019, CLIN EXP PHARMACOL P, V46, P475, DOI 10.1111/1440-1681.13065
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   Fuentes Paredes F de M, 2008, GUIA MANEJO CUIDADO, V0, P0
   Gharibi B, 2012, INT J OBESITY, V36, P397, DOI 10.1038/ijo.2011.129
   Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004
   Gomez-Smith M, 2016, PHYSIOL BEHAV, V167, P382, DOI 10.1016/j.physbeh.2016.09.029
   Gonzalez RG, 2015, REV INT ACUPUNT, V9, P57
   Heckman MA, 2010, J FOOD SCI, V75, PR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Hernandez I, 2004, ENDOCRINOL DIAB NUTR, V51, P35
   Higa Talita S, 2014, INT J PHYSIOL PATHOPHYSIOL PHARMACOL, V6, P47
   Johnson AR, 2016, BIOCHEM BIOPH RES CO, V473, P545, DOI 10.1016/j.bbrc.2016.03.113
   McIntosh VJ, 2012, J CARDIOVASC PHARM T, V17, P21, DOI 10.1177/1074248410396877
   Metro D, 2017, J CLIN TRANSL ENDOCR, V10, P22, DOI 10.1016/j.jcte.2017.10.001
   Moy GA, 2013, PHYSIOL BEHAV, V109, P69, DOI 10.1016/j.physbeh.2012.11.008
   Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407
   Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013
   Paredes JL, 2009, KASMERA, V37, P74
   Pettenuzzo LF, 2008, PHYSIOL BEHAV, V95, P295, DOI 10.1016/j.physbeh.2008.06.003
   Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18
   Speakman J, 2016, LAB ANIM-UK, V42, P413
   Sweeney P, 2016, APPETITE, V101, P171, DOI 10.1016/j.appet.2016.03.013
   Tofovic SP, 2007, RENAL FAILURE, V29, P891, DOI 10.1080/08860220701569846
   Urz√∫a Z, 2012, J INT MED RES, V40, P2220, DOI 10.1177/030006051204000620
   Wierzejska Regina, 2012, ROCZ PANSTW ZAKL HIG, V63, P141
   Wynne CDL, 1998, MODELS ACTION MECH A, V0, P0
   Zapata FJ, 2020, J FUNCT FOODS, V64, P0, DOI 10.1016/j.jff.2019.103646
   Zheng XY, 2014, PHARMACOL BIOCHEM BE, V122, P136, DOI 10.1016/j.pbb.2014.03.027
NR 32
TC 0
Z9 0
U1 0
U2 3
PU ARCHIVOS LATINOAMERICANOS NUTRICION
PI CARACAS
PA APARTADO 62778 CHACAO, AVENIDA FRANCISCO MIRANDA, CARACAS 1060, VENEZUELA
SN 0004-0622
EI 2309-5806
J9 ARCH LATINOAM NUTR
JI Arch. Latinoam. Nutr.
PD DEC 15
PY 2021
VL 71
IS 4
BP 300
EP 309
DI 10.37527/2021.71.4.007
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA YL8FL
UT WOS:000746123200007
DA 2025-04-28
ER

PT J
AU Kim, Y
   Lee, J
   Oh, JH
   Chang, HJ
   Sohn, DK
   Shin, A
   Kim, J
AF Kim, Youngyo
   Lee, Jeonghee
   Oh, Jae Hwan
   Chang, Hee Jin
   Sohn, Dae Kyung
   Shin, Aesun
   Kim, Jeongseon
TI The Association between Coffee Consumption and Risk of Colorectal Cancer in a Korean Population
SO NUTRIENTS
LA English
DT Article
DE coffee; colon cancer; rectal cancer; case-control study; coffee additives
ID cholesterol-raising factor; type-2 diabetes-mellitus; metaanalysis; cafestol; acid; diterpenes; kahweol
AB This study was performed to investigate the association between coffee consumption and risk of colorectal cancer in a Korean population and examine whether the association can be altered by adjustment for intake of coffee additives. We conducted a case-control study involving 923 colorectal cancer cases and 1846 controls matched by sex and age (within 5 years). A semi-quantitative food frequency questionnaire was used to assess coffee intakes. High coffee consumption was associated with lower odds of developing colorectal cancer (>= 3 cups/day vs. no drinks, OR = 0.68; 95% CI: 0.49-0.96). When we additionally controlled for consumption of coffee additives including sugar and cream, the inverse association became stronger (>= 3 cups/day vs. no drinks, OR = 0.22; 95% CI: 0.14-0.33), and a significant inverse linear trend was shown (P-trend < 0.0001). The inverse associations were observed for proximal (P-trend = 0.0001) and distal (P-trend = 0.0003) colon cancer, and rectal cancer (P-trend < 0.0001) in the stratified analysis by anatomical sub-sites. Regarding sex, inverse associations between coffee consumption and colorectal cancer were found for men (P-trend < 0.0001) and women (P-trend = 0.0021). In the stratified analysis by obese status of subjects, inverse linear trends were observed in both non-obese and obese people (P-trend < 0.0001). High coffee consumption may be associated with a lower risk of colorectal cancer in the Korean population and the degree of decrease in the odds of developing colorectal cancer changes by adjustment for intake of coffee additives.
C1 [Kim, Youngyo] Gyeongsang Natl Univ, Dept Food & Nutr, Inst Agr & Life Sci, Jinju 52828, South Korea.
   [Kim, Youngyo; Lee, Jeonghee; Kim, Jeongseon] Natl Canc Ctr, Dept Canc Biomed Sci, Grad Sch Canc Sci & Policy, Goyang 10408, South Korea.
   [Oh, Jae Hwan; Chang, Hee Jin; Sohn, Dae Kyung] Natl Canc Ctr Hosp, Ctr Colorectal Canc, Natl Canc Ctr, Goyang 10408, South Korea.
   [Shin, Aesun] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul 03080, South Korea.
C3 Gyeongsang National University; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Seoul National University (SNU)
RP Kim, J (corresponding author), Natl Canc Ctr, Dept Canc Biomed Sci, Grad Sch Canc Sci & Policy, Goyang 10408, South Korea.
EM youngyokim@gnu.ac.kr; jeonghee@ncc.re.kr; jayoh@ncc.re.kr; heejincmd@ncc.re.kr; gsgsbal@ncc.re.kr; shinaesun@snu.ac.kr; jskim@ncc.re.kr
FU National Cancer Center in Korea [1910330, 2010260]
CR Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657
   Unknown -, 2004, INTERNATIONAL STATISTICAL CLASSIFICATION OF DISEASES AND RELATED HEALTH PROBLEMS, V0, P0
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   BROWN SR, 1990, GUT, V31, P450, DOI 10.1136/gut.31.4.450
   Cavin C, 2002, FOOD CHEM TOXICOL, V40, P1155, DOI 10.1016/S0278-6915(02)00029-7
   Cohen BE, 2019, CLIN DRUG INVEST, V39, P197, DOI 10.1007/s40261-018-0732-3
   Delouya G, 2018, HORM MOL BIOL CLIN I, V36, P0, DOI 10.1515/hmbci-2018-0049
   Gadaleta RM, 2017, MOL ASPECTS MED, V56, P66, DOI 10.1016/j.mam.2017.04.002
   Galeone C, 2010, CANCER CAUSE CONTROL, V21, P1949, DOI 10.1007/s10552-010-9623-5
   Guraya SY, 2015, WORLD J GASTROENTERO, V21, P6026, DOI 10.3748/wjg.v21.i19.6026
   Higgins LG, 2008, TOXICOL APPL PHARM, V226, P328, DOI 10.1016/j.taap.2007.09.018
   Je YJ, 2009, INT J CANCER, V124, P1662, DOI 10.1002/ijc.24124
   JEMAL A, 2011, CA-CANCER J CLIN, V61, P134, DOI 10.3322/caac.20115
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Jung KW, 2019, CANCER RES TREAT, V51, P431, DOI 10.4143/crt.2019.139
   Kim M, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10121963
   Kim Y, 2019, EUR J EPIDEMIOL, V34, P731, DOI 10.1007/s10654-019-00524-3
   Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375
   Li GW, 2013, PUBLIC HEALTH NUTR, V16, P346, DOI 10.1017/S1368980012002601
   Lin TK, 2018, GLOBALIZATION HEALTH, V14, P0, DOI 10.1186/s12992-018-0344-y
   Mancini A, 2015, MOLECULES, V20, P17339, DOI 10.3390/molecules200917339
   NAGENGAST FM, 1995, EUR J CANCER, V31A, P1067, DOI 10.1016/0959-8049(95)00216-6
   Nakagawa HS, 2017, INT J CANCER, V141, P298, DOI 10.1002/ijc.30746
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Poole R, 2017, BMJ-BRIT MED J, V359, P0, DOI 10.1136/bmj.j5024
   Porta M, 2003, EUR J EPIDEMIOL, V18, P289, DOI 10.1023/A:1023700216945
   Post SM, 1997, ARTERIOSCL THROM VAS, V17, P3064, DOI 10.1161/01.ATV.17.11.3064
   Ricketts ML, 2007, MOL ENDOCRINOL, V21, P1603, DOI 10.1210/me.2007-0133
   Schmit SL, 2016, CANCER EPIDEM BIOMAR, V25, P634, DOI 10.1158/1055-9965.EPI-15-0924
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Vitaglione P, 2012, FOOD FUNCT, V3, P916, DOI 10.1039/c2fo30037k
   Wang JW, 2013, PEDIATR OBES, V8, P284, DOI 10.1111/j.2047-6310.2012.00108.x
   Welsh JA, 2011, CIRCULATION, V123, P249, DOI 10.1161/CIRCULATIONAHA.110.972166
NR 33
TC 12
Z9 14
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG 15
PY 2021
VL 13
IS 8
BP 
EP 
DI 10.3390/nu13082753
PG 12
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA UH7ZN
UT WOS:000690143900001
PM 34444913
DA 2025-04-28
ER

PT J
AU Lehtonen, A
   Uusitalo, L
   Auriola, S
   Backman, K
   Heinonen, S
   Keski-Nisula, L
   Pasanen, M
   Pekkanen, J
   Tuomainen, TP
   Voutilainen, R
   Hantunen, S
   Lehtonen, M
AF Lehtonen, Anni
   Uusitalo, Lauri
   Auriola, Seppo
   Backman, Katri
   Heinonen, Seppo
   Keski-Nisula, Leea
   Pasanen, Markku
   Pekkanen, Juha
   Tuomainen, Tomi-Pekka
   Voutilainen, Raimo
   Hantunen, Sari
   Lehtonen, Marko
TI Caffeine content in newborn hair correlates with maternal dietary intake
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Caffeine; Diet; Newborn; Pregnancy; Hair; Mass spectrometry; Food safety
ID consumption; pregnancy; paraxanthine; association; coffee; birth; risk
AB Purpose High-maternal caffeine intake during pregnancy may be harmful for perinatal outcomes and future child health, but the level of fetal cumulative exposure has been difficult to measure thus far. Here, we present maternal dietary caffeine intake during the last trimester and its correlation to caffeine content in newborn hair after birth. Methods Maternal third trimester diets and dietary caffeine intake were prospectively collected in Kuopio Birth Cohort (KuBiCo) using a 160-item food frequency questionnaire (n = 2840). Newborn hair was collected within 48 h after birth and analyzed by high-resolution mass spectrometry (HRMS) for caffeine (n = 316). Correlation between dietary caffeine intake and neonatal hair caffeine content was evaluated from 203 mother-child pairs. Results Mean dietary caffeine intake was 167 mg/days (95% CI 162-172 mg/days), of which coffee comprised 81%. Caffeine in the maternal diet and caffeine content in newborn hair correlated significantly (r = 0.50; p < 0.001). Older, multiparous, overweight women, and smokers had the highest caffeine levels in the maternal diet, as well as in their newborn babies' hair. Conclusion Caffeine exposure, estimated from newborn hair samples, reflects maternal third trimester dietary caffeine intake and introduces a new method to assess fetal cumulative caffeine exposure. Further studies to evaluate the effects of caffeine exposure on both perinatal and postnatal outcomes are warranted, since over 40% of pregnant women consume caffeine more than the current suggested recommendations (European Food Safety Association, EFSA recommendations).
C1 [Lehtonen, Anni; Tuomainen, Tomi-Pekka; Hantunen, Sari] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.
   [Uusitalo, Lauri; Backman, Katri; Keski-Nisula, Leea; Voutilainen, Raimo] Univ Eastern Finland, Inst Clin Med, Sch Med, Kuopio, Finland.
   [Uusitalo, Lauri; Keski-Nisula, Leea] Kuopio Univ Hosp, Dept Obstet & Gynecol, Kuopio, Finland.
   [Auriola, Seppo; Lehtonen, Marko] LC MS Metab Ctr, Bioctr, Kuopio, Finland.
   [Backman, Katri; Voutilainen, Raimo] Kuopio Univ Hosp, Dept Pediat, Kuopio, Finland.
   [Heinonen, Seppo] Helsinki Univ Hosp, Dept Obstet & Gynecol, Helsinki, Finland.
   [Heinonen, Seppo] Univ Helsinki, Helsinki, Finland.
   [Pasanen, Markku] Univ Eastern Finland, Sch Pharm, Kuopio, Finland.
   [Pekkanen, Juha] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland.
   [Pekkanen, Juha] Natl Inst Hlth & Welf, Environm Hlth Unit, Helsinki, Finland.
C3 University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland Hospital; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Eastern Finland; University of Helsinki; Finland National Institute for Health & Welfare
RP Uusitalo, L (corresponding author), Univ Eastern Finland, Inst Clin Med, Sch Med, Kuopio, Finland.; Uusitalo, L (corresponding author), Kuopio Univ Hosp, Dept Obstet & Gynecol, Kuopio, Finland.
EM lauriuus@uef.fi
FU University of Eastern Finland (UEF) including Kuopio University Hospital
CR Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792
   Boylan S, 2008, BMJ-BRIT MED J, V337, P0, DOI 10.1136/bmj.a2332
   DAnna-Hernandez KL, 2011, PHYSIOL BEHAV, V104, P348, DOI 10.1016/j.physbeh.2011.02.041
   De Kesel PMM, 2015, TALANTA, V144, P62, DOI 10.1016/j.talanta.2015.05.084
   Dussy F, 2014, DRUG TEST ANAL, V6, P5, DOI 10.1002/dta.1627
   Eichelberger KY, 2015, OBSTET GYNECOL, V126, P725, DOI 10.1097/AOG.0000000000001041
   ETL, 2018, FINN FOOD DRINK IND, V0, P0
   Forbes LE, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10081032
   Gareri J, 2010, FORENSIC SCI INT, V196, P27, DOI 10.1016/j.forsciint.2009.12.024
   Greenwood DC, 2014, EUR J EPIDEMIOL, V29, P725, DOI 10.1007/s10654-014-9944-x
   Huuskonen P, 2018, BMC PREGNANCY CHILDB, V18, P0, DOI 10.1186/s12884-018-2013-9
   Kaufmann A, 2012, ANAL BIOANAL CHEM, V403, P1233, DOI 10.1007/s00216-011-5629-4
   Leviton A, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10091152
   Li J, 2015, INT J GYNECOL OBSTET, V130, P116, DOI 10.1016/j.ijgo.2015.03.033
   Lyngso J, 2017, CLIN EPIDEMIOL, V9, P699, DOI 10.2147/CLEP.S146496
   Mannisto S, 1996, J CLIN EPIDEMIOL, V49, P401, DOI 10.1016/0895-4356(95)00551-X
   Mazzafera P, 2004, FRONT BIOSCI-LANDMRK, V9, P1348, DOI 10.2741/1339
   Montesano C, 2014, J PHARMACEUT BIOMED, V88, P295, DOI 10.1016/j.jpba.2013.08.050
   Sengpiel V, 2013, BMC MED, V11, P0, DOI 10.1186/1741-7015-11-42
   Stefanidou EM, 2011, EUR J OBSTET GYN R B, V158, P220, DOI 10.1016/j.ejogrb.2011.04.024
   Vitti FP, 2018, REV BRAS GINECOL OBS, V40, P749, DOI 10.1055/s-0038-1675806
NR 21
TC 11
Z9 11
U1 0
U2 12
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD FEB 15
PY 2021
VL 60
IS 1
BP 193
EP 201
DI 10.1007/s00394-020-02231-2
EA APR 2020
PG 9
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA QD5RS
UT WOS:000523112300001
PM 32246261
DA 2025-04-28
ER

PT J
AU Wee, JH
   Min, C
   Park, MW
   Park, IS
   Park, B
   Choi, HG
AF Wee, Jee Hye
   Min, Chanyang
   Park, Min Woo
   Park, Il-Seok
   Park, Bumjung
   Choi, Hyo Geun
TI Energy-drink consumption is associated with asthma, allergic rhinitis, and atopic dermatitis in Korean adolescents
SO EUROPEAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID caffeine intake; uric-acid; sugar; health; exercise; sodium; coffee
AB Background/objectives Few studies have evaluated the effects of energy drinks on allergic diseases. The purpose of this investigation was to evaluate the association between energy drinks and various allergic diseases, including asthma, allergic rhinitis, and atopic dermatitis, in a large representative Korean adolescent population. Subjects/methods This cross-sectional study used data from the Korea Youth Risk Behavior Web-based Survey collected from 2015 to 2016. A total of 129,809 participants (n = 67,056 for males; n = 62,753 for females) aged 12-18 years were included and were asked about their frequency of consumption of energy drinks such as Hot6(R), Redbull(R), and Bacchus(R). Their history of asthma, allergic rhinitis, and atopic dermatitis throughout life and in the last 12 months were obtained. The association between the frequency of energy-drink consumption and allergic diseases was analyzed using multiple logistic regression with adjustment for various covariates. Results Age, sex, physical activity, obesity, region of residence, economic level, paternal and maternal educational level, smoking, and alcohol consumption differed significantly according to the frequency of energy-drink consumption (each P < 0.001). Frequent energy-drink consumption (>= 7 times a week) was significantly associated with asthma throughout life (odds ratio [OR] = 1.30, 95% confidence interval (CI) = 1.03-1.64, P = 0.025), asthma within the last 12 months (OR = 1.65, 95% CI = 1.16-2.35, P = 0.006), allergic rhinitis within the last 12 months (OR = 1.21, 95% CI = 1.02-1.44, P = 0.030), and atopic dermatitis within the last 12 months (OR = 1.49, 95% CI = 1.17-1.90, P = 0.001) compared to no energy-drink consumption in the full-adjusted model. Conclusions Frequent energy-drink consumption is associated with allergic diseases, including asthma, allergic rhinitis, and atopic dermatitis, in Korean adolescents.
C1 [Wee, Jee Hye; Park, Bumjung; Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Sacred Heart Hosp, Anyang, South Korea.
   [Min, Chanyang; Choi, Hyo Geun] Hallym Univ, Hallym Data Sci Lab, Coll Med, Anyang, South Korea.
   [Min, Chanyang] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea.
   [Park, Min Woo] Kangdong Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.
   [Park, Il-Seok] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Dongtan Sacred Heart Hosp, Dongtan, South Korea.
C3 Hallym University; Hallym University; Seoul National University (SNU); Hallym University
RP Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Sacred Heart Hosp, Anyang, South Korea.; Choi, HG (corresponding author), Hallym Univ, Hallym Data Sci Lab, Coll Med, Anyang, South Korea.
EM pupen@naver.com
FU National Research Foundation [NRF-2018-R1D1A1A02085328, NRF-2020-R1G1A1005390]; Hallym University Research Fund [HURF 2019-31]
CR Aeberli I, 2011, AM J CLIN NUTR, V94, P479, DOI 10.3945/ajcn.111.013540
   Al-Zalabani AH, 2019, BMJ OPEN, V9, P0, DOI 10.1136/bmjopen-2019-029046
   Alfaro TM, 2018, CLIN RESPIR J, V12, P1283, DOI 10.1111/crj.12662
   Ali F, 2015, POSTGRAD MED, V127, P308, DOI 10.1080/00325481.2015.1001712
   Asero R, 2006, ALLERGY, V61, P1240, DOI 10.1111/j.1398-9995.2006.01154.x
   Bae Jisuk, 2010, J PREV MED PUBLIC HEALTH, V43, P403, DOI 10.3961/jpmph.2010.43.5.403
   Bae Jisuk, 2010, J PREV MED PUBLIC HEALTH, V43, P396, DOI 10.3961/jpmph.2010.43.5.396
   Berentzen NE, 2015, EUR J CLIN NUTR, V69, P303, DOI 10.1038/ejcn.2014.153
   Carrillo JA, 2000, CLIN PHARMACOKINET, V39, P127, DOI 10.2165/00003088-200039020-00004
   Centers for Disease Control and Prevention, 2018, CHILDR TEEN BMI, V0, P0
   Cho SI, 2020, EUR J NUTR, V59, P3171, DOI 10.1007/s00394-019-02157-4
   COHEN S, 1975, NEW ENGL J MED, V293, P897, DOI 10.1056/NEJM197510302931803
   DeChristopher LR, 2018, BRIT J NUTR, V119, P1157, DOI 10.1017/S0007114518000417
   Dixon Anne E, 2010, PROC AM THORAC SOC, V7, P325, DOI 10.1513/pats.200903-013ST
   Ellwood P, 2013, THORAX, V68, P351, DOI 10.1136/thoraxjnl-2012-202285
   Eltahir HM, 2020, ACTA BIOCHIM POL, V67, P79, DOI 10.18388/abp.2020_2914
   Euromonitor International, 2016, EN DRINKS S KOR, V0, P0
   Gupta S, 2018, INDIAN J PEDIATR, V85, P887, DOI 10.1007/s12098-017-2484-0
   Heckman MA, 2010, COMPR REV FOOD SCI F, V9, P303, DOI 10.1111/j.1541-4337.2010.00111.x
   Jin MJ, 2016, KOREAN J FAM MED, V37, P111, DOI 10.4082/kjfm.2016.37.2.111
   Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814
   Kauffmann F, 2012, J ALLERGY CLIN IMMUN, V130, P1229, DOI 10.1016/j.jaci.2012.10.038
   Kim KB, 2019, J EXERC REHABIL, V15, P647, DOI 10.12965/jer.1938470.235
   Kim MS, 2015, HEALTH AND WELFARE POLICY FORUM, V220, P14, DOI 10.23062/2015.02.3
   Kim S, 2007, STUDY ESTABLISHMENT, V0, P18
   Kim SY, 2020, PEDIATR RES, V88, P320, DOI 10.1038/s41390-020-0749-1
   Kim SY, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0187759
   Koivusilta L, 2016, INT J PUBLIC HEALTH, V61, P299, DOI 10.1007/s00038-016-0797-9
   Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015
   Korea Centers for Disease Control and Prevention, 2015, KOR YOUTH RISK BEH W, V0, P0
   Korea Centers for Disease Control and Prevention, 2012, 5 KOR NAT HLTH NUTR, V0, P0
   Kwon JA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0072507
   Larson N, 2014, J NUTR EDUC BEHAV, V46, P181, DOI 10.1016/j.jneb.2014.02.008
   Lee KS, 2016, BMC PEDIATR, V16, P0, DOI 10.1186/s12887-016-0549-2
   Li L, 2014, ASIAN PAC J ALLERGY, V32, P93, DOI 10.12932/AP0337.32.1.2014
   Meltzer LJ, 2015, PEDIATR PULM, V50, P1360, DOI 10.1002/ppul.23179
   Î¨∏ÏßÑÏàò, 2008, CLINICAL AND EXPERIMENTAL PEDIATRICS, V51, P1
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Nordt SP, 2017, PEDIATR EMERG CARE, V33, P770, DOI 10.1097/PEC.0000000000000644
   Orbeta RL, 2006, J ADOLESCENT HEALTH, V38, P451, DOI 10.1016/j.jadohealth.2005.05.014
   Oren E, 2017, J ALLER CL IMM-PRACT, V5, P427, DOI 10.1016/j.jaip.2016.09.019
   Pacor ML, 2004, ALLERGY, V59, P192, DOI 10.1046/j.1398-9995.2003.00380.x
   Park S, 2016, PREV MED, V91, P58, DOI 10.1016/j.ypmed.2016.08.004
   Poulos NS, 2015, PERSPECT PUBLIC HEAL, V135, P316, DOI 10.1177/1757913914565388
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   Research S, 2018, GLOB EN DRINKS SOFT, V0, P0
   Rhee CS, 2014, AM J RHINOL ALLERGY, V28, PE107, DOI 10.2500/ajra.2014.28.4040
   Ruxton CHS, 2008, NUTR BULL, V33, P15, DOI 10.1111/j.1467-3010.2007.00665.x
   Sanchez Sixto E, 2013, HEALTH (IRVINE CALIF), V5, P26
   Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965
   Temple JL, 2014, PEDIATRICS, V134, PE112, DOI 10.1542/peds.2013-3962
   The International Study of Asthma and Allergies in Children (ISSAC), 2017, ISSAC MAN, V0, P0
   Visness CM, 2010, J ASTHMA, V47, P822, DOI 10.3109/02770903.2010.489388
   Walker GJ, 2007, MED SCI SPORT EXER, V39, P1554, DOI 10.1249/mss.0b013e3180a74228
   Wang CS, 2018, RESPIROLOGY, V23, P901, DOI 10.1111/resp.13339
   Wang W, 2015, CHINESE MED J-PEKING, V128, P2242, DOI 10.4103/0366-6999.162494
   Welsh EJ, 2010, COCHRANE DB SYST REV, V2010, P0
   Williams RD, 2017, AM J HEALTH BEHAV, V41, P454, DOI 10.5993/AJHB.41.4.10
   Zampelas A, 2004, AM J CLIN NUTR, V80, P862, DOI 10.1093/ajcn/80.4.862
   Zhang Y, 2015, J SCI MED SPORT, V18, P569, DOI 10.1016/j.jsams.2014.07.017
   Zucconi S, 2013, SUPPORTING PUBLICATIONS EN-394, V0, P0, DOI DOI 10.2903/SP.EFSA.2013.EN
NR 61
TC 8
Z9 9
U1 2
U2 11
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0954-3007
EI 1476-5640
J9 EUR J CLIN NUTR
JI Eur. J. Clin. Nutr.
PD JUL 15
PY 2021
VL 75
IS 7
BP 1077
EP 1087
DI 10.1038/s41430-020-00812-2
EA NOV 2020
PG 11
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA TG4AQ
UT WOS:000594792700001
PM 33257845
DA 2025-04-28
ER

PT J
AU Ohishi, T
   Fukutomi, R
   Shoji, Y
   Goto, S
   Isemura, M
AF Ohishi, Tomokazu
   Fukutomi, Ryuuta
   Shoji, Yutaka
   Goto, Shingo
   Isemura, Mamoru
TI The Beneficial Effects of Principal Polyphenols from Green Tea, Coffee, Wine, and Curry on Obesity
SO MOLECULES
LA English
DT Review
DE polyphenols; epigallocatechin-3-O-gallate; chlorogenic acid; resveratrol; curcumin; obesity; reactive oxygen species; 5&#8242; -AMP-activated protein kinase; nuclear factor-&#954; B; randomized controlled trial
AB Several epidemiological studies and clinical trials have reported the beneficial effects of green tea, coffee, wine, and curry on human health, with its anti-obesity, anti-cancer, anti-diabetic, and neuroprotective properties. These effects, which have been supported using cell-based and animal studies, are mainly attributed to epigallocatechin gallate found in green tea, chlorogenic acid in coffee, resveratrol in wine, and curcumin in curry. Polyphenols are proposed to function via various mechanisms, the most important of which is related to reactive oxygen species (ROS). These polyphenols exert conflicting dual actions as anti- and pro-oxidants. Their anti-oxidative actions help scavenge ROS and downregulate nuclear factor-kappa B to produce favorable anti-inflammatory effects. Meanwhile, pro-oxidant actions appear to promote ROS generation leading to the activation of 5 '-AMP-activated protein kinase, which modulates different enzymes and factors with health beneficial roles. Currently, it remains unclear how these polyphenols exert either pro- or anti-oxidant effects. Similarly, several human studies showed no beneficial effects of these foods, and, by extension polyphenols, on obesity. These inconsistencies may be attributed to different confounding study factors. Thus, this review provides a state-of-the-art update on these foods and their principal polyphenol components, with an assumption that it prevents obesity.
C1 [Ohishi, Tomokazu] Microbial Chem Res Fdn, Inst Microbial Chem BIKAKEN, Shizuoka 4100301, Japan.
   [Fukutomi, Ryuuta] Higuchi Inc, Qual Management Div, Minato Ku, Tokyo 1080075, Japan.
   [Shoji, Yutaka; Isemura, Mamoru] Univ Shizuoka, Grad Sch Integrated Pharmaceut & Nutr Sci, Shizuoka 4228526, Japan.
   [Goto, Shingo] Natl Agr & Food Res Org NARO, Div Citrus Res, Inst Fruit Tree & Tea Sci, Shimizu, Shizuoka 4240292, Japan.
C3 University of Shizuoka; National Agriculture & Food Research Organization - Japan
RP Ohishi, T (corresponding author), Microbial Chem Res Fdn, Inst Microbial Chem BIKAKEN, Shizuoka 4100301, Japan.
EM ohishit@bikaken.or.jp; fukutomi_ryuuta@mac.com; fukutomi_ryuuta@mac.com; gotos@affrc.go.jp; isemura@u-shizuoka-ken.ac.jp
CR Abdel-Magid AF, 2013, ACS MED CHEM LETT, V4, P16, DOI 10.1021/ml3004044
   Ahn J, 2010, AM J PHYSIOL-CELL PH, V298, PC1510, DOI 10.1152/ajpcell.00369.2009
   Andr√© DM, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-17558-w
   Bae UJ, 2018, AM J CHINESE MED, V46, P617, DOI 10.1142/s0192415x18500325
   Bao LP, 2018, INT IMMUNOPHARMACOL, V54, P245, DOI 10.1016/j.intimp.2017.11.021
   Barrio-Lopez MT, 2013, CLIN NUTR, V32, P797, DOI 10.1016/j.clnu.2012.12.002
   Baselga-Escudero L, 2014, NUCLEIC ACIDS RES, V42, P882, DOI 10.1093/nar/gkt1011
   Basil JS, 2016, J PEDIATR-US, V173, P143, DOI 10.1016/j.jpeds.2016.02.046
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Baum L, 2007, PHARMACOL RES, V56, P509, DOI 10.1016/j.phrs.2007.09.013
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Calvo D, 1998, J LIPID RES, V39, P777
   Catalano D, 2010, DIGEST DIS SCI, V55, P3200, DOI 10.1007/s10620-010-1143-3
   Chabowski A, 2005, FEBS LETT, V579, P2428, DOI 10.1016/j.febslet.2004.11.118
   Chen CY, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19092729
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Chen JL, 2016, FOOD CHEM TOXICOL, V96, P70, DOI 10.1016/j.fct.2016.07.030
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544
   Cioccoloni G, 2020, J CHEMOTHERAPY, V32, P30, DOI 10.1080/1120009X.2019.1694761
   Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200
   Cordain L, 2000, METABOLISM, V49, P1473, DOI 10.1053/meta.2000.17672
   Cotter DG, 2014, AM J PHYSIOL-ENDOC M, V307, PE176, DOI 10.1152/ajpendo.00087.2014
   Di Pierro F, 2015, EUR REV MED PHARMACO, V19, P4195
   Dostal AM, 2016, J NUTR, V146, P38, DOI 10.3945/jn.115.222414
   Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966
   Eseberri I, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0184875
   Flanagan J, 2014, PHYTOTHER RES, V28, P946, DOI 10.1002/ptr.5085
   Flechtner-Mors M, 2004, INT J OBESITY, V28, P1420, DOI 10.1038/sj.ijo.0802786
   FRIEDMAN TC, 1986, ENDOCRINOLOGY, V118, P562, DOI 10.1210/endo-118-2-562
   Fu XH, 2019, J IMMUNOL RES, V2019, P0, DOI 10.1155/2019/8042097
   Ganjali S, 2014, SCI WORLD J, V0, P0, DOI DOI 10.1155/2014/898361
   Giordo R, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21113838
   Gong WF, 2019, CELL CYCLE, V18, P1549, DOI 10.1080/15384101.2019.1612697
   Gualdoni GA, 2014, BBA-GEN SUBJECTS, V1840, P95, DOI 10.1016/j.bbagen.2013.09.009
   Guo J, 2020, J VASC RES, V57, P325, DOI 10.1159/000509217
   Haidari F, 2017, ASIA PAC J CLIN NUTR, V26, P1048, DOI 10.6133/apjcn.022017.03
   Han DD, 2019, FREE RADICAL BIO MED, V137, P1, DOI 10.1016/j.freeradbiomed.2019.04.014
   Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06
   Hayakawa S, 2018, BIOACTIVE MOLECULES IN FOOD, V0, PP1, DOI 10.3390/MOLECULES25194553
   Hayakawa S, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25194553
   Hayakawa Sumio, 2016, ASIAN PAC J CANCER PREV, V17, P1649
   Herranz-L√≥pez M, 2020, FOOD CHEM TOXICOL, V144, P0, DOI 10.1016/j.fct.2020.111606
   Honnappa CG, 2016, INT J IMMUNOPATH PH, V29, P562, DOI 10.1177/0394632016673369
   Hosseinabadi S, 2020, COMPLEMENT THER MED, V49, P0, DOI 10.1016/j.ctim.2019.102290
   Hou N, 2017, ANTI-CANCER DRUG, V28, P59, DOI 10.1097/CAD.0000000000000430
   Hsieh CH, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0201920
   Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Huang LH, 2018, BMC COMPLEM ALTERN M, V18, P0, DOI 10.1186/s12906-018-2355-x
   Huang S, 2019, THERANOSTICS, V9, P6745, DOI 10.7150/thno.34674
   Iacomino G, 2017, GENES NUTR, V12, P0, DOI 10.1186/s12263-017-0577-z
   Igarashi Y, 2017, FOOD NUTR RES, V61, P0, DOI 10.1080/16546628.2017.1334484
   Inan-Eroglu E, 2020, INT J ENV RES PUB HE, V17, P0, DOI 10.3390/ijerph17145178
   Jang MH, 2017, BIOL PHARM BULL, V40, P797, DOI 10.1248/bpb.b16-00884
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Khan MS, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/7860650
   Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kong DQ, 2019, FREE RADICAL RES, V53, P680, DOI 10.1080/10715762.2019.1621308
   Koyama T, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12103090
   Kunnumakkara AB, 2017, BRIT J PHARMACOL, V174, P1325, DOI 10.1111/bph.13621
   La XQ, 2019, J AGR FOOD CHEM, V67, P2510, DOI 10.1021/acs.jafc.8b06665
   Lee J, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9121340
   Lee MS, 2009, PHYTOTHER RES, V23, P1088, DOI 10.1002/ptr.2737
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473
   Lewandowska U, 2013, J AGR FOOD CHEM, V61, P12183, DOI 10.1021/jf404439b
   Li C, 2019, BMC COMPLEM ALTERN M, V19, P0, DOI 10.1186/s12906-019-2648-8
   Li F, 2018, FRONT PHARMACOL, V9, P0, DOI 10.3389/fphar.2018.01366
   Li QP, 2019, FOOD FUNCT, V10, P7983, DOI 10.1039/c9fo02159k
   Liang HH, 2018, LIFE SCI, V209, P43, DOI 10.1016/j.lfs.2018.07.047
   Lin XY, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0216711
   Lin Y, 2020, PHYTOTHER RES, V34, P2459, DOI 10.1002/ptr.6697
   Liu CW, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep44689
   Liu G, 2019, BIOMED RES INT, V2019, P0, DOI 10.1155/2019/5716241
   Liu J, 2019, BMC ORAL HEALTH, V19, P0, DOI 10.1186/s12903-019-0768-7
   Liu SW, 2018, J FUNCT FOODS, V40, P648, DOI 10.1016/j.jff.2017.11.048
   Lu J, 2018, LIFE SCI, V209, P324, DOI 10.1016/j.lfs.2018.08.007
   Lu XH, 2019, PHARM BIOL, V57, P250, DOI 10.1080/13880209.2019.1594311
   Lukasiewicz E, 2005, PUBLIC HEALTH NUTR, V8, P315, DOI 10.1079/PHN2004680
   Ma FY, 2017, PHARM BIOL, V55, P1263, DOI 10.1080/13880209.2017.1297838
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Mar√©chal L, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19051529
   Mirzaaghaei S, 2019, ACS OMEGA, V4, P8421, DOI 10.1021/acsomega.9b00224
   Mousavi SM, 2020, CRIT REV FOOD SCI, V60, P171, DOI 10.1080/10408398.2018.1517724
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nakamae I, 2019, MOLECULES, V24, P0, DOI 10.3390/molecules24224067
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Nozari E, 2020, LIFE SCI, V259, P0, DOI 10.1016/j.lfs.2020.118293
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, P0, DOI 10.1155/2011/382852
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Osella Alberto R, 2014, REV FAC CIEN MED UNIV NAC CORDOBA, V71, P113
   Pan J, 2017, ONCOTARGET, V8, P65743, DOI 10.18632/oncotarget.19445
   Pastor RF, 2019, CRIT REV FOOD SCI, V59, P1237, DOI 10.1080/10408398.2017.1400517
   Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265
   Peng SG, 2018, BIOMED RES INT, V2018, P0, DOI 10.1155/2018/8594767
   Posadino AM, 2019, BIOMOLECULES, V9, P0, DOI 10.3390/biom9060209
   Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Qin S, 2017, NUTR J, V16, P0, DOI 10.1186/s12937-017-0293-y
   Qin SN, 2019, DRUG DES DEV THER, V13, P2759, DOI 10.2147/DDDT.S215358
   Rakshit S, 2010, BIOCHEM PHARMACOL, V80, P1662, DOI 10.1016/j.bcp.2010.08.013
   Ramdani LH, 2020, ACTA VIROL, V64, P276, DOI 10.4149/av_2020_309
   Ran ZL, 2019, MOL MED REP, V19, P1024, DOI 10.3892/mmr.2018.9749
   Reddy AT, 2020, LIFE SCI, V258, P0, DOI 10.1016/j.lfs.2020.118136
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Sadeghi A, 2018, INFLAMMOPHARMACOLOGY, V26, P1265, DOI 10.1007/s10787-018-0466-0
   Sae-tan S, 2011, FOOD FUNCT, V2, P111, DOI 10.1039/c0fo00155d
   Saeki K, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23061295
   Sahebkar A, 2016, PHARMACOL RES, V107, P234, DOI 10.1016/j.phrs.2016.03.026
   Sakamoto Naoya, 2017, NONCODING RNA RES, V2, P83, DOI 10.1016/j.ncrna.2017.05.002
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Saraf-Bank S, 2019, PHYTOTHER RES, V33, P2015, DOI 10.1002/ptr.6370
   Shao WJ, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0028784
   Silva J, 2021, ALCOHOL, V91, P1, DOI 10.1016/j.alcohol.2020.10.002
   Singh AP, 2019, MED RES REV, V39, P1851, DOI 10.1002/med.21565
   Soga S, 2013, BIOSCI BIOTECH BIOCH, V77, P1633, DOI 10.1271/bbb.130147
   Soltani A, 2019, J CELL PHYSIOL, V234, P2241, DOI 10.1002/jcp.27192
   Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005
   Subedi L, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/8092713
   Suzuki T, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21101305
   Swinnen JV, 1997, P NATL ACAD SCI USA, V94, P12975, DOI 10.1073/pnas.94.24.12975
   Tan Y, 2017, WORLD J GASTROENTERO, V23, P3805, DOI 10.3748/wjg.v23.i21.3805
   Tanabe H, 2017, OBES CONTROL THER, V4, P1, DOI 10.15226/2374-8354/4/3/00142
   Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Thomson CA, 2012, INT J OBESITY, V36, P1158, DOI 10.1038/ijo.2012.84
   Tian L, 2019, J CELL MOL MED, V23, P4666, DOI 10.1111/jcmm.14351
   Tian LL, 2017, CELL DEATH DIS, V8, P0, DOI 10.1038/cddis.2016.455
   Tian WX, 2006, CURR MED CHEM, V13, P967, DOI 10.2174/092986706776361012
   TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X
   Tsai CY, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19010016
   Tsai KL, 2018, MOL NUTR FOOD RES, V62, P0, DOI 10.1002/mnfr.201700928
   Ueda-Wakagi M, 2018, FOOD FUNCT, V9, P4223, DOI 10.1039/c8fo00807h
   UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644
   Vidot DC, 2016, METAB SYNDR RELAT D, V14, P354, DOI 10.1089/met.2015.0171
   Vlavcheski F, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12040914
   Wada Y, 2019, SURG TODAY, V49, P536, DOI 10.1007/s00595-019-1761-0
   Wahab A, 2017, MOLECULES, V22, P0, DOI 10.3390/molecules22081329
   Wang F, 2020, ORAL DIS, V26, P815, DOI 10.1111/odi.13290
   Wang H, 2015, SHOCK, V44, P173, DOI 10.1097/SHK.0000000000000390
   Wang L, 2020, DRUG DES DEV THER, V14, P4451, DOI 10.2147/DDDT.S266502
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Watanabe T, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11071617
   Weisberg SP, 2008, ENDOCRINOLOGY, V149, P3549, DOI 10.1210/en.2008-0262
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Wu CH, 2003, OBES RES, V11, P1088, DOI 10.1038/oby.2003.149
   Xian YX, 2020, N-S ARCH PHARMACOL, V393, P2009, DOI 10.1007/s00210-019-01777-1
   Xicota L, 2020, CLIN NUTR, V39, P1292, DOI 10.1016/j.clnu.2019.05.028
   Xu M, 2019, FOOD FUNCT, V10, P7489, DOI 10.1039/c9fo00502a
   Yan B, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/1346958
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641
   Yang F, 2017, FRONT PHARMACOL, V8, P0, DOI 10.3389/fphar.2017.00929
   Yang JS, 2012, IN VIVO, V26, P971
   Yi JJ, 2020, FOOD CHEM TOXICOL, V135, P0, DOI 10.1016/j.fct.2019.111051
   Yonekura Y, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12051370
   Yu H, 2019, TECHNOL CANCER RES T, V18, P0, DOI 10.1177/1533033819870781
   Yu TZ, 2019, J CELL PHYSIOL, V234, P6371, DOI 10.1002/jcp.27370
   Yuan H, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13199
   Zeng JH, 2020, MOL NUTR FOOD RES, V64, P0, DOI 10.1002/mnfr.202000452
   Zhang LZ, 2020, COPD, V17, P333, DOI 10.1080/15412555.2020.1780576
   Zhang R, 2006, BIOTECHNOL APPL BIOC, V43, P1, DOI 10.1042/BA20050064
   Zhang S, 2017, ANTICANCER RES, V37, P464, DOI 10.21873/anticanres.11338
   Zhang WT, 2020, WORLD ALLERGY ORGAN, V13, P0, DOI 10.1016/j.waojou.2020.100473
   Zhong X, 2019, MOL NUTR FOOD RES, V63, P0, DOI 10.1002/mnfr.201801230
   Zhong Y, 2020, EXP THER MED, V20, P1856, DOI 10.3892/etm.2020.8915
   Zhou TW, 2020, PHYTOTHER RES, V34, P2074, DOI 10.1002/ptr.6674
   Zhou Y, 2016, BIOCHEM BIOPH RES CO, V469, P1083, DOI 10.1016/j.bbrc.2015.12.094
NR 174
TC 72
Z9 72
U1 2
U2 54
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JAN 15
PY 2021
VL 26
IS 2
BP 
EP 
DI 10.3390/molecules26020453
PG 22
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA PY5BT
UT WOS:000612060200001
PM 33467101
DA 2025-04-28
ER

PT J
AU Liu, MT
   Qin, J
   Cong, J
   Yang, YB
AF Liu, Mengting
   Qin, Jian
   Cong, Jing
   Yang, Yubin
TI Chlorogenic Acids Inhibit Adipogenesis: Implications of Wnt/Œ≤-Catenin Signaling Pathway
SO INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID 3t3-l1 cell-differentiation; metabolism; accumulation; obesity
AB In our previous in vitro study, we found that chlorogenic acid (CGA) inhibited adipocyte differentiation and triglyceride (TG) accumulation, but the underlying mechanism is still unclear. Accumulative genetic evidence supports that canonical Wnt signaling is a key modulator on adipogenesis. Methods. In this study, 3T3-L1 cells were induced adipogenic differentiation and then treated with CGA. We investigate the effect of CGA in inhibiting adipogenesis and evaluate its role in modulating Wnt10b (wingless integration1 10b), beta-catenin, glycogen synthase kinase-3 beta (GSK-3 beta), and peroxisome proliferator-activated receptor gamma (PPAR-gamma) involved in the Wnt (wingless integration1)/beta-catenin signaling pathway. Results. The result showed that after CGA treatment, lipid accumulation and TG level decreased significantly in 3T3-L1 cells, indicating that CGA could inhibit adipogenesis. In addition, CGA repressed the induction of adipocyte differentiation biomarkers as PPAR-gamma, adipocyte protein 2 (aP2), fatty acid synthase (FAS), and lipoprotein lipase (LPL), and the secretion of GSK-3 beta in a dose-dependent manner upregulated the expression of beta-catenin and Wnt10b both in gene and protein levels. Moreover, CGA induced phosphorylation of GSK-3 beta and promoted the accumulation of free cytosolic beta-catenin in 3T3-L1 adipocytes. Conclusion. Overall, these findings gave us the implications that CGA inhibits adipogenesis via the canonical Wnt signaling pathway.
C1 [Liu, Mengting; Yang, Yubin] Guangdong Pharmaceut Univ, Affiliated Hosp 1, Guangzhou 510080, Peoples R China.
   [Qin, Jian] Sun Yat Sen Univ, Affiliated Hosp 7, Shenzhen 518000, Peoples R China.
   [Cong, Jing] Giant Praise HK Pharmaceut Grp Ltd, Acad Dept, Changchun 130033, Peoples R China.
C3 Guangdong Pharmaceutical University; Sun Yat Sen University
RP Yang, YB (corresponding author), Guangdong Pharmaceut Univ, Affiliated Hosp 1, Guangzhou 510080, Peoples R China.
EM liuying120660@163.com; qingq1997813@163.com; vsb989@163.com; yybin@mail.sysu.edu.cn
FU CGA monomer; Giant Praise (HK) Pharmaceutical Group Limited; Guangdong Provincial Administration of Traditional Chinese Medicine Project [20181052]; Guangdong Natural Science Fund Project [2018A030313411]; Chinese National Natural Science Foundation [82104716]
CR Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
   Ahn J, 2010, AM J PHYSIOL-CELL PH, V298, PC1510, DOI 10.1152/ajpcell.00369.2009
   Ambele MA, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21124283
   Bahmad HF, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9102326
   Sanchez MB, 2017, BIOMED PHARMACOTHER, V94, P169, DOI 10.1016/j.biopha.2017.07.086
   Bessesen DH, 2018, LANCET DIABETES ENDO, V6, P237, DOI 10.1016/S2213-8587(17)30236-X
   Chang E, 2019, MOLECULES, V24, P0, DOI 10.3390/molecules24061157
   Chen H, 2014, CELL SIGNAL, V26, P2583, DOI 10.1016/j.cellsig.2014.07.017
   Chen JL, 2018, J NUTR BIOCHEM, V59, P84, DOI 10.1016/j.jnutbio.2018.06.005
   Chen N, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.00792
   Chi YY, 2016, FOOD SCI BIOTECHNOL, V25, P1147, DOI 10.1007/s10068-016-0183-7
   de S√° PM, 2017, COMPR PHYSIOL, V7, P635, DOI 10.1002/cphy.c160022
   Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3
   Feng S, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21101278
   Gong XJ, 2017, BIOMED CHROMATOGR, V31, P0, DOI 10.1002/bmc.4008
   Hao S, 2016, PHARM BIOL, V54, P251, DOI 10.3109/13880209.2015.1029054
   Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3
   Ji E, 2014, INT J OBESITY, V38, P1035, DOI 10.1038/ijo.2013.202
   Kong L, 2021, J FOOD BIOCHEM, V45, P0, DOI 10.1111/jfbc.13795
   Ma LY, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19092785
   MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016
   Mart√≠nez-L√≥pez S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Moorer MC, 2018, ENDOCRINOL METAB, V33, P318, DOI 10.3803/EnM.2018.33.3.318
   Nijhawan P, 2020, MOL BIOL REP, V47, P8091, DOI 10.1007/s11033-020-05784-x
   Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483
   Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950
   Santana-G√°lvez J, 2017, MOLECULES, V22, P0, DOI 10.3390/molecules22030358
   Smith KB, 2016, PRIMARY CARE, V43, P121, DOI 10.1016/j.pop.2015.10.001
   Son JW, 2020, DIABETES METAB J, V44, P802, DOI 10.4093/dmj.2020.0258
   Song Y, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9060554
   Tang LJ, 2015, CELL PHYSIOL BIOCHEM, V37, P143, DOI 10.1159/000430340
   Tian YY, 2016, FOOD SCI BIOTECHNOL, V25, P1753, DOI 10.1007/s10068-016-0267-4
NR 32
TC 14
Z9 15
U1 2
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1687-8337
EI 1687-8345
J9 INT J ENDOCRINOL
JI Int. J. Endocrinol.
PD NOV 20
PY 2021
VL 2021
IS 
BP 
EP 
DI 10.1155/2021/2215274
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA XT7KG
UT WOS:000733761200001
PM 34845409
DA 2025-04-28
ER

PT J
AU Fukutomi, R
   Ohishi, T
   Koyama, Y
   Pervin, M
   Nakamura, Y
   Isemura, M
AF Fukutomi, Ryuuta
   Ohishi, Tomokazu
   Koyama, Yu
   Pervin, Monira
   Nakamura, Yoriyuki
   Isemura, Mamoru
TI Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases
SO MOLECULES
LA English
DT Review
DE polyphenols; EGCG; chlorogenic acid; resveratrol; curcumin; NDD; ROS; AMPK; NF-&#954; B
AB Many observational and clinical studies have shown that consumption of diets rich in plant polyphenols have beneficial effects on various diseases such as cancer, obesity, diabetes, cardiovascular diseases, and neurodegenerative diseases (NDDs). Animal and cellular studies have indicated that these polyphenolic compounds contribute to such effects. The representative polyphenols are epigallocatechin-3-O-gallate in tea, chlorogenic acids in coffee, resveratrol in wine, and curcumin in curry. The results of human studies have suggested the beneficial effects of consumption of these foods on NDDs including Alzheimer's and Parkinson's diseases, and cellular animal experiments have provided molecular basis to indicate contribution of these representative polyphenols to these effects. This article provides updated information on the effects of these foods and their polyphenols on NDDs with discussions on mechanistic aspects of their actions mainly based on the findings derived from basic experiments.
C1 [Fukutomi, Ryuuta] Higuchi Inc, Qual Management Div, Minato Ku, Tokyo 1080075, Japan.
   [Ohishi, Tomokazu] Microbial Chem Res Fdn, Inst Microbial Chem BIKAKEN, Shizuoka 4100301, Japan.
   [Koyama, Yu] Shizuoka Eiwa Gakuin Univ, Jr Coll, Suruga Ku, Shizuoka 4228545, Japan.
   [Pervin, Monira; Nakamura, Yoriyuki; Isemura, Mamoru] Univ Shizuoka, Tea Sci Res Ctr, Suruga Ku, Shizuoka 4228526, Japan.
C3 University of Shizuoka
RP Fukutomi, R (corresponding author), Higuchi Inc, Qual Management Div, Minato Ku, Tokyo 1080075, Japan.; Isemura, M (corresponding author), Univ Shizuoka, Tea Sci Res Ctr, Suruga Ku, Shizuoka 4228526, Japan.
EM fukutomi_ryuuta@mac.com; ohishit@bikaken.or.jp; y.koyama@shizuoka-eiwa.ac.jp; monira689@yahoo.com; yori.naka@u-shizuoka-ken.ac.jp; isemura@u-shizuoka-ken.ac.jp
CR Al-Edresi S, 2020, NEUROBIOL AGING, V94, P24, DOI 10.1016/j.neurobiolaging.2020.04.012
   Arntzen KA, 2010, ACTA NEUROL SCAND, V122, P23, DOI 10.1111/j.1600-0404.2010.01371.x
   Ascherio A, 2001, ANN NEUROL, V50, P56, DOI 10.1002/ana.1052
   Baghbaderani S, 2020, PSYCHOPHARMACOLOGY, V0, P0, DOI DOI 10.1007/s00213-020-05633-6
   Quintana JLB, 2007, NEUROL RES, V29, P91, DOI 10.1179/174313206X152546
   Quintana JLB, 2009, J AM COLL NUTR, V28, P1
   Basli A, 2012, OXID MED CELL LONGEV, V2012, P0, DOI 10.1155/2012/805762
   Bastianetto S, 2015, BBA-MOL BASIS DIS, V1852, P1195, DOI 10.1016/j.bbadis.2014.09.011
   Baum L, 2008, J CLIN PSYCHOPHARM, V28, P110, DOI 10.1097/jcp.0b013e318160862c
   Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455
   Benedetti MD, 2000, NEUROLOGY, V55, P1350, DOI 10.1212/WNL.55.9.1350
   Bhat A, 2019, BIOFACTORS, V45, P666, DOI 10.1002/biof.1533
   Birch AM, 2014, J NEUROINFLAMM, V11, P0, DOI 10.1186/1742-2094-11-25
   Biswas SK, 2005, ANTIOXID REDOX SIGN, V7, P32, DOI 10.1089/ars.2005.7.32
   Boulos C, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11081896
   Cai ZY, 2013, NEUROMOL MED, V15, P25, DOI 10.1007/s12017-012-8207-9
   Camfield DA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0082897
   Chandra V, 2001, NEUROLOGY, V57, P985, DOI 10.1212/WNL.57.6.985
   Checkoway H, 2002, AM J EPIDEMIOL, V155, P732, DOI 10.1093/aje/155.8.732
   Chen HL, 2015, PARKINSONISM RELAT D, V21, P1200, DOI 10.1016/j.parkreldis.2015.08.020
   Chen Y, 2019, MOL MED REP, V19, P3783, DOI 10.3892/mmr.2019.10010
   Cho ES, 2009, MUTAT RES-FUND MOL M, V661, P18, DOI 10.1016/j.mrfmmm.2008.10.021
   Chuang YH, 2016, NEUROEPIDEMIOLOGY, V47, P192, DOI 10.1159/000450855
   Ciaramelli C, 2018, FOOD CHEM, V252, P171, DOI 10.1016/j.foodchem.2018.01.075
   Cicero AFG, 2019, ARCH MED SCI, V15, P936, DOI 10.5114/aoms.2019.85463
   Cole GM, 2007, ADV EXP MED BIOL, V595, P197
   Cox KHM, 2015, J PSYCHOPHARMACOL, V29, P642, DOI 10.1177/0269881114552744
   Cropley V, 2012, PSYCHOPHARMACOLOGY, V219, P737, DOI 10.1007/s00213-011-2395-0
   de la Torre R, 2020, CLIN NUTR, V39, P378, DOI 10.1016/j.clnu.2019.02.028
   de la Torre R, 2016, LANCET NEUROL, V15, P801, DOI 10.1016/S1474-4422(16)30034-5
   Di Fabio E, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25204603
   Dietz C, 2017, FOOD RES INT, V99, P72, DOI 10.1016/j.foodres.2017.05.002
   DiSilvestro RA, 2012, NUTR J, V11, P0, DOI 10.1186/1475-2891-11-79
   Dong SZ, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0031211
   Dong X, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12030840
   Du K, 2018, MOL NUTR FOOD RES, V62, P0, DOI 10.1002/mnfr.201700890
   Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920
   Evans HM, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9010027
   Fan Y, 2005, NEUROSCI LETT, V374, P222, DOI 10.1016/j.neulet.2004.10.063
   Feng L, 2015, J PREV ALZHEIMERS DIS, V2, P136, DOI 10.14283/jpad.2015.57
   Feng L, 2010, J NUTR HEALTH AGING, V14, P433
   Fischer K, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10070852
   Freyssin A, 2020, NEURAL REGEN RES, V15, P843, DOI 10.4103/1673-5374.268970
   Fukuyama K, 2018, MOL NUTR FOOD RES, V62, P0, DOI 10.1002/mnfr.201800238
   Gagliardi S, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25225389
   Ganguli M, 2000, ARCH NEUROL-CHICAGO, V57, P824, DOI 10.1001/archneur.57.6.824
   Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x
   Gelber RP, 2011, J ALZHEIMERS DIS, V23, P607, DOI 10.3233/JAD-2010-101428
   Gigante AF, 2018, NEUROL SCI, V39, P551, DOI 10.1007/s10072-018-3253-1
   Gocmez SS, 2016, NEUROBIOL LEARN MEM, V131, P131, DOI 10.1016/j.nlm.2016.03.022
   Goozee KG, 2016, BRIT J NUTR, V115, P449, DOI 10.1017/S0007114515004687
   Granzotto A, 2014, FRONT AGING NEUROSCI, V6, P0, DOI 10.3389/fnagi.2014.00095
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Gu YJ, 2018, AGING MENT HEALTH, V22, P1232, DOI 10.1080/13607863.2017.1339779
   Guo YJ, 2016, MOL NUTR FOOD RES, V60, P2161, DOI 10.1002/mnfr.201600111
   Guo YF, 2017, NEUROREPORT, V28, P590, DOI 10.1097/wnr.0000000000000803
   Han J, 2010, NEUROSCIENCE, V169, P1039, DOI 10.1016/j.neuroscience.2010.05.049
   Hayakawa S, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25194553
   Hayakawa Sumio, 2016, ASIAN PAC J CANCER PREV, V17, P1649
   He Miao, 2012, ZHONG YAO CAI, V35, P1641
   Hern√°n MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277
   Hishikawa Nozomi, 2012, AYU, V33, P499, DOI 10.4103/0974-8520.110524
   Hoelzl C, 2010, MOL NUTR FOOD RES, V54, P1722, DOI 10.1002/mnfr.201000048
   Hu G, 2007, MOVEMENT DISORD, V22, P2242, DOI 10.1002/mds.21706
   Huang HC, 2012, J ALZHEIMERS DIS, V32, P981, DOI 10.3233/JAD-2012-120688
   Ide K, 2016, NUTR J, V15, P0, DOI 10.1186/s12937-016-0168-7
   Ishida K, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12020494
   Ishida K, 2020, NEUROSCI RES, V154, P35, DOI 10.1016/j.neures.2019.05.001
   Jayaraj RL, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/236182
   Jayasena T, 2013, AGEING RES REV, V12, P867, DOI 10.1016/j.arr.2013.06.003
   Jin F, 2008, EUR J PHARMACOL, V600, P78, DOI 10.1016/j.ejphar.2008.10.005
   Jomova K, 2012, TRANSIT METAL CHEM, V37, P127, DOI 10.1007/s11243-012-9583-6
   Kandinov B, 2009, PARKINSONISM RELAT D, V15, P41, DOI 10.1016/j.parkreldis.2008.02.011
   Kawabata K, 2019, MOLECULES, V24, P0, DOI 10.3390/molecules24020370
   Kelsey NA, 2010, MOLECULES, V15, P7792, DOI 10.3390/molecules15117792
   Kennedy DO, 2010, AM J CLIN NUTR, V91, P1590, DOI 10.3945/ajcn.2009.28641
   Khatri DK, 2016, PHARMACOL BIOCHEM BE, V150, P39, DOI 10.1016/j.pbb.2016.09.002
   Khatri DK, 2016, PHARMACOGN MAG, V12, PS116, DOI 10.4103/0973-1296.182168
   Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022
   Kim JW, 2019, TRANSL PSYCHIAT, V9, P0, DOI 10.1038/s41398-019-0604-5
   Kim JS, 2010, J CLIN NEUROSCI, V17, P1165, DOI 10.1016/j.jocn.2010.01.042
   Kim J, 2012, NEUROCHEM INT, V60, P466, DOI 10.1016/j.neuint.2012.02.004
   Kim TY, 2020, ANTIOXIDANTS-BASEL, V9, P0, DOI 10.3390/antiox9070583
   Kim YS, 2015, NEUROEPIDEMIOLOGY, V44, P51, DOI 10.1159/000371710
   Kitamura K, 2016, DEMENT GER COGN D EX, V6, P341, DOI 10.1159/000447963
   Koukoulitsa C, 2016, J ENZYM INHIB MED CH, V31, P67, DOI 10.3109/14756366.2014.1003928
   Kucukgoncu S, 2019, J CLIN PSYCHOPHARM, V39, P182, DOI 10.1097/JCP.0000000000001012
   Kuriyama S, 2006, AM J CLIN NUTR, V83, P355
   Kwok MK, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep36500
   Kwon SH, 2010, EUR J PHARMACOL, V649, P210, DOI 10.1016/j.ejphar.2010.09.001
   Larsson SC, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10101501
   Lee JW, 2009, J NUTR, V139, P1987, DOI 10.3945/jn.109.109785
   Lee K, 2012, EUR J PHARMACOL, V689, P89, DOI 10.1016/j.ejphar.2012.05.028
   Levites Y, 2003, FASEB J, V17, P952, DOI 10.1096/fj.02-0881fje
   Levites Y, 2001, J NEUROCHEM, V78, P1073, DOI 10.1046/j.1471-4159.2001.00490.x
   Li D, 2017, BRAIN RES, V1654, P1, DOI 10.1016/j.brainres.2016.10.013
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001
   Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074
   Liu JB, 2016, J IMMUNOL RES, V2016, P0, DOI 10.1155/2016/4962351
   Liu QP, 2016, NUTRITION, V32, P628, DOI 10.1016/j.nut.2015.11.015
   Louis ED, 2003, NEUROLOGY, V61, P24, DOI 10.1212/01.WNL.0000072330.07328.D6
   Albarracin SL, 2012, NUTR NEUROSCI, V15, P1, DOI 10.1179/1476830511Y.0000000028
   Ma QL, 2013, J BIOL CHEM, V288, P4056, DOI 10.1074/jbc.M112.393751
   Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009
   Maiti P, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/495091
   Mandel S, 2004, J NEUROCHEM, V88, P1555, DOI 10.1046/j.1471-4159.2003.02291.x
   Marx W, 2018, NUTR REV, V76, P432, DOI 10.1093/nutrit/nuy010
   Mehlig K, 2008, AM J EPIDEMIOL, V167, P684, DOI 10.1093/aje/kwm366
   Mishra S, 2008, ANN INDIAN ACAD NEUR, V11, P13, DOI 10.4103/0972-2327.40220
   Miyazaki I, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8030221
   Miyoshi N, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25112588
   Mohorko N, 2010, J NEUROPATH EXP NEUR, V69, P405, DOI 10.1097/NEN.0b013e3181d709eb
   MORANO A, 1994, ACTA NEUROL SCAND, V89, P164
   Moussa C, 2017, J NEUROINFLAMM, V14, P0, DOI 10.1186/s12974-016-0779-0
   Mythri RB, 2012, CURR PHARM DESIGN, V18, P91, DOI 10.2174/138161212798918995
   Nakajima Y, 2007, LIFE SCI, V80, P370, DOI 10.1016/j.lfs.2006.09.017
   Nam SM, 2014, J MED FOOD, V17, P641, DOI 10.1089/jmf.2013.2965
   Ng CH, 2012, J NEUROSCI, V32, P14311, DOI 10.1523/JNEUROSCI.0499-12.2012
   Ng TP, 2008, AM J CLIN NUTR, V88, P224, DOI 10.1093/ajcn/88.1.224
   Ng TP, 2006, AM J EPIDEMIOL, V164, P898, DOI 10.1093/aje/kwj267
   Noguchi-Shinohara M, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0096013
   Noyce AJ, 2019, MOVEMENT DISORD, V34, P1864, DOI 10.1002/mds.27873
   Oboh G, 2013, NEUROCHEM RES, V38, P413, DOI 10.1007/s11064-012-0935-6
   Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025
   Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185
   Orhan I, 2004, J ETHNOPHARMACOL, V91, P57, DOI 10.1016/j.jep.2003.11.016
   Palacios JA, 2010, J CELL BIOL, V191, P1299, DOI 10.1083/jcb.201005160
   Pan J, 2012, TRANSL NEURODEGENER, V1, P0, DOI 10.1186/2047-9158-1-16
   Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498
   Perez Carlos A, 2008, CURR BIOACT COMPD, V4, P150, DOI 10.2174/157340708786305952
   Pervin M, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23061297
   Pervin Monira, 2017, BIOCHEM BIOPHYS REP, V9, P180, DOI 10.1016/j.bbrep.2016.12.012
   Polito CA, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10050655
   Poole R, 2017, BMJ-BRIT MED J, V359, P0, DOI 10.1136/bmj.j5024
   Porquet D, 2013, AGE, V35, P1851, DOI 10.1007/s11357-012-9489-4
   Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123
   Qiao PF, 2020, CURR ALZHEIMER RES, V17, P735, DOI 10.2174/1567205017666201111120919
   Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200
   Rainey-Smith SR, 2016, BRIT J NUTR, V115, P2106, DOI 10.1017/S0007114516001203
   Ramis MR, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12020326
   Rane JS, 2017, J ALZHEIMERS DIS, V60, P999, DOI 10.3233/JAD-170351
   Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002
   Reuter S, 2011, GENES NUTR, V6, P93, DOI 10.1007/s12263-011-0222-1
   Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005
   Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107
   Ringman JM, 2012, ALZHEIMERS RES THER, V4, P0, DOI 10.1186/alzrt146
   Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674
   Rossetti F, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25184276
   S√§√§ksj√§rvi K, 2008, EUR J CLIN NUTR, V62, P908, DOI 10.1038/sj.ejcn.1602788
   Saitou K, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10101337
   Scholey A, 2012, APPETITE, V58, P767, DOI 10.1016/j.appet.2011.11.016
   Selkoe D, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a011460
   Sharma N, 2018, INFLAMMOPHARMACOLOGY, V26, P349, DOI 10.1007/s10787-017-0402-8
   Shen W, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0140739
   Shen WJ, 2012, BRAIN RES BULL, V88, P487, DOI 10.1016/j.brainresbull.2012.04.010
   Shi M, 2020, INT J NEUROSCI, V130, P700, DOI 10.1080/00207454.2019.1702547
   Shirai Y, 2020, PUBLIC HEALTH NUTR, V23, P1049, DOI 10.1017/S1368980019002659
   Singh AP, 2019, MED RES REV, V39, P1851, DOI 10.1002/med.21565
   Singh NA, 2016, NUTR J, V15, P0, DOI 10.1186/s12937-016-0179-4
   Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203
   Singh SS, 2018, FRONT PHARMACOL, V9, P0, DOI 10.3389/fphar.2018.00757
   Singh SS, 2020, OXID MED CELL LONGEV, V2020, P0, DOI 10.1155/2020/6571484
   Small GW, 2018, AM J GERIAT PSYCHIAT, V26, P266, DOI 10.1016/j.jagp.2017.10.010
   Solfrizzi V, 2015, J ALZHEIMERS DIS, V47, P889, DOI 10.3233/JAD-150333
   Soo SK, 2020, MECH AGEING DEV, V190, P0, DOI 10.1016/j.mad.2020.111297
   Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005
   Sun CY, 2013, PHARMACOL BIOCHEM BE, V105, P76, DOI 10.1016/j.pbb.2013.02.002
   Sun XY, 2019, CURR ALZHEIMER RES, V16, P710, DOI 10.2174/1567205016666190801153751
   Suzuki T, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21101305
   Tabatabaei NH, 2013, FUNCT NEUROL, V28, P107, DOI 10.11138/FNeur/2013.28.2.107
   Tan EK, 2003, J NEUROL SCI, V216, P163, DOI 10.1016/j.jns.2003.07.006
   Tan LC, 2008, AM J EPIDEMIOL, V167, P553, DOI 10.1093/aje/kwm338
   Tanabe H, 2017, OBES CONTROL THER, V4, P1, DOI 10.15226/2374-8354/4/3/00142
   Tanaka K, 2011, PARKINSONISM RELAT D, V17, P446, DOI 10.1016/j.parkreldis.2011.02.016
   Teraoka M, 2012, J CLIN BIOCHEM NUTR, V51, P122, DOI 10.3164/jcbn.D-11-00030
   Turner RS, 2015, NEUROLOGY, V85, P1383, DOI 10.1212/WNL.0000000000002035
   Uchiumi Fumiaki, 2011, CURR AGING SCI, V4, P1
   van Gelder BM, 2007, EUR J CLIN NUTR, V61, P226, DOI 10.1038/sj.ejcn.1602495
   Van Leeuw R, 2014, J FOOD COMPOS ANAL, V36, P40, DOI 10.1016/j.jfca.2014.07.001
   Venigalla M, 2015, NEURAL REGEN RES, V10, P1181, DOI 10.4103/1673-5374.162686
   Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061
   Voulgaropoulou SD, 2019, BRAIN RES, V1725, P0, DOI 10.1016/j.brainres.2019.146476
   Walker JM, 2015, J ALZHEIMERS DIS, V44, P561, DOI 10.3233/JAD-140981
   Wang XX, 2020, DIABET METAB SYND OB, V13, P1061, DOI 10.2147/DMSO.S243560
   Wasim S, 2020, CUREUS J MED SCIENCE, V12, P0, DOI 10.7759/cureus.9578
   Wei BB, 2019, ACTA PHARMACOL SIN, V40, P1490, DOI 10.1038/s41401-019-0243-7
   Wightman EL, 2012, HUM PSYCHOPHARM CLIN, V27, P177, DOI 10.1002/hup.1263
   Witte AV, 2014, J NEUROSCI, V34, P7862, DOI 10.1523/JNEUROSCI.0385-14.2014
   Wojtowicz S, 2020, NEUROCHEM RES, V45, P972, DOI 10.1007/s11064-020-02993-5
   Wu L, 2017, CLIN NUTR, V36, P730, DOI 10.1016/j.clnu.2016.05.015
   Wu YC, 2011, NEUROSIGNALS, V19, P163, DOI 10.1159/000328516
   Xu W, 2015, J NEUROL NEUROSUR PS, V86, P1299, DOI 10.1136/jnnp-2015-310548
   Yadav E, 2019, NEUROCHEM RES, V44, P1665, DOI 10.1007/s11064-019-02792-7
   Yanagisawa D, 2011, J ALZHEIMERS DIS, V24, P33, DOI 10.3233/JAD-2011-102100
   Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641
   Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200
   Yang LL, 2019, MOL NUTR FOOD RES, V63, P0, DOI 10.1002/mnfr.201801432
   Yang L, 2016, AGE AGEING, V45, P707, DOI 10.1093/ageing/afw088
   Zaw JJT, 2021, CLIN NUTR, V40, P820, DOI 10.1016/j.clnu.2020.08.025
   Zhang H, 2012, J NEUROSCI, V32, P15565, DOI 10.1523/JNEUROSCI.3668-12.2012
   Zhang S, 2020, PHYTOMEDICINE, V79, P0, DOI 10.1016/j.phymed.2020.153316
   Zhang YQ, 2019, MOL MED REP, V20, P4587, DOI 10.3892/mmr.2019.10723
   Zhang YW, 2011, MOL BRAIN, V4, P0, DOI 10.1186/1756-6606-4-3
   Zhang YQ, 2017, BMC NEUROSCI, V18, P0, DOI 10.1186/s12868-017-0387-7
   Zhao ZM, 2020, NUTR NEUROSCI, V23, P971, DOI 10.1080/1028415X.2019.1581460
   Zheng KM, 2017, MOL NEUROBIOL, V54, P1967, DOI 10.1007/s12035-016-9802-9
   Zhou TT, 2018, MOL MED REP, V17, P4883, DOI 10.3892/mmr.2018.8470
NR 208
TC 49
Z9 49
U1 2
U2 29
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JAN 15
PY 2021
VL 26
IS 2
BP 
EP 
DI 10.3390/molecules26020415
PG 28
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA PX6KY
UT WOS:000611464300001
PM 33466849
DA 2025-04-28
ER

PT J
AU Jin, F
   Qiao, C
AF Jin, Feng
   Qiao, Chong
TI Association of maternal caffeine intake during pregnancy with low birth weight, childhood overweight, and obesity: a meta-analysis of cohort studies
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Review
ID coffee consumption; preterm birth; growth; outcm; risk
AB Background Epidemiological studies reported inconsistent results on the associations between maternal caffeine intake during pregnancy and risk of low birth weight (LBW) and childhood overweight and obesity in their offspring. Methods We conducted a meta-analysis of cohort studies to quantitatively assess these associations. Pertinent studies were identified by searching PubMed and Embase through June 2019. Study-specifics risk estimates were combined using fixed effects models, or random-effects models when significant heterogeneity was detected. Dose-response analysis was modeled by using restricted cubic splines. Results A total of 15 cohort studies, with 102,347 pregnancy women, was included in the meta-analysis. The pooled relative risk (RR) for LBW was 1.33 (95% CI: 1.12, 1.57) for mothers with the highest compared with the lowest level of caffeine intake during pregnancy, with significant heterogeneity across studies (I-2 = 49.3%,P = 0.032). The pooled RR was 1.07 (95% CI: 1.02, 1.11) for each 100 mg/day increase of caffeine intake. The pooled RR for childhood overweight and obesity was 1.39 (95% CI: 1.15, 1.69) for mothers with the highest compared with the lowest level of caffeine intake during pregnancy. No significant heterogeneity across studies was detected (I-2 = 38.9%,P = 0.179). The pooled RR was 1.31 (95% CI: 1.11, 1.55) for each 100 mg/day increase of caffeine intake. No evidence of publication bias was indicated. Conclusions Maternal caffeine intake during pregnancy is associated with higher risk of LBW and childhood overweight and obesity. Further studies may focus on investigating the potential mechanisms before the recommendation of complete avoidance of caffeine intake during pregnancy.
C1 [Jin, Feng; Qiao, Chong] China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R China.
C3 China Medical University
RP Qiao, C (corresponding author), China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R China.
EM qiaochong2002@hotmail.com
CR Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792
   Bech BH, 2006, INT J EPIDEMIOL, V35, P948, DOI 10.1093/ije/dyl116
   Boylan S, 2008, BMJ-BRIT MED J, V337, P0, DOI 10.1136/bmj.a2332
   Bracken MB, 2003, AM J EPIDEMIOL, V157, P456, DOI 10.1093/aje/kwf220
   Chen LW, 2019, AM J CLIN NUTR, V109, P1648, DOI 10.1093/ajcn/nqz019
   Chen LW, 2018, AM J CLIN NUTR, V108, P1301, DOI 10.1093/ajcn/nqy219
   Cho Won Kyoung, 2016, KOREAN J PEDIATR, V59, P1, DOI 10.3345/kjp.2016.59.1.1
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Desai M, 2011, SEMIN REPROD MED, V29, P237, DOI 10.1055/s-0031-1275517
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Eskenazi B, 1999, EPIDEMIOLOGY, V10, P242, DOI 10.1097/00001648-199905000-00009
   FORTIER I, 1993, AM J EPIDEMIOL, V137, P931, DOI 10.1093/oxfordjournals.aje.a116763
   GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237
   Greenwood DC, 2014, EUR J EPIDEMIOL, V29, P725, DOI 10.1007/s10654-014-9944-x
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso LM, 2001, EPIDEMIOLOGY, V12, P447, DOI 10.1097/00001648-200107000-00015
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Jahanfar S, 2015, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD006965.pub4
   Li DK, 2015, INT J OBESITY, V39, P658, DOI 10.1038/ijo.2014.196
   LINN S, 1982, NEW ENGL J MED, V306, P141, DOI 10.1056/NEJM198201213060304
   MARTIN TR, 1987, AM J EPIDEMIOL, V126, P813, DOI 10.1093/oxfordjournals.aje.a114718
   MCDONALD AD, 1992, AM J PUBLIC HEALTH, V82, P87, DOI 10.2105/AJPH.82.1.87
   MILLS JL, 1993, JAMA-J AM MED ASSOC, V269, P593, DOI 10.1001/jama.269.5.593
   Modzelewska D, 2019, BMC PREGNANCY CHILDB, V19, P0, DOI 10.1186/s12884-019-2215-9
   Moher D, 2009, BMJ-BRIT MED J, V339, P0, DOI 10.1136/bmj.i4086
   Okubo H, 2015, NUTR RES, V35, P309, DOI 10.1016/j.nutres.2015.02.009
   OLSEN J, 1991, EPIDEMIOLOGY, V2, P370, DOI 10.1097/00001648-199109000-00011
   Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265
   Papadopoulou E, 2018, BMJ OPEN, V8, P0, DOI 10.1136/bmjopen-2017-018895
   Peacock A, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10030319
   Poole R, 2017, BMJ-BRIT MED J, V359, P0, DOI 10.1136/bmj.j5024
   Rhee J, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0132334
   Roh E, 2016, EXP MOL MED, V48, P0, DOI 10.1038/emm.2016.4
   Sasaki S, 2017, PEDIATR RES, V82, P19, DOI 10.1038/pr.2017.70
   Sengpiel V, 2013, BMC MED, V11, P0, DOI 10.1186/1741-7015-11-42
   Signorello LB, 2001, OBSTET GYNECOL, V98, P1059, DOI 10.1016/S0029-7844(01)01575-7
   van der Hoeven T, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0177619
   Vitti FP, 2018, REV BRAS GINECOL OBS, V40, P749, DOI 10.1055/s-0038-1675806
   Voerman E, 2016, OBESITY, V24, P1170, DOI 10.1002/oby.21466
   Wikoff D, 2017, FOOD CHEM TOXICOL, V109, P585, DOI 10.1016/j.fct.2017.04.002
   Xn D, 2012, TOXICOL APPL PHARM, V264, P395, DOI 10.1016/j.taap.2012.08.016
   Xu D, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044497
   ,, 2010, OBSTETRICS & GYNECOLOGY (NEW YORK), V116, P467
NR 43
TC 26
Z9 27
U1 8
U2 27
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD FEB 15
PY 2021
VL 45
IS 2
BP 279
EP 287
DI 10.1038/s41366-020-0617-4
EA JUN 2020
PG 9
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA PY9SZ
UT WOS:000539167100001
PM 32518355
DA 2025-04-28
ER

PT J
AU Kolb, H
   Martin, S
   Kempf, K
AF Kolb, Hubert
   Martin, Stephan
   Kempf, Kerstin
TI Coffee and Lower Risk of Type 2 Diabetes: Arguments for a Causal Relationship
SO NUTRIENTS
LA English
DT Review
DE coffee; diabetes; caffeine; chlorogenic; acids; hepatosteatosis; beta cells; hormesis; Nrf2
ID transcription factor nrf2; pathway in-vitro; components chlorogenic acid; aryl-hydrocarbon receptor; beta-cell dysfunction; decaffeinated coffee; insulin sensitivity; caffeic acid; diterpenes cafestol; glucose-metabolism
AB Prospective epidemiological studies concur in an association between habitual coffee consumption and a lower risk of type 2 diabetes. Several aspects of these studies support a cause-effect relationship. There is a dependency on daily coffee dose. Study outcomes are similar in different regions of the world, show no differences between sexes, between obese versus lean, young versus old, smokers versus nonsmokers, regardless of the number of confounders adjusted for. Randomized controlled intervention trials did not find a consistent impact of drinking coffee on acute metabolic control, except for effects of caffeine. Therefore, lowering of diabetes risk by coffee consumption does not involve an acute effect on the post-meal course of blood glucose, insulin or insulin resistance. Several studies in animals and humans find that the ingestion of coffee phytochemicals induces an adaptive cellular response characterized by upregulation and de novo synthesis of enzymes involved in cell defense and repair. A key regulator is the nuclear factor erythroid 2-related factor 2 (Nrf2) in association with the aryl hydrocarbon receptor, AMP-activated kinase and sirtuins. One major site of coffee actions appears to be the liver, causing improved fat oxidation and lower risk of steatosis. Another major effect of coffee intake is preservation of functional beta cell mass via enhanced mitochondrial function, lower endoplasmic reticulum stress and prevention or clearance of aggregates of misfolded proinsulin or amylin. Long-term preservation of proper liver and beta cell function may account for the association of habitual coffee drinking with a lower risk of type 2 diabetes, rather than acute improvement of metabolic control.
C1 [Kolb, Hubert; Martin, Stephan] Univ Duesseldorf, Fac Med, Moorenstr 5, D-40225 Dusseldorf, Germany.
   [Kolb, Hubert; Martin, Stephan; Kempf, Kerstin] Duesseldorf Catholic Hosp Grp, West German Ctr Diabet & Hlth, Hohensandweg 37, D-40591 Dusseldorf, Germany.
RP Kempf, K (corresponding author), Duesseldorf Catholic Hosp Grp, West German Ctr Diabet & Hlth, Hohensandweg 37, D-40591 Dusseldorf, Germany.
EM hubert.kolb@hhu.de; stephan.martin@uni-duesseldorf.de; kerstin.kempf@wdgz.de
FU Gesellschaft von Freunden und Forderern der Heinrich-HeineUniversitat Dusseldorf e.V.
CR Accili D, 2016, DIABETES OBES METAB, V18, P117, DOI 10.1111/dom.12723
   Alferink LJM, 2018, SEMIN LIVER DIS, V38, P193, DOI 10.1055/s-0038-1666869
   Alperet DJ, 2020, AM J CLIN NUTR, V111, P448, DOI 10.1093/ajcn/nqz306
   Altieri F, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11010186
   Amin N, 2012, MOL PSYCHIATR, V17, P1116, DOI 10.1038/mp.2011.101
   Aranaz P, 2019, MOLECULES, V24, P0, DOI 10.3390/molecules24061045
   Araujo AR, 2020, ADV EXP MED BIOL, V1250, P159, DOI 10.1007/978-981-15-3262-7_11
   Arunagiri A, 2019, ELIFE, V8, P0, DOI 10.7554/eLife.44532
   Bakuradze T, 2016, MOL NUTR FOOD RES, V60, P682, DOI 10.1002/mnfr.201500668
   Balstad TR, 2011, MOL NUTR FOOD RES, V55, P185, DOI 10.1002/mnfr.201000204
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Baumel-Alterzon S, 2021, TRENDS ENDOCRIN MET, V32, P7, DOI 10.1016/j.tem.2020.11.002
   Berti F, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21051823
   Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7
   Boettler U, 2011, MOL NUTR FOOD RES, V55, P798, DOI 10.1002/mnfr.201100115
   Boettler U, 2011, J NUTR BIOCHEM, V22, P426, DOI 10.1016/j.jnutbio.2010.03.011
   Boncler M, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0180022
   Brandt A, 2019, REDOX BIOL, V21, P0, DOI 10.1016/j.redox.2018.101092
   Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P753, DOI 10.1016/j.bbadis.2011.11.002
   Carlstr√∂m M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   Carrasco-Pozo C, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/3839756
   Cavin C, 2008, FOOD CHEM TOXICOL, V46, P1239, DOI 10.1016/j.fct.2007.09.099
   Chaari A, 2020, INT J BIOL MACROMOL, V164, P1794, DOI 10.1016/j.ijbiomac.2020.08.080
   Chaari A, 2020, INT J BIOL MACROMOL, V162, P284, DOI 10.1016/j.ijbiomac.2020.06.170
   Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z
   Chen YP, 2019, CLIN NUTR, V38, P2552, DOI 10.1016/j.clnu.2018.11.030
   Ciaramelli C, 2018, FOOD CHEM, V252, P171, DOI 10.1016/j.foodchem.2018.01.075
   Ciolino HP, 1999, BIOCHEM J, V340, P715, DOI 10.1042/0264-6021:3400715
   Cornelis MC, 2018, J INTERN MED, V283, P544, DOI 10.1111/joim.12737
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Cornelis MC, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10101343
   Cornelis MC, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002033
   Costea T, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20051062
   Costes S, 2013, DIABETES, V62, P327, DOI 10.2337/db12-1326
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dubey R, 2019, BIOCHEM J, V476, P889, DOI 10.1042/BCJ20180820
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   EFSA, 2016, EFSA J, V14, P0, DOI 10.2903/j.efsa.2016.4552
   Esser N, 2020, DIABETOLOGIA, V63, P2007, DOI 10.1007/s00125-020-05245-x
   Farias-Pereira R, 2019, FOOD SCI BIOTECHNOL, V28, P1287, DOI 10.1007/s10068-019-00662-0
   Favari C, 2021, MOL NUTR FOOD RES, V65, P0, DOI 10.1002/mnfr.202000875
   Fouzder C, 2021, TOXICOL IN VITRO, V70, P0, DOI 10.1016/j.tiv.2020.105038
   Franco R, 2019, ANTIOXIDANTS-BASEL, V8, P0, DOI 10.3390/antiox8090373
   Fratantonio D, 2017, BIOFACTORS, V43, P54, DOI 10.1002/biof.1312
   Fu JQ, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/639191
   Fukuyama K, 2018, MOL NUTR FOOD RES, V62, P0, DOI 10.1002/mnfr.201800238
   Ganesan Kumar, 2020, EUR J PHARMACOL, V888, P173606, DOI 10.1016/j.ejphar.2020.173606
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Greenberg JA, 2010, DIABETES CARE, V33, P278, DOI 10.2337/dc09-1539
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Hang D, 2020, DIABETES CARE, V43, P2588, DOI 10.2337/dc20-0800
   Hardie DG, 2014, J INTERN MED, V276, P543, DOI 10.1111/joim.12268
   Harpaz Eynav, 2017, JOURNAL OF BASIC AND CLINICAL PHYSIOLOGY AND PHARMACOLOGY, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Hayat U, 2021, ANN HEPATOL, V20, P0, DOI 10.1016/j.aohep.2020.08.071
   Higgins LG, 2008, TOXICOL APPL PHARM, V226, P328, DOI 10.1016/j.taap.2007.09.018
   Hjellvik V, 2011, EPIDEMIOLOGY, V22, P418, DOI 10.1097/EDE.0b013e31821083e3
   Hu WH, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25173769
   Ishida K, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12020494
   Ishikawa T, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0102152
   Iside C, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.01225
   Islam B, 2015, DRUG DES DEV THER, V9, P4943, DOI 10.2147/DDDT.S86705
   Jahic A, 2020, NEUROCHEM INT, V140, P0, DOI 10.1016/j.neuint.2020.104806
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kalthoff S, 2010, GASTROENTEROLOGY, V139, P1699, DOI 10.1053/j.gastro.2010.06.048
   Kalthoff S, 2010, J BIOL CHEM, V285, P5993, DOI 10.1074/jbc.M109.075770
   Kanner J, 2020, ANTIOXIDANTS-BASEL, V9, P0, DOI 10.3390/antiox9090797
   Karadas O, 2019, APPL BIOCHEM BIOTECH, V188, P514, DOI 10.1007/s12010-018-02934-7
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Kempf K, 2015, EUR J NUTR, V54, P845, DOI 10.1007/s00394-014-0763-3
   Kobayashi H, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21103561
   K√∂hle C, 2007, BIOCHEM PHARMACOL, V73, P1853, DOI 10.1016/j.bcp.2007.01.009
   Kolb H, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12061842
   Kolb H, 2018, BMC MED, V16, P0, DOI 10.1186/s12916-018-1225-1
   Kolb H, 2017, BMC MED, V15, P0, DOI 10.1186/s12916-017-0901-x
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Kuang A, 2020, EUR J NUTR, V59, P1529, DOI 10.1007/s00394-019-02009-1
   Kuang A, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10121851
   Kumar A, 2018, DIABETES, V67, P1561, DOI 10.2337/db17-0943
   Labbadia J, 2017, CELL REP, V21, P1481, DOI 10.1016/j.celrep.2017.10.038
   Lane JD, 2008, DIABETES CARE, V31, P221, DOI 10.2337/dc07-1112
   Lang R, 2013, ANAL BIOANAL CHEM, V405, P8487, DOI 10.1007/s00216-013-7288-0
   Lecoultre V, 2014, AM J CLIN NUTR, V99, P268, DOI 10.3945/ajcn.113.069526
   Lei LM, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.00662
   Le√≥n-Gonz√°lez AJ, 2015, BIOCHEM PHARMACOL, V98, P371, DOI 10.1016/j.bcp.2015.07.017
   Li CG, 2018, BIOMED PHARMACOTHER, V97, P1229, DOI 10.1016/j.biopha.2017.11.063
   Liang NJ, 2019, MOL CELL BIOCHEM, V457, P105, DOI 10.1007/s11010-019-03516-9
   Liu GJ, 2020, REDOX BIOL, V37, P0, DOI 10.1016/j.redox.2020.101701
   Liu XN, 2018, INT J EPIDEMIOL, V47, P1887, DOI 10.1093/ije/dyy173
   Lotito SB, 2006, FREE RADICAL BIO MED, V41, P1727, DOI 10.1016/j.freeradbiomed.2006.04.033
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI 10.1039/C4FO00042K
   MacKenzie T, 2007, METABOLISM, V56, P1694, DOI 10.1016/j.metabol.2007.07.013
   Marselli L, 2020, CELL REP, V33, P0, DOI 10.1016/j.celrep.2020.108466
   McCusker RR, 2006, J ANAL TOXICOL, V30, P611, DOI 10.1093/jat/30.8.611
   Meex RCR, 2021, MOL NUTR FOOD RES, V65, P0, DOI 10.1002/mnfr.201900942
   Moens C, 2020, MOL NUTR FOOD RES, V64, P0, DOI 10.1002/mnfr.201901009
   Moisey LL, 2008, AM J CLIN NUTR, V87, P1254, DOI 10.1093/ajcn/87.5.1254
   Murakami A, 2014, ARCH BIOCHEM BIOPHYS, V557, P3, DOI 10.1016/j.abb.2014.04.018
   Murakami A, 2012, FOOD FUNCT, V3, P462, DOI 10.1039/c2fo10274a
   Naoi M, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20102451
   Nicolopoulos K, 2020, CLIN NUTR, V39, P3467, DOI 10.1016/j.clnu.2020.03.009
   Ohnaka Keizo, 2012, J NUTR METAB, V2012, P207426, DOI 10.1155/2012/207426
   Oketch-Rabah HA, 2020, TOXICOL REP, V7, P386, DOI 10.1016/j.toxrep.2020.02.008
   Olson KR, 2020, REDOX BIOL, V37, P0, DOI 10.1016/j.redox.2020.101731
   Olthof MR, 2011, NUTR METAB, V8, P0, DOI 10.1186/1743-7075-8-10
   Paur I, 2010, FREE RADICAL BIO MED, V48, P1218, DOI 10.1016/j.freeradbiomed.2010.02.005
   Poole R, 2017, BMJ-BRIT MED J, V359, P0, DOI 10.1136/bmj.j5024
   Priftis A, 2018, MOL MED REP, V17, P8325, DOI 10.3892/mmr.2018.8924
   Rakvaag E, 2016, EUR J NUTR, V55, P2221, DOI 10.1007/s00394-015-1032-9
   Raleigh D, 2017, J MOL ENDOCRINOL, V59, PR121, DOI 10.1530/JME-17-0105
   Reis CEG, 2018, BRIT J NUTR, V119, P1029, DOI 10.1017/S000711451800034X
   Ren YQ, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20174238
   Robertson TM, 2015, BRIT J NUTR, V114, P1218, DOI 10.1017/S0007114515002640
   Rothhammer V, 2019, NAT REV IMMUNOL, V19, P184, DOI 10.1038/s41577-019-0125-8
   Safe S, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21186654
   Said MA, 2020, J AM HEART ASSOC, V9, P0, DOI 10.1161/JAHA.120.016808
   Salminen A, 2016, CELL SIGNAL, V28, P887, DOI 10.1016/j.cellsig.2016.03.009
   Salomone F, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9010085
   Salomone F, 2014, TRANSL RES, V163, P593, DOI 10.1016/j.trsl.2013.12.001
   Sauer T, 2013, AMINO ACIDS, V44, P1427, DOI 10.1007/s00726-012-1222-1
   Schultheis J, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/7518510
   Seow WJ, 2020, MOL NUTR FOOD RES, V64, P0, DOI 10.1002/mnfr.202000527
   Shaito A, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21062084
   Shao B, 2020, FREE RADICAL BIO MED, V159, P107, DOI 10.1016/j.freeradbiomed.2020.06.033
   Shi AM, 2018, INT IMMUNOPHARMACOL, V54, P125, DOI 10.1016/j.intimp.2017.11.007
   Shi XQ, 2016, NUTR J, V15, P0, DOI 10.1186/s12937-016-0220-7
   Sinisi V, 2015, FOOD CHEM, V168, P332, DOI 10.1016/j.foodchem.2014.07.080
   Sirota R, 2015, REDOX BIOL, V4, P48, DOI 10.1016/j.redox.2014.11.012
   Stefanello N, 2019, FOOD CHEM TOXICOL, V123, P298, DOI 10.1016/j.fct.2018.10.005
   Taguchi C, 2015, NUTRIENTS, V7, P10269, DOI 10.3390/nu7125530
   Taylor R, 2019, LANCET DIABETES ENDO, V7, P726, DOI 10.1016/S2213-8587(19)30076-2
   Tong RY, 2020, OXID MED CELL LONGEV, V2020, P0, DOI 10.1155/2020/2543504
   Tung WC, 2020, ARCH BIOCHEM BIOPHYS, V694, P0, DOI 10.1016/j.abb.2020.108589
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   Tuomilehto J, 2009, DIABETES CARE, V32, PS189, DOI 10.2337/dc09-S308
   Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13
   Vachali PP, 2016, BIOSENSORS-BASEL, V6, P0, DOI 10.3390/bios6010006
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dam RM, 2020, NEW ENGL J MED, V383, P369, DOI 10.1056/NEJMra1816604
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Vicente SJV, 2014, J AGR FOOD CHEM, V62, P116, DOI 10.1021/jf401777m
   Vitaglione P, 2019, J NUTR SCI, V8, P0, DOI 10.1017/jns.2019.10
   Volz N, 2012, J AGR FOOD CHEM, V60, P9631, DOI 10.1021/jf302258u
   Wang DJ, 2015, MOL NUTR FOOD RES, V59, P1025, DOI 10.1002/mnfr.201400544
   Wang ZK, 2020, NANOTECHNOLOGY, V31, P0, DOI 10.1088/1361-6528/ab70fb
   Watanabe S, 2017, METAB SYNDR RELAT D, V15, P170, DOI 10.1089/met.2016.0114
   Wedick NM, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-93
   Wei MJ, 2018, TOXICOL SCI, V162, P99, DOI 10.1093/toxsci/kfx230
   Weir GC, 2020, LANCET DIABETES ENDO, V8, P249, DOI 10.1016/S2213-8587(20)30022-X
   Wong THT, 2020, BRIT J NUTR, V124, P785, DOI 10.1017/S0007114520001750
   Wu CZ, 2020, BMC ORAL HEALTH, V20, P0, DOI 10.1186/s12903-020-01180-w
   Yang J, 2014, BMJ OPEN, V4, P0, DOI 10.1136/bmjopen-2014-005632
   Younes M, 2018, EFSA J, V16, P0, DOI 10.2903/j.efsa.2018.5239
   Yuan S, 2020, DIABETOLOGIA, V63, P2359, DOI 10.1007/s00125-020-05253-x
   Zamora-Ros R, 2016, EUR J NUTR, V55, P1359, DOI 10.1007/s00394-015-0950-x
   Zamora-Ros R, 2013, BRIT J NUTR, V110, P1500, DOI 10.1017/S0007114513000688
NR 157
TC 41
Z9 44
U1 2
U2 23
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD APR 15
PY 2021
VL 13
IS 4
BP 
EP 
DI 10.3390/nu13041144
PG 17
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA RR8QP
UT WOS:000643356200001
PM 33807132
DA 2025-04-28
ER

PT J
AU Kadar, NNMA
   Ahmad, F
   Teoh, SL
   Yahaya, MF
AF Muhammad Abdul Kadar, Nellysha Namela
   Ahmad, Fairus
   Teoh, Seong Lin
   Yahaya, Mohamad Fairuz
TI Caffeic Acid on Metabolic Syndrome: A Review
SO MOLECULES
LA English
DT Review
DE caffeic acid; metabolic syndrome; phenolic compound; obesity; dyslipidemia; hyperglycemia; hypertension
ID oxidative stress; phenethyl ester; antioxidant property; phenolic-acids; insulin-resistance; chlorogenic acid; ellagic acid; in-vitro; propolis; mice
AB Metabolic syndrome (MetS) is a constellation of risk factors that may lead to a more sinister disease. Raised blood pressure, dyslipidemia in the form of elevated triglycerides and lowered high-density lipoprotein cholesterol, raised fasting glucose, and central obesity are the risk factors that could lead to full-blown diabetes, heart disease, and many others. With increasing sedentary lifestyles, coupled with the current COVID-19 pandemic, the numbers of people affected with MetS will be expected to grow in the coming years. While keeping these factors checked with the polypharmacy available currently, there is no single strategy that can halt or minimize the effect of MetS to patients. This opens the door for a more natural way of controlling the disease. Caffeic acid (CA) is a phytonutrient belonging to the flavonoids that can be found in abundance in plants, fruits, and vegetables. CA possesses a wide range of beneficial properties from antioxidant, immunomodulatory, antimicrobial, neuroprotective, antianxiolytic, antiproliferative, and anti-inflammatory activities. This review discusses the current discovery of the effect of CA against MetS.
C1 [Muhammad Abdul Kadar, Nellysha Namela; Ahmad, Fairus; Teoh, Seong Lin; Yahaya, Mohamad Fairuz] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Anat, Kuala Lumpur 56000, Malaysia.
   [Muhammad Abdul Kadar, Nellysha Namela] Univ Malaysia Sabah, Fac Med & Hlth Sci, Dept Biomed Sci & Therapeut, Kota Kinabalu 88400, Sabah, Malaysia.
C3 Universiti Kebangsaan Malaysia; Universiti Malaysia Sabah
RP Yahaya, MF (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Anat, Kuala Lumpur 56000, Malaysia.
EM nellysha.namela@ums.edu.my; fairusahmad@ukm.edu.my; teohseonglin@ukm.edu.my; mfairuzy@ukm.edu.my
FU PPUKM Fundamental Grant [FF-2019-014]
CR Agunloye OM, 2018, J FOOD BIOCHEM, V42, P0, DOI 10.1111/jfbc.12604
   Agunloye OM, 2018, J FOOD BIOCHEM, V42, P0, DOI 10.1111/jfbc.12541
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Ando K, 2009, FREE RADICAL BIO MED, V47, P213, DOI 10.1016/j.freeradbiomed.2009.04.030
   Armutcu F, 2015, EXP THER MED, V9, P1582, DOI 10.3892/etm.2015.2346
   Azuma K, 2000, J AGR FOOD CHEM, V48, P5496, DOI 10.1021/jf000483q
   Bhullar KS, 2014, EUR J PHARMACOL, V730, P125, DOI 10.1016/j.ejphar.2014.02.038
   Bocco BM, 2016, BRAZ J MED BIOL RES, V49, P0, DOI 10.1590/1414-431X20155003
   Boulang√© CL, 2016, GENOME MED, V8, P0, DOI 10.1186/s13073-016-0303-2
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Chait A, 2020, FRONT CARDIOVASC MED, V7, P0, DOI 10.3389/fcvm.2020.00022
   Chao CY, 2010, MOL NUTR FOOD RES, V54, P388, DOI 10.1002/mnfr.200900087
   Choudhary S, 2016, INFLAMMOPHARMACOLOGY, V24, P347, DOI 10.1007/s10787-016-0287-y
   Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024
   Dantas MB, 2018, AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, V12, P263, DOI 10.5897/ajpp2018.4937
   Due√±as M, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/850902
   Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3
   Eid HM, 2017, PHARM BIOL, V55, P2026, DOI 10.1080/13880209.2017.1345952
   El-Denshary E-E-DS, 2015, INT J SCI RES PUBL, V5, P1
   Engin AB, 2017, ADV EXP MED BIOL, V960, P327, DOI 10.1007/978-3-319-48382-5_14
   Etchegoyen M, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00196
   Feldman F, 2021, NUTRIENTS, V13, P0, DOI 10.3390/nu13020672
   Feng Y, 2020, NUTR DIABETES, V10, P0, DOI 10.1038/s41387-020-0107-8
   Filipe HAL, 2018, FREE RADICAL BIO MED, V115, P215, DOI 10.1016/j.freeradbiomed.2017.12.002
   Freeman AM, 2021, STATPEARLS, V0, P0
   G√∂√ßer H, 2011, INT J FOOD SCI NUTR, V62, P821, DOI 10.3109/09637486.2011.585963
   Gonna H, 2019, DIABETES OBES METAB, V21, P6, DOI 10.1111/dom.13691
   G√ºl√ßin I, 2006, TOXICOLOGY, V217, P213, DOI 10.1016/j.tox.2005.09.011
   Gun A, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/3419479
   Hanson RL, 2002, DIABETES, V51, P3120, DOI 10.2337/diabetes.51.10.3120
   Hashim KN, 2021, MOLECULES, V26, P0, DOI 10.3390/molecules26040808
   Hassan NA, 2014, CHEM-BIOL INTERACT, V213, P28, DOI 10.1016/j.cbi.2014.01.019
   Honecker J, 2021, INT J OBESITY, V45, P2108, DOI 10.1038/s41366-021-00883-6
   Ibitoye OB, 2018, ARCH PHYSIOL BIOCHEM, V124, P410, DOI 10.1080/13813455.2017.1415938
   Jayarathne Shasika, 2017, PREV NUTR FOOD SCI, V22, P251
   Jensen MD, 2020, ENDOCRIN METAB CLIN, V49, P229, DOI 10.1016/j.ecl.2020.02.002
   Jimenez V, 2021, DEV PSYCHOBIOL, V63, P0, DOI 10.1002/dev.22127
   Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163
   Kasprzak-Drozd K, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22073715
   Kassi E, 2011, BMC MED, V9, P0, DOI 10.1186/1741-7015-9-48
   Kassim M, 2010, NUTR RES, V30, P650, DOI 10.1016/j.nutres.2010.08.008
   Kepa M, 2018, BIOMED RES INT, V2018, P0, DOI 10.1155/2018/7413504
   Kim HM, 2018, NUTRITION, V55-56, P63, DOI 10.1016/j.nut.2018.03.010
   Kim YH, 2014, J EXERC REHABIL, V10, P209, DOI 10.12965/jer.140145
   Koga M, 2019, TISSUE CELL, V60, P14, DOI 10.1016/j.tice.2019.07.006
   Kolgazi M, 2021, CHEM-BIOL INTERACT, V334, P0, DOI 10.1016/j.cbi.2020.109351
   Korac B, 2021, REDOX BIOL, V42, P0, DOI 10.1016/j.redox.2021.101887
   Kumar S, 2013, SCI WORLD J, V0, P0, DOI DOI 10.1155/2013/162750
   Kumar SR, 2019, EVID-BASED COMPL ALT, V2019, P0, DOI 10.1155/2019/9752826
   Lee DH, 2014, J ATHEROSCLER THROMB, V21, P23
   Leonard W, 2021, COMPR REV FOOD SCI F, V20, P710, DOI 10.1111/1541-4337.12663
   Li AX, 2022, HEART FAIL REV, V27, P1387, DOI 10.1007/s10741-021-10109-6
   Li PG, 2005, HYPERTENS RES, V28, P369, DOI 10.1291/hypres.28.369
   Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942
   Lu Y, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep13824
   Manaf MRA, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-87248-1
   Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058
   Martinez-Ferran M, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12061549
   Matboli M, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-02320-z
   Mendoza MF, 2020, CURR OPIN CARDIOL, V35, P389, DOI 10.1097/HCO.0000000000000749
   Monserrat-Mesquida M, 2020, ANTIOXIDANTS-BASEL, V9, P0, DOI 10.3390/antiox9030236
   Mu HN, 2021, FOOD RES INT, V143, P0, DOI 10.1016/j.foodres.2021.110240
   Nam GS, 2018, BIOTECHNOL BIOPROC E, V23, P641, DOI 10.1007/s12257-018-0424-0
   Nie JR, 2017, J AGR FOOD CHEM, V65, P9041, DOI 10.1021/acs.jafc.7b02880
   Nolan CJ, 2015, DIABETES, V64, P673, DOI 10.2337/db14-0694
   Oboh G, 2021, J FOOD BIOCHEM, V45, P0, DOI 10.1111/jfbc.13384
   Orsolic N, 2021, MOLECULES, V26, P0, DOI 10.3390/molecules26113262
   Panche AN, 2016, J NUTR SCI, V5, P0, DOI 10.1017/jns.2016.41
   Pappan N, 2021, STATPEARLS, V0, P0
   Parekh PJ, 2014, FRONT ENDOCRINOL, V5, P0, DOI 10.3389/fendo.2014.00047
   Pereira P, 2006, BASIC CLIN PHARMACOL, V99, P374, DOI 10.1111/j.1742-7843.2006.pto_533.x
   Piazzon A, 2012, J AGR FOOD CHEM, V60, P12312, DOI 10.1021/jf304076z
   Poplawski J, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-69866-3
   Putteeraj M, 2018, CURR DRUG TARGETS, V19, P1710, DOI 10.2174/1389450119666180326125252
   Quinn KJ, 2017, SCI DATA, V4, P0, DOI 10.1038/sdata.2017.167
   Ramli NZ, 2019, INT J ENV RES PUB HE, V16, P0, DOI 10.3390/ijerph16244987
   Ranasinghe P, 2017, BMC PUBLIC HEALTH, V17, P0, DOI 10.1186/s12889-017-4041-1
   Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214
   Saibabu V, 2015, ADV PHARMACOL SCI, V2015, P0, DOI 10.1155/2015/823539
   Salmas RE, 2017, CELL BIOCHEM FUNCT, V35, P304, DOI 10.1002/cbf.3277
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Shin EJ, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20123055
   Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3
   Surikow S, 2019, HEART LUNG CIRC, V28, PS132, DOI 10.1016/j.hlc.2019.06.004
   Taher MA, 2015, IRAQI J PHARM SCI, V24, P18
   Touyz RM, 2020, CAN J CARDIOL, V36, P659, DOI 10.1016/j.cjca.2020.02.081
   Vanella L, 2016, PPAR RES, V2016, P0, DOI 10.1155/2016/7359521
   Castro MFV, 2021, LIFE SCI, V277, P0, DOI 10.1016/j.lfs.2021.119421
   Vinayagam R, 2016, PHYTOTHER RES, V30, P184, DOI 10.1002/ptr.5528
   Weng YC, 2012, EVID-BASED COMPL ALT, V2012, P0, DOI 10.1155/2012/984780
   Wu H, 2021, J HYPERTENS, V39, P0
   Xu J, 2020, J FUNCT FOODS, V74, P0, DOI 10.1016/j.jff.2020.104061
   Xu WG, 2020, TROP J PHARM RES, V19, P1227, DOI 10.4314/tjpr.v19i6.17
   Zhang Z, 2016, ONCOTARGET, V7, P31790, DOI 10.18632/oncotarget.9306
NR 94
TC 73
Z9 73
U1 5
U2 50
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1420-3049
J9 MOLECULES
JI Molecules
PD SEP 15
PY 2021
VL 26
IS 18
BP 
EP 
DI 10.3390/molecules26185490
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA UZ1FR
UT WOS:000701958200001
PM 34576959
DA 2025-04-28
ER

PT J
AU Lee, D
   Kim, JY
   Qi, Y
   Park, S
   Lee, HL
   Yamabe, N
   Kim, H
   Jang, DS
   Kang, KS
AF Lee, Dahae
   Kim, Ji-Young
   Qi, Yutong
   Park, Sangsu
   Lee, Hye Lim
   Yamabe, Noriko
   Kim, Hocheol
   Jang, Dae Sik
   Kang, Ki Sung
TI Phytochemicals from the flowers of Prunus persica (L.) Batsch: Anti-adipogenic effect of mandelamide on 3T3-L1 preadipocytes
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Prunus persica (L.) Batsch; Mandelamide; Adipocytes; Adipogenesis
ID diet-induced obesity; adipocyte differentiation; p38mapk; cells; acid; mice
AB Flowers of Prunus persica (L.) Batsch (Rosaceae), known as peach blossoms, have been reported to exert anti-obesity effects by improving hepatic lipid metabolism in obese mice. However, little is known regarding the anti-adipogenic effects of the phenolic compounds isolated from P. persica flowers. This study investigated the inhibitory effects of compounds extracted from P. persica flowers (PPF) on adipogenesis in 3T3-L1 murine preadipocytes using adipogenic differentiation assays. Additionally, we compared the anti-adipogenic effects of the phenolic compounds isolated from PPF, such as prunasin amide (1), amygdalin amide (2), prunasin acid (3), mandelamide (4), methyl caffeate (5), ferulic acid (6), chlorogenic acid (7), benzyl alpha-L-xylpyranosyl-(1 -> 6)-beta-D- glucopyranoside (8), prunin (9), naringenin (10), nicotiflorin (11), astragalin (12), afzelin (13), and uridine (14), on adipogenesis in 3T3-L1 murine preadipocytes. PPF and compounds 4-7 and 10 significantly inhibited adipogenesis. Among them, mandelamide (4) exhibited the maximum inhibitory activity with an IC50 of 36.04 +/- 1.82 mu M. Additionally, mandelamide downregulated the expression of key adipogenic markers, such as extra cellular signal-regulated kinase, c-Jun-N-terminal kinase, P38, CCAAT/enhancer-binding protein alpha, CCAAT/enhancer-binding protein beta, peroxisome proliferator activated receptor gamma, and glucocorticoid receptor. These results indicate that mandelamide is an active ingredient of PPF possessing anti-obesity properties.
C1 [Lee, Dahae; Yamabe, Noriko; Kang, Ki Sung] Gachon Univ, Coll Korean Med, Seongnam 13120, South Korea.
   [Kim, Ji-Young; Qi, Yutong; Jang, Dae Sik] Kyung Hee Univ, Grad Sch, Dept Life & Nanopharmaceut Sci, Seoul 02447, South Korea.
   [Park, Sangsu] Kyung Hee Univ, Grad Sch, Dept Fundamental Pharmaceut Sci, Seoul 02447, South Korea.
   [Lee, Hye Lim] Daejeon Univ, Dept Pediat, Coll Korean Med, Daejeon, South Korea.
   [Kim, Hocheol] Kyung Hee Univ, Dept Herbal Pharmacol, Coll Korean Med, Seoul 02447, South Korea.
C3 Gachon University; Kyung Hee University; Kyung Hee University; Daejeon University; Kyung Hee University
RP Kang, KS (corresponding author), Gachon Univ, Coll Korean Med, Seongnam 13120, South Korea.; Jang, DS (corresponding author), Kyung Hee Univ, Grad Sch, Dept Life & Nanopharmaceut Sci, Seoul 02447, South Korea.
EM dsjang@khu.ac.kr; kkang@gachon.ac.kr
FU National Research Foundation of Korea (NRF) - Ministry of Science and ICT (MSIT) , Korea [NRF-2019R1A2C1083945]; Basic Science Research Program through the NRF [2019R1F1A1059173]
CR Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963
   Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018
   Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392
   Chang E, 2019, MOLECULES, V24, P0, DOI 10.3390/molecules24061157
   Giuffrida D, 2013, FRUITS, V68, P39, DOI 10.1051/fruits/2012049
   Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957
   Halder D, 2014, J FOOD BIOCHEM, V38, P216, DOI 10.1111/jfbc.12040
   Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213
   Ilavenil S, 2017, J FUNCT FOODS, V37, P293, DOI 10.1016/j.jff.2017.08.002
   Koh EJ, 2017, MOLECULES, V22, P0, DOI 10.3390/molecules22050745
   Kusuyama J, 2016, J LIPID RES, V57, P1806, DOI 10.1194/jlr.M067207
   Kwak CS, 2018, NUTR RES PRACT, V12, P29, DOI 10.4162/nrp.2018.12.1.29
   Lee D, 1900, V11, V0, P0
   Lim H, 2015, NUTR RES PRACT, V9, P599, DOI 10.4162/nrp.2015.9.6.599
   Madsen MS, 2014, MOL CELL BIOL, V34, P939, DOI 10.1128/MCB.01344-13
   Marcelin G, 2010, CURR OPIN PHARMACOL, V10, P588, DOI 10.1016/j.coph.2010.05.008
   Matsushita K, 2017, LAB INVEST, V97, P1158, DOI 10.1038/labinvest.2017.42
   Ntambi JM, 2000, J NUTR, V130, P3122S, DOI 10.1093/jn/130.12.3122S
   Ou CY, 2014, J BIOL CHEM, V289, P17078, DOI 10.1074/jbc.M114.548081
   Peng SG, 2018, BIOMED RES INT, V2018, P0, DOI 10.1155/2018/8594767
   Richard AJ, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/549750
   Song J, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11092176
   Sweeney G, 1999, J BIOL CHEM, V274, P10071, DOI 10.1074/jbc.274.15.10071
   Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718
   Vasileva LV, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21249740
   Verhoog N, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0110702
   Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218
   Wu HT, 2020, FASEB J, V34, P2958, DOI 10.1096/fj.201901925R
   Yazid NSM, 2019, MALAYS J FUNDAM APPL, V15, P561
NR 29
TC 10
Z9 10
U1 5
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
EI 1464-3405
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD OCT 1
PY 2021
VL 49
IS 
BP 
EP 
DI 10.1016/j.bmcl.2021.128326
EA AUG 2021
PG 6
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA UR3AQ
UT WOS:000696625300008
PM 34403725
DA 2025-04-28
ER

PT J
AU Alzaben, AS
   Alnashwan, NI
   Alatr, AA
   Alneghamshi, NA
   Alhashem, AM
AF Alzaben, Abeer Salman
   Alnashwan, Noha Ibrahim
   Alatr, Afnan Abdullah
   Alneghamshi, Nourah Abdullah
   Alhashem, Anwar Mohammed
TI Effectiveness of a nutrition education and intervention programme on nutrition knowledge and dietary practice among Princess Nourah Bint Abdulrahman University's population
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Nutrition; Knowledge; Practice; Intervention nutrition education; Nutritional knowledge; Dietary practices; Nutritional intervention programmes
ID vegetable consumption; nonmedical students; saudi-arabia; obesity; habits; fruit
AB Objective: The study sought to assess the influence of nutrition education and intervention programmes on nutrition knowledge and dietary practice among both students and staff (including faculty) of Princess Nourah Bint Abdulrahman University in Saudi Arabia. Design: A pretest-posttest, non-randomised experimental study design was implemented at Princess Nourah Bint Abdulrahman University in Riyadh City between September 2019 and February 2020. Setting: Princess Nourah Bint Abdulrahman University is the largest women's university in the world and has eighteen colleges and institutions and around ninety academic programmes. Participants: The survey was completed by 1824 participants (1350 students and 474 staff/faculty) before the intervention and by a different cohort of 1731 participants (1317 students and 414 staff/faculty) after the intervention. In total, an independent sample of 3555 staff and students participated. Participants were asked about dietary knowledge and practices. Dietary knowledge entailed food variety and nutrients, fast food and its poor nutritional value, and the influence of cooking style on the nutritional quality of food. Dietary practices involved eating breakfast; consuming salt/sugar, eating high-salt food; eating pre-packaged food and consumption of vegetables, fruits, supplements, water and caffeine. Results: The majority of the sample consisted of students (75 center dot 1 %) and had not been diagnosed with any disease (73 center dot 7 %). The result of the current study showed that nutrition knowledge improved after completion of the nutrition programme. Conclusions: The nutrition awareness programme improved students' nutritional knowledge; however, there was no significant effect on their dietary practices. Future nutrition awareness programmes should separate activities for students and staff, focusing on one target population at a time.
C1 [Alzaben, Abeer Salman] Princess Nourah Bint Abdulrahman Univ, Dept Hlth Sci, Coll Hlth & Rehabil Sci, Clin Nutr Program, Riyadh, Saudi Arabia.
   [Alnashwan, Noha Ibrahim; Alatr, Afnan Abdullah; Alneghamshi, Nourah Abdullah] Princess Nourah Bint Abdulrahman Univ, Nutr Dept Deanship Students Affairs, Riyadh, Saudi Arabia.
   [Alhashem, Anwar Mohammed] Princess Nourah Bint Abdulrahman Univ, Hlth Educ Program, Dept Hlth Sci, Coll Hlth & Rehabil Sci, POB 84428, Riyadh 11671, Saudi Arabia.
C3 Princess Nourah bint Abdulrahman University; Princess Nourah bint Abdulrahman University; Princess Nourah bint Abdulrahman University
RP Alhashem, AM (corresponding author), Princess Nourah Bint Abdulrahman Univ, Hlth Educ Program, Dept Hlth Sci, Coll Hlth & Rehabil Sci, POB 84428, Riyadh 11671, Saudi Arabia.
EM amalhashem@pnu.edu.sa
FU Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University through the Fasttrack Research Funding Program
CR Abood DA, 2004, J NUTR EDUC BEHAV, V36, P135, DOI 10.1016/S1499-4046(06)60150-4
   Al-Rethaiaa AS, 2010, NUTR J, V9, P0, DOI 10.1186/1475-2891-9-39
   Alnader HM, 2019, UNIV JORDAN, V46, P17
   Alqarni S, 2016, JOURNAL OF OBESITY EAT DISORDER, V2, P0, DOI 10.21767/2471-8203.100025
   Alrashedi W, 2018, J FOOD MICROBIOLOGY, V3, P0
   Althumiri NA, 2018, FOOD DRUG REGUL SCI J, V1, P1, DOI 10.32868/rsj.v1i1.21
   Bakhotmah BA, 2012, ECOL FOOD NUTR, V51, P313, DOI 10.1080/03670244.2012.691388
   Bano R, 2013, IOSR JOURNAL OF NURSING AND HEALTH SCIENCE, V2, P29
   Delavari M, 2013, BMC PUBLIC HEALTH, V13, P0, DOI 10.1186/1471-2458-13-458
   Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x
   Epuru S, 2014, JOURNAL OF DENTAL AND MEDICAL SCIENCES, V13, P68, DOI 10.9790/0853-13156874
   Gardner B, 2014, INT J BEHAV NUTR PHY, V11, P0, DOI 10.1186/s12966-014-0135-7
   Ha EJ, 2011, J NUTR EDUC BEHAV, V43, P263, DOI 10.1016/j.jneb.2010.02.008
   Ha EJ, 2009, NUTR J, V8, P0, DOI 10.1186/1475-2891-8-50
   Ha EJ, 2009, J NUTR EDUC BEHAV, V41, P103, DOI 10.1016/j.jneb.2008.07.001
   Liu HC, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10111810
   Monga Shaveta, 2008, STUD HOME COMM SCI, V2, P99
   Moradi-Lakeh M, 2017, PUBLIC HEALTH NUTR, V20, P1075, DOI 10.1017/S1368980016003141
   Organization WH, 2020, OB OV, V0, P0
   Pearson N, 2010, PUBLIC HEALTH NUTR, V13, P876, DOI 10.1017/S1368980010000121
   Phagava H, 2019, GEORGIAN MED NEWS, V0, P118
   Poddar KH, 2010, J AM DIET ASSOC, V110, P1723, DOI 10.1016/j.jada.2010.08.008
   Saeidlou Sakineh Nouri, 2016, MAEDICA (BUCUR), V11, P286
   Sajwani Rubina A, 2009, JPMA JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, V59, P650
   Saudi Food and Drug Authority, 2018, SFDA LAUNCH HLTH FOO, V0, P0
   Spronk I, 2014, BRIT J NUTR, V111, P1713, DOI 10.1017/S0007114514000087
   World Health Organization, 2020, HLTH DIET, V0, P0
   Worsley A, 2002, ASIA PAC J CLIN NUTR, V11, PS579, DOI 10.1046/j.1440-6047.11.supp3.7.x
   Zulfiqar F, 2019, PAK HEART J, V52, P41
NR 29
TC 10
Z9 11
U1 2
U2 27
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD MAY 15
PY 2021
VL 24
IS 7
BP 1854
EP 1860
DI 10.1017/S1368980021000604
PG 7
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA RW1FH
UT WOS:000646268400029
PM 33563363
DA 2025-04-28
ER

PT J
AU He, XY
   Zheng, SJ
   Sheng, Y
   Miao, T
   Xu, J
   Xu, WT
   Huang, KL
   Zhao, CH
AF He, Xiaoyun
   Zheng, Shujuan
   Sheng, Yao
   Miao, Tong
   Xu, Jia
   Xu, Wentao
   Huang, Kunlun
   Zhao, Changhui
TI Chlorogenic acid ameliorates obesity by preventing energy balance shift in high-fat diet induced obese mice
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE chlorogenic acid; energy expenditure; gut microbiota; intake; obesity
ID metabolic syndrome; gene-expression; oral glucose; cholesterol; release; caffeine; extract; plasma
AB BACKGROUND Chlorogenic acid is a type of phenolic acid found in many plants. Chlorogenic acid has an anti-obesity effect with an unclear mechanism. The present study aimed to investigate the regulatory effect of chlorogenic acid on energy balance in high-fat diet (HFD) induced obese C57BL/6J mice administrated 100 mg kg(-1)chlorogenic acid for 13 weeks. RESULTS The consumption of chlorogenic acid ameliorated HFD induced obesity. Chlorogenic acid did not change the physical activity but significantly decreased food intake and increased body temperature, thermal dissipation and brown adipose tissue activity. Moreover, chlorogenic acid improved glucose tolerance but had a moderate impact on other blood indices. Additionally, chlorogenic acid failed to restore the microbiota change associated with HFD induced obesity, but modified the gut bacterial composition in a unique way. CONCLUSION Supplementation with chlorogenic acid can improve HFD induced obesity and associated glucose intolerance mainly via regulating food intake and energy expenditure.
C1 [He, Xiaoyun; Zheng, Shujuan; Sheng, Yao; Miao, Tong; Xu, Jia; Xu, Wentao; Huang, Kunlun] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China.
   [He, Xiaoyun; Zheng, Shujuan; Sheng, Yao; Miao, Tong; Xu, Jia; Xu, Wentao; Huang, Kunlun] China Agr Univ, Coll Food Sci & Nutr Engn, Special Food Res Ctr, Beijing, Peoples R China.
   [Zhao, Changhui] Jilin Univ, Coll Food Sci & Engn, Dept Food Qual & Safety, Jilin, Jilin, Peoples R China.
C3 China Agricultural University; China Agricultural University; Jilin University
RP Huang, KL (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China.; Zhao, CH (corresponding author), Jilin Univ, Coll Food Sci & Engn, Dept Food Qual & Safety, Jilin, Jilin, Peoples R China.
EM foodsafety66@cau.edu.cn; czhao@jlu.edu.cn
CR Anderson GH, 2012, J NUTR, V142, P1163S, DOI 10.3945/jn.111.149617
   Vali√±as MA, 2017, FOOD CHEM, V229, P837, DOI 10.1016/j.foodchem.2017.02.150
   Awad MA, 2000, SCI HORTIC-AMSTERDAM, V83, P249, DOI 10.1016/S0304-4238(99)00124-7
   Barahuie F, 2016, SCI ADV MATER, V8, P501, DOI 10.1166/sam.2016.2662
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Budryn G, 2009, EUR FOOD RES TECHNOL, V228, P913, DOI 10.1007/s00217-008-1004-x
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Chi QB, 2017, INT J MED MUSHROOMS, V19, P1001, DOI 10.1615/IntJMedMushrooms.2017024486
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Deka SJ, 2017, CURR MOL MED, V17, P79, DOI 10.2174/1566524017666170209160619
   Derosa G, 2012, EXPERT OPIN DRUG SAF, V11, P459, DOI 10.1517/14740338.2012.675326
   Frank J, 2003, J AGR FOOD CHEM, V51, P2526, DOI 10.1021/jf026127k
   Han YY, 2018, J FUNCT FOODS, V45, P462, DOI 10.1016/j.jff.2018.04.027
   Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Khan A, 1998, EUR J PHARMACOL, V349, P325, DOI 10.1016/S0014-2999(98)00188-5
   Koyuncu I, 2018, CELL MOL BIOL, V64, P75, DOI 10.14715/cmb/2018.64.1.14
   Lin WY, 2011, EUR J CLIN INVEST, V41, P659, DOI 10.1111/j.1365-2362.2010.02455.x
   Marotz Clarisse A, 2016, YALE JOURNAL OF BIOLOGY AND MEDICINE, V89, P383
   Mayer MA, 2009, CURR CLIN PHARMACOL, V4, P53, DOI 10.2174/157488409787236128
   Morris MJ, 2008, APPETITE, V51, P387
   Muthulakshmi S, 2015, J PHYSIOL BIOCHEM, V71, P29, DOI 10.1007/s13105-014-0376-6
   Pal S, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9020091
   Peng BJ, 2015, BIOMED ENVIRON SCI, V28, P894, DOI 10.3967/bes2015.123
   Plazas M, 2013, NOT BOT HORTI AGROBO, V41, P26
   Romieu I, 2017, CANCER CAUSE CONTROL, V28, P247, DOI 10.1007/s10552-017-0869-z
   SALERA M, 1982, J CLIN ENDOCR METAB, V55, P329, DOI 10.1210/jcem-55-2-329
   S√°nchez-Villavicencio ML, 2017, BMC COMPLEM ALTERN M, V17, P0, DOI 10.1186/s12906-016-1519-9
   Sheng Y, 2019, FOOD SCI NUTR, V7, P1295, DOI 10.1002/fsn3.962
   Slimestad R, 2005, J AGR FOOD CHEM, V53, P7251, DOI 10.1021/jf050737d
   Voss JD, 2019, INT J OBESITY, V43, P437, DOI 10.1038/s41366-018-0060-y
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wang XM, 2018, J FUNCT FOODS, V40, P365, DOI 10.1016/j.jff.2017.11.013
   Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011
   Zhai BQ, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-21421-x
   Zhang TH, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10081055
   Zhao SG, 2016, CELL REP, V14, P2872, DOI 10.1016/j.celrep.2016.02.076
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
NR 40
TC 61
Z9 61
U1 6
U2 113
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD JAN 30
PY 2021
VL 101
IS 2
BP 631
EP 637
DI 10.1002/jsfa.10675
EA AUG 2020
PG 7
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology
SC Agriculture; Chemistry; Food Science & Technology
GA PA4FG
UT WOS:000557526200001
PM 32683698
DA 2025-04-28
ER

PT J
AU Barrag√°n-Zarate, GS
   Alexander-Aguilera, A
   Lagunez-Rivera, L
   Solano, R
   Soto-Rodr√≠guez, I
AF Barragan-Zarate, Gabriela Soledad
   Alexander-Aguilera, Alfonso
   Lagunez-Rivera, Luicita
   Solano, Rodolfo
   Soto-Rodriguez, Ida
TI Bioactive compounds from Prosthechea karwinskii decrease obesity, insulin resistance, pro-inflammatory status, and cardiovascular risk in Wistar rats with metabolic syndrome
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Orchid; UPLC-ESI-qTOF-MS/MS; Hypotriglyceridemic; HS-CRP; Adiponectin; TNF-alpha; HOMA-IR
ID c-reactive protein; oxidative stress; chlorogenic acid; adipose-tissue; adiponectin; association; sensitivity; embelin; fat; mechanisms
AB Ethnopharmacological relevance: The orchid Prosthechea karwinskii is a species endemic to Mexico, which is used in traditional medicine to lower glucose levels in patients with diabetes, and to treat inflammation-related problems. Recent studies have shown that this orchids can reduce glucose, cholesterol, and triglyceride levels in Wistar rats, which were previously induced to have metabolic syndrome (MS). Aim of the study: To evaluate the effect of P. karwinskii leaves extract on the components of metabolic syndrome: obesity, insulin resistance, pro-inflammatory status, and cardiovascular risk in a Wistar rat model, and to identify the bioactive compounds in the extract. Materials and methods: UPLC-ESI-qTOF-MS/MS was used to identify the compounds present in the extract. MS was induced in Wistar rats through administration of a 40% sucrose diet for 20 weeks. The rats were divided into five groups that received different treatments for 4 weeks: one group without any treatment, one group receiving metformin (200 mg/kg p.o.), and three groups receiving different doses of P. karwinskii leaves extract (100, 200, and 300 mg/kg p.o.). The animals' body weights were recorded weekly, and at the end of the experiment, they were sacrificed after fasting for 18 h to determine the levels of glucose, insulin, insulin resistance index, total cholesterol, triglycerides, and adiponectin in the serum, as well as levels of TNF-alpha and HS-CRP in the serum and liver homogenates. The abdominal and pericardial fat weights were also recorded. Results: The main bioactive compounds of the extract were quinic acid, neochlorogenic acid, chlorogenic acid, rutin, kaempferol-3-o-beta-rutinoside, and embelin, known to exhibit MS-related bioactivity. Oral administration of P. karwinskii leaves extract at a dose of 300 mg/kg decreased weight gain, abdominal and pericardial fat deposits, and insulin resistance. At the end of the treatment, levels of triglycerides, TNF-alpha, HS-CRP, and adiponectin returned to levels similar to normal. Conclusion: P. karwinskii extract (300 mg/kg) had an anti-obesity effect, decreased insulin resistance, pro inflammatory status, and cardiovascular risk in rats with induced MS by increasing adiponectin levels and decreasing TNF-alpha and HS-CRP levels. The compounds identified in the extract could be responsible for these effects, acting alone or in synergy, as several compounds in the extract are known to have MS-related bioactivity. The foliar extract of P. karwinskii has potential as an effective alternative to a cocktail of drugs used to treat problems associated with MS.
C1 [Barragan-Zarate, Gabriela Soledad; Lagunez-Rivera, Luicita; Solano, Rodolfo] Inst Politecn Nacl, Ctr Interdisciplinario Invest Desarrollo Integral, Lab Extracc & Anal Prod Nat Vegetales, Hornos 1003 Santa Cruz Xoxocotlan, Oaxaca 71230, Oaxaca, Mexico.
   [Alexander-Aguilera, Alfonso; Soto-Rodriguez, Ida] Univ Veracruzana, Fac Bioanal, Carmen Serdan S-N,Flores Magon, Veracruz 91700, Veracruz, Mexico.
   [Alexander-Aguilera, Alfonso] Univ Cristobal Colon, Escuela Med, Carretera Veracruz Medellin S-N,Col Puente Moreno, Boca Del Rio 94271, Veracruz, Mexico.
C3 Instituto Politecnico Nacional - Mexico; Universidad Veracruzana
RP Lagunez-Rivera, L (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Invest Desarrollo Integral, Lab Extracc & Anal Prod Nat Vegetales, Hornos 1003 Santa Cruz Xoxocotlan, Oaxaca 71230, Oaxaca, Mexico.
EM gabybarraganzarate@hotmail.com; aalexander_2000@yahoo.com; llagunez@ipn.mx; solanogo@yahoo.com.mx; isoto@uv.mx
FU CONACYT (Consejo Nacional de Ciencia y Tecnologia) [270428]; Instituto Politecnico Nacional (IPN) [SIP20161270, SIP-2016RE/50, SIP-20170263, SIP-20180451, SIP20180382]
CR Ajmal Masihur Rehman, 2014, INDIAN HEART J, V66, P574, DOI 10.1016/j.ihj.2014.08.006
   Alexander-Aguilera A, 2011, J PHYSIOL BIOCHEM, V67, P595, DOI 10.1007/s13105-011-0106-2
   Anh√™ FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142
   Unknown -, 2016, J CIM, V0, P0
   Ballak DB, 2015, CYTOKINE, V75, P280, DOI 10.1016/j.cyto.2015.05.005
   Calle MC, 2012, DIABETES METAB, V38, P183, DOI 10.1016/j.diabet.2011.11.006
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z
   Garcia GC, 2014, REV BRAS FARMACOGN, V24, P153
   El-Shiekh RA, 2019, J ETHNOPHARMACOL, V238, P0, DOI 10.1016/j.jep.2019.111893
   Fuentes E, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0090699
   Gallagher EJ, 2011, MED CLIN N AM, V95, P855, DOI 10.1016/j.mcna.2011.06.001
   Ghadge AA, 2018, CYTOKINE GROWTH F R, V39, P151, DOI 10.1016/j.cytogfr.2018.01.004
   Ghorbani A, 2017, BIOMED PHARMACOTHER, V96, P305, DOI 10.1016/j.biopha.2017.10.001
   Gupta R, 2012, J DIABETES, V4, P248, DOI 10.1111/j.1753-0407.2012.00187.x
   Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4
   Jang SA, 2017, BIOMED PHARMACOTHER, V96, P563, DOI 10.1016/j.biopha.2017.10.021
   Jang YS, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21020226
   Joo N-S, 2017, MATURITAS, V0, PP184, DOI 10.1016/j.maturitas.2017.03.220
   Kahl KG, 2017, PROG NEURO-PSYCHOPH, V72, P30, DOI 10.1016/j.pnpbp.2016.08.005
   Kim M, 2015, NEUROCHEM RES, V40, P1792, DOI 10.1007/s11064-015-1659-1
   Kulabas SS, 2018, J ETHNOPHARMACOL, V223, P88, DOI 10.1016/j.jep.2018.04.043
   Kumar GK, 2011, EUR J PHARMACOL, V662, P63, DOI 10.1016/j.ejphar.2011.04.037
   Louis JM, 2020, CYTOKINE, V125, P0, DOI 10.1016/j.cyto.2019.154815
   Villase√±or JL, 2016, REV MEX BIODIVERS, V87, P559, DOI 10.1016/j.rmb.2016.06.017
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McCracken E, 2018, CLIN DERMATOL, V36, P14, DOI 10.1016/j.clindermatol.2017.09.004
   Mich√°likov√° D, 2019, SAUDI PHARM J, V27, P1196, DOI 10.1016/j.jsps.2019.10.002
   Mirhafez SR, 2016, EUR J CLIN NUTR, V70, P1298, DOI 10.1038/ejcn.2016.111
   Naik SR, 2013, PHYTOMEDICINE, V20, P797, DOI 10.1016/j.phymed.2013.03.003
   Nakamura Y, 2004, HEART, V90, P528, DOI 10.1136/hrt.2003.011114
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3
   Park SY, 2018, ENVIRON TOXICOL PHAR, V62, P1, DOI 10.1016/j.etap.2018.06.001
   Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730
   Prasad S, 2012, PREV MED, V54, PS29, DOI 10.1016/j.ypmed.2011.11.011
   Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251
   Rojas-Olivos A, 2017, ALEX J MED, V53, P311, DOI 10.1016/j.ajme.2016.11.004
   Saklayen MG, 2018, CURR HYPERTENS REP, V20, P0, DOI 10.1007/s11906-018-0812-z
   Shah RV, 2017, JACC-CARDIOVASC IMAG, V10, P1016, DOI 10.1016/j.jcmg.2016.10.024
   Solano R, 2020, DATA BASE SNIB-CONABIO, V0, Project KT005
   Barrag√°n-Zarate GS, 2020, J ETHNOPHARMACOL, V253, P0, DOI 10.1016/j.jep.2020.112632
   Srikanthan K, 2016, INT J MED SCI, V13, P25, DOI 10.7150/ijms.13800
   Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676
   Tschritter O, 2003, DIABETES, V52, P239, DOI 10.2337/diabetes.52.2.239
   Voils SA, 2014, DIABETES METAB SYND, V8, P88, DOI 10.1016/j.dsx.2014.04.021
   Wang SW, 2012, NEUROTOXICOLOGY, V33, P482, DOI 10.1016/j.neuro.2012.03.003
   Yeh CH, 2014, FREE RADICAL BIO MED, V69, P249, DOI 10.1016/j.freeradbiomed.2014.01.028
   Yoon K, 2018, DIABETES METAB SYND, V12, P977, DOI 10.1016/j.dsx.2018.06.008
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
   Zheng JP, 2020, J ETHNOPHARMACOL, V246, P0, DOI 10.1016/j.jep.2019.112225
NR 53
TC 8
Z9 8
U1 1
U2 23
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD OCT 28
PY 2021
VL 279
IS 
BP 
EP 
DI 10.1016/j.jep.2021.114376
EA JUL 2021
PG 10
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine
GA UA4FL
UT WOS:000685116600004
PM 34181956
DA 2025-04-28
ER

PT J
AU Redondo-Puente, M
   Mateos, R
   Seguido, MA
   Garc√≠a-Cordero, J
   Gonz√°lez, S
   Tarradas, RM
   Bravo-Clemente, L
   Sarri√°, B
AF Redondo-Puente, Monica
   Mateos, Raquel
   Seguido, Miguel A.
   Garcia-Cordero, Joaquin
   Gonzalez, Susana
   Tarradas, Rosa M.
   Bravo-Clemente, Laura
   Sarria, Beatriz
TI Appetite and Satiety Effects of the Acute and Regular Consumption of Green Coffee Phenols and Green Coffee Phenol/Oat Œ≤-Glucan Nutraceuticals in Subjects with Overweight and Obesity
SO FOODS
LA English
DT Article
DE green coffee; beta-glucan; nutraceutical; polyphenols; satiety; ghrelin; leptin; overweight
ID chlorogenic acid; dietary fiber; body-weight; metabolic syndrome; food-intake; tea; supplementation; increases; viscosity; responses
AB Green coffee has weight management properties, yet its effects on appetite and satiety remain unclear as few, mainly acute, studies perform objective measurements. Therefore, the influence on appetite/satiety of acute and regular consumption of two nutraceuticals, a decaffeinated green coffee phenolic extract (GC) alone or combined with oat beta-glucans (GC/BG), with known satiating properties, has been analysed subjectively using visual analog scales (VAS) and objectively measuring actual food intake and postprandial appetite and satiety hormones. A randomised, cross-over, blind trial was carried out in 29 overweight volunteers who consumed GC or GC/BG twice a day for 8 weeks. After acute (day = 0) and regular consumption (day = 56) of the nutraceuticals, satiety was measured at 30, 60, 90, 150, and 210 min, as well as food intake at breakfast (30 min) and lunch (300 min). Additionally, in a subgroup of participants (n = 9), cholecystokinin, peptide-YY, glucagon-like-peptide-1, ghrelin and leptin concentrations were analysed in blood samples taken at the same time-points. According to VAS results, GC/BG reduced hunger more efficiently than GC. However, there were no statistically significant differences in food intake. Comparing the effects of the acute consumption of GC/BG and GC, leptin concentration at 150 min was higher after GC/BG intake vs. GC. Moreover, when comparing the effects of regularly consuming the two nutraceuticals, maximum ghrelin level decreased with GC/BG vs. GC. In conclusion, acute and regular effects of the nutraceuticals on appetite/satiety differed, and subjective and objective results partially agreed; GC/BG may reduce hunger more efficiently than GC.
C1 [Redondo-Puente, Monica; Mateos, Raquel; Seguido, Miguel A.; Garcia-Cordero, Joaquin; Gonzalez, Susana; Tarradas, Rosa M.; Bravo-Clemente, Laura; Sarria, Beatriz] CSIC, Dept Metab & Nutr, Inst Food Sci Technol & Nutr ICTAN CSIC, Jose Antonio Novais 10, Madrid 28040, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN)
RP Sarri√°, B (corresponding author), CSIC, Dept Metab & Nutr, Inst Food Sci Technol & Nutr ICTAN CSIC, Jose Antonio Novais 10, Madrid 28040, Spain.
EM m.redondo@ictan.csic.es; raquel.mateos@ictan.csic.es; m.seguido@ictan.csic.es; yoaquin1995@gmail.com; s.gonzalez@ictan.csic.es; rosa.tarradas.valero@gmail.com; lbravo@ictan.csic.es; beasarria@ictan.csic.es
FU panish Ministry of Economy and Competitivity [AGL2015-69986-R]; Ministry of Science, Innovation and Universities [PEJ2018-001982-A]; Comunidad de Madrid;  [PEJD-2017-PRE_BIO-4225]
CR Anini Y, 2003, DIABETES, V52, P252, DOI 10.2337/diabetes.52.2.252
   Asbaghi O, 2020, COMPLEMENT THER MED, V51, P0, DOI 10.1016/j.ctim.2020.102424
   Barber TM, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12103209
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Beck EJ, 2009, NUTR RES, V29, P705, DOI 10.1016/j.nutres.2009.09.012
   Bergmann NC, 2019, DIABETOLOGIA, V62, P665, DOI 10.1007/s00125-018-4810-0
   Boix-Castej√≥n M, 2018, FOOD FUNCT, V9, P3173, DOI 10.1039/C8FO00367J
   Capomolla AS, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11061271
   Chaudhri OB, 2008, ANNU REV PHYSIOL, V70, P239, DOI 10.1146/annurev.physiol.70.113006.100506
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Crespo Mayte Alvarez, 2009, ENDOCRINOL NUTR, V56, P317, DOI 10.1016/S1575-0922(09)71946-1
   Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908
   Dikeman CL, 2006, CRIT REV FOOD SCI, V46, P649, DOI 10.1080/10408390500511862
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   G√≥mez-Juaristi M, 2018, FOOD CHEM, V240, P1028, DOI 10.1016/j.foodchem.2017.08.003
   Greenberg JA, 2012, J AM COLL NUTR, V31, P160, DOI 10.1080/07315724.2012.10720023
   Hassanzadeh-Rostami Z, 2021, EXP CLIN ENDOCR DIAB, V129, P322, DOI 10.1055/a-0998-3883
   Hussein GME, 2011, BIOL PHARM BULL, V34, P1849, DOI 10.1248/bpb.34.1849
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Juvonen KR, 2009, J NUTR, V139, P461, DOI 10.3945/jn.108.099945
   Kristensen M, 2011, APPETITE, V56, P65, DOI 10.1016/j.appet.2010.11.147
   McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037
   M√©ndez-del Villar M, 2014, METAB SYNDR RELAT D, V12, P497, DOI 10.1089/met.2014.0082
   M√ºller M, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10030275
   Olthof MR, 2011, NUTR METAB, V8, P0, DOI 10.1186/1743-7075-8-10
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Panickar KS, 2013, MOL NUTR FOOD RES, V57, P34, DOI 10.1002/mnfr.201200431
   Rebello CJ, 2016, NUTR REV, V74, P131, DOI 10.1093/nutrit/nuv063
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Sarri√° B, 2020, FOODS, V9, P0, DOI 10.3390/foods9091191
   Stuby J, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11092238
   Timper K, 2017, DIS MODEL MECH, V10, P679, DOI 10.1242/dmm.026609
   Ueno H, 2008, REGUL PEPTIDES, V145, P12, DOI 10.1016/j.regpep.2007.09.011
   Vitaglione P, 2009, APPETITE, V53, P338, DOI 10.1016/j.appet.2009.07.013
   Wanders AJ, 2011, OBES REV, V12, P724, DOI 10.1111/j.1467-789X.2011.00895.x
   Weickert MO, 2006, BRIT J NUTR, V96, P795, DOI 10.1017/BJN20061902
   Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992
   Yuliana ND, 2011, OBES REV, V12, P499, DOI 10.1111/j.1467-789X.2010.00790.x
   Zaremba SMM, 2018, APPETITE, V128, P197, DOI 10.1016/j.appet.2018.06.019
NR 41
TC 12
Z9 12
U1 0
U2 17
PU MDPI
PI BASEL
PA MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND
SN 
EI 2304-8158
J9 FOODS
JI Foods
PD NOV 15
PY 2021
VL 10
IS 11
BP 
EP 
DI 10.3390/foods10112511
PG 15
WC Food Science & Technology
SC Food Science & Technology
GA XL2TP
UT WOS:000728002000001
PM 34828792
DA 2025-04-28
ER

PT J
AU Antunes, ABS
   Cunha, DB
   Baltar, VT
   Steluti, J
   Pereira, RA
   Yokoo, EM
   Sichieri, R
   Marchioni, DM
AF Souza Antunes, Anna Beatriz
   Cunha, Diana Barbosa
   Baltar, Valeria Troncoso
   Steluti, Josiane
   Pereira, Rosangela Alves
   Yokoo, Edna Massae
   Sichieri, Rosely
   Marchioni, Dirce Maria
TI Dietary patterns of Brazilian adults in 2008-2009 and 2017-2018
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Adult; Feeding Behavior; Factor Analysis; Socioeconomic Factors; Diet Surveys
ID risk; associations; obesity; disease
AB OBJECTIVES: To identify dietary patterns among Brazilian adults based on the National Dietary Surveys (INA - Inqueritos Nacionais de Alimentacao) in 2008-2009 and 2017-2018, and to verify in the second period the adherence to the patterns according to sociodemographic factors and Brazilian regions. METHODS: We analyzed the first of two days of adults' food consumption (19-59 years) in INA data from 2008-2009 (n = 21,630) and 2017-2018 (n = 28,901). Dietary patterns were derived by exploratory factor analysis from 19 food groups, considering the complexity of the sample design. We evaluated the factor scores according to sex, age group, region, per capita income, and education for the INA data in 2017-2018. RESULTS: We identified three patterns in the two surveys: (1) "traditional", characterized by rice, beans, and meat; (2) "breads and butter/margarine", characterized by breads, oils, and fats (including margarine/butter) and, coffee and teas in 2008-2009; and (3) "western", characterized by sodas, pizzas, snacks, flour, pasta, and sweets in 2017-2018. The "traditional" pattern had greater adherence among men, residents of the Midwest region and individuals with incomplete primary education. "Bread and butter/margarine" pattern had greater adherence among males, individuals aged between 40 and 59 years, from the Southeast region, and with income between 1 and 2 minimum wages per capita. Male individuals, aged between 19 and 39 years, from the South region, with per capita income greater than two minimum wages, and education level equal to or greater than primary education showed greater adherence to the "western" pattern. CONCLUSION: The dietary patterns identified in 2008-2009 and 2017-2018 were similar, and we observed the maintenance of the "traditional" pattern, which includes rice, beans, and meat. Adherence to the dietary patterns varies according to sex, age group, region, per capita income, and education level.
C1 [Souza Antunes, Anna Beatriz] Univ Estado Rio de Janeiro, Inst Med Social, Programa Posgrad Saude Colet, Rio De Janeiro, RJ, Brazil.
   [Cunha, Diana Barbosa; Sichieri, Rosely] Univ Estado Rio de Janeiro, Inst Med Social, Dept Epidemiol, Rio De Janeiro, RJ, Brazil.
   [Baltar, Valeria Troncoso; Yokoo, Edna Massae] Univ Fed Fluminense, Inst Saude Colet, Dept Epidemiol & Bioestat, Niteroi, RJ, Brazil.
   [Steluti, Josiane] Univ Fed Sao Paulo, Inst Saude & Soc, Dept Polit Publ & Saude Colet, Santos, SP, Brazil.
   [Pereira, Rosangela Alves] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Dept Nutr Social & Aplicada, Rio De Janeiro, RJ, Brazil.
   [Marchioni, Dirce Maria] Univ Sao Paulo, Fac Saude Publ, Dept Nutr, Sao Paulo, SP, Brazil.
C3 Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal Fluminense; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo
RP Antunes, ABS (corresponding author), Univ Estado Rio de Janeiro, Inst Med Social, Rua Sao Francisco Xavier,524,7 Andar,Bloco E, BR-20550900 Rio De Janeiro, RJ, Brazil.
EM antunes.abnutri@gmail.com
FU Conselho Nacional Cientifico e Tecnologico (CNPq) [443369/2016-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) [001]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ -CNE/2015)
CR Unknown -, 2007, APPLIED MULTIVARIATE STATISTICAL ANALYSIS, V0, P0
   Baltar VT, 2018, CAD SAUDE PUBLICA, V34, P0, DOI 10.1590/0102-311x00111917
   Martins APB, 2013, REV SAUDE PUBL, V47, P656, DOI 10.1590/S0034-8910.2013047004968
   Cardoso LD, 2016, CAD SAUDE PUBLICA, V32, P0, DOI 10.1590/0102-311X00066215
   Conway JM, 2003, AM J CLIN NUTR, V77, P1171, DOI 10.1093/ajcn/77.5.1171
   Cunha DB, 2010, BRIT J NUTR, V104, P908, DOI 10.1017/S0007114510001479
   de Carvalho AM, 2016, BRIT J NUTR, V115, P2011, DOI 10.1017/S0007114516000969
   Selem SSD, 2014, J ACAD NUTR DIET, V114, P1216, DOI 10.1016/j.jand.2014.01.007
   Vilela AAF, 2014, CAD SAUDE PUBLICA, V30, P502, DOI 10.1590/0102-311X00167512
   Instituto Brasileiro de Geografia e Estatistica, 2011, DIR PESQ COORD TRAB, V0, P0
   Instituto Brasileiro de Geografia e Estatistica, 2020, DIR PESQ COORD TRAB, V0, P0
   Jaime PC, 2015, EPIDEMIOL SERV SAUDE, V24, P267, DOI 10.5123/S1679-49742015000200009
   Kerver JM, 2003, AM J CLIN NUTR, V78, P1103, DOI 10.1093/ajcn/78.6.1103
   Levy RB, 2012, REV SAUDE PUBL, V46, P6, DOI 10.1590/S0034-89102011005000088
   Arruda SPM, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-654
   Massarani FA, 2015, CAD SAUDE PUBLICA, V31, P2535, DOI 10.1590/0102-311X00090314
   McEvoy CT, 2014, J ACAD NUTR DIET, V114, P1759, DOI 10.1016/j.jand.2014.05.001
   Medina Lhais de Paula Barbosa, 2019, REV. BRAS. EPIDEMIOL., V22, PE190011.SUPL.2, DOI 10.1590/1980-549720190011.supl.2
   Medina-Rem√≥n A, 2018, CRIT REV FOOD SCI, V58, P262, DOI 10.1080/10408398.2016.1158690
   Michels KB, 2005, NUTR RES REV, V18, P241, DOI 10.1079/NRR2005107
   Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287
   Rezagholizadeh F, 2017, NUTR RES, V41, P1, DOI 10.1016/j.nutres.2017.01.006
   Romeiro Ariane Cristina Thoaldo, 2020, REV. BRAS. EPIDEMIOL., V23, Pe200090, DOI 10.1590/1980-549720200090
   Santos Iolanda Karla Santana dos, 2020, REV. BRAS. EPIDEMIOL., V23, Pe200035, DOI 10.1590/1980-549720200035
   Santos RD, 2015, BRIT J NUTR, V114, P822, DOI 10.1017/S0007114515002445
   Satija A, 2018, TRENDS CARDIOVAS MED, V28, P437, DOI 10.1016/j.tcm.2018.02.004
   Sichieri R, 2002, OBES RES, V10, P42, DOI 10.1038/oby.2002.6
   Souza AD, 2013, REV SAUDE PUBL, V47, PS190, DOI 10.1590/S0034-89102013000700005
   Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4
NR 29
TC 18
Z9 18
U1 1
U2 3
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO, BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD JUN 15
PY 2021
VL 55
IS 
BP 
EP 
DI 10.11606/s1518-8787.2021055003437
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA XI8UA
UT WOS:000726378000004
PM 34852165
DA 2025-04-28
ER

PT J
AU Li, DZ
   Jia, Y
   Yu, J
   Liu, Y
   Li, FH
   Liu, YM
   Wu, QQ
   Liao, XY
   Zeng, Z
   Wan, Z
   Zeng, R
AF Li, Dongze
   Jia, Yu
   Yu, Jing
   Liu, Yi
   Li, Fanghui
   Liu, Yanmei
   Wu, Qinqin
   Liao, Xiaoyang
   Zeng, Zhi
   Wan, Zhi
   Zeng, Rui
TI Adherence to a Healthy Lifestyle and the Risk of All-Cause Mortality and Cardiovascular Events in Individuals With Diabetes: The ARIC Study
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE diabetes; healthy lifestyle; mortality; cardiovascular events and mortality; cohort study
ID body-mass index; atherosclerosis risk; physical-activity; follow-up; metaanalysis; mellitus; disease; adults; association; obesity
AB Objective: The relationship between combined healthy lifestyle and cardiovascular (CV) events in diabetes is unclear. We aim to investigate the association between a healthy lifestyle score (HLS) and the risk of mortality and CV events in diabetes. Methods: We examined the associations of six lifestyle factors scores (including healthy diet, moderate alcohol and regular coffee intakes, never smoking, physical activity, and normal weight) with diabetes in the Atherosclerosis Risk in Communities (ARIC) study of 3,804 participants with diabetes from the United States at baseline. Primary outcomes included all-cause mortality, CV mortality, and composite CV events (heart failure hospitalizations, myocardial infarction, fatal coronary heart disease, and stroke). Results: Among these diabetic participants, 1,881 (49.4%), 683 (18.0%), and 1,600 (42.0%) cases of all-cause mortality, CV mortality, and CV events were documented, respectively, during the 26 years of follow-up. Further, the prevalence of these adverse events became lower with the increase of HLS (all P < 0.001). In the risk-factors adjusted Cox regression model, compared to participants with HLS of 0, participants with HLS of 2 had significant lower risk of all-cause mortality (HR = 0.811, 95% CI: 0.687-0.957, P = 0.013), CV mortality (HR = 0.744, 95% CI: 0.576-0.962, P = 0.024), and CV events (HR = 0.789, 95% CI: 0.661-0.943, P = 0.009). The association of HLS with CV events was stronger for women than men (P for interaction <0.05). Conclusion: Adherence to a healthy lifestyle was associated with a lower risk of CV events and mortality in diabetics. Our findings suggest that the promotion of a healthy lifestyle would help reduce the increasing healthcare burden of diabetes.
C1 [Li, Dongze; Jia, Yu; Liu, Yi; Zeng, Zhi; Wan, Zhi; Zeng, Rui] Sichuan Univ, West China Hosp, Dept Emergency Med, Chengdu, Peoples R China.
   [Li, Dongze; Jia, Yu; Liu, Yi; Zeng, Zhi; Wan, Zhi; Zeng, Rui] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Res Lab Emergency Med,Disaster Med, Chengdu, Peoples R China.
   [Yu, Jing] Sichuan Univ, West China Sch Nursing, West China Hosp, Chengdu, Peoples R China.
   [Li, Fanghui; Zeng, Rui] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu, Peoples R China.
   [Liu, Yanmei] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu, Peoples R China.
   [Wu, Qinqin] Sichuan Univ, West China Hosp, Hlth Management Ctr, Chengdu, Peoples R China.
   [Liao, Xiaoyang] Sichuan Univ, West China Hosp, Dept Gen Practice, Chengdu, Peoples R China.
   [Liao, Xiaoyang] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Chengdu, Peoples R China.
C3 Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University
RP Zeng, R (corresponding author), Sichuan Univ, West China Hosp, Dept Emergency Med, Chengdu, Peoples R China.; Zeng, R (corresponding author), Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Res Lab Emergency Med,Disaster Med, Chengdu, Peoples R China.; Zeng, R (corresponding author), Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu, Peoples R China.
EM zengrui_0524@126.com
FU Sichuan Science and Technology Program [2020YFS0154, 2020YFSY0014]; Sichuan University West China Hospital [2018HXFH001, 2018HXFH027, 2020HXFH050]; Sichuan University West China Nursing Discipline Development Special Fund Project [HXHL20046, HXHL19023]; Chengdu Science and Technology Bureau [2019-YF05-00322-SN]; National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University [Z20191009]
CR Arnett DK, 2019, CIRCULATION, V140, PE596, DOI 10.1161/CIR.0000000000000677
   Barazzoni R, 2018, EAT WEIGHT DISORD-ST, V23, P149, DOI 10.1007/s40519-018-0481-6
   Barba C, 2004, LANCET, V363, P157, DOI 10.1016/s0140-6736(03)15268-3
   Becerra-Tomas N, 2020, CRIT REV FOOD SCI, V60, P1207, DOI 10.1080/10408398.2019.1565281
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282
   Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062
   Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222
   Chomistek AK, 2015, J AM COLL CARDIOL, V65, P43, DOI 10.1016/j.jacc.2014.10.024
   Cosentino F, 2020, EUR HEART J, V41, P255, DOI 10.1093/eurheartj/ehz486
   Costanzo P, 2015, ANN INTERN MED, V162, P610, DOI 10.7326/M14-1551
   da Silva RC, 2016, ARQ BRAS CARDIOL, V107, P10, DOI 10.5935/abc.20160091
   Das SR, 2020, J AM COLL CARDIOL, V76, P1117, DOI 10.1016/j.jacc.2020.05.037
   Eckel RH, 2014, J AM COLL CARDIOL, V63, P2960, DOI 10.1016/j.jacc.2013.11.003
   Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905
   Haj Mouhamed D, 2016, ANN CARDIOL ANGEIOL (PARIS), V65, P21, DOI 10.1016/j.ancard.2014.12.001
   Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492
   Hu G, 2005, DIABETES CARE, V28, P799, DOI 10.2337/diacare.28.4.799
   Hussain A, 2021, J AM COLL CARDIOL, V77, P559, DOI 10.1016/j.jacc.2020.11.063
   Jacobs S, 2017, BRIT J NUTR, V118, P312, DOI 10.1017/S0007114517002033
   Komorita Y, 2020, BMJ OPEN DIAB RES CA, V8, P0, DOI 10.1136/bmjdrc-2020-001252
   Li YP, 2020, BMJ-BRIT MED J, V368, P0, DOI 10.1136/bmj.l6669
   Li YP, 2018, CIRCULATION, V138, P345, DOI 10.1161/CIRCULATIONAHA.117.032047
   Lin CC, 2012, DIABETES CARE, V35, P105, DOI 10.2337/dc11-0930
   Loef M, 2012, PREV MED, V55, P163, DOI 10.1016/j.ypmed.2012.06.017
   Long GH, 2014, DIABETES CARE, V37, P1712, DOI 10.2337/dc13-1731
   Lv J, 2017, INT J EPIDEMIOL, V46, P1410, DOI 10.1093/ije/dyx074
   Lv J, 2017, J AM COLL CARDIOL, V69, P1116, DOI 10.1016/j.jacc.2016.11.076
   Morse SA, 2010, CURR HYPERTENS REP, V12, P120, DOI 10.1007/s11906-010-0099-1
   Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21
   Napoli R, 2020, NUTR METAB CARDIOVAS, V30, P1926, DOI 10.1016/j.numecd.2020.07.012
   N√∂thlings U, 2010, J DIABETES, V2, P112, DOI 10.1111/j.1753-0407.2010.00069.x
   Nyberg ST, 2018, LANCET PUBLIC HEALTH, V3, PE490, DOI 10.1016/S2468-2667(18)30139-7
   ODoherty MG, 2016, EUR J EPIDEMIOL, V31, P455, DOI 10.1007/s10654-015-0112-8
   OKeefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Pan A, 2015, CIRCULATION, V132, P1795, DOI 10.1161/CIRCULATIONAHA.115.017926
   Patel YR, 2018, CLIN NUTR, V37, P139, DOI 10.1016/j.clnu.2016.11.003
   Paterson AD, 2007, DIABETES CARE, V30, P2107, DOI 10.2337/dc06-1441
   Petersen M, 2003, DIABETES CARE, V26, P917
   Polsky S, 2017, CURR DIABETES REP, V17, P0, DOI 10.1007/s11892-017-0950-8
   RICHARDSON MT, 1995, INT J EPIDEMIOL, V24, P685, DOI 10.1093/ije/24.4.685
   Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523
   Loureiro LMR, 2018, INT J SPORT NUTR EXE, V28, P284, DOI 10.1123/ijsnem.2017-0342
   Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736
   Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/s0140-6736(10)60484-9
   SASAKI A, 1989, DIABETES RES CLIN PR, V7, P33, DOI 10.1016/0168-8227(89)90042-9
   Schrieks IC, 2015, DIABETES CARE, V38, P723, DOI 10.2337/dc14-1556
   Stenholm S, 2016, INT J EPIDEMIOL, V45, P1260, DOI 10.1093/ije/dyw126
   Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039
   van Dam RM, 2008, BMJ-BRIT MED J, V337, P0, DOI 10.1136/bmj.a1440
   Vetter C, 2019, NAT REV ENDOCRINOL, V15, P194, DOI 10.1038/s41574-019-0164-z
   WHO Guidelines Approved by the Guidelines Review Committee, 2020, WHO GUID PHYS ACT SE, V0, P0
   WILLETT W, 1983, AM HEART J, V105, P417, DOI 10.1016/0002-8703(83)90358-7
   WILLETT WC, 1987, J AM DIET ASSOC, V87, P43
   Zaccardi F, 2017, DIABETOLOGIA, V60, P240, DOI 10.1007/s00125-016-4162-6
   Zhang DD, 2017, METABOLISM, V75, P36, DOI 10.1016/j.metabol.2017.08.001
NR 56
TC 9
Z9 9
U1 0
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
EI 
J9 FRONT NUTR
JI Front. Nutr.
PD JUL 5
PY 2021
VL 8
IS 
BP 
EP 
DI 10.3389/fnut.2021.698608
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA TK6LL
UT WOS:000674267500001
PM 34291073
DA 2025-04-28
ER

PT J
AU Symonds, ME
   Pope, M
   Bloor, I
   Law, J
   Alagal, R
   Budge, H
AF Symonds, Michael E.
   Pope, Mark
   Bloor, Ian
   Law, James
   Alagal, Reham
   Budge, Helen
TI Adipose tissue growth and development:the modulating role of ambient temperature
SO JOURNAL OF ENDOCRINOLOGY
LA English
DT Review
DE adipose tissue; development; nutrition; lipid
ID brown fat; nonshivering thermogenesis; energy-metabolism; caffeine; thermoregulation; expression; micrornas; obesity; trpv1; homeostasis
AB Adipose tissue is usually laid down in small amounts in the foetus and is characterised as possessing small amounts of the brown adipose tissue-specific mitochondrial uncoupling protein (UCP)1. In adults, a primary factor determining the abundance and function of UCP1 is ambient temperature. Cold exposure causes activation and the rapid generation of heat through the free flow of protons across the mitochondria with no requirement to convert ADP to ATP. In rodents, housing at an ambient temperature below thermoneutrality promotes the appearance of beige like adipocytes. These arise as discrete regions of UCP1 containing cells in white fat depots. There is increasing evidence to show that to gain credible translational results on brown and beige fat function in rodent models that they should be housed at thermoneutrality. This not only reflects the type of environment in which humans spend a majority of their time, but is in accord with the rise of global temperature caused by industrialisation and the uncontrolled burning of fossil fuels. There is now good evidence in adult humans, that stimulating brown fat can improve glucose homeostasis which can be achieved either by nutritional or pharmacological interventions. The challenge, therefore, is to establish credible developmental models in animals maintained at thermoneutrality which will elucidate the true impact of nutrition. The primary focus should fall specifically on the components of breast milk and how these modulate long term effects on brown or beige fat development and function.
C1 [Symonds, Michael E.; Pope, Mark; Bloor, Ian; Law, James; Budge, Helen] Univ Nottingham, Div Child Hlth Obstet & Gynaecol, Early Life Res Unit, Nottingham, England.
   [Symonds, Michael E.] Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham, England.
   [Symonds, Michael E.] Univ Nottingham, Biomed Res Ctr, Sch Med, Nottingham, England.
   [Alagal, Reham] Princess Nourah Bint AbdulRahman Univ, Dept Phys Sport Sci, Riyadh, Saudi Arabia.
C3 University of Nottingham; University of Nottingham; University of Nottingham; Princess Nourah bint Abdulrahman University
RP Symonds, ME (corresponding author), Univ Nottingham, Div Child Hlth Obstet & Gynaecol, Early Life Res Unit, Nottingham, England.; Symonds, ME (corresponding author), Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham, England.; Symonds, ME (corresponding author), Univ Nottingham, Biomed Res Ctr, Sch Med, Nottingham, England.
EM michael.Symonds@nottingham.ac.uk
FU Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University through the Fast-track Research Funding Program
CR Albustanji L, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00209
   Arany Z, 2019, NEW ENGL J MED, V381, P2270, DOI 10.1056/NEJMcibr1911353
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Barreca A, 2020, NAT CLIM CHANGE, V10, P77, DOI 10.1038/s41558-019-0632-4
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, PE671, DOI 10.1152/ajpendo.1995.269.4.E671
   BUKOWIECKI LJ, 1983, AM J PHYSIOL, V244, PR500, DOI 10.1152/ajpregu.1983.244.4.R500
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Cannon B, 2020, EXP PHYSIOL, V105, P1191, DOI 10.1113/EP087875
   Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989
   Clarke L, 1998, EXP PHYSIOL, V83, P651, DOI 10.1113/expphysiol.1998.sp004146
   Cypess AM, 2014, CELL METAB, V20, P408, DOI 10.1016/j.cmet.2014.07.025
   Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f
   Darr√© L, 2015, MOL PHARMACEUT, V12, P4454, DOI 10.1021/acs.molpharmaceut.5b00641
   de Jong JMA, 2019, NAT METAB, V1, P830, DOI 10.1038/s42255-019-0101-4
   Derbenev AV, 2016, SEMIN IMMUNOPATHOL, V38, P397, DOI 10.1007/s00281-015-0529-x
   Deshmukh AS, 2019, CELL METAB, V30, P963, DOI 10.1016/j.cmet.2019.10.001
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Fainberg HP, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-27376-3
   Finlin BS, 2020, J CLIN INVEST, V130, P2319, DOI 10.1172/JCI134892
   GIRALT M, 1990, EUR J BIOCHEM, V193, P297, DOI 10.1111/j.1432-1033.1990.tb19336.x
   Gliniak CM, 2019, J CLIN INVEST, V129, P2198, DOI 10.1172/JCI128830
   Ha M, 2008, BBA-GENE REGUL MECH, V1779, P735, DOI 10.1016/j.bbagrm.2008.03.004
   Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889
   Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001
   Icli B, 2017, CARDIOVASC RES, V113, P1024, DOI 10.1093/cvr/cvx098
   Jimenez-Pavon D, 2019, OBESITY, V27, P1932, DOI 10.1002/oby.22635
   Kahn CR, 2019, J CLIN INVEST, V129, P3990, DOI 10.1172/JCI129187
   Kalinovich AV, 2017, BIOCHIMIE, V134, P127, DOI 10.1016/j.biochi.2017.01.007
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843
   Law J, 2019, HANDB EXP PHARMACOL, V251, P259, DOI 10.1007/164_2018_137
   Law J, 2018, J NUCL MED, V59, P516, DOI 10.2967/jnumed.117.190546
   Law JM, 2019, J ENDOCR SOC, V3, P2411, DOI 10.1210/js.2019-00342
   Lichtenbelt WDV, 2011, AM J PHYSIOL-REG I, V301, PR285, DOI 10.1152/ajpregu.00652.2010
   Luo ZD, 2012, CELL RES, V22, P551, DOI 10.1038/cr.2011.205
   MELLOR DJ, 1986, Q J EXP PHYSIOL CMS, V71, P361, DOI 10.1113/expphysiol.1986.sp002995
   Merrick D, 2019, SCIENCE, V364, P353, DOI 10.1126/science.aav2501
   Mostyn A, 2002, FASEB J, V16, P1438, DOI 10.1096/fj.02-0077fje
   Nedergaard J, 1986, BROWN ADIPOSE TISSUE, V0, P152
   OMara AE, 2020, J CLIN INVEST, V130, P2209, DOI 10.1172/JCI131126
   Ojha S, 2016, JCI INSIGHT, V1, P0, DOI 10.1172/jci.insight.87460
   Okamatsu-Ogura Y, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-49754-1
   Protsiv M, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.49555
   Robinson L, 2014, J PEDIATR-US, V164, P318, DOI 10.1016/j.jpeds.2013.10.005
   Sacks H, 2013, DIABETES, V62, P1783, DOI 10.2337/db12-1430
   Scotney H, 2017, METABOLISM, V70, P125, DOI 10.1016/j.metabol.2017.01.024
   Seale P, 2009, DIABETES, V58, P1482, DOI 10.2337/db09-0622
   Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362
   Solomon CG, 2019, NEW ENGL J MED, V380, P209, DOI 10.1056/NEJMp1817067
   Song AY, 2020, J CLIN INVEST, V130, P247, DOI 10.1172/JCI129167
   Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8
   Symonds ME, 2012, DIABETOLOGIA, V55, P1597, DOI 10.1007/s00125-012-2505-5
   SYMONDS ME, 1992, P NUTR SOC, V51, P165, DOI 10.1079/PNS19920026
   SYMONDS ME, 1995, EXP PHYSIOL, V80, P907, DOI 10.1113/expphysiol.1995.sp003905
   Symonds ME, 2007, REPROD FERT DEVELOP, V19, P53, DOI 10.1071/RD06130
   Symonds Michael E, 2018, F1000RES, V7, P0, DOI 10.12688/f1000research.14585.1
   Symonds ME, 2018, J ENDOCRINOL, V238, PR53, DOI 10.1530/JOE-18-0084
   Symonds ME, 2015, ANNU REV NUTR, V35, P295, DOI 10.1146/annurev-nutr-071813-105330
   Symonds ME, 2013, SCIENTIFICA, V2013, P0, DOI 10.1155/2013/305763
   Symonds ME, 2012, J PEDIATR-US, V161, P892, DOI 10.1016/j.jpeds.2012.04.056
   Velickovic K, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-45540-1
   Velickovic K, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-23267-9
   Villarroya F, 2017, NAT REV ENDOCRINOL, V13, P26, DOI 10.1038/nrendo.2016.136
   Vosselman MJ, 2013, AM J CLIN NUTR, V98, P57, DOI 10.3945/ajcn.113.059022
   Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621
   Yu HD, 2019, J CLIN INVEST, V129, P2485, DOI 10.1172/JCI125646
NR 67
TC 6
Z9 7
U1 1
U2 11
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND
SN 0022-0795
EI 1479-6805
J9 J ENDOCRINOL
JI J. Endocrinol.
PD JAN 15
PY 2021
VL 248
IS 1
BP R19
EP R28
DI 10.1530/JOE-20-0075
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA PQ1QK
UT WOS:000606323100002
PM 33232264
DA 2025-04-28
ER

PT J
AU Quarta, S
   Scoditti, E
   Carluccio, MA
   Calabriso, N
   Santarpino, G
   Damiano, F
   Siculella, L
   Wabitsch, M
   Verri, T
   Favari, C
   Del Rio, D
   Mena, P
   De Caterina, R
   Massaro, M
AF Quarta, Stefano
   Scoditti, Egeria
   Carluccio, Maria Annunziata
   Calabriso, Nadia
   Santarpino, Giuseppe
   Damiano, Fabrizio
   Siculella, Luisa
   Wabitsch, Martin
   Verri, Tiziano
   Favari, Claudia
   Del Rio, Daniele
   Mena, Pedro
   De Caterina, Raffaele
   Massaro, Marika
TI Coffee Bioactive N-Methylpyridinium Attenuates Tumor Necrosis Factor (TNF)-Œ±-Mediated Insulin Resistance and Inflammation in Human Adipocytes
SO BIOMOLECULES
LA English
DT Article
DE coffee bioactives; N-methylpyridinium; adipocytes; inflammation; insulin resistance
ID proliferator-activated receptors; adipose triglyceride lipase; tnf-alpha; in-vitro; 3t3-l1 adipocytes; oxidative stress; terminal kinase; obesity; expression; tissue
AB Although coffee consumption has been historically associated with negative health outcomes, recent evidence suggests a lower risk of metabolic syndrome, obesity and diabetes among regular coffee drinkers. Among the plethora of minor organic compounds assessed as potential mediators of coffee health benefits, trigonelline and its pyrolysis product N-methylpyridinium (NMP) were preliminary shown to promote glucose uptake and exert anti-adipogenic properties. Against this background, we aimed at characterizing the effects of trigonelline and NMP in inflamed and dysfunctional human adipocytes. Human Simpson-Golabi-Behmel syndrome (SGBS) adipocytes were treated with NMP or, for comparison, trigonelline, for 5 h before stimulation with tumor necrosis factor (TNF)-alpha. NMP at concentrations as low as 1 mu mol/L reduced the stimulated expression of several pro-inflammatory mediators, including C-C Motif chemokine ligand (CCL)-2, C-X-C Motif chemokine ligand (CXCL)-10, and intercellular adhesion Molecule (ICAM)-1, but left the induction of prostaglandin G/H synthase (PTGS)2, interleukin (IL)-1 beta, and colony stimulating factor (CSF)1 unaffected. Furthermore, NMP restored the downregulated expression of adiponectin (ADIPOQ). These effects were functionally associated with downregulation of the adhesion of monocytes to inflamed adipocytes. Under the same conditions, NMP also reversed the TNF-alpha-mediated suppression of insulin-stimulated Ser473 Akt phosphorylation and attenuated the induction of TNF-alpha-stimulated lipolysis restoring cell fat content. In an attempt to preliminarily explore the underlying mechanisms of its action, we show that NMP restores the expression of the master regulator of adipocyte differentiation peroxisome proliferator-activated receptor (PPAR)gamma and downregulates activation of the pro-inflammatory mitogen-activated protein jun N-terminal kinase (JNK). In conclusion, NMP reduces adipose dysfunction in pro-inflammatory activated adipocytes. These data suggest that bioactive NMP in coffee may improve the inflammatory and dysmetabolic milieu associated with obesity.
C1 [Quarta, Stefano; Damiano, Fabrizio; Siculella, Luisa; Verri, Tiziano] Univ Salento, Dept Biol & Environm Sci & Technol DISTEBA, I-73100 Lecce, Italy.
   [Scoditti, Egeria; Carluccio, Maria Annunziata; Calabriso, Nadia; Massaro, Marika] Natl Res Council CNR, Inst Clin Physiol IFC, I-73100 Lecce, Italy.
   [Santarpino, Giuseppe] Paracelsus Med Univ, Cardiovasc Ctr, D-90471 Nurnberg, Germany.
   [Santarpino, Giuseppe] Citta di Lecce Hosp, GVM Care & Res, I-73100 Lecce, Italy.
   [Santarpino, Giuseppe] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Cardiac Surg Unit, I-88100 Catanzaro, Italy.
   [Wabitsch, Martin] Univ Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol Diabet & Obes, D-89075 Ulm, Germany.
   [Favari, Claudia; Del Rio, Daniele; Mena, Pedro] Univ Parma, Dept Food & Drugs, Human Nutr Unit, I-43125 Parma, Italy.
   [De Caterina, Raffaele] Pisa Univ Hosp, Cardiol Div, I-56126 Pisa, Italy.
   [De Caterina, Raffaele] Fdn Villa Serena Ric, I-65013 Pescara, Italy.
C3 University of Salento; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Magna Graecia University of Catanzaro; Ulm University; University of Parma; University of Pisa; Azienda Ospedaliero Universitaria Pisana
RP Massaro, M (corresponding author), Natl Res Council CNR, Inst Clin Physiol IFC, I-73100 Lecce, Italy.; De Caterina, R (corresponding author), Pisa Univ Hosp, Cardiol Div, I-56126 Pisa, Italy.; De Caterina, R (corresponding author), Fdn Villa Serena Ric, I-65013 Pescara, Italy.
EM stefano.quarta3@unisalento.it; egeria.scoditti@ifc.cnr.it; maria.carluccio@ifc.cnr.it; nadia.calabriso@ifc.cnr.it; gsantarpino@gymnet.it; fabrizio.damiano@unisalento.it; luisa.siculella@unisalento.it; Martin.Wabitsch@uniklinik-ulm.de; tiziano.verri@unisalento.it; daudia.favari@unipr.it; daniele.delrio@unipr.it; pedromiguel.menaparreno@unipr.it; raffaele.decaterina@unipi.it; marika.massaro@ifc.cnr.it
CR Allott EH, 2012, CLIN TRANSL ONCOL, V14, P774, DOI 10.1007/s12094-012-0863-6
   Baek JH, 2017, BMB REP, V50, P566, DOI 10.5483/BMBRep.2017.50.11.031
   Barbato DL, 2014, CELL DEATH DIFFER, V21, P113, DOI 10.1038/cdd.2013.137
   Barbato DL, 2014, MEDIAT INFLAMM, V2014, P0, DOI 10.1155/2014/917698
   Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018
   Bl√ºher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8
   Boden Guenther, 2006, CURR DIAB REP, V6, P177, DOI 10.1007/s11892-006-0031-x
   Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09
   Boettler U, 2011, J NUTR BIOCHEM, V22, P426, DOI 10.1016/j.jnutbio.2010.03.011
   Bozulic L, 2009, CURR OPIN CELL BIOL, V21, P256, DOI 10.1016/j.ceb.2009.02.002
   Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, PC1232, DOI 10.1152/ajpcell.00008.2006
   Bresciani L, 2020, MOL NUTR FOOD RES, V0, P0, DOI DOI 10.1002/mnfr.202000489
   Capurso C, 2012, VASC PHARMACOL, V57, P91, DOI 10.1016/j.vph.2012.05.003
   Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051
   Chac√≥n MR, 2007, OBESITY, V15, P664, DOI 10.1038/oby.2007.578
   Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8
   Curat CA, 2006, DIABETOLOGIA, V49, P744, DOI 10.1007/s00125-006-0173-z
   Czech MP, 2020, MOL METAB, V34, P27, DOI 10.1016/j.molmet.2019.12.014
   Dal Canto E, 2019, EUR J PREV CARDIOL, V26, P25, DOI 10.1177/2047487319878371
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Feng J, 2020, DIABET METAB SYND OB, V13, P1399, DOI 10.2147/DMSO.S236127
   Filip-Ciubotaru Florina, 2011, REV MED CHIR SOC MED NAT IASI, V115, P477
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Gao P, 2020, MED SCI MONITOR, V26, P0, DOI 10.12659/MSM.924334
   Good Manuela, 2006, DIAB VASC DIS RES, V3, P26, DOI 10.3132/dvdr.2006.003
   Grygiel-G√≥rniak B, 2014, NUTR J, V13, P0, DOI 10.1186/1475-2891-13-17
   Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439
   Hamden Khaled, 2013, SCI PHARM, V81, P233, DOI 10.3797/scipharm.1211-14
   Han CY, 2012, J BIOL CHEM, V287, P10379, DOI 10.1074/jbc.M111.304998
   HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Hurrle S, 2017, BIOMED J, V40, P257, DOI 10.1016/j.bj.2017.06.007
   Ishizuka K, 2007, ENDOCRINOLOGY, V148, P2994, DOI 10.1210/en.2006-1702
   Jeong Jun Hyun, 2015, J EXERC NUTRITION BIOCHEM, V19, P65, DOI 10.5717/jenb.2015.15060203
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Jin D, 2014, CYTOKINE, V69, P196, DOI 10.1016/j.cyto.2014.06.005
   Kain V, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15197
   Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, PE1736, DOI 10.1152/ajpendo.00122.2007
   Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, PE115, DOI 10.1152/ajpendo.00317.2005
   Kim K, 2005, BIOCHEM BIOPH RES CO, V327, P460, DOI 10.1016/j.bbrc.2004.12.026
   Kolb H, 2021, NUTRIENTS, V13, P0, DOI 10.3390/nu13041144
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Kumar Priti, 2018, COLD SPRING HARB PROTOC, V2018, P0, DOI 10.1101/pdb.prot095505
   Kurylowicz A, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25092224
   Lang R, 2013, ANAL BIOANAL CHEM, V405, P8487, DOI 10.1007/s00216-013-7288-0
   Lang R, 2010, ANAL CHEM, V82, P1486, DOI 10.1021/ac902616k
   Lee A, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11061274
   Lee MW, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8060854
   Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200
   Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012
   Li YY, 2019, EXP THER MED, V18, P1331, DOI 10.3892/etm.2019.7698
   Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132
   Massaro M, 2016, PHARMACOL RES, V107, P125, DOI 10.1016/j.phrs.2016.02.027
   Moreno-Viedma V, 2016, CARDIOVASC DIABETOL, V15, P0, DOI 10.1186/s12933-016-0441-2
   Nandipati KC, 2017, MOL CELL BIOCHEM, V426, P27, DOI 10.1007/s11010-016-2878-8
   Ng ACT, 2021, NAT REV CARDIOL, V18, P291, DOI 10.1038/s41569-020-00465-5
   Pillon NJ, 2021, CELL, V184, P1530, DOI 10.1016/j.cell.2021.02.012
   Polvani S, 2016, WORLD J GASTROENTERO, V22, P2441, DOI 10.3748/wjg.v22.i8.2441
   Rebollo-Hernanz M, 2019, ANTIOXIDANTS-BASEL, V8, P0, DOI 10.3390/antiox8080279
   Rebollo-Hernanz M, 2019, FOOD CHEM TOXICOL, V132, P0, DOI 10.1016/j.fct.2019.110672
   Riedel A, 2014, FOOD FUNCT, V5, P454, DOI 10.1039/c3fo60320b
   Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319
   Saeed M, 2019, CRIT REV FOOD SCI, V59, P3293, DOI 10.1080/10408398.2018.1489368
   Samoggia A, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11030653
   Schultze SM, 2012, EXPERT REV MOL MED, V14, P0, DOI 10.1017/S1462399411002109
   Semen S, 2017, FOOD CHEM, V215, P92, DOI 10.1016/j.foodchem.2016.07.176
   Shahinfar H, 2021, NUTR METAB CARDIOVAS, V31, P2526, DOI 10.1016/j.numecd.2021.05.014
   Shimobayashi M, 2018, J CLIN INVEST, V128, P1538, DOI 10.1172/JCI96139
   Silakari O, 2021, CONCEPTS AND EXPERIMENTAL PROTOCOLS OF MODELLING AND INFORMATICS IN DRUG DESIGN, V0, PP131, DOI 10.1016/B978-0-12-820546-4.00006-4
   Solinas G, 2017, MOL METAB, V6, P0, DOI 10.1016/j.molmet.2016.12.001
   Somoza V, 2003, J AGR FOOD CHEM, V51, P6861, DOI 10.1021/jf034750e
   Stadler RH, 2002, J AGR FOOD CHEM, V50, P1192, DOI 10.1021/jf011234k
   Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005
   Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13
   Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045
   Tzanavari T, 2010, CURR DIR AUTOIMMUN, V11, P145, DOI 10.1159/000289203
   Vasileva LV, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21249740
   Porto ACV, 2019, COFFEE: CONSUMPTION AND HEALTH IMPLICATIONS, V0, P432
   Wei F, 2015, COFFEE IN HEALTH AND DISEASE PREVENTION, V0, PP149, DOI 10.1016/B978-0-12-409517-5.00017-6
   Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229
NR 81
TC 12
Z9 12
U1 0
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2218-273X
J9 BIOMOLECULES
JI Biomolecules
PD OCT 15
PY 2021
VL 11
IS 10
BP 
EP 
DI 10.3390/biom11101545
PG 20
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA XI9RM
UT WOS:000726439000001
PM 34680177
DA 2025-04-28
ER

